Total Synthesis of (+)-Discodermolide by Catalytic Stereoselective Borylation Reactions by Yu, Zhiyong
Persistent link: http://hdl.handle.net/2345/bc-ir:103737
This work is posted on eScholarship@BC,
Boston College University Libraries.
Boston College Electronic Thesis or Dissertation, 2014
Copyright is held by the author. This work is licensed under a Creative Commons
Attribution 4.0 International License. http://creativecommons.org/licenses/by/4.0/
Total Synthesis of (+)-Discodermolide
by Catalytic Stereoselective Borylation
Reactions
Author: Zhiyong Yu
Boston College 
The Graduate School of Arts and Sciences 
Department of Chemistry 
 
TOTAL SYNTHESIS OF (+)-DISCODERMOLIDE  
BY  
CATALYTIC STEREOSELECTIVE BORYLATION REACTIONS 
 
a dissertation 
by 
ZHIYONG YU 
submitted in partial fulfillment of the requirements 
for the degree of 
Doctor of Philosophy 
 
Dec. 2014 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
©copyright by ZHIYONG YU 
2014 
 TOTAL SYNTHESIS OF (+)-DISCODERMOLIDE  
BY  
CATALYTIC STEREOSELECTIVE BORYLATION REACTIONS  
 
by  
ZHIYONG YU 
 
Dissertation Advisor: 
James P. Morken 
 
ABSTRACT: (+)-Discodermolide is a marine natural product and is one of the most 
potent microtubule stabilizers in human cell lines. Because of its unique linear structure 
and important properties, a number of total syntheses of (+)-discodermolide and its 
derivatives have been reported. Herein, an efficient, highly convergent, and 
stereocontrolled total synthesis is presented (Chapter 2). The synthesis relied on the 
development of three catalytic and stereoselective processes: platinum-catalyzed 
asymmetric diene diboration, nickel-catalyzed diastereoselective hydroboration of chiral 
dienes (Chapter 1), and nickel-catalyzed borylative diene-aldehyde coupling (see Chapter 
4). Combination of these reactions allows preparation of the target in a short sequence. 
Moreover, the development of rhodium-catalyzed asymmetric hydroformylation (Chapter 
3) makes this approach the first Roche ester free (+)-discodermolide synthesis.  
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Chapter 1 
Nickel-Catalyzed Diastereoselective 1,4-Hydroboration 
of Chiral 1,3-Dienols 
1.1 Introduction 
Polyketides are a class of secondary metabolites that often possess active 
bioactivity and useful pharmacological properties (selected examples shown in Figure 
1.1).
1
 One key characteristic of polyketides is the repeated presence of 1,3-oxygenation 
on the carbon backbone (highlighted in red in Figure 1.1), which is produced during the 
biosynthesis by decarboxylative condensation of malonic carboxylic acids followed by 
ketone reduction.
2
 This process installs two carbons at one time and is repeated until an 
appropriate chain length is reached (Figure 1.2a). In the development of non-enzymatic 
syntheses of polyketides, a similar two-carbon installation process is also achieved by 
asymmetric aldol reaction with high selectivity, efficacy, and predictability (Figure 
1.2b).
3
 
                                                     
1
 (a) Macrolide Antibiotics. Chemistry, Biology, and Practice, 2nd ed.; Omura, S., Ed.; Academic 
Press: New York, 2002. (b) Polyketides Biosynthesis, Biological Activity, and Genetic 
Engineering; Rimando, A. M., Baerson, S. R., Eds.; ACS Symposium Series 955; American 
Chemical Society: Washington, DC, 2007. (c) Newman, D. J.; Cragg, G. M. J. Nat. Prod. 2007, 
70, 461. (d) Newman,D. J.; Grothaus, P.G.; Cragg, G. M. Chem. Rev. 2009, 109, 3012. (e) 
O’Hagan, D. The Polyketide Metabolites; Ellis Horwood: Chichester,U.K., 1991. 
2
 For a review, see: J. Staunton, K. J. Weissman, Nat. Prod. Rep. 2001, 18, 380. 
3
 (a) Schetter, B.; Mahrwald, R. Angew. Chem. Int. Ed. 2006, 45, 7506. For the first synthesis of 
erythromycin A see: (b) Woodward, R. B.; Logusch, E.; Nambiar, K. P.; Sakan, K.; Ward, D. E. 
Au-Yeung, B. W.; Balaram, P.; Browne, L. J.; Card, P. J.; Chen, C. H. J. Am. Chem. Soc. 1981, 
103, 3215. For selected examples of related syntheses, see: (c) Martin, S. F.; Hida, T.; Kym, P. R.; 
Loft, M.; Hodgson, A. J. Am. Chem. Soc. 1997, 119, 3193. (d) Corey, E. J.; Kim, S.; Yoo, S.; 
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Figure 1.1. Selected Polyketide Natural Products 
 
 
Figure 1.2. Biosynthesis and Chemical Syntheses of Polyketides 
 
                                                                                                                                                              
Nicolaou, K. C.; Melvin, L. S.; Brunelle, D. J.; Falck, J. R.; Trybulski, E. J.; Lett, R.; Sheldrake, 
P. W. J. Am. Chem. Soc. 1978, 100, 4620. (e) Stork, G.; Rychnovsky, S. D. J. Am. Chem. Soc. 
1987, 109, 1565. (f) Myles, D. C.; Danishefsky, S. J. J. Org. Chem. 1990, 55, 1636. (g) Evans, D. 
A.; Kim, A. S.; Metternich, R.; Novack, V. J. J. Am. Chem. Soc. 1998, 120, 5921. (h) Stang, E. 
M.; White, M. C. Nat. Chem. 2009, 1, 547. (i) Chandra, B.; Fu, D.; Nelson, S. G. Angew. Chem. 
Int. Ed. 2010, 45, 2591. 
 3 
 
Although the aldol reaction has been widely used to construct β-hydoxy carbonyls 
for polyketide syntheses, a number of other useful methods have been developed as 
alternatives, such as allylation of carbonyls.
4
 Asymmetric allylation of carbonyls is one of 
the most efficient methods to provide diastereo- and enantiomerically enriched 
homoallylic alcohols. Importantly, the associated versatile olefin can be converted to 1,3-
dioxygenated motif that maps onto polyketide structures (Scheme 1.1).  
Scheme 1.1. Allylation as an Important Tool for Polyketide Syntheses 
 
 Although the existing methods construct polyketides efficiently, there still 
remains a great need to develop creative methods to rapidly build the polyketide moiety. 
This chapter will focus on the development of a novel Ni-catalyzed diastereoselective 
1,4-hydroboration of 1,3-dienols that delivers highly selective homoallylic alcohol 
derivatives for polyketide syntheses. 
1.2 Background 
1.2.1. Vinylogous Aldol Reactions for Polyketide Syntheses 
Despite the fact that decades of beautiful, powerful and profoundly influential 
chemistry have been devoted to the synthesis of polyketides, there still remains a great 
need to develop new methods to construct such structures “ideally”.5 For example, the 
                                                     
4
 For reviews, see: (a) Schinzer, D. Synthesis 1988, 263. (b) Fleming, I.; Dunogues, J.; Smithers, 
R. Org. React. 1989, 37, 57. (c) Hoffman, R. W. Pure Appl. Chem. 1988, 60, 123. For chiral allyl 
& allenyl silanes, see: (d) Masse, C. E.; Panek, J. S. Chem. Rev. 1995, 95, 1293. For 
enantioselective catalysis, see: (e) Yus, M.; González-Gómez, J. C.; Foubelo, F. Chem. Rev. 2011, 
111, 7774. 
5
 Gaich, T.; Baran, P. S. J. Org. Chem. 2010, 75, 4657. 
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aldol reaction plays a very important role in ketide syntheses (Section 1.1), but separate 
multi-step transformations are required when the molecule contains unsaturation next to 
the propionate as shown in discodermolide and migrastatin (Figure 1.1). The vinylogous 
aldol has been developed to address this issue, which uses treatment of an extended 
enolate 1.1 with an aldehyde to generate a product with an adjacent olefin moiety (1.2) 
(Scheme 1.2).  But, unfortunately, such vinylogous aldol reaction is only anti-selective 
and only highly enantioselective when aromatic aldehydes or α,β-unsaturated aldehydes 
are used.
6
 
Scheme 1.2. Catalytic Asymmetric Vinylogous Aldol Reactions 
 
1.2.2. Crotylation for Polyketide Syntheses and Preparation of Crotyl Metal 
Reagents 
The ketide unit with adjacent unsaturation can also be prepared by addition of a 
crotyl metal reagent to a prochiral aldehyde, and this reaction can be accomplished with 
excellent stereo- and enantioselectivity.
7
 For example, addition of a crotylboronate to an 
aldehyde furnishes syn- or anti-propionate motifs bearing adjacent olefin in one step 
(Scheme 1.3).  
                                                     
6
 (a) Denmark, S. E.; Heemstra Jr., J. R.; Beutner, G. L. Angew. Chem. Int. Ed. 2005, 44, 4682. (b) 
Brodmann, T.; Lorenz, M.; Schäckel, R.; Simsek, S.; Kalesse, M. Synlett. 2009, 174. 
7
 Reviews on catalytic asymmetric carbonyl allylation: (a) Denmark, S. E.; Fu, J. Chem. Rev. 
2003, 103, 2763. (b) Yanagisawa, A. In Comprehensive Asymmetric Catalysis, Supplement 
Jacobsen, E. N.; Pfaltz, A.; Yamamoto, H. Eds.; Springer-Verlag, Berlin, 2004, Vol. 2, 97. (c) For 
selected recent examples: (e) Jain, P.; Antilla, J. C. J. Am. Chem. Soc. 2010, 132, 11884. (f) 
Rauniyar, V.; Hall, D. G. Angew.Chem. Int. Ed. 2006, 45, 2426. (g) Wada, R.; Oisaki, K.; Kanai, 
M.; Shibasaki, M. J. Am. Chem. Soc. 2004, 126, 8910. (h) Lou, S.; Moquist, P. N.; Schaus, S. E. J. 
Am. Chem. Soc. 2006, 128, 12660. (i) Kim, I. S.; Han, S. B.;Krische, M. J. J. Am. Chem. Soc. 
2009, 131, 2514. (j) Kim, I. S.; Ngai, M.-Y.; Krische, M. J. J. Am. Chem. Soc. 2008, 130, 14891. 
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Scheme 1.3. Examples of Carbonyl Crotylation 
 
In addition to their relative non-toxicity,
8
 another major advantage of crotylboron 
reagents is that syn- or anti-selectivity of crotylation is completely controlled by the 
configuration of the reagent (Scheme 1.3).
7a
 However, preparation of configurationally 
defined substituted allylboron reagents still remains a challenging task. The first part of 
this introduction will primarily focus on the syntheses of stable allylboronic esters, which 
have been widely used in carbonyl crotylations. Allylboronic esters are usually prepared 
by (1) addition of a stereodefined allylmetal to an electrophilic boronic ester; (2) addition 
of a vinylmetal reagent to an α-chloroboronic ester; 9  (3) one carbon homologation of a 
vinylboronic ester;
10
 (4) metal catalyzed isomerization of vinylboronic ester;
11
 (5) cross 
metathesis of a terminal olefin with vinylboronic ester;
12
 (6) palladium catalyzed 
borylation of allyl electrophiles
13
 (Figure 1.3). 
                                                     
8
 (a) Hall, D. G. Boronic Acid-based Receptors and Sensors for Saccharides. In Boronic Acids; 
Hall, D. G., Ed.; Wiley-VCH:Weinheim, Germany, 2005; pp 441-475. (b) Yang, W.; Gao, X.; 
Wang, B. Biological and Medicinal Applications of Boronic Acids. In Boronic Acids; Hall, D. G., 
Ed.; Wiley-VCH:Weinheim, Germany, 2005; pp 481–512. 
9
 (a) Wuts, P. G. M.; Thompson, A. P.; Callen, G. R. J. Org. Chem. 1983, 48, 5398. (b) Hoffman, 
R. W.; Schlapbach, A. Tetrahedron 1992, 48, 1959. (c) Hoffman, R. W.; Schlapbach, A. Liebigs 
Ann. Chem. 1990, 1243. 
10
 Thadani, A, N.; Batey, R. A. Tetrahedron Lett. 2003, 44, 8051. 
11
 Yamamoto, Y.; Miyaira, T.; Ohmura, T.; Miyaura, N. J. Org. Chem. 1999, 64, 296. 
12
 (a) Yamamoto, Y.; Takahashi, M.; Miyaura, N. Synlett 2002, 128. (b) Goldberg, S. D.; Grubbs, 
R. H. Angew. Chem., Int. Ed. 2002, 41, 807.  
13
 (a) Ishiyama, T.; Ahiko, T.; Miyaura, N. Tetrahedron Lett. 1996, 37, 6889. (b) Dutheuil, G.; 
Selander, N.; Szabo, K. J.; Aggarwal, V. K. Synthesis 2008, 14, 2293. (c) Zhang, P.; Roundtree, I. 
A.; Morken, J. P. Org. Lett. 2012, 14, 1416. 
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Figure 1.3. Syntheses of Crotylboron Reagents 
 
The methods mentioned above are only (E)-selective or require the use of 
stoichiometric stereodefined (Z)-allylmetal reagents as starting material. A catalytic 
method to prepare (Z)-allylboronic esters would be valuable and attractive for the 
construction of syn-homoallylic alcohols (Scheme 1.3). This goal has been achieved by 
several research groups,
14
 including the Morken group using a Ni-catalyzed 1,4-
hydroboration of 1,3-dienes 1.3 (Scheme 1.4, equation 3)
15
, and the Hoveyda group 
utilizing a W-based aryloxide pyrrolidine complex catalyzed (Z)-selective cross 
metathesis of allylboronic pinacol ester 1.5 with monosubstituted olefins (Scheme 1.4,  
equation 4).
16
 
 
 
 
                                                     
14
 For hydroboration of dienes, see: Satoh, M.; Nomoto, Y.; Miyaura, N.; Suzuki, A. Tetrahedron 
Lett. 1989, 30, 3789.(b) Wu, J. Y.; Moreau, B.; Ritter, T. J. Am. Chem. Soc. 2009, 131, 12915.  
15
 (a) Ely, R. J.; Morken, J. P. J. Am. Chem. Soc. 2010, 132, 2534. (b) Ely, R. J.; Morken, J. P. 
Org. Synth. 2011, 88, 342. 
16
 Kiesewetter, E. T.; O’Brien, R. V.; Yu, E. C.; Meek, S. J., Schrock, R. R.; Hoveyda. A. H. J. 
Am. Chem. Soc. 2013, 135, 6026. 
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Scheme 1.4. Selected Catalytic Routes to (Z)-Allylboronic Esters 
 
As described above, crotylboron reagents can be prepared selectively and add to 
carbonyls to provide homoallylic alcohols. Krishe and co-workers have developed an 
alternative method to construct polyketides via a Ru- and Ir-catalyzed enantio- and 
diastereoselective hydrohydroxylalkylation of butadiene and aldehyde.
17
 This class of 
transfer hydrogenation reactions provides a powerful and novel way to construct ketide 
units that bypasses the use of stoichiometric chiral auxiliaries, premetallated carbon 
nucleophiles, and discrete alcohol-to-aldehyde redox reactions. Depending on the choice 
of catalytic chiral phosphoric acid, syn- or anti-products were obtained selectively in 
good diatereoselectivity and high enantioselectivity (Scheme 1.5). It is suspected that the 
anti-π-crotylruthinium intermediate is formed kinetically as a result of hydrometalation of 
the s-cis conformer of butadiene, and its isomerization is retarded in the presence of the 
                                                     
17
 For stereoselective ruthenium catalyzed crotylation of alcohol C–H bonds, see: (a) Zbieg, J. R.; 
Moran, J.; Krische, M. J. J. Am. Chem. Soc. 2011, 133, 10582; (b) Zbieg, J. R.; Yamaguchi, E.; 
McInturff, E. L.; Krische, M. J. Science 2012, 336, 324; (c) McInturff, E. L.; Yamaguchi, E.; 
Krische, M. J. J. Am. Chem. Soc. 2012, 134, 20628. For iridium catalyzed allylation of alcohol C–
H bonds, see: (d) Kim, I. S.; Ngai, M.-Y.; Krische, M. J. J. Am. Chem. Soc. 2008, 130, 6340; (e) 
Kim, I. S.; Ngai, M.-Y.; Krische, M. J. J. Am. Chem. Soc. 2008, 130, 14891; (f) Lu, Y.; Kim, I. S.; 
Hassan, A.; Del Valle, D. J.; Krische, M. J. Angew. Chem. Int. Ed. 2009, 48, 5018; (g) Hassan, A.; 
Lu, Y.; Krische, M. J. Org. Lett. 2009, 11, 3112; (h) Schmitt, D. C.; Dechert-Schmitt A.-M. R.; 
Krische, M. J. Org. Lett. 2012, 14, 6302; (i) Dechert-Schmitt, A.-M. R.; Schmitt, D. C.; Krische, 
M. J. Angew. Chem. Int. Ed.2013, 52, 3195. 
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sterically demanding TADDOL-derived phosphoric acid (Acid 1). Thus, the kinetic 
hydrometalation stereoselectivity is preserved as (Z)-σ-crotylruthenium intermediate and 
leads to the syn-diastereomer 1.7 after crotylation with an aldehyde.
17c
 If the binol 
derived phosphoric acid (Acid 2) was used, anti-π-crotylruthenium intermediate will 
quickly isomerize to its syn-isomer, followed by crotylation with an aldehyde delivering 
trans-homoallylic alcohol 1.8.
17b 
Scheme 1.5. Enantioselective Ruthenium-Catalyzed Crotylation via Butadiene Hydro-
hydroxyalkylation 
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1.2.3. Crotylation with α-Chiral Crotyl Metals for Polyketide Syntheses 
Aforementioned creative methods could rapidly construct ketide moieties, but the 
products only possess terminal olefins and require further functionalizations to construct 
internal olefins that are more commonly observed in polyketide natural products (Figure 
1.1). However, such ketide fragment 1.10 with internal olefins can be prepared using 
chiral crotylation reagent 1.9 that contains other useful functional groups (Scheme 1.6, 
equation 5). Thus, methods to synthesize functionalized and enantiomerically enriched 
crotyl metal 1.9 are valuable for polyketide synthesis. These methods are generally 
divided into two categories: (1) those prepared from stoichiometric chiral auxiliary/ligand; 
(2) from achiral materials via asymmetric catalysis. 
Scheme 1.6. General Asymmetric Crotylation of Aldehyde 
 
1.2.3.1. α-Chiral Crotylation Reagents Prepared Using Stoichiometric 
Auxiliary/Ligand 
The enantioselective deprotonation of allylic carbarmate 1.11, followed by 
addition of an electrophilic metal halide, pioneered by Hoppe, is a powerful synthetic 
method to prepare α-chiral crotylation reagent 1.12 (Scheme 1.7). 18  Enantioselective 
deprotonation is usually achieved using an alkyl lithium as a base and a chiral diamine 
(e.g. sparteine) as a ligand; the most commonly used electrophilic metals are boron, 
silicon, titanium, and tin.
18b 
                                                     
18
 For book and review, see: (a) Hoppe, D.; Christoph, G. Z.; Marek, I. (Eds.), The Chemistry of 
Functional Groups Part 1; Wiley: Chichester 2004, 1055-1164. (b) Hoppe, D.; Hense, T. Angew. 
Chem. Int. Ed. 1997, 36, 2282. 
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Scheme 1.7. (−)-Sparteine Mediated Enantioselective Deprotonation 
 
 Ardisson and co-workers have used this method to prepare chiral crotyltitanate 
1.14 via sparteine-mediated deprotonation of allylic carbarmate 1.13 with n-BuLi; 
transmetalation to titanium iso-propoxide occurs with complete inversion of 
configuration (Scheme 1.8).
19
 Chiral crotyltitanate 1.14 was treated with propionaldehyde, 
constructing (Z)-anti-homoallylic alcohol 1.15 with a versatile vinylcarbarmate motif. 
Further transformations, including Fritsch-Buttenberg-Wiechell rearrangement
20
 and 
nickel-catalyzed cross-couplings,
21
 can convert vinylcarbarmate 1.15 to key intermediates 
in the total synthesis of tyonolide
22
 and discodermolide.
23
 However, this method is 
limited to the synthesis of anti-adducts due to the stereochemical instability of 
crotyltitanate 1.14. 
 
 
 
 
                                                     
19
 H. Paulsen. C. Graeve, D. Hoppe. Synthesis 1996, 141. 
20
 For a review, see: Knorr, R. Chem. Rev. 2004, 104, 3795. 
21
 Kocienski, P.; Dixon, N. J. Synlett, 1989, 1, 52 
22
 Berque, I.; Le Ménez, P. L.; Razon, P.; Mahuteau, J.; Férézou, J.-P.; Pancrazi, A.; Ardisson, J.; 
Brion, J.-D. J. Org. Chem. 1999, 64, 373. 
23
 de Lemos, E.; Porée, F.-H.; Commerçon, A.; Betzer, J.-F.; Pancrazi, A.; Ardisson, J. Angew. 
Chem. Int. Ed. 2007, 46, 1917. 
 11 
 
Scheme 1.8. Chiral Crotyltitanate for the Synthesis of Homoallylic Alcohol 
 
 Very similar to Ardisson’s strategy, Aggarwal and co-workers also took 
advantage of enantioselective deprotonation of allylic carbarmates to prepare α-
substituted allylboronic esters (Scheme 1.9).
24
 Enantioselective deprotonation of 
carbarmate 1.16 was achieved by sparteine ligated s-BuLi, followed by homologation 
with trans-crotylboronic ester, delivering chiral crotyl boronic esters 1.17 (Scheme 1.9, 
equation 6). Upon addition of an aldehyde, anti-homoallylic alcohols 1.19 were produced 
via allylboration with excellent diastereoselectivity and chirality transfer. When cis-
crotylboronic ester 1.18 was used, syn-adducts 1.20 were obtained (Scheme 1.9, equation 
7). Unlike crotyltitanate, both syn- and anti-adducts are accessible due to the stable 
stereochemical geometry of crotylboronic esters (1.17 and 1.18). In both cases, Lewis 
acids were necessary to accelerate allylboration.
25
 
                                                     
24
 (a) Althaus, M.; Mahmood, A.; Suárez, J. R.; Thomas, S. P.; Aggarwal, V. K. J. Am. Chem. Soc. 
2010, 132, 4025. (b) Chen, L. Y.; Scott, H. K.; Hesse, M. J.; Willis, C. L.; Aggarwal. V. K. J. Am. 
Chem. Soc. 2013, 135, 5316. 
25
 (a) Lachance, H.; Lu, X.; Gravel, M.; Hall, D. G. J. Am. Chem. Soc. 2003, 125, 10160. (b) 
Kennedy, J. W. J.; Hall, D. G. Angew. Chem. Int. Ed. 2003, 42, 4732. (c) Rauniyar, V.; Hall, D. G. 
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Scheme 1.9. Production and Allylation of α-Substituted E- and Z-Crotyl Boronic Esters 
 
Chiral 1,1-dimetal crotyl reagents would furnish allylation products with 
vinylmetal groups for further functionalization as demonstrated by Roush (Scheme 
1.10).
26
 The enantiomerically enriched 1,1-dimetal crotyl reagent 1.22 was prepared by 
an enantioconvergent hydroboration of racemic allenylstannane 1.21 with Brown’s d-
diisopinocampheyl-borane ((
d
Ipc)2BH).
27
 Hydroboration of one enantiomer of 1.21 
directly provides desired 1.22, while the hydroboration product of the other enantiomer is 
unstable and isomerizes to 1.22 via 1,3-boratropic shift.
28
 Crotylboron 1.22 reacted with 
an aldehyde to provide anti-homoallylic alcohol 1.23 with good yield and excellent 
                                                                                                                                                              
J. Am. Chem. Soc. 2004, 126, 4518. (d) Rychnovsky, S. D.; Thomas, C. R. Org. Lett. 2000, 2, 
1217. 
26
 Chen, M.; Roush, W. R. J. Am. Chem. Soc. 2011, 133, 5744. 
27
 (a) Brown, H. C.; Yoon, N. M. Isr. J. Chem. 1977, 15, 12. (b) Brown, H. C.; Singaram, B. J. 
Org. Chem. 1984, 49, 945. 
28
 ) (a) Hancock, K. G.; Kramer, J. D. J. Am. Chem. Soc. 1973, 95, 6463. (b) Kramer, G. W.; 
Brown, H. C. J. Organomet. Chem. 1977, 132, 9. (c) Hoffmann, R. W.; Zeiss, H. J. J. Org. Chem. 
1981, 46, 1309. (d) Henriksen, U.; Snyder, J. P.; Halgren, T. A. J. Org. Chem. 1981, 46, 3767. (e) 
Brown, H. C.; Jadhav, P. K.; Bhat, K. S. J. Am. Chem. Soc. 1985, 107, 2564. (f) Wang, K. K.; Gu, 
Y. G.; Liu, C. J. Am. Chem. Soc. 1990, 112, 4424. (g) Gu, Y. G.; Wang, K. K. Tetrahedron Lett. 
1991, 32, 3029. (h) Narla, G.; Brown, H. C. Tetrahedron Lett. 1997, 38, 219. (i) Fang, G. Y.; 
Aggarwal, V. K. Angew. Chem. Int. Ed. 2007, 46, 359. (j) Canales, E.; Gonzalez, A. Z.; 
Soderquist, J. A. Angew. Chem. Int. Ed. 2007, 46, 397. (k) Gonzalez, A. Z.; Soderquist, J. A. Org. 
Lett. 2007, 9, 1081. 
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diastereoselectivity. The product contains vinylstannane as a functional group which can 
be used in Stille cross coupling reactions. 
Scheme 1.10. Production and Allylation of Chiral α-Stannane Crotylboron Reagent 
 
1.2.3.2. Chiral Crotyl Metals Prepared from Achiral Materials via Asymmetric 
Catalysis 
Above mentioned reactions can efficiently generate α-chiral crotyl metal reagents 
and deliver both syn- and anti-vinylogous aldol products; however, all of these reactions 
involve the use of stoichiometric chiral reagents [e.g. (−)-sparteine and (+)-pinene], and 
stoichiometric amount of base and metal (e.g. BuLi and tin). Such auxiliary based 
chemistry is not desired from the standpoint of atom-economy when compared to 
catalytic methods.
29
 Thus, it is extremely valuable to synthesize enantiomerically 
enriched α-chiral crotyl metal reagents from achiral and readily available hydrocarbon 
feedstocks via an asymmetric catalytic method. 
Morken and co-workers have disclosed an asymmetric Pt-catalyzed 1,2-diboration 
of achiral cis- and 1,1-disubstituted 1,3-dienes 1.21 delivering chiral crotylboronic 
pinacol ester 1.22 with good enantioselectivity (Scheme 1.11).
30
 These 1,2-diboron 
intermediates participated in allylation reactions with various aldehydes furnishing syn-
homoallylic alcohols 1.23 with good distereoselectivity and chirality transfer. The 
                                                     
29
 Trost, B. M. Angew. Chem. Int. Ed. 1995, 34, 259. 
30
 Kliman, L. T.; Mlynarski, S. N.; Ferris, G. E.; Morken, J. P. Angew. Chem. Int. Ed. 2012, 51, 
521. 
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allylboronic ester in product 1.23 could serve as a functional handle for further 
transformations, such as direct oxidation to allylic alcohols (Scheme 1.11, 1.24 and 1.25) 
and tandem allylations in the presence of a second carbonyl (Scheme 1.12). Only syn-
homoallylic alcohols can be prepared by this method due to the fact that Pt-catalyzed 1,2-
diboration only occurs on cis- and 1,1-disubstituted 1,3-diene substrates. 
Scheme 1.11. Catalytic Diene 1,2-Diboration to Produce α-Chiral Crotylboron Reagent 
 
When diboron 1.22 was treated with dialdehyde 1.26 or ketoaldehyde 1.27, the 
remaining allylboronic ester in 1.23 reacted intramolecularly with the second carbonyl to 
build up carbocyclic structures (1.31-1.33) with high diastereo- and enantioselectivity 
(Scheme 1.12).
31
 This methodology rapidly constructed the core structure of pumilaside 
aglycon and the synthesis was completed in only six steps from simple achiral 
hydrocarbons.  
 
 
 
                                                     
31
 Ferris, G. E.; Hong, K.; Roundtree, I. A.; Morken, J. P. J. Am. Chem. Soc. 2013, 135, 2501. 
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Scheme 1.12. Tandem Diene Diboration/Double Allylation of Dicarbonyls 
 
Besides α-chiral crotylboron reagents (Scheme 1.9, 1.10 and 1.11), α-chiral crotyl 
silanes also play an important role in polyketide fragment syntheses.
32
 It is worth pointing 
out that, unlike crotylboron reagents, crotylsilanes often react with carbonyls under an 
“open transition state” mechanism.33 Using methods developed by Panek and co-workers, 
optically active crotylsilane 1.35 was synthesized via Cu(I)-catalyzed enantioselective Si-
H insertion of an α-diazo vinylester 1.34 (Scheme 1.13).34After recrystallization from 
pentane to obtain high enantiomeric excess, crotylsilane 1.35 underwent Lewis acid 
mediated crotylation with aromatic aldehydes generating vinylogous aldol adducts 1.36 
in good yield and diatereoselectivity (Scheme 1.13, equation 8). In order to obtain 
synthetically useful levels of yield for aliphatic aldehydes, it was necessary to use 
                                                     
32
 (a) Masse, C. E.; Panek, J. S. Chem. Rev. 1995, 95, 1293. (b) Panek, J. S.; Yang, M. J. Am. 
Chem. Soc. 1991, 113, 9868. (c) Panek, J. S.; Yang, M.; Xu, F. J. Org. Chem. 1992, 57, 5790. 
33
 Fleming, I. Org. React. 1989, 37, 57. 
34
 Wu, J.; Chen, Y.; Panek, J. S. Org. Lett. 2010, 12, 2112. 
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crotylsilane 1.37 which is prepared by a two-step reduction/protection sequence from 
1.35 (Scheme 1.13, equation 9). 
Scheme 1.13. Production and Crotylation of Enantiomerically Enriched Crotyl Silanes 
 
 Most of the aforementioned chiral crotylboronates and crotylsilanes are 
reasonably stable for purification (e.g. crotylsilane 1.35); however, it would be more 
efficient and operationally simple if such α-chiral crotylmetal reagents were generated 
and used in-situ. Recently, Hoveyda and co-workers reported the generation of chiral 
allylcopper reagent 1.40 from copper boration of achiral mono-substituted allene 1.39, 
followed by an in-situ addition to aldehydes and ketones (Scheme 1.14).
35
 The 
stereoselectiviety was controlled by a chiral bulky phosphine (L1 and L2) that ligated to 
copper. Syn-homoallylic alcohols 1.41 and tertiary alcohols 1.42 were obtained with high 
diastereoselectivity and moderate to good enantioselectivity. Most importantly, these 
products (1.41 and 1.42) contain a valuable vinylboron moiety for further 
functionalization, such as oxidation to form methyl ketones, C-B bond bromination to 
produce vinyl bromides, and Suzuki cross couplings.  
                                                     
35
 Meng, F.-K.; Jang, H.-J.; Jung, B.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2013, 52, 5046. 
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Scheme 1.14. Production of Chiral Crotylcopper and in situ Addition to Aldehydes and 
Ketones 
 
Great success has been achieved in the preparation of α-chiral crotyl metal 
reagents followed by their allylation to carbonyls. However, excluding Ardisson’s 
example (Scheme 1.8), these methodologies only provide homoallylic alcohols with 
trans-alkenes or 1,1-disubstituted alkenes. But a number of polyketides (Figure 1.1) 
contain cis-alkenes bearing adjacent propionate moieties, which were usually prepared by 
cis-selective olefination reactions of aldehydes
36
 prepared from hydroboration of 1,1-
disubstituted alkenes (Scheme 1.15, equation 10). The main drawback of this strategy is 
that multiple transformations are required to construct appropriate olefin reagents. Based 
on previously published results
15
 in our laboratory, it was considered that a Ni-catalyzed 
diastereoselective 1,4-hydroboration of a chiral dienol would deliver the required ketide 
                                                     
36
 (a) Kishi, Y. Aldrichimica Acta. 1980, 13, 23. (b) Nagaoka, H.; Kishi, Y. Tetrahedron 1981, 37, 
3873. (c) Still, W. C.; Barrish, J. C. J. Am. Chem. Soc. 1983, 105, 2487. (d) Midland, M. M.; 
Kwon, Y. C. J. Am. Chem. Soc. 1983, 105, 3725. (e) Houk, K. N.; Rondan, N. G.; Wu, Y.-D.; 
Netz, J. T.; Paddon-Row: M. N. Tetrahedron 1984, 40, 2257. 
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unit containing both propionate moiety and adjacent cis-alkene (Scheme 1.15, equation 
11). We expected the neighboring alcohol/ether functional groups may control the 
diastereoselectivity and allow formation of the syn- or anti-product. 
Scheme 1.15. Ketide Sythesis via Ni-catalyzed Diastereoselective Hydroboration 
 
1.3. Development of Ni-Catalyzed Diastereoselective 1,4-Hydroboration 
of 1,3-Dienols
37
 
Previously, our laboratory has reported a Ni-catalyzed hydroboration of 1,3-
dienes providing cis-allylboronic ester with high yield and Z-selectivity.
15
 Hydroboration 
of 2,4-dimethyl-pentadiene 1.43 resulted a trisubstituted allylboronic ester 1.44 with high 
Z-selectivity and yield (Scheme 1.16, equation 12). This example is quite interesting and 
important because (1) hydroboration of trisubstituted olefin is rare;
38
 (2) synthetically 
                                                     
37
 Ely, R. J.; Yu, Z.; Morken, J. P. manuscript in preparation. 
38
 (a) Smith, S. M.; Takacs, J. M. J. Am. Chem. Soc. 2010, 132, 1740. (b) Smith, S. M.; Thacker, 
M. C.;Takacs, J. M. J. Am. Chem. Soc. 2008, 130, 3734. (c) Hadebe, S. W.; Robinson, R. S. 
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challenging trisubstitued Z-olefin is prepared in one catalytic step. Thus, further 
investigation of this class of substrates was warranted. It is worth noting that a chiral 
center is built during this process if the starting material is prochiral; thus it provided an 
opportunity to study the diastereoselectivity of hydroboration of corresponding chiral 1,3-
dienes 1.45 bearing an adjacent hydroxyl group (Scheme 1.16, equation 13). 
Scheme 1.16. Design of Ni-catalyzed 1,4-Hydroboration of Chiral 1,3-Dienes 
 
The TBS-protected dienol ether 1.47 was chosen as a probe substrate to test our 
hypothesis. Diene 1.47 was subject to standard hydroboration conditions (2.5 mol % 
Ni(cod)2, 2.5 mol % PCy3, 0.25 M in toluene), and we were pleased to isolate the syn-
allylic alcohol 1.48 with 10:1 dr and 86% yield after oxidation (Table 1.1, entry 1). 
Several ligands were screened, but none of them were as effective as tricyclohexyl-
phosphine (Table 1.1, entry 2 and 3). Changing the solvent to THF enhanced 
diastereoselectivity (Table 1.1, entry 4; 12:1 vs 10:1); as did lowering the temperature to 
0 
o
C (Table 1.1, entry 5; 14:1 vs 12:1). Further decreasing temperature to −20 oC caused 
incomplete conversion even after prolonged reaction time (Table 1.1, entry 6). 
                                                                                                                                                              
Tetrahedron Lett.2006, 47, 1299. (d) Edwards, D. R.; Crudden, C. M.; Yam, K. Adv. Synth. Catal. 
2005, 347, 50. (e) Evans, D. A.; Fu, G. C.; Hoveyda, A. H. J. Am. Chem. Soc. 1992, 114, 6671. (f) 
Evans, D. A.; Fu, G. C.; Anderson, B. A. J. Am. Chem. Soc. 1992, 114, 6679. 
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Considering the alcohol protecting group could dramatically affect reaction selectivity,
39
 
various protecting groups with different sizes and electronic properties were tested. A 
smaller TES protecting group on the alcohol led to good yield but slightly lower 
diastereoselectivity compared to the TBS-protected substrate (Table 1.1, entry 7). The 
larger TBDPS-protecting group produced the desired product as a single diastereomer 
(determined by 
1
H-NMR), but it required longer reaction time at elevated temperature in 
order to reach full conversion (Table 1.1, entry 8). Both the benzyl protecting group and 
the free alcohol diminished diastereoselectivity and isolated yield (Table 1.1, entry 9 and 
10). It’s worth pointing out that 1,4-hydroboration products were the only detectable 
regioisomer in all examples.  
 
 
 
 
 
 
 
 
 
 
 
 
                                                     
39
 (a) Evans, D. A.; Fu, G. C.; Hoveyda, A. H. J. Am. Chem. Soc. 1988, 110, 6917. (b) Evans, D. 
A.; Fu, G. C.; Hoveyda, A. H. J. Am. Chem. Soc. 1991, 114, 6671. (c) Still, W. C.; Barrish, J. C. J. 
Am. Chem. Soc. 1983, 105, 2487. 
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Table 1.1. Reaction Condition Optimization and Protecting Group Evaluationa 
 
entry P solvent temp. (
o
C) dr
b 
yield(%)
c 
1 TBS toluene rt 10:1 86 
2
d 
TBS toluene rt 6:1 82 
3
e 
TBS toluene rt 2:1 82 
4 TBS THF rt 12:1 86 
5 TBS THF 0 14:1 89 
6
f 
TBS THF -20 14:1 N.D. 
7 TES THF 0 12:1 93 
8
g 
TBDPS THF rt >20:1 80 
9
f 
Bn THF 0 7:1 72 
10
h 
H THF 0 6:1 56 
a
 Reactions were conducted at a concentration of 0.25 M and oxidized with 30% H2O2 
and 3M NaOH. 
b
 Determined by 
1
H NMR analysis of the crude reaction mixture. 
c
 
Isolated yield of purified material. Values are an average of two experiments. 
d
 Reaction 
run with P(Cyp)3 as ligand. 
e
 Reaction run with P(n-Bu)3 as ligand. 
f
 Reaction run for 12 
h. 
g
 Reaction run for 24 h. 
h
 2.0 equiv. HB(pin) employed. 
 
 With optimum reaction conditions in hand (2.5 mol % Ni(cod)2, 2.5 mol % PCy3, 
0.25M in THF, 0 
o
C), various TBS-protected dienols were tested in Ni-catalyzed 
hydroboration reactions (Table 1.2). Linear alkyl substitution at the carbinol position 
(1.49) (Table 1.2, entry 1) enhanced diastereoselectivity while maintaining good yield 
compared to methyl substituted dienol ether 1.39 (Table 1.1). Sterically demanding 
substrates (1.51 and 1.53) also participated in this reaction delivering desired product, 
though longer reaction time and elevated temperature were required for full conversion 
(Table 1.2, entry 2 and 3). Substrates bearing ether (1.55) and ester (1.57) functional 
 22 
 
groups were well tolerated in this reaction and provided desired allyl alcohols with high 
levels of diastereoselectivity (Table 1.2, entry 4 and 5). Unfortunately, Weinreb’s amide 
(1.59) and terminal olefin (1.60) were not tolerated in nickel-catalyzed hydroboration 
(Table 1.2, entry 6-7). These reactions might be inhibited by strong intramolecular 
coordination of basic functional groups to the metal center, preventing migratory 
insertion. Enantiomerically enriched dienol ether 1.61 provided the syn/syn-stereotriad 
1.62 with good yield and diastereoselectivity (Table 1.2, entry 8), while anti/syn-
stereotriad 1.64 was obtained from the anti-substrate 1.63 (Table 1.2, entry 9). 
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Table 1.2. Substrate Scope of Ni-catalyzed Hydroborationa 
 
entry substrate product yield (%)
b 
dr 
1 
  
90 >20:1 
2
c 
  
98 10:1 
3
c,d 
  
86 6:1 
4 
  
88 >20:1 
5
e 
  
80 >20:1 
6 
 
- - - 
7
c,f 
 
- - - 
8
c
 
  
91 6:1 
9
c 
  
77 6:1 
a
 Reactions conducted at [substrate] = 0.25 M and oxidized with 30% H2O2 and 3 M 
NaOH. 
b
 Isolated yield of purified material. Values are an average of two experiments.  
c
 Reaction run for 12 h. 
d
 Reaction run at rt. 
e
 Oxidation with buffered (pH = 7) 30% 
H2O2. 
f
 Reaction run at 40 
o
C. 
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 Substrates with functionalized dienes were also tested (Table 1.3). A mixture of 
3:1 E:Z-dienes 1.65 participated in this catalytic hydroboration reaction, although higher 
temperature was required for complete conversion (Table 1.3, entry 1). Interestingly, both 
(E)- and (Z)-isomers gave the same syn-diastereomer 1.48, suggesting that it’s not 
necessary to prepare isomerically pure 1,3-diene for this hydroboration methodology. 
Considering the s-cis conformer of diene is the active species, it is not surprising that 
diminished reactivity was observed when 2-methyl substitution was removed (Table 1.3, 
entry 2). This is because the 2-methyl group of 1.47 off-sets the A(1,3) strain introduced 
by converting s-trans conformer to s-cis conformer (Scheme 1.17, equation 14). Thus, 
extra energy was required to achieve the reactive s-cis conformer in the absence of 2-
methyl substitution in 1.66 (Scheme 1.17, equation 15). The required substitution at 2-
position was not limited to methyl group; both phenyl- (1.67) and PhMe2Si-substituted 
(1.69) dienes participated in the hydroboration process to construct trisubstituted (Z)-
olefin with good yield and high diastereoselectivity (Table 1.3, entry 3 and 4). It is worth 
pointing out that the vinylsilane moiety in 1.70 could serve as a handle for further 
functionalization.
40
 Thus, various trisubstituted (Z)-olefins bearing different 
vinylsubstitutions can be prepared via this intermediate vinylsilane. 
 
 
                                                     
40
 For selected vinylsilane transformations: (a) Fleming, I.; Barbero, A.; Walter, D. Chem. Rev. 
1997, 97, 2063. (b) Langkopf, E.; Schinzer, D. Chem. Rev. 1995, 95, 1375. (c) Hiyama, T. in: 
Handbook of Organopalladium Chemistry for Organic Synthesis (Ed.: Negishi, E-i.), Wiley-
Interscience, New York, 2002, Vol. 1, 285–309; (d) Hiyama, T. in: Metal-Catalyzed Cross-
Coupling Reactions (Eds.: Diederich, F.; Stang, J. P.), Wiley-VCH, Weinheim, 1998, pp. 421–
452. (e) Colvin, E. W. Silicon in Organic Sythesis., Butterworths, 1981. (f) Pawluc, P.; Prukała, 
W.; Marciniec, B. Eur. J. Org. Chem. 2010, 219. (g) Trost, B.M.; Ball, Z. T.; Laemmerhold, K. 
M. J. Am. Chem. Soc., 2005, 127, 10028. (i) Sore, H. F; Galloway, W. R. J. D.; Spring, D. R. 
Chem. Soc. Rev. 2012, 41, 1845. 
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Table 1.3. Substrates with Non-methyl Substituted Dienesa 
 
entry substrate product yield (%)
b 
dr 
1
c 
  
40 17:1 
2
 
 
- - - 
3
d 
  
91 9:1 
4
e 
  
84 >10:1 
a
 Reactions conducted at [substrate] = 0.25 M and oxidized with 30% H2O2 and 3 M 
NaOH. 
b
 Isolated yield of purified material. Values are an average of two experiments. 
c
 3:1 (Z:E)-mixture. 
d
 Reaction run at 60 
o
C. 
e
 Reaction run at 40 
o
C. 
 
Scheme 1.17. Explanation of the Importance of 2-Methyl Substitution 
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Allylboronates are versatile intermediates;
41
 however, in the examples above they 
were only oxidized to allylic alcohols (Table 1.1, 1.2 and 1.3). Thus, other useful 
transformations were carried out on the intermediate allylboronic esters 1.71 from Ni-
catalyzed hydroboration (Scheme 1.18). For example, one carbon homologation
42
 was 
performed to construct homoallylic alcohol 1.72 with excellent yield and without erosion 
of diastereoselectivity. With Aggarwal’s selective protodeboration procedure, 43  1,1-
disubstituted alkene 1.73 could be isolated with good yield and regioselectivity. Using 
mCPBA, the trisubstituted alkene of allylboronic ester 1.71 was epoxidized with 
concomitant oxidation of the C-B bond furnishing epoxide 1.74 with good 
diastereoselectivity. The observed syn-selectivity of 1.74 was likely the result of 
approach of mCPBA from the least hindered face of the olefin, while minimizing A(1,3) 
strain.
44
 It is necessary to point out that the intermediate allylboronic ester 1.71 was used 
directly after Ni-catalyzed hydroboration without any purification in all of these 
transformations.  
 
 
 
 
                                                     
41
 For a review of Suzuki-Miyaura coupling, see: (a) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 
95, 2457. For halogenations, see: (b) Brown, H. C.; Hamaoka, T.; Ravindran, N. J. Am. Chem. 
Soc. 1973, 95, 6456. For examples and review of 1,2-migration, see: (c) Fernandez, E.; Maeda, K.; 
Hooper, M. W.; Brown, J. M. Chem. Eur. J. 2000, 6, 1840. (d) Thomas, S. P.; French, R. M.; 
Jheengut, V.; Aggarwal, V. K. Chemical Record 2009, 9, 24. (e) Mlynarski, S. N.; Karns, A. S.;  
Morken, J. P. J. Am. Chem. Soc. 2012,134, 16449. (f) Bagutski, V.; Elford, T. G.; Aggarwal, V. K. 
Angew. Chem. Int., Ed. 2011, 50, 1080. 
42
 (a) Sadhu, K. M.; Matteson, D. S. Organometallics 1985, 4, 1687. (b) Chen, A. C.; Ren, L.; 
Crudden, C. M. Chem. Commun. 1999, 611. (c) Chen, A. C.; Ren, L.; Crudden, C. M. J. Org. 
Chem. 1999, 64, 9704. (d) Ren, L.; Crudden, C. M. Chem. Commun. 2000, 721. 
43
 Nave, S.; Sonawane, R. P.; Elford, T. G.; Aggarwal, V. K. J. Am. Chem. Soc. 2010, 132, 17096. 
44
 Jung, M. E.; D’Amico, D. C. J. Am. Chem. Soc. 1997, 119, 12150. 
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Scheme 1.18. Transformations of Intermediate Allylboronic Pinacol Ester 
 
 Directed catalytic hydrogenation of trisubstituted olefin 1.76, which was prepared 
via two-step sequence from hydroboration product 1.75, gave fully saturated compound 
1.77 with good yield and diastereoselectivity (Scheme 1.19). The skipped methyl and 
adjacent syn-propionate moiety within 1.77 map onto common polyketide framework. 
This demonstrated that Ni-catalyzed hydroboration of chiral dienol is also capable of 
delivering saturated polyketide backbones. 
Scheme 1.19. Directed Catalytic Hydrogenation of Hydroboration Product 
 
 To examine the synthetic utility of Ni-catalyzed diastereoselective hydroboration, 
a gram scale reaction was performed (Scheme 1.20). The easily accessible TBDPS-
protected dienol ether 1.78 was subject to standard hydroboration conditions. Although 
the reaction didn’t reach full conversion after prolonged reaction time (which may be 
attributed to degradation of active catalyst over time), the desired allylboronic ester 1.79 
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was easily separated from the unreacted starting material with excellent diastereo-
selectivity and good yield based on recovered starting material.  
Scheme 1.20. Gram Scale of Ni-Catalyzed Hydroboration 
 
 The excellent diastereoselectivity in the above hydroboration examples can be 
explained by transition states shown in Figure 1.4, similar to a hypothesis made by 
Burgess.
45
 We hypothesize that the nickel complex approaches the diene in a manner that 
the C-O bond, the best π-acceptor at the carbon stereocenter, is anti-planar to the 
incoming metal complex (1.80). This would allow maximized stabilization of the newly 
formed bond by lowering the HOMO-LUMO energy gap due to the mixing of π* of the 
diene and σ* of the C-O bond. At the same time, in order to minimize steric interaction, 
hydrogen (the smallest group at the carbon stereocenter) is preferentially directed towards 
the large metal center. Thus, the desired syn-diastereomer 1.81 is produced via transition 
state 1.80. This model also explains the observed trend that larger protecting groups 
enhance diastereoselectivity due to the increased undesired interaction in undesired 
transition state 1.82. 
 
 
 
                                                     
45
 Burgess, K.; van der Donk, W. A.; Jarstifer, M. B.; Ohlmeyer, M. J. J. Am. Chem. Soc. 1991, 
113, 6139. 
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Figure 1.4. Proposed Model for Ni-Catalyzed Hydroboration 
 
1.4. Conclusion and Outlook 
 We have developed a Ni-catalyzed 1,4-hydroboration of chiral 1,3-dienols that 
efficiently constructs polyketide fragments with syn-propionate moieties bearing adjacent 
challenging (Z)-trisubstituted olefins. A wide range of substituents were tolerated and the 
intermediate allylboronic ester was successfully transformed to various functional groups. 
This methodology is developed as a tool to construct challenging structures and facilitate 
polyketide natural product synthesis. It is of great interest to apply this method to 
complex molecule syntheses, such as (+)-discodermolide (Figure 1.1) whose C9-C15 
fragment maps on closely to the hydroboration product (Chapter 2).  
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1.5. Experimental Procedures 
 
General Information  
1
H-NMR spectra were recorded on Varian Unity Inova 500 MHz and Varian 
Gemini 400 MHz spectrometers.  Chemical shifts are reported in ppm with the solvent 
resonance as the internal standard (CDCl3: 7.26 ppm, C6D6: 7.16 ppm).  Data are reported 
as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t = triplet, q 
= quartet, p = pentet, br = broad, m = multiplet), coupling constants (Hz) and assignment.  
13
C{
1
H}NMR spectra were recorded on Varian Unity Inova 500 MHz (125 MHz) and 
Varian Gemini 400 MHz (100 MHz) spectrometers.  Chemical shifts are reported in ppm 
with the solvent resonance as the internal standard (CDCl3: 77.23 ppm).  Infrared (IR) 
spectra were recorded on a Bruker Spectrometer. Frequencies are reported in 
wavenumbers (cm
-1
) as follows: strong (s), broad (br), medium (m), and weak (w).  High-
resolution mass spectrometry (ESI) was performed at Boston College, Chestnut Hill, MA.   
Analytical chiral supercritical fluid chromatography (SFC) was performed on a Thar 
Supercritical Chromatograph equipped with an auto sampler and a Waters photodiode 
array detector with isopropanol as the modifier. 
 Liquid Chromatography was performed using forced flow (flash chromatography) 
on silica gel (SiO2, 40-63 µm) purchased from Silicycle. Thin Layer Chromatography 
was performed on 25 µm silica gel plates purchased from Silicycle Visualization was 
performed using ultraviolet light (254 nm), phosphomolybdic acid (PMA) in ethanol, 
potassium permanganate (KMnO4) in water, or cerium (IV) sulfate and ammonium 
molybdate in sulfuric acid (CAM).  
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All reactions were conducted in oven- or flame-dried glassware under an inert 
atmosphere of nitrogen or argon.  Toluene, tetrahydrofuran, methylene chloride, and 
diethyl ether were purified using Pure Solv MD-4 solvent purification system, from 
Innovative Technology, Inc., by passing the solvent through two activated alumina 
columns after being purged with argon. Bis(1,5-cyclooctadiene)nickel(0) (Ni(cod)2), 
tricyclohexylphosphine (PCy3), tetrapropylammonium perruthenate, and tetrakis-
(triphenylphosphine) palladium(0) were purchased from Strem Chemicals, Inc.  4,4,5,5-
Tetramethyl-1,3,2-dioxaborolane (pinacolborane) was graciously donated by BASF and 
used without further purification. TBSOTf and TESOTf were purchased from GFS and 
were distilled prior to use. Trans-1,3-pentadiene was purchased from ChemSampCo. 
Ethyl 2-(triphenylphosphoranylidene)propanoate was purchased from Accela ChemBio 
or Aldrich. All other reagents were purchased from Aldrich, Acros or Fisher and used 
without further purification.  
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I. Preparation of Starting Materials 
The protected dienols in Table 1.1 and 1.2 were prepared from the common 
aldehyde SI-2, which is available from alcohol SI-1 via known ester.
46
  
 
Preparation of (E)-2,4-dimethylpenta-2,4-dien-1-ol (SI-1) 
 
In the dry-box, a flame-dried 250 mL round-bottom flask was charged with 
LiAlH4 (1.30 g, 33.68 mmol). The reaction flask was sealed with a septum, removed 
from the dry-box, and a nitrogen line was attached. The flask was cooled to 0 °C, 
followed by the addition of THF (66 mL). (E)-Ethyl-2,4-dimethylpenta-2,4-dienoate 
(4.33 g, 28.07 mmol) was added dropwise, and the reaction was allowed to stir for 1 h. 
The reaction was quenched with MeOH, followed by the addition of Rochelle’s salt (30 
mL), and the reaction was then allowed to stir vigorously for 2 h. The reaction mixture 
was diluted with Et2O and H2O and the layers were separated. The aqueous layer was 
extracted with Et2O (3 x 20 mL), and the combined organics were dried over MgSO4, 
filtered, and concentrated by rotary evaporation to afford SI-1 a clear, colorless oil (3.09 
g, 98%).   
 
                                                     
46
 Kemper, J.; Studer, A. Angew. Chem. Int. Ed. 2005, 44, 4914. 
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 (E)-2,4-Dimethylpenta-2,4-dien-1-ol (SI-1). 
1
H NMR (400 MHz, 
CDCl3):  5.90 (1H, dd, J = 1.2 Hz, 1.2 Hz), 4.99 (1H, t, J = 1.6 Hz), 4.84 
(1H, s), 4.04 (2H, s), 1.86 (3H, s), 1.83 (3H, s); 
13
C NMR (100 MHz, CDCl3): δ 141.7, 
136.5, 127.2, 115.3, 69.3, 23.7, 15.5; IR (neat): 3411 (br, m), 2965 (m), 2927 (m), 2874 
(m), 1717 (s), 1376 (s), 1039 (s); HRMS-(ESI
+
) for C7H13O [M+H]: calculated: 
113.0966, found: 113.0969.  
 
Preparation of (E)-2,4-dimethylpenta-2,4-dienal (SI-2) 
 
A flame-dried 250 mL round-bottom flask containing a magnetic stir bar was 
charged with 4Å MS, 4-methylmorpholine N-oxide (4.90 g, 42.00 mmol), CH2Cl2 (130 
mL), MeCN (10 mL), and SI-1 (3.09 g, 27.54 mmol). The reaction was allowed to stir for 
20 min, then cooled to 0 
o
C and tetrapropylammonium perruthenate (295 mg, 0.84 mmol) 
was added. The reaction was allowed to stir for 2 h while warming to room temperature. 
The reaction mixture was concentrated by rotary evaporation, then filtered through a pad 
of silica gel, washing with Et2O. The solution was concentrated to provide SI-2 as a clear, 
light yellow oil (2.43 g, 80%).   
 
 (E)-2,4-Dimethylpenta-2,4-dienal (SI-2). 
1
H NMR (400 MHz, CDCl3): δ 
9.39 (1H, s), 6.71 (1H, t, J = 1.5 Hz), 5.32 (1H, t, J = 2.0 Hz), 5.26 (1H, s), 
2.02 (3H, s), 1.91 (3H, d, J = 1.5 Hz); 
13
C NMR (125 MHz, CDCl3): δ 196.1, 152.0, 
141.0, 137.8, 123.4, 22.6, 10.6; IR (neat): 3406 (br, w), 2980 (m), 2934 (m), 2875 (m), 
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1689 (s), 1445 (m), 1376 (m), 1023 (s); HRMS-(ESI
+
) for C7H11O [M+H]: calculated: 
111.0810, found: 111.0811. 
 
Representative procedure for organometallic nucleophile addition to aldehyde SI-2 
 
Preparation of (E)-3,5-dimethylhexa-3,5-dien-2-ol (1.47-H, Table 1.1) 
A flame-dried 100 mL round-bottom flask containing a magnetic stir bar, under 
an atmosphere of nitrogen, was charged with MeLi (3.12 mL of a 1.6 M solution in Et2O, 
4.99 mmol), and Et2O (20 mL). The reaction flask was cooled to −78 °C, and SI-2 (500.0 
mg, 4.54 mmol) was added dropwise. The reaction was allowed to stir at −78 oC for 1 h 
or until the reaction was complete by TLC. The reaction was quenched with water, and 
the layers were separated. The aqueous layer was extracted with Et2O (3 x 15 mL), and 
the combined organics were dried over MgSO4, filtered, and concentrated by rotary 
evaporation. The crude material was purified by silica gel chromatography (10:1 
hexanes:ethyl acetate) to afford a colorless oil (458.0 mg, 80%). Rf = 0.24 (10:1 
hexanes:ethyl acetate, stain in KMnO4). 
 
 (E)-3,5-Dimethylhexa-3,5-dien-2-ol (1.47-H). 
1
H NMR (500 MHz, 
CDCl3): δ 5.88 (1H, d, J = 1.0 Hz), 4.98 (1H, q, J = 1.5 Hz), 4.81 (1H, 
t, J = 1.0 Hz), 4.21 (1H, q, J = 6.5 Hz), 1.83 (3H, s), 1.81 (3H, s), 1.26 (3H, d, J = 6.5 
Hz); 
13
C NMR (125 MHz, CDCl3): δ 141.7, 140.5, 126.4, 115.2, 73.9, 23.8, 21.8, 13.4; 
IR (neat): 3339 (br, m), 2972 (m), 2932 (w), 2874 (w), 1443 (m), 1370 (m), 1103 (s), 954 
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(s); HRMS-(ESI
+
) for C8H15O [M+H]: calculated: 127.1123, found: 127.1123. The crude 
reaction mixture was purified by silica gel chromatography (10:1 hexanes:ethyl acetate) 
to afford a colorless oil (458.0 mg, 80%). Rf = 0.24 (10:1 hexanes:ethyl acetate, stain in 
KMnO4). 
 
Representative procedure for TBS-protection of dienols 
 
Preparation of (E)-tert-butyl((3,5-dimethylhexa-3,5-dien-2-yl)oxy)dimethylsilane (1.47-
TBS, Table 1.1): 
 
A flame-dried round-bottom flask containing a magnetic stir bar, under an 
atmosphere of nitrogen, was charged wtih (E)-3,5-dimethylhexa-3,5-dien-2-ol (88.0 mg, 
0.70 mmol) in CH2Cl2 (4 mL) and 2,6-lutidine (0.13 mL, 1.05 mmol). The reaction flask 
was cooled to −78 °C, followed by dropwise addition of freshly distilled TBSOTf (0.19 
mL, 0.84 mmol). The reaction was allowed to stir for 1 h or until done by TLC, then 
quenched with water. The layers were separated, and the aqueous layer was extracted 
with CH2Cl2 (3 x 10 mL). The combined organics were dried over Na2SO4, filtered, and 
concentrated by rotary evaporation. The crude reaction mixture was purified by silica gel 
chromatography (hexanes) to afford a clear, colorless oil (136.0 mg, 81%). Rf = 0.53 
(hexanes, stain in KMnO4). 
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 (E)-tert-Butyl((3,5-dimethylhexa-3,5-dien-2-yl)oxy)dimethylsilane 
(1.47-TBS, Table 1.1).  
1
H NMR (500 MHz, CDCl3): δ 5.84 (1H, s), 
4.96 (1H, s), 4.79 (1H, s), 4.17 (1H, q, J = 6.5Hz), 1.85 (3H, s), 1.76 (3H, s), 1.21 (3H, d, 
J = 6.5 Hz), 0.89 (9H, s), 0.05 (3H, s), 0.02 (3H, s); 
13
C NMR (125 MHz, CDCl3): δ 
142.2, 131.0, 125.6, 114.6, 74.5, 26.1, 23.9, 23.5, 18.5, 13.5, -4.6, -4.7; IR (neat): 3084 
(m), 2958 (m), 2887 (m), 1462 (w), 1443 (w), 1369 (w), 1254 (m), 1082 (m), 1030 (m), 
995 (m), 978 (m), 864 (s), 773 (s), 549 (m); HRMS-(ESI
+
) for C14H28OSi [M+H
+
]: 
calculated: 241.1988, found: 241.1977.  
 
 (E)-((3,5-Dimethylhexa-3,5-dien-2-yl)oxy)triethylsilane (1.47-TES, 
Table 1.1). The titled compound was synthesized according to the 
representative procedure for the TBS-protection of dienols but with TESOTf. 
1
H NMR 
(400 MHz, CDCl3): δ 5.85 (1H, d, J = 1.0 Hz), 4.96 (1H, q, J = 1.5 Hz), 4.79 (1H, t, J = 
1.0 Hz), 4.17 (1H, dq, J = 6.0 Hz, 1.0 Hz), 1.85 (3H, s), 1.77 (3H, d, J = 1.5 Hz), 1.23 
(3H, d, J = 6.5 Hz), 0.95 (9H, t, J = 7.5 Hz), 0.59 (6H, q, J = 7.5 Hz); 
13
C NMR (125 
MHz, CDCl3): δ 142.1, 140.9, 125.7, 114.6, 74.2, 23.9, 23.5, 13.4, 7.1, 5.0; IR (neat): 
2955 (m), 2912 (m), 2877 (m), 1457 (w), 1238 (m), 1056 (s), 1004 (s), 724 (s); HRMS-
(ESI
+
) for C14H29OSi [M+H]: calculated: 241.1988, found: 241.1996. The crude reaction 
mixture was purified by silica gel chromatography (hexanes) to afford a clear, colorless 
oil (263.0 mg, 92%). Rf  = 0.42 (hexanes, stain in KMnO4). 
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Preparation of (E)-tert-butyl((3,5-dimethylhexa-3,5-dien-2-yl)oxy)diphenylsilane (1.47-
TBDPS, Table 1.1) 
 
A flame-dried round-bottom flask containing a stir bar was charged with (E)-3,5-
dimethylhexa-3,5-dien-2-ol (30.0 mg, 0.24 mmol), imidazole (19.6 mg, 0.29 mmol), and 
CH2Cl2 (1.2 mL). The reaction flask was cooled to 0 °C, then TBDPSCl (0.07 mL, 0.29 
mmol) was added dropwise and the reaction was allowed to stir at 0 
o
C for 4 h. The 
reaction was diluted with water and the layers were separated. The aqueous layer was 
extracted with CH2Cl2 (3 x 10 mL) and the combined organics were dried over Na2SO4, 
filtered, and concentrated by rotary evaporation. The crude reaction mixture was purified 
by silica gel chromatography (hexanes) to afford a colorless oil (60.0 mg, 68%). Rf = 0.28 
(hexanes, stain in KMnO4). 
 
 (E)-tert-Butyl((3,5-dimethylhexa-3,5-dien-2-yl)oxy)diphenylsilane 
(1.47-TBDPS, Table 1.1).  
1
H NMR (500 MHz, CDCl3): δ 7.67 (1H, t, 
J = 1.5 Hz), 7.65 (1H, t, J = 1.5 Hz), 7.45-7.33 (6H, m), 5.69 (1H, s), 4.94 (1H, s), 4.73 
(1H, s), 4.19 (1H, q, J = 6.5 Hz), 1.79 (3H, s), 1.78 (3H, t, J = 1.5 Hz), 1.19 (3H, dd, J = 
6.5 Hz, 1.5 Hz), 1.08 (9H, s); 
13
C NMR (125 MHz, CDCl3): δ 142.1, 140.3, 136.2, 136.1, 
134.9, 134.4, 129.7, 129.6, 127.7, 127.6, 126.3, 114.5, 75.4, 27.2, 23.8, 23.3, 19.5, 13.4; 
IR (neat): 3071 (w), 2965 (m), 2932 (m), 2892 (w), 2858 (m), 1473 (w), 1461 (w), 1428 
(m), 1389 (w), 1470 (w), 1189 (s), 1110 (s), 1079 (m), 1054 (w), 1027 (m), 891 (w), 764 
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(m), 739 (m), 701 (s), 506 (s), 485 (m); HRMS-(ESI
+
) for C24H33OSi [M+H]: calculated: 
365.2303, found: 365.2301. 
 
Preparation of (E)-(((3,5-dimethylhexa-3,5-dien-2-yl)oxy)methyl)benzene (1.47-Bn, 
Table 1.1) 
 
  In the dry-box, a flamed-dried 25 mL 2-neck round-bottom flask was charged 
wtih NaH (45.0 mg, 1.90 mmol). The reaction flask was sealed with a septum, removed 
from the dry-box, and a nitrogen line was attached. The flask was cooled to 0 °C, 
followed by the addition of THF (8 mL). (E)-3,5-dimethylhexa-3,5-dien-2-ol (200 mg, 
1.59 mmol) was then added in THF (1 mL) dropwise, and the reaction was allowed to stir 
for 15 min. Benzyl bromide (0.21 mL, 1.75 mmol) was then added dropwise, and the 
reaction was refluxed for 12 h. The reaction was diluted with water and the layers were 
separated. The aqueous layer was extracted with EtOAc (3 x 15 mL), and the combined 
organics were dried over Na2SO4, filtered, and concentrated by rotary evaporation. The 
crude reaction mixture was purified by silica gel chromatography (hexanes) to afford a 
clear, colorless oil (256.0 mg, 75%). Rf = 0.27 (100:1 hexanes:ethyl acetate, stain in 
KMnO4). 
 
 (E)-(((3,5-Dimethylhexa-3,5-dien-2-yl)oxy)methyl)benzene (1.47-
Bn, Table 1.1). 
1
H NMR (500 MHz, CDCl3): δ 7.37-7.33 (4H, m), 
7.29-7.26 (1H, m), 5.88 (1H, s), 5.03 (1H, q, J = 1.5 Hz), 4.89 (1H, t, J = 1.0 Hz), 4.48 
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(1H, d, J = 11.5 Hz), 4.28 (1H, d, J = 12.0 Hz), 3.88 (1H, q, J = 6.4 Hz), 1.92 (3H, s), 
1.83 (3H, d, J = 1.5 Hz), 1.31 (3H, d, J = 6.4 Hz); 
13
C NMR (100 MHz, CDCl3): δ 141.8, 
139.1, 137.9, 129.1, 128.5, 127.9, 127.6, 115.5, 81.3, 70.0, 23.9, 20.5, 12.5; IR (neat): 
3032 (m), 2980 (m), 2874 (m), 1718 (s), 1452 (s), 1269 (s), 1093 (s), 698 (s); HRMS-
(ESI
+
) for C15H21O [M+H]: calculated: 217.1592, found: 217.1585.  
 
Preparation of (E)-tert-butyl((2,4-dimethylnona-1,3-dien-5-yl)oxy)dimethylsilane 
 
The title compound was synthesized as shown above following the Representative 
Organometallic Nucleophile Addition Procedure with n-BuLi (2.5 M solution in 
hexanes), followed by protection using the representative TBSOTf protection procedure. 
 
 (E)-2,4-Dimethylnona-1,3-dien-5-ol (1.49-H). 
1
H NMR (500 MHz, 
CDCl3): δ 5.87 (1H, s), 5.00 (1H, q, J = 1.5 Hz), 4.83 (1H, t, J = 1.0 
Hz), 4.02 (1H, t, J = 6.5 Hz), 1.86 (3H, s), 1.71 (3H, d, J = 1.5 Hz), 1.59-1.54 (2H, m), 
1.37-1.32 (4H, m), 0.91 (3H, t, J = 7.0 Hz); 
13
C NMR (100 MHz, CDCl3): δ 141.7, 139.3, 
127.8, 115.3, 78.5. 34.9, 28.2, 23.8, 22.8, 14.2, 13.2; IR (neat): 3353 (br, m), (2957 (s), 
2930 (s), 2860 (s), 1448 (m), 1000 (s), 891 (s); HRMS-(ESI
+
) for C11H21O [M+H]: 
calculated: 169.1592, found: 169.1590. The crude reaction mixture was purified by silica 
gel chromatography (10:1 hexanes:ethyl acetate) to afford a clear, colorless oil (200 mg, 
75%). Rf = 0.32 (10:1 hexanes:ethyl acetate, stain in KMnO4). 
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 (E)-tert-Butyl((2,4-dimethylnona-1,3-dien-5-
yl)oxy)dimethylsilane (Table 1.2, entry 1). 
1
H NMR (500 MHz, 
CDCl3): δ 5.78 (1H, s), 4.96 (1H, q, J = 1.5 Hz), 4.79 (1H, t, J = 1.0 Hz), 3.94 (1H, t, J = 
6.0 Hz), 1.85 (3H, s), 1.73 (3H, d, J = 1.5 Hz), 1.56-1.42 (2H, m), 1.33-1.27 (4H, m), 
0.91-0.86 (12H, m), 0.04 (3H, s), 0.00 (3H, s); 
13
C NMR (100 MHz, CDCl3): δ 142.1, 
140.0, 127.1, 114.5, 79.2, 36.3, 28.2, 25.9, 23.9, 22.9, 18.5, 14.3, 13.2, −4.3, −4.8; IR 
(neat): 2956 (s), 2930 (s), 2857 (s), 1716 (w), 1462 (m), 1254 (s), 1075 (s), 892 (s), 774 
(s); HRMS-(ESI
+
) for C17H35OSi [M+H]: calculated: 282.2457, found: 282.2453. The 
crude reaction mixture was purified on silica gel (hexanes) to afford a clear, colorless oil 
(197 mg, 90%). Rf = 0.27 (hexanes, stain in KMnO4). 
 
Preparation of (E)-2,4,6-trimethylhepta-4,6-dien-3-ol 
 
The title compound was synthesized as shown above following the representative 
organometallic nucleophile addition procedure with isopropylmagnesium chloride (2.0 M 
solution in THF), followed by protection using the representative TBSOTf protection 
procedure. 
 
 (E)-2,4,6-Trimethylhepta-4,6-dien-3-ol (1.51-H). 
1
H NMR (500 
MHz, CDCl3): δ 5.82 (1H, s), 4.98 (1H, s), 4.81 (1H, s), 3.60 (1H, d, J 
= 13.0 Hz), 1.84 (3H, s), 1.78 (1H, m), 1.76 (3H, s), 0.97 (3H, d, J = 6.5 Hz), 0.80 (3H, 
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d, J = 7.0 Hz); 
13
C NMR (125 MHz, CDCl3): δ 141.7, 138.5, 129.0, 115.2, 84.5, 31.4, 
23.8, 19.7, 18.6, 13.3; IR (neat): 3397 (w), 2956 (s), 2929 (s), 2859 (m), 1632 (w), 1461 
(m), 1382 (m), 1297 (w), 1252 (m), 1179 (w), 1064 (s), 1015 (s), 891 (s), 836 (s), 774 (s), 
670 (s), 551 (m); HRMS-(ESI
+
) for C10H19O [M+H]: calculated: 155.1436, found: 
155.1436. The crude reaction mixture was purified by silica gel chromatography (8:1 
hexanes:diethyl ether) to afford a clear, colorless oil (190.0 mg, 31%). Rf = 0.43 (4:1 
hexanes: diethyl ether, stain in KMnO4). 
 
 (E)-tert-Butyldimethyl((2,4,6-trimethylhepta-4,6-dien-3-
yl)oxy)silane (Table 1.2, entry 2). 
1H NMR (500 MHz, CDCl3): δ 
5.74 (1H, s), 4.97 (1H, q, J = 1.0 Hz), 4.79 (1H, d, J = 1.0 Hz), 3.52 (1H, d, J = 7.5 Hz), 
1.84 (3H, s), 1.74-1.72 (4H, m), 0.91 (3H, d, J = 6.5 Hz), 0.90 (9H, s), 0.76 (3H, d, J = 
7.0 Hz), 0.02 (3H, s), −0.02 (3H, s); 13C NMR (125 MHz, CDCl3): δ 142.0, 138.9, 128.6, 
114.5, 85.3, 32.4, 26.1, 23.9, 19.7, 19.2, 18.5, 13.4, −4.3, −4.8; IR (neat): 2956 (m), 2929 
(m), 2857 (m), 1470 (m), 1251 (s), 1061 (s), 890 (s), 834 (s); HRMS-(ESI
+
) for 
C16H33OSi [M+H]: calculated: 269.2301, found: 269.2303. The crude reaction mixture 
was purified by silica gel chromatography (hexanes) to afford a clear, colorless oil (38.0 
mg, 56%). Rf = 0.60 (hexanes, stain in KMnO4). 
 
Preparation of (E)-tert-butyldimethyl((2,2,4,6-tetramethylhepta-4,6-dien-3-yl)oxy)-
silane 
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The title compound was synthesized as shown above following the representative 
organometallic nucleophile addition procedure with t-BuLi (1.6 M solution in pentane), 
followed by protection using the representative TBSOTf protection procedure. 
 
 (E)-2,2,4,6-Tetramethylhepta-4,6-dien-3-ol (1.53-H). 
1
H NMR 
(500 MHz, CDCl3): δ 5.83 (1H, s), 5.01 (1H, q, J = 1.5 Hz), 4.83 (1H, 
t, J = 1.0 Hz), 3.77 (1H, s), 1.86 (3H, d, J = 1.0 Hz), 1.85 (3H, d, J = 1.5 Hz), 0.94 (9H, 
s); 
13
C NMR (125 MHz, CDCl3): δ 141.7, 138.3, 130.0, 115.2, 85.6, 26.9, 25.3, 24.0, 
16.4; IR (neat): 3453 (br, w), 2956 (s), 2910 (s), 2871 (s), 1727 (m), 1465 (m), 1365 (s), 
1059 (s); HRMS-(ESI
+
) for C11H21O [M+H]: calculated: 169.1592, found: 169.1597. The 
crude reaction mixture was purified by silica gel chromatography (20:1 hexanes:ethyl 
acetate) to afford a clear, colorless oil (207.0 mg, 51%). Rf = 0.30 (20:1 hexanes:ethyl 
acetate, stain in KMnO4). 
 
 (E)-tert-Butyldimethyl((2,2,4,6-tetramethylhepta-4,6-dien-3-
yl)oxy)silane (Table 3.2, entry 3). 
1
H NMR (500 MHz, CDCl3): δ 
5.74 (1H, s), 4.98 (1H, t, J = 1.5 Hz), 4.79 (1H, t, J = 1.0 Hz), 3.63 (1H, d, J = 1.0 Hz), 
1.84 (3H, s), 1.77 (3H, d, J = 1.5 Hz), 1.08 (9H, s), 0.88 (9H, s), 0.03 (3H, s), −0.05 (3H, 
s); 
13
C NMR (100 MHz, CDCl3): δ 142.0, 138.8, 129.9, 115.6, 86.4, 36.7, 27.1, 26.1, 
25.9, 23.9, 18.5, −4.4, −5.2; IR (neat): 2955 (s), 2929 (m), 2858 (m), 1462 (m), 1361 (m), 
1250 (m). 1076 (s), 835 (s), 774 (s); HRMS-(ESI
+
) for C17H35OSi [M+H]: calculated: 
283.2457, found: 283.2454. The crude reaction mixture was purified by silica gel 
chromatography (hexanes) to afford a clear, colorless oil (87.0 mg, 25%). Rf = 0.73 
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(hexanes, stain in KMnO4). 
 
Preparation of (E)-1-(benzyloxy)-5,7-dimethylocta-5,7-dien-4-ol 
 
The title compound was synthesized by adding the known Grignard reagent
47
 to 
aldehyde SI-2 following the representative organometallic nucleophile addition 
procedure, followed by protection using the representative TBSOTf protection procedure. 
 
 (E)-1-(Benzyloxy)-5,7-dimethylocta-5,7-dien-4-ol (1.55-H). 
1
H NMR (500 MHz, CDCl3): δ 7.36-7.33 (4H, m), 7.30-7.26 
(1H, m), 5.88 (1H, s), 4.82 (1H, s), 4.52 (2H, s), 4.03 (1H, br, s), 3.53-3.50 (2H, m), 2.17-
2.16 (1H, m), 1.86 (3H, s), 1.79 (3H, s), 1.73-1.64 (4H, m); 
13
C NMR (100 MHz, 
CDCl3): δ 141.8, 139.1, 138.5, 128.6, 127.9, 127.8, 127.7, 115.3, 78.0, 73.2, 70.6, 32.5, 
26.4, 23.9, 13.6; IR (neat): 3417 (w), 2938 (m), 2857 (m), 1495 (m), 1362 (m), 1309 (w), 
1259 (w), 1204 (w), 1097 (s), 1054 (s) 1027 (s), 998 (s), 890 (s), 734 (s), 696 (s), 611 
(m), 555 (m), 520 (m); HRMS-(ESI
+
) for C17H25O2 [M+H]: calculated: 261.1855, found: 
261.1846. The crude reaction mixture was purified by silica gel chromatography (5:1 
hexanes:diethyl ether) to afford a clear, colorless oil (400.0 mg, 70%). Rf = 0.33 (5:1 
hexanes:ethyl acetate, stain in KMnO4). 
 
 
                                                     
47
 Qian, H.; Han, X.; Widenhoefer, R. A. J. Am. Chem. Soc. 2004, 126, 9536. 
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 (E)-((1-(Benzyloxy)-5,7-dimethylocta-5,7-dien-4-
yl)oxy)(tert-butyl)dimethylsilane (Table 1.2, entry 4). 
1
H 
NMR (500 MHz, CDCl3): δ 7.34-7.32 (4H, m), 7.32-7.25 (1H, m), 5.78 (1H, s), 4.96 (1H, 
s), 4.78 (2H, s), 4.50 (2H, s), 3.97 (1H, t, J = 6.0 Hz), 3.49-3.44 (2H, m), 1.84 (3H, s), 
1.73 (3H, s), 1.69-1.65 (1H, m), 1.60-1.53 (3H, m), 0.87 (9H, s), 0.03 (3H, s), −0.01 (3H, 
s); 
13
C NMR (100 MHz, CDCl3): δ 142.0, 139.6, 138.9, 128.6, 127.9, 127.7, 127.3, 114.7, 
78.9, 73.1, 70.1, 33.1, 26.3, 26.1, 23.9, 18.4, 13.3, −4.4, −4.8; IR (neat): 2953 (m), 2929 
(m), 2855 (m), 1472 (w), 1454 (w), 1361 (w), 1254 (m), 1204 (w), 1096 (s), 1070 (s), 
1028 (m), 1004 (m), 893 (m), 835 (s), 774 (s), 734 (m), 697 (m); HRMS-(ESI
+
) for 
C23H39O2Si [M+H]: calculated: 375.2719, found: 375.2722. The crude reaction mixture 
was purified by silica gel chromatography (40:1 hexanes:diethyl ether) to afford a clear, 
colorless oil (289.0 mg, 96%). Rf = 0.41 (20:1 hexanes:diethyl ether, stain in KMnO4). 
 
Preparation of (E)-ethyl 3-((tert-butyldimethylsilyl)oxy)-4,6-dimethylhepta-4,6-dienoate 
 
A flame-dried two-neck round-bottom flask containing a magnetic stir bar and 
internal thermometer was charged with dry diisopropylamine (0.28mL, 2.00 mmol) and 
THF (3.0 mL). The flask was cooled to −78 °C and n-BuLi (0.84mL, 2.00 mmol) was 
added dropwise. The solution was allowed to warm to 0 °C and stir for 15 min. The 
reaction flask was then cooled to −78 °C, and ethyl acetate (0.20 mL, 2.0 mmol, distilled) 
in THF (1.0 mL) was added dropwise, maintaining an internal temperature below -70
 
°C. 
The reaction was allowed to stir at −78 °C for 1.5 h, then a solution of SI-2 (213 mg, 1.82 
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mmol) in THF (1.0 mL) was added dropwise at −78 °C. The reaction was allowed to stir 
at −78 °C for 40 min. The reaction was quenched with water (3.0 mL), diluted with ethyl 
acetate (10 mL), and the layers were separated. The aqueous layer was extracted with 
ethyl acetate (3 x 10 mL), and the combined organics were dried over Na2SO4, filtered, 
and concentrated by rotary evaporation. The crude material was purified by silica gel 
chromatography (3:1 hexanes:diethyl ether) to afford the title compound as a clear, 
colorless oil (288.0 mg, 75%). Rf = 0.51 (3:1 hexanes:ethyl acetate, stain with KMnO4). 
 
 (E)-Ethyl 3-hydroxy-4,6-dimethylhepta-4,6-dienoate (1.57-
H). 
1
H NMR (500 MHz, CDCl3): δ 5.97 (1H, s), 5.01 (1H, p, J = 
1.5 Hz), 4.83 (1H, t, J = 1.0 Hz), 4.46 (1H, t, J = 4.0 Hz), 4.18 (2H, q, J = 7.0 Hz), 2.85 
(1H, d, J = 3.5 Hz), 2.58 (1H, d, J = 4.0 Hz), 2.56 (1H, d, J = 1.0 Hz), 1.85 (3H, s), 1.82 
(3H, d, J = 1.5 Hz), 1.27 (3H, t, J = 7.0 Hz); 
13
C NMR (125 MHz, CDCl3): δ 172.8, 
141.5, 137.0, 128.1, 115.6, 73.9, 61.0, 40.4, 23.7, 14.4, 13.9; IR (neat): 3466 (m), 3082 
(w), 2981 (m), 2938 (m), 1734 (s), 1719 (s), 1445 (m), 1371 (m), 1300 (m), 1272 (s), 
1178 (s), 1160 (s), 1019 (s), 894 (s), 522 (m); HRMS-(ESI
+
) for C11H27O2 [M-H2O+H]: 
calculated: 181.1229, found: 181.1231.  
 
 (E)-Ethyl-3-((tert-butyldimethylsilyl)oxy)-4,6-dimethylhepta-
4,6-dienoate (Table 3.2, entry 5). The compound was 
synthesized from 1.57-H following the representative TBS-protection procedure. 
1
H 
NMR (500 MHz, CDCl3): δ 5.87 (1H, s), 4.98 (1H, s), 4.80 (1H, s), 4.50 (1H, dd, J = 
9.0Hz, 4.5 Hz), 4.12 (2H, qd, J = 7.5 Hz, 7.5 Hz), 2.56 (1H, dd, J = 14.0 Hz, 9.0 Hz), 
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2.42 (1H, dd, J = 13.5 Hz, 4.0 Hz), 1.84 (3H, s), 1.77 (3H, s), 1.26 (3H, t, J = 7.0 Hz), 
0.86 (9H, s), 0.04 (3H, s), 0.00 (3H, s); 
13
C NMR (125 MHz, CDCl3): δ 171.6, 141.6, 
138.2, 115.3, 76.2, 60.6, 42.8, 25.9, 23.7, 18.3, 14.5, 13.0, −4.5, −5.1; IR (neat): 2956 
(m), 2930 (m), 2857 (m), 1738 (s), 1472 (w), 1463 (w), 1445 (w), 1371 (m), 1273 (m), 
1252 (s), 1165 (s), 1078 (s), 1024 (s), 1007 (s), 954 (m), 832 (s), 812 (m), 777 (s), 700 
(m), 666 (w); HRMS-(ESI
+
) for C17H33O3Si [M+H]: calculated: 313.2199, found: 
313.2201. The crude reaction mixture was purified by silica gel chromatography (40:1 
hexanes:diethyl ether) to afford a clear, colorless oil (198.0 mg, 84%). Rf = 0.30 (40:1 
hexanes: diethyl ether, stain in KMnO4). 
 
Preparation of (E)-3-((tert-butyldimethylsilyl)oxy)-N-methoxy-N,4,6-trimethylhepta-
4,6-dienamide 
 
A flame- dried two-neck round-bottom flask containing a magnetic stir bar was 
charged with N,O-dimethylhydroxylamine hydrochloride (237.0 mg, 2.44 mmol) and 
THF (3.25 mL). The flask was cooled to −78 °C and n-BuLi (2.0 mL, 4.88 mmol in 
hexanes) was added dropwise at −78 °C. The reaction was allowed to warm to room 
temperature and stir for 10 min. The flask was then cooled to −78 °C, and 1.59-H (120.0 
mg, 0.61 mmol) in THF (1.0 mL) was added dropwise at −78 °C and allowed to stir for 
2h at −78 °C. The reaction was quenched with saturated NH4Cl (5.0 mL), diluted with 
ethyl acetate (10 mL), and the layers were separated. The aqueous layer was extracted 
with ethyl acetate (3 x 10 mL) and the combined organics were dried over Na2SO4, 
 47 
 
filtered, and concentrated by rotary evaporation. The crude material was purified by silica 
gel chromatography (3:1 hexanes:diethyl ether) to afford the title compound as a clear, 
colorless oil (100.0 mg, 89%). Rf = 0.14 (3:1 hexanes:ethyl acetate, stain with KMnO4). 
 
 (E)-5-Hydroxy-2-methoxy-6,8-dimethylnona-6,8-dien-3-one 
(1.59-H). 
1
H NMR (500 MHz, CDCl3): δ 5.99 (1H, s), 5.00 
(1H, p, J = 1.5 Hz), 4.84 (1H, s), 4.46 (1H, d, J = 8.5 Hz), 3.86 (1H, s), 3.69 (3H, s), 3.20 
(3H, s), 2.71 (1H, d, J = 16.0 Hz), 2.61 (1H, dd, J = 16.5 Hz, 10.0 Hz), 1.86 (3H, s), 1.83 
(3H, s); 
13
C NMR (125 MHz, CDCl3): δ 173.8, 141.7, 137.3, 127.6, 115.4, 73.6, 61.5, 
37.3, 32.1, 23.8, 14.3; IR (neat): 3422 (m), 2965 (m), 2921 (m), 2855 (m), 1636 (s), 1440 
(s), 1385 (s), 1179 (m), 1105 (m), 997 (m), 939 (s), 890 (s), 603 (m), 524 (m), 485 (m), 
432 (s); HRMS-(ESI
+
) for C11H20O3N [M+H]: calculated: 214.1443, found: 214.1441. 
 
(E)-3-((tert-Butyldimethylsilyl)oxy)-N-methoxy-N,4,6-
trimethylhepta-4,6-dienamide (Table 3.2, entry 6). The 
compound was synthesized from 1.59-H following the representative TBS-protection 
procedure. 
1
H NMR (500 MHz, CDCl3): δ 5.92 (1H, s), 4.98 (1H, s), 4.80 (1H, s), 4.59 
(1H, dd, J = 9.5 Hz, 4.0 Hz), 3.71 (3H, s), 3.81 (3H, s), 2.89 (1H, t, J = 10.0 Hz), 2.33 
(1H, dd, J = 13.5 Hz, 4.0 Hz), 1.84 (3H, s), 1.80 (3H, s), 0.86 (9H, s), 0.04 (3H, s), 0.00 
(3H, s); 
13
C NMR (125 MHz, CDCl3): δ 141.8, 138.8, 127.7, 115.1, 77.6, 76.0, 61.6, 
39.4, 32.2, 26.0, 23.7, 18.4, 13.5, −4.6, −4.9; IR (neat): 2955 (m), 2930 (m), 2896 (w), 
2856 (m), 1664 (s), 1463 (m), 1441 (m), 1383 (s), 1250 (s), 1180 (m), 1004 (m), 972 (w), 
947 (m), 892 (m), 812 (s), 777 (s), 668 (w); HRMS-(ESI
+
) for C17H33O3NSi [M+H]: 
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calculated: 328.2308, found: 328.2315. The crude reaction mixture was purified by silica 
gel chromatography (10:1 hexanes:diethyl ether) to afford a clear, colorless oil (120.0 
mg, 72%). Rf = 0.17 (10:1 hexanes: ethyl acetate, stain in KMnO4). 
 
Preparation of (±)-tert-butyldimethyl(((E)-3,5,7-trimethylocta-1,5,7-trien-4-yl)oxy)-
silane 
 
To a flame-dried 20-dram vial with stir bar was added (E)-2-(but-2-en-1-yl)-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane
48
 (300 mg, 1.65 mmol) followed by aldehyde SI-
2 (173 mg, 1.57 mmol) in toluene (3.2 mL). The vial was capped and heated to 60 °C and 
allowed to stir for 12 h. The reaction mixture was cooled to 0 °C, diluted with THF (2 
mL), and 3 M NaOH (1 mL) was added. The mixture was allowed to stir for 1 h, then 
EtOAc (10 mL) and H2O (10 mL) were added and the layers were separated. The 
aqueous layer was extracted with ethyl acetate (3 x 10 mL), and the combined organics 
were dried over Na2SO4, filtered, and concentrated by rotary evaporation. The crude 
material was purified by silica gel chromatography (50:1 hexanes:EtOAc) to afford the 
title compound as a clear, colorless oil (156.0 mg, 60%). Rf = 0.30 (50:1 hexanes:ethyl 
acetate, stain with KMnO4).  
 
 
                                                     
48
 Zhang, P.; Roundtree, I. A.; Morken, J. P. Org. Lett. 2012, 14, 1416. 
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 (3S*,4S*,E)-3,5,7-Trimethylocta-1,5,7-trien-4-ol (1.60-H). 
1
H 
NMR (500 MHz, CDCl3): δ 5.86 (1H, s), 5.75 (1H, ddd, J = 17.5 Hz, 
10.0 Hz, 8.5 Hz), 5.21 (1H, ddd, J = 17.5 Hz, 2.0 Hz, 1.0 Hz), 5.17 (1H, ddd, 10.0 Hz, 
2.0 Hz, 1.0 Hz), 5.01 (1H, t, J = 1.5 Hz), 4.84 (1H, t, J = 1.0 Hz), 3.67 (1H, dd, J = 8.5 
Hz, 2.5 Hz), 2.35 (1H, ddq, J = 15.0 Hz, 8.0 Hz, 7.0 Hz), 1.88 (3H, s), 1.82 (3H, s), 0.92 
(3H, d, J = 7.0 Hz); 
13
C NMR (125 MHz, CDCl3): δ 141.6, 141.2, 136.8, 130.3, 116.8, 
115.4, 81.9, 42.6, 23.8, 17.0, 13.0; IR (neat): 3424 (w), 2963 (s), 2927 (s), 2858 (m), 
1637 (m), 1452 (s), 1373 (s), 1011 (s), 893 (s); HRMS-(ESI
+
) for C11H19O [M+H]: 
calculated: 167.1436, found: 167.1440. 
 
tert-butyldimethyl(((3S*,4S*,E)-3,5,7-trimethylocta-1,5,7-trien-
4-yl)oxy)silane (Table 3.2, entry 7). The title compound was 
synthesized from 1.60-H following the representative TBS-protection procedure. 
1
H 
NMR (500 MHz, CDCl3): δ 5.85 (1H, ddd, J = 17.0 Hz, 10.5, Hz, 7.5 Hz), 5.75 (1H, s), 
5.00 (1H, ddd, J = 10.5 Hz, 2.0 Hz, 2.0 Hz), 4.98-4.96 (1H, m), 4.97 (1H, s), 4.78 (1H, s), 
3.67 (1H, d, J = 7.5 Hz), 2.31 (1H, ddq, J = 7.5 Hz, 7.5 Hz, 7.5 Hz), 1.83 (3H, s), 1.74 
(3H, s), 0.92-0.83 (12H, m), 0.22 (3H, s), −0.03 (3H, s); 13C NMR (125 MHz, CDCl3): δ 
142.1, 141.9, 138.4, 128.9, 114.7, 114.0, 83.6, 42.4, 26.1, 23.8, 18.5, 16.8, 13.4, −4.3, 
−4.8; IR (neat): 2962 (s), 2929 (s), 2858 (s), 1636 (w), 1452 (m), 1252 (m), 1066 (s), 833 
(s), 773 (s);  HRMS-(ESI
+
) for C17H33OSi [M+H]: calculated: 281.2301, found: 281.2296. 
The crude reaction mixture was purified by silica gel chromatography (hexanes) to afford 
a clear, colorless oil (288 mg, 85%). Rf = 0.40 (hexanes, stain in KMnO4). 
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Preparation of (5R,6S)-2,2,3,3,6,9,9,10,10-nonamethyl-5-((E)-4-methylpenta-2,4-dien-
2-yl)-4,8-dioxa-3,9-disilaundecane 
 
To a flame-dried 100 mL round-bottom flask with magnetic stir bar was added 
(R)-4-benzyl-3-propionyloxazolidin-2-one then was purged with N2. The flask was 
cooled to 0 °C and CH2Cl2 (20 mL) and diisopropylethylamine (1.33 mL, 7.62 mmol) 
were added, followed by the dropwise addition of dibutylboryl trifluoromethanesulfonate 
(6.5 mL of a 1.0 M solution in CH2Cl2, 6.54 mmol). The reaction mixture was allowed to 
stir at 0 °C for 1 h then cooled to −78 °C. Aldehyde SI-2 (600 mg, 5.45 mmol) was then 
added and the reaction was allowed to stir for 30 min. The reaction mixture was warmed 
to 0 °C and allowed to stir for an additional 1 h, followed by the addition of pH=7 buffer 
(5 mL), MeOH (5 mL), and H2O2 (5 mL). The reaction mixture was allowed to stir for 1 
h, warming to room temperature, then diluted with EtOAc (50 mL) and the layers were 
separated. The aqueous layer was extracted with ethyl acetate (3 x 20 mL), and the 
combined organics were dried over Na2SO4, filtered, and concentrated by rotary 
evaporation. The crude material was purified by silica gel chromatography (4:1 
hexanes:EtOAc) to afford the title compound as a clear, yellow oil (1.44 g, 77%). Rf = 
0.10 (4:1 hexanes:ethyl acetate, stain with KMnO4). 
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 (R)-4-Benzyl-3-((2R,3R,E)-3-hydroxy-2,4,6-
trimethylhepta-4,6-dienoyl)oxazolidin-2-one (1.61-Au*). 
1
H 
NMR (500 MHz, CDCl3): δ 7.36-7.32 (2H, m), 7.30-7.28 (1H, 
m), 7.22-7.20 (2H, m), 6.05 (1H, d, J = 1.0 Hz), 5.00 (1H, t, J = 1.5 Hz), 4.82 (1H, t, J = 
1.0 Hz), 4.70 (1H, m), 4.40 (1H, s, br), 4.24-4.17 (2H, m), 4.02 (1H, dddd, J = 7.0 Hz, 
3.5 Hz, 3.5 Hz, 3.5 Hz), 3.27 (1H, dd, J = 13.5 Hz, 3.5 Hz), 2.93 (1H, d, J = 3.0 Hz), 
2.80 (1H, dd, J = 13.5 Hz, 9.5 Hz), 1.86 (3H, s), 1.79 (3H, d, J = 0.50 Hz), 1.21 (3H, d, J 
= 7.0 Hz); 
13
C NMR (125 MHz, CDCl3): δ 177.1, 152.9, 141.5, 135.0, 129.6, 129.2, 
128.0, 127.7, 115.2, 75.4, 66.2, 55.3, 40.3, 37.8, 23.7, 15.2, 10.4; IR (neat): 3508 (w), 
3083 (w), 3028 (w), 2972 (w), 1776 (s), 1696 (s), 1382 (s), 1209 (s), 1108 (s), 702 (s). 
HRMS-(ESI
+
) for C20H24NO3 [M+H-H2O]: calculated: 326.1756, found: 326.1753. [α]D
22
 
= −33.9 (c = 1.2, CHCl3, l = 50 mm). 
 
 A 20-dram vial containing a magnetic stir bar was charged with 1.61-Au*, MeOH 
(0.02 mL), and THF (1.8 mL) then sealed with a septum and cooled to 0 °C. Lithium 
borohydride (0.22 mL of a 2.0 M solution in tetrahydrofuan, 0.44 mmol) was added 
dropwise and the reaction was allowed to stir for 1 h. The reaction was quenched with 
H2O (2 mL) followed by the addition of saturated potassium sodium tartrate solution (5 
mL) and the reaction mixture was allowed to stir for 3 h. The reaction was diluted with 
EtOAc (10 mL) and the layers were separated. The aqueous layer was extracted with 
ethyl acetate (3 x 20 mL), and the combined organics were dried over Na2SO4, filtered, 
and concentrated by rotary evaporation. The crude material was purified by silica gel 
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chromatography (1:1 hexanes:EtOAc) to afford the title compound as a clear, yellow oil 
(73 mg, 98%). Rf = 0.2 (1:1 hexanes:ethyl acetate, stain with KMnO4).  
 
 (2S,3R,E)-2,4,6-Trimethylhepta-4,6-diene-1,3-diol (1.61-OH). 
1
H 
NMR (500 MHz, CDCl3): δ 5.92 (1H, d, J = 1.0 Hz), 4.99 (1H, t, J = 
1.5 Hz), 4.80 (1h, t, J = 1.5 Hz), 4.16 (1H, d, J = 4.0 Hz), 3.65 (2H, d, J = 5.5 Hz), 2.56 
(1H, s, br), 2.02 (3H, s), 1.90 (1H, dqd, J = 7.0 Hz, 5.5 Hz, 4.0 Hz), 1.85 (3H, s), 1.75 
(3H, d, J = 1.5Hz), 0.88 (3H, d, J = 7.0 Hz); 
13
C NMR (125 MHz, CDCl3): δ 141.7, 
137.8, 127.1, 115.0, 78.9, 66.9, 37.8, 24.0, 15.2, 10.5; IR (neat): 3373 (s), 2966 (s), 2932 
(s), 2876 (s), 1743 (m), 1629 (w), 1450 (s), 1375 (s), 1030 (s), 892 (s). HRMS-(ESI
+
) for 
C10H19O2 [M+H]: calculated: 171.1385, found: 171.1390. [α]D
22
 = +18.4 (c = 1.0, CHCl3, 
l = 50 mm).  
 
 (5R,6S)-2,2,3,3,6,9,9,10,10-Nonamethyl-5-((E)-4-methylpenta-
2,4-dien-2-yl)-4,8-dioxa-3,9-disilaundecane (Table 1.2, Entry 
8). The title compound was synthesized from 1.61-OH following the representative TBS-
protection procedure. 
1
H NMR (500 MHz, CDCl3): δ 5.82 (1H, s), 4.96 (1H, dd, J = 2.0 
Hz, 2.0 Hz), 4.77 (1H, s), 3.98 (1H, d, J = 5.5 Hz), 3.47 (1H, dd, J = 10.0 Hz, 6.0 Hz), 
3.51 (1H, dd, J = 10.0 Hz, 6.0 Hz), 1.81 (3H, s), 1.75-1.70 (1H, m), 1.71 (3H, d, J = 1.5 
Hz), 0.90 (9H, s), 0.89 (9H, s), 0.04 (3H, s), 0.02 (3H, s), 0.02 (3H, s), −0.02 (3H, s); 13C 
NMR (125 MHz, CDCl3): δ142.1, 138.3, 127.8, 114.3, 78.4, 65.5, 40.1, 26.1, 26.1, 24.1, 
18.5, 14.5, 12.0, −4.3, −4.95, −5.0, −5.2; IR (neat); 2956 (s), 2928 (s), 2857 (s), 1471 (m), 
1388 (w), 1252 (s), 1060 (s), 835 (s), 774 (s). HRMS-(ESI
+
) for C22H47O2Si2 [M+H]: 
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calculated: 399.3115, found: 399.3119. [α]D
22
 = +10.0 (c = 1.0, CHCl3, l = 50 mm). The 
crude reaction mixture was purified by silica gel chromatography (hexanes) to afford a 
clear, colorless oil (104.0 mg, 35%). Rf = 0.47 (hexanes, stain in KMnO4). 
 For preparation and characterization data of compound 1.63 (Table 1.2, Entry 9), 
see supporting information of Chapter 2. 
 
Preparation of (Z)-tert-butyl((3,5-dimethylhexa-3,5-dien-2-yl)oxy)dimethylsilane 
The title compound was synthesized as shown in the scheme below from the 
known alcohol SI-3.
49
 
 
A flame-dried 6-dram vial containing a magnetic stir bar, under nitrogen, was 
charged with t-BuLi (1.6 mL of a 1.6 M solution in pentane, 2.56 mmol) and Et2O (1.5 
mL). The vial was cooled to −78 °C and 2-bromopropene (0.20 mL, 1.28 mmol) was 
added dropwise. The reaction was allowed to stir for 30 min at −78 °C, then ZnCl2 (174.5 
mg, 1.28 mmol) in THF (3 mL) was added. The reaction was allowed to warm to room 
temperature and stir for 30 min. The reaction mixture was then transferred via cannula to 
a separate flame-dried 6-dram vial, with a magnetic stir bar, containing Pd(PPh3)4 (37 
mg, 0.032 mmol), SI-4 (209.0 mg, 0.64 mmol), and THF (2 mL). The reaction was 
allowed to stir at room temperature for 12 h, followed by filtration through a pad of silica 
gel, washing with Et2O. The solution was concentrated by rotary evaporation and the 
                                                     
49
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crude reaction mixture was purified by silica gel chromatography (400:1 hexanes:ethyl 
acetate) to afford a clear, colorless oil (104.0 mg, 68%). Rf = 0.50 (400:1 hexanes:ethyl 
acetate, stain in KMnO4). The product contains ~10% (E)-tert-butyl((3,5-dimethylhexa-
3,5-dien-2-yl)oxy)dimethylsilane.  
 
 (Z)-tert-Butyl((3,5-dimethylhexa-3,5-dien-2-yl)oxy)dimethylsilane 
(Table 1.3, entry 1). 
1
H NMR (500 MHz, CDCl3): δ 5.55 (1H, t, J =  
1.0 Hz), 4.97 (1H, q, J = 6.5 Hz), 4.95 (1H, t, J = 1.5 Hz), 4.61 (1H, q, J = 1.5 Hz), 1.79 
(3H, t, J = 1.0 Hz), 1.75 (3H, d, J = 1.5 Hz), 1.23 (3H, d, J = 6.5 Hz), 0.87 (9H, s), 0.00 
(3H, s), -0.02 (3H, s); 
13
C NMR (100 MHz, CDCl3): δ 141.9, 141.6, 126.5, 113.9, 66.4, 
26.1, 24.0, 23.4, 18.4, 17.5, −4.8, −4.8; IR (neat): 2955 (m), 2929 (m), 2857 (m), 1471 
(m), 1252 (s), 1078 (s), 832 (s), 773 (s); HRMS-(ESI
+
) for C14H29OSi [M+H]: calculated: 
241.1988, found: 241.1998.  
 
Proof of Stereochemistry 
(Z)-alkene stereochemistry was proven by NOE correlation as shown below. 
 
Preparation of Dienes in Table 1.3 
The dienes in Table 1.3 (entries 2-4) were prepared from the common vinyl iodide 
SI-6, which is available from the known alcohol SI-5.
50 
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A flame-dried 50 mL round-bottom flask containing a magnetic stir bar was 
cooled to 0 °C and charged wtih (E)-4-iodo-3-methylbut-3-en-2-ol SI-5 (1.07 g, 5.05 
mmol), CH2Cl2 (16 mL), imidazole (378.0 mg, 5.55 mmol), and TBSCl (837.0 mg, 5.55 
mmol). The reaction was allowed to stir for 12 h, warming to room temperature. The 
reaction was diluted with water and the layers were separated. The aqueous layer was 
extracted with CH2Cl2 (3 x 20 mL) and the combined organics were dried over Na2SO4, 
filtered, and concentrated by rotary evaporation.  
 
 (E)-tert-Butyl((4-iodo-3-methylbut-3-en-2-yl)oxy)dimethylsilane (SI-
6). 
1
H NMR (400 MHz, CDCl3): δ 6.19 (1H, s), 4.30 (1H, q, J = 6.0 Hz), 
1.79 (3H, d, J = 1.2 Hz), 1.21 (3H, d, J = 6.0 Hz), 0.88 (9H, s), 0.04 (3H, s), 0.01 (3H, s); 
13
C NMR (100 MHz, CDCl3): δ 151.7, 76.9, 73.3, 26.0, 23.4, 20.1, 18.4, −4.8, −4.8; IR 
(neat): 2954 (m), 2929 (m), 2857 (m), 1471 (w), 1252 (m), 1088 (s), 834 (s), 775 (s); 
HRMS-(ESI
+
) for C11H27INOSi [M+NH4]: calculated: 344.0907, found: 344.0919. The 
crude reaction mixture was purified by silica gel chromatography (hexanes) to afford a 
clear, colorless oil (1.38 g, 84%). Rf = 0.48 (hexanes, stain in KMnO4). 
 
Preparation of (E)-tert-butyldimethyl((3-methylhexa-3,5-dien-2-yl)oxy)silane 
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In the dry-box, a flame-dried round bottom flask containing a magnetic stir bar, 
was charged with Pd(PPh3)4 (54.5 mg, 0.05 mmol). The flask was sealed with a septum, 
removed from the box and cooled to 0 °C. (E)-4-Iodo-3-methylbut-3-en-2-ol SI-5 (200 
mg, 0.94 mmol) in toluene (6.8 mL) was then added  and allowed to stir for 20 min, 
followed by the dropwise addition of vinyl magnesium bromide (2.82 mL, 1.0 M in THF, 
2.82 mmol). The solution was allowed to stir for 1 h at 0 °C, then was warmed to room 
temperature and allowed to stir for an additional 30 min. The reaction was quenched with 
a saturated solution of ammonium chloride (5 mL) followed by the addition of water (5 
mL) and the layers were separated. The aqueous layer was extracted with ethyl acetate (3 
x 10 mL), and the combined organics were dried over Na2SO4 and concentrated by rotary 
evaporation. The crude material was purified by silica gel chromatography (44.0 mg, 
42%). The representative procedure for TBS-protection of dienols was used to make the 
titled diene 1.66. 
 
 (E)-tert-Butyldimethyl((3-methylhexa-3,5-dien-2-yl)oxy)silane 
(Table 1.3, entry 2). 
1
H NMR (500 MHz, CDCl3): δ 6.58 (1H, dt, J = 
17.0 Hz, 11.0 Hz), 6.19 (1H, d, J = 11.0 Hz), 5.16 (1H, dd, J = 17.0 Hz, 2.5 Hz), 5.06 
(1H, dd, J = 10.0 Hz, 2.0 Hz), 4.20 (1H, q, J = 6.5 Hz), 1.73 (3H, d, J = 1.0 Hz), 1.21 
(3H, d, J = 6.5 Hz), 0.89 (9H, s), 0.05 (3H, s), 0.02 (3H, s); 
13
C NMR (125 MHz, 
CDCl3): δ 142.7, 133.3, 124.1, 73.7, 26.1, 26.0, 23.4, 18.5, 12.4, −4.6, −4.7; HRMS-
(ESI
+
) for C13H27OSi [M+H]: calculated: 227.1831, found: 227.1842. The crude reaction 
mixture was purified by silica gel chromatography (hexanes) to afford a clear, colorless 
oil (55.0 mg, 62%). Rf = 0.34 (hexanes, stain in KMnO4). 
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Representative procedure for Negishi cross-coupling 
A flame-dried 6-dram vial containing a magnetic stir bar, under an atmosphere of 
nitrogen, was charged with t-BuLi (2.2 mL of a 1.6 M solution in pentane, 3.50 mmol) 
and Et2O (2 mL). The vial was cooled to −78 
o
C and α-bromostyrene (0.23 mL, 1.75 
mmol) was added dropwise. The reaction was allowed to stir for 30 min at −78 oC, then 
ZnCl2 (238 mg, 1.75 mmol) in THF (2 mL) was added. The reaction was allowed to 
warm to room temperature and stir for 30 min. The reaction mixture was then transferred 
via cannula to a separate flame-dried 6-dram vial, containing a magnetic stir bar, 
Pd(PPh3)4 (67.0 mg, 0.060 mmol), SI-6 (380.0 mg, 1.16 mmol), and THF (2 mL). The 
reaction was allowed to stir at room temperature for 12 h, followed by filtration through a 
pad of silica gel, washing with Et2O. The solution was concentrated by rotary 
evaporation. The crude reaction mixture was purified by silica gel chromatography 
(hexanes) to afford a clear, colorless oil (248.0 mg, 70%). Rf = 0.38 (hexanes, stain in 
KMnO4). 
 
 (E)-tert-Butyldimethyl((3-methyl-5-phenylhexa-3,5-dien-2-
yl)oxy)silane (Table 1.3, entry 3). 
1
H NMR (400 MHz, CDCl3): δ 
7.40-7.37 (2H, m), 7.34- 7.24 (3H, m), 6.17 (1H, s), 5.56 (1H, d, J = 1.6 Hz), 5.10 (1H, t, 
J = 1.6 Hz), 4.30 (1H, q, J = 6.4 Hz), 1.66 (3H, d, J = 1.2 Hz), 1.28 (3H, d, J = 6.4 Hz), 
0.92 (9H, s), 0.09 (3H, s), 0.08 (3H, s); 
13
C NMR (100 MHz, CDCl3): δ 145.1, 144.0, 
141.4, 128.4, 127.6, 126.7, 123.5, 114.9, 74.0, 26.1, 23.7, 18.5, 13.8, −4.5, −4.7; IR 
(neat): 3082 (w), 3026 (m), 2929 (m), 1462 (w), 1250 (m), 1084 (s), 834 (s), 774 (s), 703 
(s); HRMS-(ESI
+
) for C19H31OSi [M+H]: calculated: 303.2144, found: 303.2129.  
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 (E)-tert-Butyl((5-(dimethyl(phenyl)silyl)-3-methylhexa-3,5-
dien-2-yl)oxy)dimethylsilane (Table 1.3, entry 4). The title 
compound was synthesized following the representative Negishi cross-coupling 
procedure with (1-bromovinyl)dimethyl(phenyl)silane.
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1
H NMR (400 MHz, CDCl3): δ 
7.51-7.49 (2H, m), 7.35-7.32 (3H, m), 5.94 (1H, s), 5.60 (1H, dd, J = 3.6 Hz, 2.0 Hz), 
5.54 (1H, dd, J = 3.6 Hz, 1.2 Hz), 4.15 (1H, q, J = 6.4 Hz), 1.60 (3H, d, J = 1.2 Hz), 1.18 
(3H, d,  J = 6.4 Hz), 0.85 (9H, s), 0.35 (6H, s), 0.00 (3H, s), −0.04 (3H, s); 13C NMR 
(100 MHz, CDCl3): δ148.2, 140.2, 138.2, 134.2, 129.2, 128.0, 127.9, 125.1, 74.0, 26.1, 
23.7, 18.4, 12.9, −3.0, −3.1, −4.6, −4.8; IR (neat): 2955 (m), 2928 (m), 2857 (w), 1471 
(w), 1248 (s), 1083 (s), 1053 (s), 832 (s), 773 (s), 773 (s), 698 (s); HRMS-(ESI
+
) for 
C21H35OSi2 [M+H]: calculated: 359.2226, found: 359.2231. The crude reaction mixture 
was purified by silica gel chromatography (hexanes) to afford a clear, colorless oil (648.0 
mg, 95%). Rf = 0.23 (hexanes, stain in KMnO4). The purified product was not reactive in 
the hydroboration reaction. To further purify, the product was heated with a heat gun 
while under vacuum to remove any volatiles. The oil was then filtered through a pad of 
silica gel, washing with hexanes. The resulting diene was a 3:1 E:E to E:Z mixture.  
 
II. Representative Procedure for Diene Hydroboration/Oxidation & Full Charac-
terization and Proof of Stereochemistry 
In the dry-box, an oven-dried 6-dram vial containing a magnetic stir bar was 
charged successively with Ni(cod)2 (0.20 mL of a 31.30 µM solution of Ni(cod)2 in THF, 
6.20 µmol), PCy3 (0.2 mL of a  31.3 0 µM solution of PCy3 in THF, 6.20 µmol), THF 
(1.00 mL, 0.25M), pinacolborane (33.5 mg, 0.26 mmol), and (E)-tert-butyl((3,5-
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dimethylhexa-3,5-dien-2-yl)oxy)dimethylsilane (60 mg, 0.25 mmol). The vial was sealed 
with a polypropylene cap, removed from the dry-box, immediately cooled to °C 
(ice/water), and allowed to stir for 3 h. The reaction mixture was kept at 0 °C and charged 
with 3 M sodium hydroxide (1 mL), and 30% hydrogen peroxide (0.75 mL). The reaction 
was gradually warmed to room temperature and allowed to stir for 4 h, at which time the 
vial was cooled to 0 °C (ice/water) and saturated aqueous sodium thiosulfate (1 mL) was 
added dropwise. The reaction mixture was diluted with ethyl acetate and the layers were 
separated. The aqueous layer was extracted with ethyl acetate (3 x 15 mL) and the 
combined organic layers were dried over Na2SO4, filtered, and concentrated by rotary 
evaporation. The crude reaction mixture was purified by silica gel chromatography.  
 
syn-(Z)-2,4-Dimethylhex-2-ene-1,5-diol (Table 1.1, entry 10). 
1
H 
NMR (500 MHz, CDCl3): δ 5.09 (1H, d, J = 11.5 Hz), 4.20 (1H, d, J 
= 11.5 Hz), 3.79 (1H, d, J = 11.5 Hz), 3.66 (1H, qd, J = 6.5 Hz, 6.5 
Hz), 2.66-2.62 (1H, m), 1.80 (3H, s), 1.05 (3H, d, J = 6.5 Hz), 0.91 (3H, d, J = 6.5 Hz); 
13
C NMR (100 MHz, CDCl3): δ 136.9, 129.6, 71.4, 61.5, 38.6, 22.7, 18.3, 17.9; IR (neat): 
3315 (m), 2967 (m), 2930 (m), 2873 (m), 1450 (m), 1375 (m), 1316 (w), 1192 (w), 1155 
(w), 1087 (m), 1003 (s), 949 (m), 932 (m), 901 (m), 866 (w), 602 (m), 559 (m); HRMS-
(ESI
+
) for C8H18O2 [M+H]: calculated: 145.1229, found: 145.1225. The crude reaction 
mixture was purified by silica gel chromatography (1:1 hexanes:diethyl ether) to afford a 
clear, colorless oil (47.0 mg, 56%, 6:1 dr). Rf = 0.19 (1:1 hexanes:ethyl acetate, stain in 
PMA). 
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Proof of Stereochemistry: (Z)-alkene stereochemistry was proven by NOE correlation as 
shown below. Syn-stereochemistry was proven by converting to known diol
52
  by 
ozonolysis/reduction. 
 
 
syn-(Z)-5-((tert-Butyldimethylsilyl)oxy)-2,4-dimethylhex-2-en-1-ol 
(Table 1.1, entry 5). 
1
H NMR (500 MHz, C6D6): δ 5.03 (1H, d, J = 
10.0 Hz), 4.01 (1H, d, J = 12.0 Hz), 3.90 (1H, d, J = 11.5 Hz), 3.51 (1H, quin, J = 6.0 
Hz), 2.48 (1H, ddq, J = 10.0 Hz, 7.0 Hz, 5.5 Hz), 1.78 (3H, d, J = 1.5 Hz), 1.03 (3H, d, J 
= 6.5 Hz), 0.99 (9H, s), 0.96 (3H, d, J = 7.0 Hz), 0.07 (3H, s), 0.06 (3H, s); 
13
C NMR 
(125 MHz, C6D6): δ 136.1, 131.1, 73.6, 62.1, 40.5, 26.5, 22.4, 21.4, 18.8, 18.2, −3.9, 
−4.3; IR (neat): 3334 (br, w), 2957 (m), 2929 (m), 2856 (m), 1462 (w), 1253 (s), 1093 
(s), 1005 (s), 959 (s), 834 (s), 773 (s); HRMS-(ESI
+
) for C14H31O2Si [M+H]: calculated: 
259.2093, found: 259.2089. The crude reaction mixture was purified by silica gel 
chromatography (10:1 hexanes:ethyl acetate) to afford a clear, colorless oil (57.0 mg, 
89%, 14:1 dr). Rf = 0.24 (10:1 hexanes:ethyl acetate, stain in PMA). 
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Proof of Stereochemistry: (Z)-alkene and syn-stereochemistry were proven by 
comparison to (Z)-2,4-dimethylhex-2-ene-1,5-diol (Table 1.1, entry 10) after deprotection 
as shown below.  
 
 
syn-(Z)-2,4-Dimethyl-5-((triethylsilyl)oxy)hex-2-en-1-ol (Table 
1.1, entry 7). 
1
H NMR (500 MHz, C6D6): δ 5.04 (1H, ddd, J = 10.0 
Hz, 1.5 Hz, 1.0 Hz), 4.12 (1H, d, J = 11.5 Hz), 3.89 (1H, d, J = 12.0 Hz), 3.56 (1H, dq, J 
= 6.0 Hz, 5.0 Hz), 2.57 (1H, ddq, J = 10.0 Hz, 7.0 Hz, 5.0 Hz), 1.82 (3H, d, J = 1.5 Hz), 
1.03 (3H, d, J = 6.0 Hz), 1.00 (9H, t, J = 8.0 Hz), 0.94 (3H, d, J = 8.0 Hz), 0.61 (6H, q, J 
= 8.0 Hz); 
13
C NMR (100 MHz, C6D6): δ 137.1, 130.4, 73.5, 62.1, 40.4, 22.7, 20.5, 18.4, 
7.5, 5.6; IR (neat): 3322 (br, w), 2957 (s), 2930 (s), 2856 m), 1472 (m), 1251 (s), 1085 
(s), 1050 (s), 938 (s), 771 (s); HRMS-(ESI
+
) for C14H31O2Si [M+H]: calculated: 
259.2093, found: 259.2090. The crude reaction mixture was purified by silica gel 
chromatography (10:1 hexanes:ethyl acetate) to afford a clear, colorless oil (61.3 mg, 
95%, 12:1 dr). Rf = 0.30 (10:1 hexanes:ethyl acetate, stain in PMA). 
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Proof of Stereochemistry: (Z)-alkene and syn-stereochemistry were proven by 
comparison to (Z)-2,4-dimethylhex-2-ene-1,5-diol (Table 1.1, entry 10) after deprotection 
as shown below.  
 
 
syn-(Z)-5-((tert-Butyldiphenylsilyl)oxy)-2,4-dimethylhex-2-en-1-ol 
(Table 1.1, entry 8). 
1
H NMR (500 MHz, CDCl3): δ 7.70-7.67 (4H, 
m), 7.44-7.35 (6H, m), 5.17 (1H, d, J = 10.5 Hz), 4.07 (1H, d, J = 
11.5 Hz), 4.00 (1H, d, J = 12.0 Hz), 3.72 (1H, quin, J = 6.5 Hz), 2.55 (1H, dqd, J = 10.0 
Hz, 6.5 Hz, 6.5 Hz), 1.79 (3H, s), 1.06 (9H, s), 0.94 (3H, d, J = 6.5 Hz), 0.94 (3H, d, J 
=7.0 Hz); 
13
C NMR (125 MHz, CDCl3): δ 136.2, 136.1, 135.0, 134.7, 134.3, 131.6, 
130.0, 129.7, 127.7, 127.6, 74.1, 62.2, 39.7, 27.3, 21.8, 20.4, 19.6, 17.5; IR (neat): 3341 
(w), 3071 (w), 2964 (m), 2931 (m), 2858 (m), 1472 (w), 1427 (m), 1376 (w), 1109 (s), 
1007 (s), 958 (m), 739 (m), 701 (s), 688 (m), 611 (m), 505 (s), 488 (m); HRMS-(ESI
+
) 
for C24H35O2Si [M+H]: calculated: 383.2406, found: 383.2408. The crude reaction 
mixture was purified by silica gel chromatography (2:1 hexanes:diethyl ether) to afford a 
clear, colorless oil (28.0 mg, 80%,  >20:1 dr). Rf = 0.48 (1:1 hexanes:diethyl ether, stain 
in PMA). 
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Proof of Stereochemistry: (Z)-alkene geometry and syn-stereochemistry were proven by 
comparison to (Z)-2,4-dimethylhex-2-ene-1,5-diol (Table 1.1, entry 1) after deprotection 
as shown below.  
 
 
syn-(Z)-5-(Benzyloxy)-2,4-dimethylhex-2-en-1-ol (Table 1.1, entry 
9). The reaction was performed with the representative procedure but 
for 12 h. 
1
H NMR (500 MHz, CDCl3): δ 7.35-7.34 (4H, m), 7.32-7.26 (1H, m), 5.10 (1H, 
d, J = 10.0 Hz), 4.61 (1H, d, J = 11.5 Hz), 4.46 (1H, d, J = 11.5 Hz), 3.77 (1H, br, d, J = 
11.0 Hz), 3.40 (1H, quin, J = 6.5 Hz), 2.8-2.75 (1H, m), 2.50 (1H, br, s), 1.82 (3H, s), 
1.11 (3H, d, J = 6.0 Hz), 0.96 (3H, d, J = 7.0 Hz); 
13
C NMR (125 MHz, CDCl3): δ 138.4, 
136.8, 129.9, 128.6, 128.1, 127.9, 79.1, 70.9, 61.8, 37.3, 22.7, 18.3, 14.8; IR (neat): 3395 
(m), 2968 (m), 2929 (m), 2870 (m), 1452 (m), 1474 (m), 1203 (w), 1094 (s), 1064 (s), 
1005 (s), 947 (w), 929 (w), 865 (w), 735 (s), 697 (s), 610 (w); HRMS-(ESI
+
) for 
C15H23O2 [M+H]: calculated: 235.1698, found: 235.1720. The crude reaction mixture was 
purified by silica gel chromatography (2:1 hexanes:diethyl ether) to afford a clear, 
colorless oil (46.8 mg, 72%, 7:1 dr). Rf = 0.35 (1:1 hexanes:diethyl ether, stain in PMA). 
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Proof of Stereochemistry: (Z)-alkene stereochemistry was proven by NOE correlation as 
shown below. Syn-stereochemistry was proven by converting to known compound
53
 by 
ozonolysis/reduction. 
 
 
syn-(Z)-5-((tert-Butyldimethylsilyl)oxy)-2,4-dimethylnon-2-en-1-
ol (Table 1.2, entry 1). 
1
H NMR (500 MHz, CDCl3): δ 5.16 (1H, d, 
J = 10.0 Hz), 4.11 (1H, d, J = 11.5 Hz), 4.04 (1H, d, J = 11.5 Hz), 3.47 (1H, dt, J = 6.0 
Hz, 4.5 Hz), 2.55 (1H, ddq, J = 10.0 Hz, 7.0 Hz, 4.5 Hz), 1.80 (3H, d, J = 1.5 Hz), 1.62 
(1H, br, s), 1.48-1.34 (2H, m), 1.30-1.23 (4H, m), 0.93 (3H, d, J = 7.0 Hz), 0.90 (9H, s), 
0.88 (3H, t, J = 7.0 Hz), 0.05 (3H, s), 0.04 (3H, s); 
13
C NMR (125 MHz, CDCl3): δ 
134.1, 132.3, 77.0, 62.0, 37.5, 34.3, 27.7, 26.3, 23.2, 21.9, 18.5, 17.2, 14.3, −4.1, −4.2; IR 
(neat): 3335 (br, w), 2956 (s), 2930 (s), 2858 (s), 1461 (m), 1253 (s), 1005 (s), 834 (s), 
773 (s); HRMS-(ESI
+
) for C17H37O2Si [M+H]: calculated: 301.2563, found: 301.2570. 
The crude reaction mixture was purified by silica gel chromatography (10:1 
hexanes:ethyl acetate) to afford a clear, colorless oil (57.3 mg, 92%, >20:1 dr). Rf = 0.41 
(10:1 hexanes:ethyl acetate, stain in PMA). 
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Proof of Stereochemistry: (Z)-alkene stereochemistry was proven by NOE correlation as 
shown below. The relative configuration was assigned by comparison of the 
1
H NMR 
spectrum with the known diol,
54
  after conversion of the title compound to the known diol 
by ozonolysis/reduction/deprotection as shown below. 
 
 
syn-(Z)-5-((tert-Butyldimethylsilyl)oxy)-2,4,6-trimethylhept-2-en-
1-ol (Table 1.2, entry 2). The reaction was performed with the 
representative procedure but for 12 h. 
1
H NMR (500 MHz, CDCl3): 
δ 5.14 (1H, d, J = 10.0 Hz), 4.10 (2H, s), 3.19 (1H, t, J = 4.5 Hz), 2.58 (1H, qdd, J = 
12.5Hz, 4.0 Hz, 4.0 Hz), 1.78 (3H, s), 1.76-1.68 (1H, m), 0.93 (3H, d, J = 6.0 Hz), 0.91 
(9H, s), 0.88 (3H, d, J = 7.5 Hz), 0.83 (3H, d, J = 6.0 Hz), 0.04 (6H, s); 
13
C NMR (125 
MHz, CDCl3): δ 133.3, 133.0, 81.8, 62.1, 36.5, 32.1, 26.5, 21.7, 20.7, 18.8, 18.1, 17.7, 
−3.4, −3.5; IR (neat): 3310 (w), 2957 (m), 2930 (m), 2857 (m), 1472 (m), 1462 (m), 1384 
(w), 1252 (m), 1182 (w), 1119 (m), 1086 (m), 1049 (s), 972 (w), 939 (w), 834 (s), 797 
(m), 771 (s), 671 (m); HRMS-(ESI
+
) for C16H35O2Si [M+H]: calculated: 287.2406, 
found: 287.2400. The crude reaction mixture was purified by silica gel chromatography 
(2:1 hexanes:diethyl ether) to afford a clear, colorless oil (67.0 mg, 98%, 10:1 dr). Rf = 
0.51 (1:1 hexanes:ethyl acetate, stain in PMA). 
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Proof of Stereochemistry: (Z)-alkene stereochemistry was proven by NOE correlation as 
shown below. Syn-stereochemistry was proven by converting to the known compound
55
 
by ozonolysis/reduction. 
 
 
 syn-(Z)-5-((tert-Butyldimethylsilyl)oxy)-2,4,6,6-tetramethylhept-
2-en-1-ol (Table 1.2, entry 3). The reaction was performed with the 
representative procedure but ran for 12 h at rt. 
1
H NMR (400 MHz, CDCl3): δ 5.34 (1H, 
d, J = 10.0 Hz), 4.14 (1H, d, J = 12.0 Hz), 4.11 (1H, d, J = 12.0 Hz), 3.19 (1H, d, J = 2.0 
Hz), 2.76 (1H, ddq, J = 10.0 Hz, 6.5 Hz, 2.0 Hz), 1.78 (3H, d, J = 1.5 Hz), 1.3 (1H, br, 
s), 0.95-0.92 (12H, m), 0.89 (9H, s), 0.08 (3H, s), 0.04 (3H, s); 
13
C NMR (100 MHz, 
CDCl3): δ 135.9, 131.3, 83.8, 61.8, 37.2, 33.9, 27.4, 26.6, 21.5, 19.0, 17.0, -2.6, -3.8; IR 
(neat): 3314 (br, w), 2955 (s), 2930 (s), 2857 (s), 1472 (m), 1252 (s), 1096 (s), 1026 (s), 
876 (s), 770 (s); HRMS-(ESI
+
) for C17H37O2Si [M+H]: calculated: 301.2563, found: 
301.2552. The crude reaction mixture was purified by silica gel chromatography (10:1 
hexanes:ethyl acetate) to afford a clear, colorless oil (57.0 mg, 89%, 7:1 dr). Rf = 0.35 
(10:1 hexanes:ethyl acetate, stain in PMA). 
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Proof of Stereochemistry: (Z)-alkene stereochemistry was proven by NOE correlation as 
shown below. Syn-stereochemistry was proven by analyzing the chemical shift (3.51 ppm 
in CDCl3) and J-value (1.5 Hz) between H3 and H2 of the diol shown below synthesized 
by ozonolysis/reduction.
56
 
 
 
 syn-(Z)-8-(benzyloxy)-5-((tert-butyldimethylsilyl)oxy)-
2,4-dimethyloct-2-en-1-ol (Table 1.2, entry 4). 
1
H NMR 
(500 MHz, CDCl3): δ 7.36-7.25 (5H, m), 5.06 (1H, d, J = 10.0 Hz), 4.50 (1H, d, J = 12.0 
Hz), 4.47 (1H, d, J = 12.0 Hz), 4.25 (1H, dd, J = 12.0 Hz, 4.0 Hz), 3.87 (1H, dd, J = 11.5 
Hz, 8.0 Hz), 3.57 (1H, ddd, J = 9.0 Hz, 5.0 Hz, 5.0 Hz), 3.49-3.46 (1H, m), 3.37-3.33 
(1H, m), 2.60 (1H, qdd, J = 10.5 Hz, 6.5 Hz, 6.5 Hz), 2.16 (1H, dd, J = 4.0 Hz, 4.0 Hz), 
1.77 (3H, s), 1.64-1.62 (3H, m), 1.49-1.43 (1H, m), 0.94 (3H, d, J = 6.5Hz), 0.89 (9H, s), 
0.05 (3H, s), 0.03 (3H, s); 
13
C NMR (100 MHz, CDCl3): δ 138.5, 134.6, 131.7, 128.6, 
128.0, 127.8, 76.3, 73.2, 70.6, 61.8, 37.2, 31.3. 26.2, 24.8, 21.8, 18.5, 18.0, −4.1, −4.3; IR 
(neat): 3395 (m), 1968 (m), 2929 (m), 2870 (m), 1452 (m), 1474 (m), 1203 (w), 1094 (s), 
1064 (s), 1005 (s), 947 (w), 929 (w), 865 (w), 735 (s), 697 (s), 610 (w); HRMS-(ESI
+
) for 
C23H41O3Si [M+H]: calculated: 393.2825, found: 393.2813. The crude reaction mixture 
was purified by silica gel chromatography (6:1 hexanes:diethyl ether) to afford a clear, 
colorless oil (41.0 mg, 88%, >20:1 dr). Rf = 0.51 (3:1 hexanes:ethyl acetate, stain in 
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PMA). 
 
Proof of Stereochemistry: (Z)-alkene stereochemistry proven by NOE correlation as 
shown below. Syn-stereochemistry was proven by converting to known compound
57
 by 
ozonolysis/reduction. 
 
 
 syn-(Z)-Ethyl-3-((tert-butyldimethylsilyl)oxy)-7-hydroxy-
4,6-dimethylhept-5-enoate (Table 1.2, entry 5). The reaction 
was performed with the representative procedure but oxidized with pH=7 buffer instead 
of 3 M NaOH.  
1
H NMR (500 MHz, CDCl3): δ 5.04 (1H, d, J = 11.5 Hz), 4.28 (1H, d, J 
= 11.5 Hz), 4.10 (2H, dq, J = 8.5Hz, 7.5 Hz), 3.88 (1H, d, J = 12.0 Hz), 3.83 (1H, td, J = 
5.5 Hz, 5.5 Hz), 2.70 (1H, qdd, J = 10.5 Hz, 7.0 Hz, 7.0 Hz), 2.46 (2H, d, J = 5.5 Hz), 
1.79 (3H, s), 1.25 (3H, t, J =7.5 Hz), 0.96 (3H, d, J = 6.5 Hz), 0.88 (9H, s), 0.07 (3H, s), 
0.06 (3H, s); 
13
C NMR (125 MHz, CDCl3): δ 172.4, 135.8, 130.9, 73.9, 61.9, 60.8, 41.1, 
38.6, 26.0, 22.1, 18.3, 17.8, 14.3, −4.4, −4.5; IR (neat): 2957 (m), 2930 (m), 2857 (m), 
1725 (s), 1472 (w), 1462 (w), 1374 (m), 1252 (s), 1175 (m), 1070 (s), 1006 (s), 940 (m), 
832 (s), 774 (s), 666 (w); HRMS-(ESI
+
) for C17H35O4Si [M+H]: calculated: 331.2305, 
found: 331.2292. The crude reaction mixture was purified by silica gel chromatography 
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(3:1 hexanes:diethyl ether) to afford a clear, colorless oil (27.0 mg, 80%, >20:1 dr). Rf = 
0.57 (3:1 hexanes:ethyl acetate, stain in PMA). 
 
Proof of Stereochemistry: (Z)-alkene stereochemistry was proven by NOE correlation as 
shown below. Syn-stereochemistry was proven by converting to the known compound
12
 
shown below. 
 
 
 (4R,5S,6S,Z)-5,7-Bis((tert-butyldimethylsilyl)oxy)-2,4,6-
trimethylhept-2-en-1-ol (Table 1.2, entry 8). The reaction 
was performed with the representative procedure but at 0 °C 
for 12 h. 
1
H NMR (500 MHz, CDCl3): δ 5.06 (1H, d, J = 10.0 Hz), 4.12 (1H, d, J = 11.5 
Hz), 3.60 (1H, dd, J = 7.0 Hz, 2.5 Hz), 3.41 (1H, dd, J = 10.0 Hz, 8.0 Hz), 3.35 (1H, dd, 
J = 10.0 Hz), 2.58 (1H, dqd, J = 10.0 Hz, 7.0 Hz, 7.0 Hz), 1.77, (3H, s), 1.71 (1H, dq, J 
= 7.0 Hz, 2.0 Hz), 0.94 (3H, d, J = 6.5 Hz), 0.89 (9H, s), 0.87 (9H, s), 0.75 (3H, d, J = 
7.0 Hz), 0.05 (3H, s), 0.04 (3H, s), 0.02 (6H, s); 
13
C NMR (125 MHz, CDCl3): δ 133.7, 
132.8, 75.8, 66.0, 62.1, 39.3, 37.3, 26.5, 26.4, 21.8, 19.0, 18.8, 18.4, 10.8, −3.4, −3.8, 
−5.0, −5.1; IR (neat): 3345 (w), 2928 (s), 2980 (s), 2857 (s), 1472 (w), 1253 (s), 1089 (s), 
835 (s), 774 (s). HRMS-(ESI
+
) for C22H49O3Si2 [M+H]: calculated: 417.3220, found: 
417.3211. [α]D
22
 = +10.0 (c = 1.0, CHCl3, l = 50 mm). The crude reaction mixture was 
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purified on silica gel (10:1 hexanes:ethyl acetate) to afford a clear, colorless oil (57.8 mg, 
92%, 6:1 dr). Rf = 0.40 (10:1 hexanes:ethyl acetate, stain in PMA). 
 
Proof of Stereochemistry: (Z)-alkene stereochemistry proven by NOE correlation as 
shown below. Syn-stereochemistry was proven by ozonolysis/reduction/protection to 
furnish the symmetrical compound as determined by 
1
H and 
13
C NMR. 
 
 
 (6R,7r,8S)-7-((tert-Butyldimethylsilyl)oxy)-
2,2,3,3,6,8,11,11,12,12-decamethyl-4,10-dioxa-3,11-
disilatridecane. Representative 
1
H and 
13
C NMR signals: 
1
H NMR (500 MHz, C6D6): δ 
3.75 (1H, dd, J = 3.5 Hz, 3.5 Hz), 3.52 (2H, dd, J = 9.5 Hz, 6.0 Hz), 3.35 (2H, dd, J = 
9.5 Hz, 7.0 Hz), 1.76 (2H, m), 0.89 (27H, s), 0.86 (3H, d, J = 7.0 Hz), 0.04-0.03 (18H, 
m); 
13
C NMR (100 MHz, CDCl3): δ 72.8, 66.1, 40.5, 26.4, 18.7, 18.5, 12.8, −3.8, −5.1, 
−5.1. 
 
 (4S,5R,6S,Z)-5,7-Bis((tert-butyldimethylsilyl)oxy)-2,4,6-
trimethylhept-2-en-1-ol. (Table 1.2, entry 9). For full 
characteristic data see Chapter 2. 
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syn-(Z)-5-((tert-Butyldimethylsilyl)oxy)-4-methyl-2-phenylhex-2-
en-1-ol (Table 1.3, entry 3). The reaction was performed with the 
representative procedure but at rt for 12 h. 
1
H NMR (500 MHz, C6D6): δ 7.52 (2H, dd, J 
= 7.0 Hz, 1.0 Hz), 7.20 (2H, dd, J = 7.5 Hz, 7.5 Hz), 7.11 (1H, ddt, J = 7.5 Hz, 7.5 Hz, 
1.0 Hz), 5.62 (1H, d, J = 10.5 Hz), 4.43 (1H, d, J = 12.0 Hz), 4.35 (1H, d, J = 12.0 Hz), 
3.59 (1H, dq, J = 11.5 Hz, 5.0 Hz), 2.68 (1H, ddq, J = 10.0 Hz, 6.5 Hz, 5.0 Hz), 1.82 
(1H, br s), 1.01 (3H, d, J = 6.0 Hz), 0.98 (9H, s), 0.07 (3H, s), 0.06 (3H, s); 
13
C NMR 
(100 MHz, C6D6): δ 142.8, 141.0, 134.7, 129.0, 127.6, 127.2, 73.6, 60.7, 41.2, 26.5, 21.0, 
18.9, 18.2, −3.9, −4.3; IR (neat): 3383 (br, w), 2957 (s), 2856 (m), 1462 (m), 1253 (s), 
1094 (s), 1005 (s), 834 (s), 772 (s); HRMS-(ESI
+
) for C19H33O2Si [M+H]: calculated: 
321.2250, found: 321.2249. The crude reaction mixture was purified on silica gel (10:1 
hexanes:ethyl acetate) to afford a clear, colorless oil (59.0 mg, 93%, 9:1 dr). Rf = 0.38 
(10:1 hexanes:ethyl acetate, stain in PMA). 
 
Proof of Stereochemistry: (Z)-alkene stereochemistry proven by NOE correlation as 
shown below. Syn-stereochemistry was proven by converting to the known diol
52
 by 
ozonolysis/reduction/deprotection as shown below. 
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 syn-(Z)-5-((tert-Butyldimethylsilyl)oxy)-2-
(dimethyl(phenyl)silyl)-4-methylhex-2-en-1-ol (Table 1.3, 
entry 4). The reaction was performed with the representative 
procedure but with 40 mg of diene, and was heated to 40 °C for 12 h. 
1
H NMR (400 
MHz, CDCl3): δ 7.55-7.53 (2H, m), 7.36-7.34 (3H, m), 5.76 (1H, d, J = 9.6 Hz), 4.27 
(1H, dd, J = 12.0 Hz, 3.0 Hz), 4.18 (1H, dd, J = 12.0 Hz, 6.8 Hz), 3.68 (1H, dq, J = 6.4 
Hz, 6.0 Hz), 2.70 (1H, ddq, J = 9.6 Hz, 6.8 Hz, 6.0 Hz), 1.69 (1H, dd, J = 4.8 Hz, 4.8 
Hz), 1.06 (3H, d, J = 6.0 Hz), 0.97 (3H, d, J = 6.8 Hz), 0.90 (9H, s), 0.40 (3H, s), 0.40 
(3H, s), 0.07 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 147.3, 139.5, 139.1, 134.2, 129.1, 
128.0, 72.7, 60.7, 40.7, 26.1, 20.6, 18.5, 17.3, −2.3, −2.3, −4.2, −4.5; IR (neat): 3422 (br, 
w), 2955 (s), 2928 (s), 2855 (s), 1462 (m), 1250 (s), 1111 (s), 1026 (s), 834 (s), 773 (s); 
HRMS-(ESI
+
) for C21H39O2Si2 [M+H]: calculated: 379.2489, found: 379.2476. The crude 
reaction mixture was purified on silica gel (15:1 hexanes:ethyl acetate) to afford a clear, 
colorless oil (36.0 mg, 84%, > 10:1 dr). Rf = 0.29 (15:1 hexanes:ethyl acetate, stain in 
KMnO4). The product contained two impurities in the crude 
1
H NMR, both in less than 
10%, that could not be separated. 
 
Proof of Stereochemistry: (Z)-alkene stereochemistry was proven by NOE correlation as 
shown below. Syn-stereochemistry was proven by converting to the known diol
58
 by 
ozonolysis/reduction as shown below. 
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III. Procedure for Hydroboration/Matteson Homologation (1.72, Scheme 1.18) 
 
In the dry-box, an oven-dried 6-dram vial containing a magnetic stir bar was 
charged successively with Ni(cod)2 (0.20 mL of a 31.30 µM solution of Ni(cod)2 in THF, 
6.20 µmol), PCy3 (0.2 mL of a  31.3 0 µM solution of PCy3 in THF, 6.2 µmol), THF 
(1.00 mL, 0.25M), pinacolborane (33.5 mg, 0.26 mmol), and (E)-tert-butyl((3,5-
dimethylhexa-3,5-dien-2-yl)oxy)dimethylsilane (60 mg, 0.25 mmol). The vial was sealed 
with a polypropylene cap, removed from the dry-box, immediately cooled to 0 °C 
(ice/water), and allowed to stir for 3 h. The cap was then exchanged for a septum, and the 
vial was flushed with nitrogen. To the vial was added THF (1.5 mL) and 
bromochloromethane (18.4 µL, 0.27 mmol), at which point the vial was cooled to −78 °C 
(dry ice/acetone). Freshly titrated n-BuLi (0.12 mL of a 2.3 M solution in hexane, 0.27 
mmol) was added dropwise, and the reaction was allowed to stir at −78 °C for 10 min. 
The reaction was then allowed to warm to room temperature and stir for 16 h. The 
reaction mixture was cooled to 0 °C and charged with 3 M sodium hydroxide (1 mL) and 
30% hydrogen peroxide (0.75 mL). The reaction was gradually warmed to room 
temperature and allowed to stir for 4 h, at which time the vial was cooled to 0 °C 
(ice/water) and saturated aqueous sodium thiosulfate (1 mL) was added dropwise. The 
reaction mixture was diluted with ethyl acetate and the layers were separated. The 
aqueous layer was extracted with EtOAc (3 x 15 mL) and the combined organic layers 
were dried over Na2SO4, filtered, and concentrated by rotary evaporation. The crude 
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reaction mixture was purified by silica gel chromatography (10:1 hexanes:ethyl acetate) 
to afford a clear, colorless oil (61.2 mg, 90%, 14:1 dr).  
 
 syn-(Z)-6-((tert-Butyldimethylsilyl)oxy)-3,5-dimethylhept-3-
en-1-ol (Scheme 1.18, 1.72). 
1
H NMR (500 MHz, C6D6): δ 5.21 
(1H, d, J = 9.5 Hz), 3.62 (1H, dq, J = 6.0 Hz, 4.5 Hz), 3.58 (2H, m), 2.54 (1H, dqd, J = 
10.0 Hz, 7.0 Hz, 6.5 Hz), 2.27 (2H, m), 1.73 (3H, s), 1.19 (3H, d, J = 6.0 Hz), 1.12-1.08 
(12H, m), 0.19 (3H, s), 0.18 (3H, s); 
13
C NMR (100 MHz, C6D6): δ 132.2, 131.9, 73.8, 
61.2, 41.2, 36.4, 26.7, 24.3, 22.4, 19.0, 18.2, −3.6, −4.1; IR (neat): 3328 (br, w), 2957 (s), 
2929 (s), 2857 (s), 1472 (m), 1448 (m), 1254 (s), 1122 (s), 1050 (s), 835 (s), 807 (s); 
HRMS-(ESI
+
) for C15H33O2Si [M+H]: calculated: 273.2250, found: 273.2237. The crude 
reaction mixture was purified by silica gel chromatography (10:1 hexanes:ethyl acetate) 
to afford a clear, colorless oil (61.2 mg, 90%, 14:1 dr). Rf = 0.30 (10:1 hexanes:ethyl 
acetate, stain in PMA). 
 
IV. Procedure for Hydroboration/Protodeboration (1.73, Scheme 1.18) 
 
           In the dry-box, an oven-dried 6-dram vial containing a magnetic stir bar was 
charged successively with Ni(cod)2 (0.1 mL of 1.3 µM solution of Ni(cod)2 in THF, 0.13 
µmol), PCy3 (0.1 mL of 1.3 µM solution of PCy3 in THF, 0.13 µmol), THF (0.05 mL), 
pinacolborane (7.7 mg, 0.06 mmol), and (E)-tert-butyl((3,5-dimethylhexa-3,5-dien-2-
yl)oxy)diphenylsilane (20.0 mg, 0.055 mmol). The vial was sealed with a polypropylene 
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cap, removed from the dry-box, and allowed to stir at room temperature for 24 h. The 
solvent was then removed by rotary evaporation, and TBAF·nH2O (26 mg, 0.11 mmol) 
was added. The vial was capped with a septum and purged with nitrogen. Toluene (1.2 
mL) was then added, followed by deionized water (2.0 µL). The septum was quickly 
exchanged for a polypropylene cap, and the reaction was allowed to stir at 60 °C for 6 h. 
The reaction was diluted with diethyl ether and run through a silica pipet column eluting 
with diethyl ether, followed by concentration by rotary evaporation. The crude material 
was purified by silica gel chromatography (40:1 hexanes:diethyl ether) to afford the title 
compound as a clear, colorless oil (17.0 mg, 83%). Rf = 0.84 (20:1 hexanes:diethyl ether, 
stain with KMnO4). 
 
syn-tert-Butyl((3,5-dimethylhex-5-en-2-yl)oxy)diphenylsilane 
(Scheme 1.18, 1.73). 
1
H NMR (500 MHz, CDCl3): δ 7.71-7.68 (4H, 
m), 7.44-7.40 (2H, m), 7.37 (4H, t, J = 7.0 Hz), 4.72 (1H, s), 4.63 (1H, s), 3.83 (1H, qd J 
= 6.0 Hz, 3.0 Hz), 2.34 (1H, dd, J = 13.0 Hz, 4.0 Hz), 1.83 (1H, dd, J = 13.5 Hz, 10.0 
Hz), 1.71-1.68 (1H, m), 1.66 (3H, s), 1.06 (9H, s), 0.97 (3H, d, J = 6.0 Hz), 0.77 (3H, d, J 
= 6.5 Hz); 
13
C NMR (125 MHz, CDCl3): δ 145.1, 136.2, 136.1, 135.3, 134.6, 129.7, 
129.6, 127.7, 127.5, 111.5, 73.0, 40.4, 37.9, 27.3, 22.4, 19.6, 19.4, 14.6; IR (neat): 3071 
(w), 2964 (m), 2932 (m), 2858 (m), 1472 (w), 1427 (m), 1380 (m), 1362 (m), 1146 (w), 
1106 (s), 1083 (s), 1043 (s), 956 (w), 888 (w), 765 (m), 701 (s); HRMS-(ESI
+
) for 
C24H35OSi [M+H]: calculated: 367.2457, found: 367.2475. The crude reaction mixture 
was purified by silica gel chromatography (20:1 hexanes:diethyl ether) to afford a clear, 
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colorless oil (17.0 mg, 83%, >20:1 dr). Rf = 0.84 (20:1 hexanes: diethyl ether, stain in 
KMnO4). 
 
V. Procedure for Hydroboration/Epoxidation (1.74, Scheme 1.18) 
 
In the dry-box, an oven-dried 6-dram vial containing a magnetic stir bar was 
charged successively with Ni(cod)2 (1.9 mg, 6.80 µmol), PCy3 (1.9mg, 6.80 µmol), THF 
(1.08 mL, 0.25M), pinacolborane (35.8 mg, 0.28 mmol), and (E)-tert-butyl((3,5-
dimethylhexa-3,5-dien-2-yl)oxy)dimethylsilane (64 mg, 0.27 mmol). The vial was sealed 
with a polypropylene cap, removed from the dry-box, and allowed to stir at 0 °C for 3 h. 
The solvent was then removed by rotary evaporation, and K2HPO4 (268 mg, 1.08 mmol) 
was added. The flask was purged with N2 and CH2Cl2 (0.7 mL) and MeOH (86 µL, 2.16 
mmol, distilled) were then added, and the flask was cooled to 0
 
°C. A solution of mCPBA 
(266.0 mg, 70%, 1.08 mmol) in CH2Cl2 (2 mL) was added dropwise at 0
 
°C and the 
reaction mixture was allowed to stir at 0
 
°C for 3 h. The crude reaction mixture was 
quenched with saturated Na2CO3 (2.0 mL), diluted with ethyl acetate (5 mL), and the 
layers were separated. The aqueous layer was extracted with ethyl acetate (3 x 5 mL) and 
the combined organic layers were washed with saturated Na2CO3, dried over Na2SO4, 
filtered, and concentrated by rotary evaporation. The crude material was purified by silica 
gel chromatography (4:1 hexanes:diethyl ether) to afford the title compound 1.74 as a 
clear, colorless oil (53.5 mg, 72%, 7:1 dr). Rf = 0.36 (4:1 hexanes:ethyl acetate, stain with 
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PMA). 
 
 (3-3-((tert-Butyldimethylsilyl)oxy)butan-2-yl)-2-methyloxiran-2-
yl)methanol (Scheme 1.18, 1.74). 
1
H NMR (500 MHz, CDCl3): δ 
3.93 (1H, qd, J = 6.0 Hz, 4.5 Hz), 3.92 (1H, quin, J = 6.5 Hz), 3.70 (1H, dd, J = 11.5 Hz, 
7.0 Hz), 3.65 (1H, dd, J = 12.0 Hz, 5.0 Hz), 2.75 (1H, d, J = 9.5 Hz), 1.40 (3H, s), 1.40-
1.35 (1H, m), 1.16 (3H, d, J = 6.0 Hz), 0.93 (3H, d, J = 6.0 Hz), 0.90 (9H, s), 0.07 (6H, 
s); 
13
C NMR (125 MHz, CDCl3): δ 69.7, 67.4, 64.2, 60.9, 40.0, 26.1, 22.1, 20.7, 18.3, 
10.9, −4.0, −4.8; IR (neat): 3446 (w), 2956 (m), 2930 (m), 2857 (m), 1726 (w), 1472 (m), 
1462 (m), 1253 (s), 1149 (m), 1117 (m), 1070 (s), 1023 (s), 960 (s), 892 (m), 835 (s), 801 
(s), 773 (s), 707 (m); HRMS-(ESI
+
) for C14H30O3Si [M+H]: calculated: 275.2043, found: 
275.2052. 
 
Proof of Stereochemistry: The relative configuration was assigned by comparison of the 
13
C NMR spectrum according to literature reports,
59
 after conversion of 1.74 into 
acetonide iii, as shown below. 
 
 
                                                     
59
 Bestmann, H. J.; Liepold, B.; Kress, A.; Hofmann, A. Chem. Eur. J. 1999, 5, 2984. 
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2,2-Dimethoxy-4,5-dimethyl-6-(prop-1-en-2-yl)-1,3-dioxane 
1
H 
NMR (500 MHz, CDCl3): δ 4.94 (1H, q, J = 1.0 Hz), 4.87 (1H, q, J = 
1.5Hz), 4.09 (1H, qd, J = 6.5 Hz, 5.0 Hz), 3.72 (1H, d, J = 8.5 Hz), 
1.85 (1H, m), 1.77 (3H, s), 1.38 (3H, s), 1.37 (3H, s), 1.11 (3H, d, J = 6.5 Hz), 0.84 (3H, 
d, J = 6.0 Hz); 
13
C NMR (125 MHz, CDCl3): δ 144.3, 112.6, 100.6, 78.9, 65.5, 37.9, 
25.5, 24.4, 18.2, 17.0, 11.9; IR (neat): 2955 (s), 2926 (s), 2863 (s), 1737 (w), 1651 (w), 
1622 (w), 1446 (m), 1377 (m), 1225 (m), 1143 (m), 1093 (m), 1022 (m), 895 (w), 861 
(w), 817 (w). 
 
VI. Procedure for Diastereoselective Hydrogenation (Scheme 1.19) 
 
In the dry-box, an oven-dried 1-dram vial containing a stir bar was charged with 
(Z)-5-hydroxy-2,4-dimethylhex-2-en-1-yl benzoate 1.76 (20 mg, 0.08 mmol), 
[Rh(nbd)dppb]BF4 (5.6mg, 0.008 mmol), and CH2Cl2 (152 µL). The vial was removed 
from the box and the mixture was stirred under 1000 psi of H2 gas in a hydrogen bomb 
for 2 h. The resulting solution was filtered through a short plug of silica gel, washing with 
diethyl ether. The solution was concentrated by rotary evaporation to afford the title 
compound as a clear, colorless oil (18.5 mg, 92%, 7:1 dr). Rf = 0.43 (4:1 hexanes: ethyl 
acetate, stain in PMA). 
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syn-(Z)-5-Hydroxy-2,4-dimethylhex-2-en-1-yl benzoate (Scheme 
1.19, 1.76). 
1
H NMR (500 MHz, CDCl3): δ 8.04 (2H, d, J = 7.5 Hz), 
7.56 (1H, t, J = 7.5 Hz), 7.44 (2H, t, J = 7.0 Hz), 5.32 (1H, d, J = 10.0 Hz), 4.92 (1H, d, 
J = 12.0 Hz), 4.82 (1H, d, J = 12.0 Hz), 3.67 (1H, qd, J = 6.0 Hz, 6.0 Hz), 2.68 (1H, qdd, 
J = 10.0 Hz, 6.0 Hz, 6.0 Hz), 1.86 (3H, s), 1.15 (3H, d, J = 6.5 Hz), 1.02 (3H, d, J = 6.5 
Hz); 
13
C NMR (125 MHz, CDCl3): δ 166.8, 133.2, 132.8, 131.2, 130.4, 129.8, 128.6, 
71.9, 64.2, 39.8, 22.0, 20.1, 17.2; IR (neat): 3411 (w), 2968 (m), 2930 (w), 2847 (w), 
1717 (s), 1601 (w), 1492 (w), 1451 (m), 1378 (m), 1314 (m), 1266 (s), 1176 (m), 1108 
(s), 1025 (s), 902 (m), 709 (s); HRMS-(ESI
+
) for C15H21O3 [M+H]: calculated: 249.1491, 
found: 249.1498. The crude reaction mixture was purified by silica gel chromatography 
(5:1 hexanes:diethyl ether) to afford a clear, colorless oil (78.0 mg, 81%). Rf = 0.28 (5:1 
hexanes: ethyl acetate, stain in PMA). 
 
5-Hydroxy-2,4-dimethylhexyl benzoate (Scheme 1.19, 1.77).
 
1
H NMR (500 MHz, CDCl3): δ 8.04 (2H, d, J = 8.5 Hz), 7.56 
(1H, t, J = 2.5 Hz), 7.44 (2H, t, J = 2.5 Hz), 4.20 (1H, dd, J = 10.5 Hz, 6.0 Hz), 4.12 
(1H, dd, J = 10.5 Hz, 6.5 Hz), 3.73 (1H, qd, J = 6.0 Hz, 4.5 Hz), 2.07-2.00 (1H, m), 
1.67-1.58 (1H, m), 1.32 (2H, ddd, J = 8.5 Hz, 5.0 Hz, 3.0Hz), 1.17 (3H, d, J = 6.5 Hz), 
1.01 (3H, d, J = 6.0 Hz), 0.90 (3H, d, J = 6.0 Hz); 
13
C NMR (125 MHz, CDCl3): δ 166.9, 
133.1, 130.6, 129.7, 128.6, 71.9, 70.7, 37.0, 36.4, 30.5, 20.4, 16.7, 14.2; IR (neat): 3473 
(w), 2966 (m), 2931 (w), 1718 (s), 1379 (w), 1314 (m), 1272 (s), 1113 (s), 1070 (m), 
1026 (w), 711 (s), 678 (w), 675 (w); HRMS-(ESI
+
) for C15H23O3 [M+H]: calculated: 
251.1647, found: 251.1644.  
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VII. Procedure for One gram Hydroboration (Scheme 1.20) 
 
 In the dry-box, a flame-dried 50 mL round-bottom flask containing a magnetic 
stir bar was charged successively with Ni(cod)2 (19.3 mg, 0.070 mmol), PCy3 (19.6 mg, 
0.070 mmol), THF (11.2 mL, 0.25M), pinacolborane (0.43 mL, 2.94 mmol), and (E)-tert-
butyl((3,5-dimethylhexa-3,5-dien-2-yl)oxy)diphenylsilane 1.78 (1.02 g, 2.80 mmol). The 
flask was capped with a septum, removed from the dry-box, and allowed to stir for 24 h 
at rt. The solvent was then removed by rotary evaporation and the crude reaction mixture 
was purified by silica gel chromatography (100:1 hexanes:ethyl acetate) to afford the title 
compound as a clear, light yellow oil (1.01 g, 74% (93% brsm), >20:1 dr). Rf = 0.29 
(100:1 hexanes:ethyl acetate, stain with KMnO4). 
 
tert-Butyl((syn-Z)-3,5-dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)hex-4-en-2-yl)oxy)diphenylsilane (Scheme 
1.20, 1.79). 
1
H NMR (500 MHz, CDCl3): δ 7.73-7.35 (4H, m), 
7.43-7.35 (6H, m), 5.00 (1H, dd, J = 9.5 Hz, 1.0 Hz), 3.68 (1H, dq, J = 6.5 Hz, 6.5 Hz), 
2.34 (1H, ddq, J = 10.0 Hz, 6.5 Hz, 6.5 Hz), 1.71 (1H, d, J = 15.0 Hz), 1.56 (1H, d, J = 
15.0 Hz), 1.21 (12H, s), 1.05 (9H, s), 1.00 (3H, d, J = 6.5 Hz), 0.95 (3H, d, J = 6.5 Hz); 
13
C NMR (125 MHz, CDCl3): δ 136.2, 136.2, 135.6, 134.7, 131.3, 129.5, 129.4, 127.8, 
127.6, 127.5, 83.3, 74.2, 41.1, 27.3, 26.1, 25.0, 24.9, 21.9, 19.7, 16.9; IR (neat): 3071 (w), 
3048 (m), 2974 (m), 2891 (m), 1472 (s), 1371 (s), 1323 (s), 1143 (s), 1109 (s), 959 (m), 
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738 (m), 702 (s), 507 (m); HRMS-(ESI
+
) for C30H45O3BSi [M+Na]: calculated: 515.3129, 
found: 515.3126.  
 82 
 
 
Chapter 2 
Total Synthesis of Discodermolide by Catalytic 
Stereoselective Borylation Reactions
1 
And 
Progress toward Oxidation-Resistant Analog Synthesis 
2.1 Introduction 
Polyketides are a class of important natural products that often show potent 
biological activities and useful pharmacological properties (Chapter 1).
2
 Indeed, 
approximately 20% of top selling small molecule drugs fall into the category of 
polyketides, and polyketides are about five times more likely to possess an active 
biological activity compared to other families of natural products.
2c,d
 While most 
polyketides are derived from soil bacteria or marine sponges and might be considered to 
be readily available, it is estimated that less than 5% of the soil bacterial are amendable to 
culture and this number is even smaller for marine sponge.
3
  
                                                     
1
 Yu, Z.; Ely, R. J.; Morken, J. P. Angew. Chem. Int. Ed. 2014, 53, 9632. 
2
 (a) Macrolide Antibiotics. Chemistry, Biology, and Practice, 2nd ed.; Omura, S., Ed.; Academic 
Press: New York, 2002. (b) Polyketides Biosynthesis, Biological Activity, and Genetic 
Engineering; Rimando, A. M., Baerson, S. R., Eds.; ACS Symposium Series 955; American 
Chemical Society: Washington, DC, 2007. (c) Newman, D. J.; Cragg, G. M. J. Nat. Prod. 2007, 
70, 461. (d) Newman, D. J.; Grothaus, P.G.; Cragg, G. M. Chem. Rev. 2009, 109, 3012. (e) 
O’Hagan, D. The Polyketide Metabolites; Ellis Horwood: Chichester,U.K., 1991. 
3
 Sait, M.; Hugenholtz P.; Janssen, P. H.; Environ. Microbiol. 2002, 4, 654. and references cited 
therein. 
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Considering their importance in drug discovery, preparation and manufacture of 
polyketides has become an important topic. Fermentation and semi-syntheses have 
provided good routes to obtain large quantity of some polyketides, and these methods are 
responsible for nearly all the polyketides on market.
4
 However it is hard to apply these 
two methods to polyketides with low isolation yield and limited natural sources. Under 
such circumstances, chemical synthesis serves as an important and powerful tool to 
construct the polyketide structure. Thus, it is of great importance to develop novel and 
reliable methods to construct polyketides concisely and rapidly. 
One example of such molecule is (+)-discodermolide, a polyketide isolated from 
sea sponge discodermia dissoluta and the most potent microtubule stabilizer yet 
discovered.
5
 Neither fermentation nor semi-synthesis is applicable to obtain large 
quantity of discodermolide, because it has very low isolation yield from nature (0.002% 
w/w) and no responsible organism for its production has been identified. Chemical 
synthesis was the only way to obtain large quantity of discodermolide, and a number of 
efforts have been attracted toward its total synthesis. While some portions of the structure 
are easily assembled, stereocontrolled construction of the trisubstituted C13-C14 (Z)-
                                                     
4
 A notable exception is eribulin which requires 33 steps (longest linear sequence) and 65 total 
steps: (a) Chase, C. E.; Fang, F. G.; Lewis, B. M.; Wilkie, G. D.; Schnaderbeck, M. J.; Zhu, X. 
Synlett, 2013, 323. (b) Austad, B. C.; Benayoud, F.; Calkins, T. L.; Campagna, S.; Chase, C. E.; 
Choi, H.-W.; Christ, W.; Costanzo, R.; Cutter, J.; Endo, A.; Fang, F. G.; Hu, Y.; Lewis, B. M.; 
Lewis, M. D.; McKenna, S.; Noland, T. A.; Orr, J. D.; Pesant, M.; Schnaderbeck, M. J.; Wilkie, 
G. D.; Abe, T.; Asai, N.; Asai, Y.;  Kayano, A.; Kimoto, Y.; Komatsu, Y.; Kubota, M.; Kuroda, 
H.; Mizuno, M.; Nakamura, T.; Omae, T.; Ozeki, N.; Suzuki, T.; Takigawa, T.; Watanabe, T.; 
Yoshizawa, K. Synlett, 2013, 327 (c) Austad, B. C.; Calkins, T. L.; Chase, C. E.; Fang, F. G.; 
Horstmann, T. E.; Hu, Y.; Lewis, B. M.; Niu, X.; Noland, T. A.; Orr, J. D.; Schaderbeck, M. J.; 
Zhang, H.; Asakawa, N.; Asai, N.; Chiba, H.; Hasebe, T.; Hoshino, Y.; Ishizuka, H.; Kajima, T.; 
Kayano, A.; Komatsu, Y.; Kubota, M.; Kuroda, H.; Miyazawa, M.; Tagami, K.; Watanabe, T. 
Synlett, 2013, 333. 
5
 Gunasekera, S. P.; Gunasekera, M.; Longley, R. E.; Schulte, G. K. J. Org. Chem. 1990, 55, 
4912. Correction: J. Org. Chem. 1991, 56, 1346. 
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olefin
6
 still remains a challenging task in discodermolide syntheses. We suspected that 
Ni-catalyzed diastereoselective hydroboration (Chapter 1) could rapidly construct the 
core trisubstituted (Z)-olefin as well as the adjacent propionate moiety, rendering a short 
and efficient synthesis of (+)-discodermolide.  
2.2 Background 
2.2.1 Discovery and Biological Activity of (+)-Discodermolide 
 In 1990, (+)-discodermolide 2.1 was first isolated by Gunaskera and co-workers 
at the Harbor Branch Oceanographic Institute by a bio-assay guided fractionation of 
extracts from the deep sea marine sponge Discodermia dissoluta.
5
 The structure was 
determined by employing a battery of NMR experiments, including 
1
H, 
13
C, COSY, long 
range COSY, and several 2D correlation experiments as well as X-ray crystallography. 
The structure was found to feature 13 stereogenic centres, a fully substituted δ-lactone, 
one C8-C9 disubstitued and one C13-C14 trisubstituted (Z)-alkene, a terminal (Z)-diene 
and a carbamate moiety (Figure 2.1). Discodermolide adopts a U-shaped conformation, 
where the internal (Z)-trisubstituted alkene locks the conformation such that A(1,3) strain 
is minimized as are syn-pentane interactions along the backbone (Figure 2.1, X-ray 
structure).  
 
 
 
                                                     
6
 For recent examples of stereocontrolled trisubstituted olefin synthesis, see; (a) Moure, A. L.; 
Arrayás, A. G.; Cárdenas, D. J.; Alonso, I.; Carretero, J. C. J. Am. Chem. Soc. 2012, 134, 7219. (b) 
Akiyama, K.; Gao, F.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2010, 49, 419. (c) Rooke, D. A.; 
Ferreira, E. M. J. Am. Chem. Soc. 2010, 132, 11926. (d) Belardi, J. K.; Micalizio, G. C. J. Am. 
Chem. Soc. 2008, 130, 16870. (e) Xie, Q.; Denton, R. W.; Parker, K. A. Org. Lett. 2008, 10, 5345. 
(f) Prantz, K.; Mulzer, J. Chem. Eur. J. 2010, 16, 485. 
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Figure 2.1. (+)-Discodermolide and Its X-ray Structure 
            
  
Compared to other microtubule stabilizing reagents, discodermolide is 
characteristically unique not only in its linear backbone structure but also in a number of 
biological activities. (+)-Discodermolide was initially identified as a highly 
immunosuppressive agent both in vitro
7
 and in vivo
8
, which was discovered by 
researchers at Harbor Branch during early biological evaluation. Further study 
demonstrated that discodermolide has antiproliferative activity which remarkably blocks 
the cell cycle at G2/M phase.
9
 Similar to paclitaxel,
10
 (+)-discodermolide stabilizes 
tubulin,
11
 but discodermolide mediated microtubule polymerization was faster than 
equimolar concentration of paclitaxel. As low as 10 µM concentration of discodermolide 
was able to promote microtubule polymerization even in the absence of GTP; however, 
paclitaxel was completely inactive under such conditions. It was also found that 
discodermolide-induced microtubules were more in number and grew shorter in length 
                                                     
7
 Longley, R. E.; Caddigan, D.; Harmony, D.; Gunasekera, M.; Gunasekera, S. Transplantation 1991, 
52, 650. 
8
 Longley, R. E.; Caddigan, D.; Harmony, D.; Gunasekera, M.; Gunasekera, S. Transplantation 1991, 
52, 656. 
9
 Longley, R. E.; Gunasekera, S. P.; Faherty, D.; McLane, J.; Dumont, F. Ann. N.Y. Acad. Sci. 1993, 
696, 94. 
10
 Parness, J., and Horwitz, S. B. J. Cell Biol. 1981, 91, 479. 
11
 ter Haar, E.; Kowalski, R. J.; Hamel, E.; Lin, C. M.; Longley, R. E.; Gunasekera, S. P.; 
Rosenkranz, H. S.; Day, B. W. Biochemistry 1996, 35, 243. 
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than the ones induced by paclitaxel. Competitive microtubule-binding experiments 
between discodermolide and paclitaxel revealed that they bind in a mutually exclusive 
manner, implying the same or overlapping binding sites on microtubules.
12
 Though a 
number of experiments were designed to find the precise discodermolide binding domain 
of tubulin, the binding mode and orientation still remain speculative.
13
 
 (+)-Discodermolide maintained cytotoxicity against taxol-resistant and multi-drug 
resistant cell lines. For example, SW620AD-300 colon carcinoma line displayed a 930-
fold increased resistance to paclitaxel, while discodermolide was only 25-fold less potent 
in this cell line.
14
 Further studies revealed the synergistic cytotoxicity of 
discodermolide/paclitaxel combination both in vitro
15
 and in vivo.
16
 Though the precise 
mechanism of the observed synergism remained unknown, it was speculated by Horwitz 
and Smith that the two agents might preferentially target different tubulin isotypes.
17
  
 The outstanding biological activities as well as challenging structures have 
rendered discodermolide a great target for total synthesis as a drug candidate. Notably, 
chemical synthesis became the sole method to obtain large quantity of discodermolide 
because of its low isolation yield (0.002% w/w) and no identifiable cultivated production 
                                                     
12
 Hung, D. T.; Chen, J.; Schreiber, S. L. Chem. Biol. 1996, 3, 287. 
13
 (a) Mattello, L. A.; LaMarche, M. J.; He, L.; Beauchamp, T. J.; Smith, A. B.; Horwita, S. B. 
Chem. Biol. 2001, 8, 843. (b) Monteagudo, E.; Cicero, D. O.; Cornett, B.; Myles, D. C.; Snyder, J. 
P. J. Am. Chem. Soc. 2001, 123, 6929. (c) Smith, A. B.; LaMarche, M. J.; Falcone-Hindley, M. 
Org. Lett. 2001, 3, 659. (d) Klein, L. E., Freeze, B. S., Smith, A. B.III, and Horwitz, S. B. Cell 
Cycle 2005, 4, 501. (e) Khrapunovich-Baine, M.; Menon, V.; Verdier-Pinard, P.; Smith, A. B. III, 
Angeletti, R. H.; Fiser, A.; Horwitz, S. B.; Xiao, H. Biochemistry 2009, 48, 11664. 
14
 Kowalski, R. J.; Giannakakou, P.; Gunasekera, S. P.; Longley, R. E.; Day, B. W.; Hamel, E. 
Mol. Pharmacol. 1997, 52, 613. 
15
 Martello, L. A.; McDaid, H. M.; Regl, D. L.; Yang, C.-P. H.; Meng, D.; Pettus, T. R. R.; 
Kaufman, M. D.; Arimoto, H.; Danishefsky, S. J.; Smith, A. B., III; Horwitz, S. B. Clin. Cancer 
Res. 2000, 6, 1978. 
16
 Honore, S.; Kamath, K.; Braguer, D.; Horwitz, S. B.; Wilson, L.; Briand, C.; Jordan, M. A. 
Cancer Res. 2004, 64, 4957. 
17
 Huang, G. S.; Lopez-Barcons, L.; Freeze, B. S.; Smith, A. B., III; Goldberg, G. L.; Horwitz, S. 
B.; McDaid, H. M. Clin. Cancer Res. 2006, 12, 298. 
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organism. Thus, it is not surprising that discodermolide became one of the most studied 
polyketide nature products. Indeed, there are 14 total syntheses of discodermolide from 
10 different groups, both in academia and industry.
18
 However, construction of C13-C14 
(Z)-trisubstituted olefin and efficient fragment union still remained the most challenging 
problems for the synthesis. Most of previous approaches prepare discodermolide from 
three equally complex fragments for convergent syntheses. Some selected examples are 
briefly discussed below. 
 
 
 
 
                                                     
18
 For completed total syntheses of discodermolide, see; (a) Nerenberg, J. B.; Hung, D. T.; 
Somers, P. K.; Schreiber, S. L. J. Am. Chem. Soc. 1993, 115, 12621. (b) Hung, D. T.; Nerenberg, 
J. B.; Schreiber, S. L. Chem. Biol. 1994, 1, 67. (c) Smith, A. B., III; Qiu, Y.; Jones, D. R.; 
Kobayashi, K. J. Am. Chem. Soc. 1995, 117, 12011. (d) Hung, D. T.; Nerenberg, J. B.; Schreiber, 
S. L. J. Am. Chem. Soc. 1996, 118, 11054. (e) Harried, S. S.; Yang, G.; Strawn, M. A.; Myles, D. 
C. J. Org. Chem. 1997, 62, 6098. (f) Marshall, J. A.;Johns, B. A. J. Org. Chem. 1998, 63, 7885. 
(g) Smith, A. B., III; Kaufman, M. D.; Beauchamp, T. J.; LaMarche, M. J.; Arimoto, H. Org. Lett. 
1999, 1, 1823. (h) Halstead, D. P. Ph.D. Thesis, Harvard University, Cambridge, MA, 1999. (i) 
Paterson, I.; Florence, G. J.; Gerlach, K.; Scott, J. Angew. Chem., Int. Ed. 2000, 39, 377. (j) 
Harried, S. S.; Lee, C. P.; Yang, G.; Lee, T. I. H.; Myles, D. C. J. Org. Chem. 2003, 68, 6646. (k) 
Smith, A. B.; Freeze, B. S.; Brouard, I.; Hirose, T. Org. Lett. 2003, 5, 4405. (l) Paterson, I.; 
Delgado, O.; Florence, G. J.; Lyothier, I.; Scott, J. P.; Sereinig, N. Org. Lett. 2003, 5, 35. (m) 
Mickel, S. J.; Niederer, D.; Daeffler, R.; Osmani, A.; Kuesters, E.; Schmid, E.; Schaer, K.; 
Gamboni, R.; Chen, W.; Loeser, E.; Kinder, F. R., Jr.; Konigsberger, K.; Prasad, K.; Ramsey, T. 
M.; Repic, O.; Wang, R.-M.; Florence, G.; Lyothier, I.; Paterson, I. Org. Process Res. Dev. 2004, 
8, 122 and references cited therein. (n) Arefolov, A.; Panek, J. S. J. Am. Chem. Soc. 2005, 127, 
5596. (o) Smith, A. B., III; Freeze, B. S.; Xian, M.; Hirose, T. Org. Lett. 2005, 7, 1825. (p) 
Paterson, I.; Lyothier, I. Org. Lett. 2004, 6, 4933. (q) de Lemos, E.; Porée, F.-H.; Commerçon, A.; 
Betzer, J.-F.; Pancrazi, A.; Ardisson, J. Angew. Chem. Int. Ed. 2007, 46, 1917. (r) see ref.1 
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2.2.2 Selected Examples of (+)-Discodermolide Syntheses and C13-C14 (Z)-Olefin 
Syntheses 
 The first total synthesis of the unnatural antipode (−)-discodermolide was 
completed by Schreiber and co-workers in 1993,
18a
 and it proved the absolute 
stereochemistry and confirmed the relative stereochemistry of the natural product. Later, 
in 1996, they reported a full article for the synthesis of the natural antipode (+)-
discodermolide (Scheme 2.1).
18d
 Retrosynthetically, the molecule was disconnected to 
three fragments (2.2, 2.3, and 2.4). (Z)-Trisubstituted olefin 2.9 was constructed via Still-
Gennari olefination
19
 from aldehyde 2.6, a compound that was prepared in 6 steps from 
commercially available Roche ester 2.5; subsequent five-step transformation furnished 
alkynyl iodide 2.3 fragment. The key fragment unions include a Nozaki-Hiyama-Kishi 
coupling
20
 of 2.2 and 2.3 to deliver adduct 2.10, followed by partial hydrogenation to 
secure the C8-C9 cis-olefin and four more steps to afford allylbromide 2.11 as left-half of 
discodermolide. A lithium enolate, prepared by deprotection of methyl ketone 2.4, 
displaced allylbromide 2.11 to build the C15-C16 bond and complete the discodermolide 
backbone. Then methylation at C15 position gave 2.12 with moderate (3:1) 
diatereoselectivity. Subsequent transformations including a directed ketone reduction and 
global deprotection completed the total synthesis of (+)-discodermolide with 24 longest 
linear sequence (36 total steps) in an overall yield of 4.3%. 
 
 
 
                                                     
19
 Still, W. C.; Gennari, C. Tetrahedron Lett. 1983, 24, 4405. 
20
 (a) Aicher, T. D.; Kishi, Y. Tetrahedron Lett. 1987, 28, 3463. (b) Takai, K.; Kuroda, T.; 
Nakatsukasa, S.; Oshima, K.; Nozaki, H. Tetrahedron Lett. 1985, 26, 5585. 
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Scheme 2.1. Schreiber’s Total Synthesis of (+)-Discodermolide 
 
 It’s worth pointing out that Schreiber’s initial plan was to perform a chelation 
controlled enolate alkylation between allylbromide 2.11 and ethyl ketone 2.13, which 
would construct discodermolide backbone 2.12 in one step (Scheme 2.2). Unfortunately 
the undesired epimer (S)-2.12 predominated when (E)- or (Z)-enolate derived from ethyl 
ketone 2.13 was used for the alkylation (subset in Scheme 2.2). It was reasoned that 
instead of the expected chelation-controlled enolate alkylation, the transition state 
conformation was set to avoid A(1,3) strain, which led to the undesired diastereomer (S)-
2.12. As a solution, the two-step addition/methylation sequence was used as 
demonstrated in Scheme 2.1. 
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Scheme 2.2. Stereoselectivity of Schreiber’s Enolate Coupling Reactions 
 
 Myles and coworkers reported their total synthesis of (−)-discodermolide in 1997, 
marking it as the third completed synthesis in the literature. The follow up paper in 2003 
presented the details for the natural (+)-isomer (Scheme 2.3).
18e
 The molecule was 
assembled from three advanced fragments (2.13, 2.14 and 2.15). The (Z)-trisubstitued 
olefin in 2.14 was installed via titanium mediate hetero-Diels-Alder reaction
21
 between 
aldehyde 2.16 and Danishefsky’s diene 2.17.22 Subsequent Luche reduction,23 a Ferrier 
rearrangement
24
 and five more steps furnished allyl iodide 2.14. Similar to Schreiber’s 
synthesis (Scheme 2.2), Myles also considered an enolate alkylation to build C15-C16 
bond. However, contrary to Schreiber’s results, the alkylation of (Z)-enolate derived from 
ethyl ketone 2.15 and allyl iodide 2.14, in a relative non-polar mixed solvent 
(hexane:THF = 45:55), proceeded smoothly with expected chelation control and gave 
desired adduct 2.21 with good yield and diastereoselectivity (6:1) at C16.
25
 Subsequent 
                                                     
21
 Springer, J. B.; DeBoard, J.; Corcoran, R. C. Tetrahedron Lett. 1995, 36, 8733. 
22
 Danishefsky, S. J.; Pearson,W. H.; Harvey, D. F.; Maring, C. J.; Springer, J. P. J. Am. Chem. 
Soc. 1985,107, 1256. 
23
 (a) Luche, J. L.; Gemal, A. L.; J. Am. Chem. Soc. 1979, 101, 5848. (b) Luche, J. L. J. Am. 
Chem. Soc. 1978, 100, 2226. 
24
 (a) Ferrier, R. J. J. Chem. Soc. 1964, 5443. (b) Ferrier, R. J.; Overend, W. G.; Ryan, A. E. J. 
Chem. Soc., Abstracts 1962, 3667. 
25
 Yang, G.; Myles, D. C. Tetrahedron Lett. 1994, 35, 2503. 
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installation of  a cis-vinyl iodide using Stork-Wittig olefination
26
 and (Z)-diene formation 
using a Peterson type olefination,
27
 as well as several additional functional group 
transformations, furnished the right-half of discodermolide (2.22). Unfortunately, a 
Nozaki-Hiyama-Kishi nickel/chromium-mediated
28
 union of vinyl iodide 2.22 and 
aldehyde 2.13 proceeded in only moderate yield (42%) and selectivity (3:1). After 
diastereomer separation and global deprotection with HF·pyridine, (+)-discodermolide 
was completed with a longest linear sequence of 25 steps (44 total steps) in an overall 
yield of 1.5%.  
 
 
 
 
 
 
 
 
 
 
 
 
                                                     
26
 Stork, G.; Zhao, K. Tetrahedron Lett. 1989, 30, 2173. 
27
 Peterson, D. J. J. Org. Chem. 1968, 33, 780. 
28
 (a) Hiyama, T.; Okude, Y.; Kimura, K.; Nozaki, H. Bull. Chem. Soc. Jpn. 1982, 55, 561. (b) 
Takai, K.; Kuroda, T.; Nakatsukasa, S.; Oshima, K.; Nozaki, H. Tetrahedron Lett. 1985, 26, 5585. 
(c) Takai, K.; Tagashira, M.; Kuroda, T.; Oshima, K.; Utimoto, K.; Nozaki, H. J. Am. Chem. Soc. 
1986, 108, 6048. (d) Jin, H.; Uenishi, J.; Christ, W. J.;Kishi, Y. J. Am. Chem. Soc. 1986, 108, 
5644. (e) Aicher, T. D.; Kishi, Y. Tetrahedron Lett. 1987, 28, 3463. 
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Scheme 2.3. Myles’ Total Synthesis of (+)-Discodermolide 
 
 In 1998, Marshall and co-workers have published a total synthesis of (+)-
discodermolide that extensively used their asymmetric propargylation for polyketide 
construction (Scheme 2.4, equation 1 and 2).
18f
 (+)-Discodermolide was assembled from 
three fragments (2.28, 2.29 and 2.30), all of which were prepared by asymmetric 
propargylation to establish various stereotriad subunits, either in syn/syn fashion (2.28 via 
equation 1),
29
 or syn/anti fashion (2.29 and 2.30 via equation 2) (Scheme 2.4).
30
 Addition 
of alkynyl lithium (prepared by deprotonation of 2.29) to aldehyde 2.28 in the presence of 
LiBr proceeded in excellent yield and good diastereoselectivity (6:1), and the product 
                                                     
29
 (a) Marshall, J. A.; Lu, Z.-H.; Johns, B. A. J. Org. Chem. 1998, 63, 817. (b) Marshall, J. A.; 
Perkins, J. F.; Wolf, M. A. J. Org. Chem. 1995, 60, 5556. 
30
 Marshall, J. A.; Adams, N. D. J. Org. Chem. 1998, 63, 3812. 
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alkyne was converted to cis-olefin 2.31 bearing requisite aldehyde functionality in four 
steps. Then Wittig-Zhao olefination
31
 of aldehyde 2.31 gave (Z)-trisubstituted vinyl 
iodide 2.32 in only 40% yield. The compound 2.32 was connected to a borane (derived 
from alkyl iodide 2.30) via Suzuki cross-coupling
32
 furnishing tetraene 2.33. Eight more 
steps completed the synthesis of (+)-discodermolide with a longest linear sequence of 30 
steps (48 total steps) in an overall yield of 1.3%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                     
31
 Chen, J.; Zhao, K. Tetrahedron Lett. 1994, 35, 2827. 
32
 For review, see: (a) Miyaura, N. Top. Curr. Chem. 2002, 219, 11. For general reviews of cross-
couplings, see: (b) Metal-Catalyzed Cross-Coupling Reactions; de Meijere, A., Diederich, F., 
Eds.; Wiley-VCH: New York, 2004. (c) Handbook of Organopalladium Chemistry for Organic 
Synthesis; Negishi, E.-I., Ed.; Wiley-Interscience: New York, 2002. 
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Scheme 2.4. Marshall’s Total Synthesis of (+)-Discodermolide 
 
In 1999, a thesis from Evans’s group became the fifth documented total synthesis 
of (+)-discodermolide.
18h
 Their route largely relied on Evans asymmetric aldol 
methodologies
33
 to establish stereotriad moieties. The details won’t be covered here, but 
                                                     
33
 (a) Evans, D. A.; Nelson, J. V.; Taber, T. R. "Stereoselective Aldol Condensations" in Topics in 
Stereochemistry,  New York, 1982; Vol. 13, p. 2. (b) Mukaiyama, T. "The Directed Aldol 
Reaction" in Organic Reactions, New York, 1982; Vol. 28, p 203. (c) Heathcock, C. H. 
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it is interesting to see a different way to introduce C13-C14 (Z)-trisubstitued olefin 
(Scheme 2.5). Aldehyde 2.34 and lactone 2.35 were adjoined by aldol condensation to 
furnish 2.36 with 3:1 diastereomerical ratio, which were separated by silica gel 
chromatography. Each diastereomer of 2.36 was converted to the same product 2.37 
under unique dehydration condition, and reduction of lactone 2.37 to methyl substituted 
alkene successfully installed C13-C14 (Z)-trisubstitued olefin (2.38). 
Scheme 2.5. Evans method to Construct (Z)-Trisubstitued Olefin 
 
The total synthesis of (+)-discodermolide
18n 
from the Panek group was an exercise 
to showcase the use of chiral crotylsilanes in C-C bond construction for polyketide 
synthesis.
34
 The three advanced fragments (2.42, 2.43 and 2.44) were efficiently 
constructed by addition of crotylsilane 2.40 to an aldehyde 2.39 with Felkin control
35
 
(Scheme 2.6, equation 3). The (Z)-trisubstituted vinylsilane 2.46 was prepared from 
TMS-alkyne 2.45 (available in five steps from crotylsilane 2.40) by a sequence of 
hydrozirconation,
36
 iodination, and palladium catalyzed methylation (Negishi coupling), 
and four more steps to afford central segment 2.43. The fragments union employed a 
                                                                                                                                                              
Asymmetric Synthesis; Morrion, J. D., Ed.; Academic Press: New York, 1984; Vol. 3, part B, p 
111. 
34
 Masse, C. E.; Panek, J. S. Chem. Rev. 1995, 95, 1293. 
35
 (a) Cherest, M.; Felkin, H.; Prudent, N. Tetrahedron Lett. 1968, 2199; (b) Anh, N. T.; 
Eisenstein, O. Nouv. J. Chim.  977, 1, 61. 
36
 Hart, D. W.; Schwartz, J. J. Am. Chem. Soc. 1974, 96, 8115. 
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highly selective 1,4-syn-1,5-anti aldol between methyl ketone 2.42 and aldehyde 2.43 
mediated by dialkylboron triflate.
37
 Converting vinylsilane 2.47 to vinyl iodide 2.48 
followed by Suzuki coupling with an alkyl iodide 2.44 derived borane gave the skeleton 
of (+)-discodermolide; four more elaborations completed the synthesis with a longest 
linear sequence of 27 steps (42 total steps) in an overall yield of 2.1%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                     
37
 (a) Paterson, I.; Gibson, K. R.; Oballa, R. M. Tetrahedron Lett. 1996, 37, 8585; (b) Paterson, I.; 
Florence, G. J.; Gerlach, K.; Scott, J. P.; Sereinig, N. J. Am. Chem. Soc. 2001, 123, 9535. (a) 
Evans, D. A.; Trotter, B.W.; Coleman, P. J.; Cote, B.; Dias, L. C.; Rajapakse, H. A.; Tyler, A. N. 
Tetrahedron 1999, 55, 8671–8726; (b) Evans, D. A.; Coleman, P. J.; Cote, B. J. Org. Chem. 1997, 
62, 788. 
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Scheme 2.6. Panek’s Total Synthesis of (+)-Discodermolide 
 
 The most recent total synthesis was from Ardisson and co-workers in 2007,
18q
 
which used crotyltitanate chemistry to construct the syn/anti-stereotriad from three 
equally complex fragments (2.52, 2.53 and 2.54) (Scheme 2.7, equation 4). The (Z)-
trisubstituted vinylstannane 2.53 was prepared from dihydrofuran 2.56 that was available 
from commercial bromoalcohol 2.55. Deprotonation of dihydrofuran 2.56 with t-BuLi 
followed by a 1,2-cuprate transfer provided a vinyllithium, which was trapped by tin 
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chloride furnishing (Z)-trisubstituted vinylstannane 2.57. Subsequent oxidation of 2.57 to 
an aldehyde followed by crotylation with chiral titanate 2.50 constructed required 
propionate 2.58 with a cis-vinylcarbarmate functionality; 2.58 was deprotonated by t-
BuLi thereby triggering Fritsch–Buttenberg–Wiechell rearrangement 38  to furnish the 
central fragment 2.53. Addition of lithiated alkyne (2.53) to Weinreb’s amide 2.52 
constructed the left-half backbone of discodermolide. Another eight-step transformation 
provided trisubstituted (Z)-vinyl iodide 2.60, which was used in a Suzuki cross coupling 
similar to Marshall and Panek’s strategies (Scheme 2.5 and 2.6). Three more elaborations 
completed the synthesis with longest linear sequence of 21 steps in an overall yield of 
2.1%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                     
38
 For a review, see: Knorr, R. Chem. Rev. 2004, 104, 3795. 
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Scheme 2.7. Ardisson’s Total Synthesis of (+)-Discodermolide 
 
 The groups that have been most involved in the chemical synthesis of (+)-
discodermolide are the Smith and Paterson laboratories. Both groups have designed and 
developed several generations of synthetic approaches in order to provide a practical way 
to prepare this biologically important polyketide. Later, their methods were combined 
and mixed by a Novartis process research team that successfully delivered 60g of (+)-
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discodermolide for early phase clinical trials.
18m
 Thus, the three approaches are discussed 
together below. 
 The Smith first-generation synthesis of the unnatural antipode (−)-discodermolide 
was reported in 1995, marked as the second approach to this molecule.
18c
 In order to 
make the synthesis more convergent and increase the yield for a Wittig phophonium salt 
preparation, a second generation approach was developed and provided one gram of (+)-
discodermolide for pre-clinical study in 2000.
18g
 However, further scale-up of the 
synthesis was limited by ultrahigh pressure and long reaction time (12.8 kbar for 7-10 
days) required for Wittig salt preparation. Thus, in 2003, a third generation effort was 
disclosed enabling the construction of Wittig phosphonium salt at ambient pressure by 
switching to smaller protecting group (TBS vs. MOM) to reduce the steric hindrance near 
reaction center. But, this improvement came at the cost of generating more cyclized by-
product.
18k
 
 Smith and co-workers didn’t stop improving the synthesis and a fourth-generation 
approach was reported in 2005 what at the time was the shortest longest-linear sequence 
of 17 steps (36 total steps) in an impressive 9% overall yield.
18o
 Similar to the previous 
three approaches, one of the central technologies was that each fragment shared the same 
precursor 2.58. Thus, it is of great importance to rapidly and reliably produce large 
quantities of common precursor 2.58 for large scale synthesis. Because of the crystalline 
solid form of norephedrine-derived Evans syn-aldol adduct 2.57 (compared to other 
amino alcohols derived aldol adducts as liquid),
39
 it can be prepared by direct 
crystallization from crude reaction mixture and only one chromatography was required to 
synthesize common precursor 2.58 from Roche ester (Scheme 2.8, equation 5). Wittig-
                                                     
39
 Gage, J. R.; Evans, D. A. Org. Synth. 1990, 68, 77. 
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Zhao olefination
31
 was employed to construct trisubstitued (Z)-vinyl iodide 2.63 from 
aldehyde 2.62 in moderate yield (41%). Due to the deactivated nature of trisubstituted 
vinyl iodide 2.63 (comparing to trialkyl-substituted olefin), the Wittig phosphonium salt 
2.60 was prepared under ambient pressure with no detectable cyclopentane byproducts 
formation. Wittig union of aldehyde 2.59 and 2.60 followed by Suzuki cross coupling 
with borane (derived from alkyl iodide 2.61) provided tetraene 2.65 efficiently. Three 
more steps completed the synthesis.  
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Scheme 2.8. Smith’s 4th Generation Synthesis of (+)-Discodermolide 
 
 Paterson and co-workers published their first-generation synthesis in 2000. This 
approach extensively utilized challenging boron mediated aldol reactions to construct and 
adjoin fragments.
18i
 Three years later, a second generation synthesis was reported with a 
few key changes, but the retrosynthetic strategy was largely analogous to their first 
generation approach.
18l
 In 2004, a third generation was disclosed employing a late-stage 
Still-Gennari olefination,
19
 which greatly improved the overall convergence.
18p
 Similar to 
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the previous two generations of synthesis, the stereotriad in each fragment (2.66, 2.67 and 
2.68, Scheme 2.9) was constructed by boron-mediated anti-aldol reaction that was well 
developed in the Paterson laboratory.
40
 Fragments union began with an anti-ester aldol 
reaction between aldehyde 2.68 and lithium enolate (derived from ester 2.67) furnishing 
right-half backbone of discodermolide (2.69) with good diastereoselectivity (6:1). It is 
worth pointing out that the 2,6-dimethyl-4-methoxylphenyl substitution in ester 2.67 is 
crucial for the ester aldol reaction, while other ester substitutions resulted lower yield and 
stereoselection. A three-step reductive removal of the ester moiety followed by another 
three-step transformation provided an intermediate aldehyde 2.70, which was subject to 
Still-Gennari olefination with β-ketophosphonate 2.66 to install the C8-C9 (Z)-olefin. 
The (+)-discodermolide synthesis was completed after another four-step transformation 
with a longest linear sequence of 24 steps (35 total steps) in an overall yield of 7.8%. 
 
 
 
 
 
 
 
 
 
 
 
                                                     
40
 Cowden, C. J.; Paterson, I. Org. React. (N.Y.) 1997, 51, 1. 
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Scheme 2.9. Paterson’s 3rd Generation Synthesis of (+)-Discodermolide 
 
 Both the Smith and Paterson groups made significant contributions to 
discodermolide syntheses; as a proof of their success, Novartis produced 60 grams of 
discodermolide for early phase clinical trials utilizing a hybrid of the Smith second-
generation synthesis and the Paterson first-generation endgame.
18m
 Multiple kilograms of 
Weinreb amide (common precursor) 2.58 was prepared via a modification of Smith’s 
route without using pyrophoric trimethylaluminum. With a large quantity of common 
precursor 2.58 in hand, three fragments were rapidly prepared (2.72 2.73 and 2.74, 
Scheme 2.10). Similar to Marshall’s approach (Scheme 2.4), vinyl iodide 2.73 underwent 
Suzuki cross-coupling with a trialkylborane (derived from alkyl iodide 2.74) furnishing a 
cleaner reaction compared to the analogous Negishi cross-coupling with in situ generated 
alkylzinc from 2.74. At this point, aldehyde 2.77 was constructed in order to transit to 
Paterson first-generation endgame. A reagent controlled asymmetric aldol addition was 
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employed: (+)-diisopinocamphenylboron enolate
41
 of methyl ketone 2.72 added to 
aldehyde 2.77 furnishing tetraene 2.78 in moderate yield and only 4:1 diastereoselectivity. 
Two more steps completed the synthesis of (+)-discodermolide with a longest linear 
sequence of 26 steps (33 total steps) and 17 purifications in an overall yield of 0.65%.  
Scheme 2.10. The Novartis 60 g Synthesis of (+)-Discodermolide 
 
 While the Novartis-Smith-Paterson hybrid synthesis is far from optimal, the 
process was able to deliver 60 grams of (+)-discodermolide that required efforts of 43 
chemists over a 20 months period. One of the most difficult and least efficient steps in the 
                                                     
41
 (a) Meyers, A. I.; Yamamoto, Y. Tetrahedron 1984, 40, 2309. (b) Meyers, A. I.; Yamamoto, Y. 
J. Am. Chem. Soc. 1981, 103, 4278. (c) Paterson, I.; Lister, M. A.; McClure, C. K. Tetrahedron 
Lett. 1986, 27, 4787. (d) Paterson, I.; Lister, M. A. Tetrahedron Lett. 1988, 29, 585. For related 
aldol reactions, see: (e) Paterson, I.; Goodman, J. M. Tetrahedron Lett. 1989, 30, 997. (f) 
Paterson, I.; Goodman, J. M.; Isaka, M. Tetrahedron Lett. 1989, 30, 7121. (g) Paterson, I.; 
McClure, C. K. Tetrahedron Lett. 1987, 28, 1229. 
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hybrid synthesis was the Wittig-Zhao olefination constructing (Z)-trisubstituted vinyl 
iodide 2.73, which only gave 25-31% yield (Scheme 2.11). The low yield was caused by 
the formation of large percentage of undesired epoxide 2.80 and the inherent instability of 
vinyl iodide 2.73.
42
 Thus, it is of great importance to develop a method that could 
effectively construct the challenging C13-C14 (Z)-trisubstituted olefin, preferably a 
catalytic process that concomitantly establishes the syn-propionate moiety adjacent to the 
olefin as well as a functional handle for further fragment union. It was considered that Ni-
catalyzed diastereoselective hydroboration of dienol (Chapter 1) could serve as a central 
methodology to rapidly construct (+)-discodermolide (Scheme 2.12).  
Scheme 2.11. The Novartis Hybrid Synthesis of (Z)-Trisubstituted Vinyl Iodide 
 
Scheme 2.12. Ni-Catalyzed Hydroboration of Dienol for Discodermolide Synthesis 
 
 Another consideration is that every previous approach to discodermolide started 
from fairly expensive Roche ester (~$20/g from Aldrich). A catalytic method that 
constructs similar building blocks from inexpensive feedstocks, such as asymmetric 
hydroformylation of terminal olefins (Chapter 3), would be valuable to organic synthesis. 
Herein, (+)-discodermolide was synthesized by three catalytic stereoselective borylation 
                                                     
42
 Arimoto, H.; Kaufman, M. D.; Kobayashi, K.; Qiu, Y.; Smith, A. B. III. Synlett. 1998, 765. 
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reactions developed in the Morken laboratory, which also marked as the first Roche ester-
free approach to this biological active molecule.  
2.3 Total Synthesis of (+)-Discodermolide 
2.3.1 Original Retrosynthetic Analysis 
In our retrosynthetic analysis, (+)-discodermolide was disconnected to three 
equally complex fragments by cleaving the C8-C9 cis-double bond and the C15-C16 
bond for a convergent synthesis. This renders β-ketophosphonate 2.81, (Z)-trisubstituted 
olefin 2.82 and diene tail 2.83 as key fragments. The C15-C16 bond could be formed by a 
homologation of secondary boronic ester 2.82 and enantiomerically enriched 
organolithium 2.83 to accomplish fragment union. Similar to Paterson’s third-generation 
synthesis (Scheme 2.9),
18p
 a challenging late stage Still-Gennari olefination between β-
ketophosphonate 2.81 and an aldehyde derived from 2.82 could furnish the C8-C9 cis-
double bond.  
The synthesis features rapid construction of three advanced fragments via three 
catalytic stereoselective borylation reactions developed in our laboratory: Ni-catalyzed 
borylative diene-aldehyde three-component coupling reaction (BDAC) (Chapter 4),
43
 Ni-
catalyzed diastereoselective hydroboration of chiral dienols (Chapter 1), and Pt-catalyzed 
asymmetric diene diboration.
44
 A highly diastereoselective Ni-catalyzed borylative diene 
(2.89) aldehyde (2.88) coupling reaction would give 1,3-diol 2.84, which has a carboxylic 
acid equivalent (R-substituent) and a terminal olefin; further transformation would 
convert 2.84 to β-ketophosphonate 2.81. The diene fragment 2.83 could arise from 
                                                     
43
 Cho, H. Y.; Morken, J. P. J. Am. Chem. Soc. 2010, 132, 7576. 
44
 (a) Burks, H. E.; Kliman, L. T.; Morken, J. P. J. Am. Chem. Soc. 2009, 131, 9134. (b) Schuster, 
C. H.; Li, B.; Morken, J. P. Angew. Chem. Int. Ed. 2011, 50, 7906. 
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selective elimination of 1,6-diol 2.87 that could be synthesized by an asymmetric Pt-
catalyzed 1,4-diboration of trans-pentadiene 2.89, followed by bis-Matteson 
homologation
45
-oxidation sequence. The chiral secondary boronic pinacol ester moiety in 
2.82 could be prepared from a homologation of allylboronic pinacol ester 2.85 with an 
enantiomerically enriched organolithium 2.86 and the allylboronic pinacol ester 2.85. The 
later (2.85) is available from a successful Ni-catalyzed diastereoselective hydroboration 
of chiral dienol 2.90 which constructs the trisubstituted (Z)-olefin and adjacent propionate 
moiety at the same time (Chapter 1). The synthesis also has the advantage that all 
advanced building blocks would come from readily available, inexpensive and achiral 
hydrocarbons. 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                     
45
 Sadhu, K.; Matteson, D. S. Organometallics 1985, 4, 1687. 
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Scheme 2.13. Retrosynthetic Analysis of (+)-Discodermolide 
 
2.3.2 Preparation of C1-C8 Fragment 
 As proposed in our retrosynthetic analysis (Scheme 2.13), the borylative three-
component coupling was tested. Our laboratory disclosed one example of the Ni-
catalyzed borylative diene aldehyde coupling using α-chiral aldehyde 2.91,43 which 
provided Felkin adduct 2.92 with 40% yield and 6:1 dr (Scheme 2.14). The required 
syn/anti/anti-stereotetraiad was constructed in one catalytic step where the chirality 
originated from the aldehyde 2.91, a product of asymmetric hydroformylation of 
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styrene.
46
 This is very exciting because the C1-C8 fragment would be constructed 
without using a Roche ester or chiral auxiliary. Most importantly, the valuable terminal 
olefin could be converted to a primary alcohol 2.93, a precursor for assembly of β-
ketophosphonate moiety 2.81 (Scheme 2.13). Originally, oxidative cleavage of phenyl 
ring
47
 in 2.94 was considered to generate requisite carboxylic acid 2.95 (Scheme 2.14). 
Unfortunately, after extensive reaction screening of conditions and protecting groups, no 
product other than decomposition of starting material could be obtained. This situation 
might be caused by the harsh oxidative reaction condition that is incompatible with 
highly oxygenated starting material 2.94.  
Scheme 2.14. Original Borylative Diene Aldehyde Coupling 
 
 Thus, it was of great importance to find another chiral aldehyde whose 
substitution can be converted to a carboxylic acid under mild conditions. Several α-chiral 
aldehydes were then screened (Table 2.1). To effect borylative coupling, 
tribenzylphosphine [P(Bn)3] was used as a ligand. This is a convenient, non-pyrophoric 
alternative to tris(trimethylsilyl)phosphine [P(TMS)3] which was originally developed for 
this reaction (see Chapter 4). The β-siloxyaldehyde 2.96 gave desired product 2.97 with 
                                                     
46
 For a review, see: Klosin, J.; Landis, C. R. Acc. Chem. Res. 2007, 40, 1251. 
47
 For a review, see; Mander, L. N.; Williams, C. M. Tetrahedron 2003, 59, 1105. 
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only 2:1 dr, though the product could be converted to the carboxylic acid required for 
lactonization (Table 2.1, entry 1). It was considered that the low diastereoselectivity was 
due to the similarity in size between hydroxylmethyl and methyl groups in 2.96; thus, a 
more steric demanding cyclic acetal-containing aldehyde was considered. As expected, 
1,3-dioxolane derived aldehyde 2.98 gave better diastereoselectivity; however, selective 
removal of dioxolane protecting group proved to be challenging in the presence of other 
acetal protecting group (Table 2.1, entry 2). Developed by Kibayashi and co-workers,
48
 
the o-xylyl acetal protecting group was employed because it can be selectively removed 
under neutral hydrogenation conditions. Accordingly, aldehyde 2.100 was prepared and 
subjected to the standard three-component coupling reaction conditions. After oxidation, 
the desired 1,3-diol 2.101 was obtained with good diastereoselectivity (6:1) as indicated 
by crude 
1
H-NMR. However, a new inseparable compound was also formed (~1:1 ratio) 
along with desired product 2.101. Later, the inseparable compound was identified as 
constitutional isomer 2.102, which resulted from transketalization of 2.101 during 
chromatography (Scheme 2.15, equation 6). In order to avoid such rearrangement, the 
concentrated crude reaction mixture was directly treated with 2,2-dimethoxylpropane and 
a catalytic amount of weak acid, pyridinium p-toluenesulfonate, to install the acetonide 
protecting group that rendered 2.103 as a stable and isolable product. If stronger acid was 
used for acetonide formation, transketalization was also observed. After extensive 
reaction optimization, 2.103 was obtained directly from aldehyde 2.100 without isolating 
any intermediate. Importantly, it was also determined that the catalyst loading for the 
three-component coupling reaction can be lowered to 5 mol % while maintaining good 
yield and stereoselection (Scheme 2.15, equation 7).  
                                                     
48
 Machinaga, N.; Kibayashi, C. Tetrahedron Lett. 1989, 30, 4165. 
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Table 2.1. Selected Aldehydes for Borylative Diene Aldehyde Coupling 
 
entry aldehyde product d.r. 
a 
yield (%) 
1
b 
  
2:1 52 
2
c 
  
5:1 ~14
d 
3
b 
  
6:1
 
~47
d 
a
 d.r. was determined by 
1
H-NMR and referred to Felkin/anti-Felkin products.      
b 
Oxidation with NaBO3. 
c
 Oxidation with NaOH/H2O2.
 d
 Contaminated by 
transketalization product.
 
 
Scheme 2.15. Problematic Transketalization and Its Solution 
 
 At the early stage of aldehyde screening (Table 2.1), the racemic aldehyde 2.100 
was prepared in five steps from 2-methyl-1,3-propandiol, and rapid preparation of 
enantiomerically enriched 2.100 still remained a challenging task. Thus, a new 
methodology, asymmetric hydroformylation of terminal olefins, was developed to 
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address this issue and delivered large quantities of the important building block 2.100. 
More than seven grams of optically active aldehyde 2.100 was prepared in one step from 
o-xylyl acetal protected acrolein 2.104 (Chapter 3), while it would cost six steps from 
Roche ester. A reliable supply of aldehyde 2.100 and optimized borolative diene-
aldehyde coupling reaction allowed a quick access to the intermediate 2.103. Accordingly, 
the next step of converting the terminal olefin to a primary alcohol was examined 
(Scheme 2.16). Similar to the observation made by Shioiri and co-workers in their 
synthesis of Calyculin A,
49
 hydroboration (e.g. BH3, 9-BBN, and catechol 
borane)/oxidation sequence applied to terminal olefin 2.103 in the presence of the 
adjacent ketal functionality gave desired primary alcohol 2.104 with irreproducible and 
poor yields. The strong Lewis acidity of the involved trialkylborane may cause 
decomposition of the Lewis basic ketal moiety. Thus, hydroboration with less Lewis 
acidic pinacolborane was considered.
50
 
 
 
 
 
 
 
 
 
 
                                                     
49
 Kabeya, M.; Hamada, Y.; Shioiri, T. Tetrahedron, 1997, 53, 9777. 
50
 Brown, H. C.; Racherla, U. S.; Pellechia, P. J. J. Org. Chem. 1990, 55, 1868. 
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Scheme 2.16. C1-C8 Fragment Synthesis 
 
 An iridium catalyzed hydroboration
51
 of terminal olefin 2.103 with pinacolborane 
furnished the corresponding less Lewis acidic alkylboronic acid pinacol ester, and 
subsequent mild sodium perborate oxidation delivered primary alcohol 2.104 with good 
and reproducible yield (71%). As designed, selective removal of the o-xylyl acetal in the 
presence of acetonide protecting group was achieved under neutral hydrogenation 
conditions with a catalytic amount of palladium oxide and atmospheric pressure of 
hydrogen gas; the intermediate product aldehyde 2.105 was used for next step without 
                                                     
51
 Yamamoto, Y.; Fijukawa, R.; Umemoto, T.; Miyaura, N. Tetrahedron, 2004, 60, 10695. 
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further purification. Subsequent Pinick oxidation
52
 of the crude aldehyde 2.105 gave 
corresponding carboxylic acid, which was esterified by treatment with a hexane solution 
of TMSCHN2, furnishing methylester 2.106 in good yield over four steps. Stepwise 
oxidation of 2.106 using Dess-Martin periodinane
53
 followed by Pinick oxidation,
52
 
provided a carboxylic acid that was treated with Ghosez reagent 2.107
54
 to generate acid 
chloride 2.108 under mild condition. It was necessary to use the Ghosez reagent 2.107 to 
synthesize acyl chloride 2.108 because only neutral reaction condition allowed survival 
of the acid-sensitive ketal protecting group (Scheme 2.17). The acyl chloride 2.108 was 
reacted immediately with the phosphoryl anion generated by deprotonation of 2.109.
55
 
Pleasingly, the acylation proceeded smoothly to afford C1-C8 fragment 2.110 with good 
yield over four steps. Starting from readily available 1,2-benzenedimethanol,
56
 β-
ketophosphonate 2.110 was conveniently prepared on several hundred milligrams scale in 
12 steps without using Roche ester or any chiral auxiliary.  
 
 
 
 
                                                     
52
 (a) Lindgren, B. O.; Nilsson, T. Acta Chem. Scand. 1973, 27, 888. (b) Bal, B. S.; Childers, W. 
E. J.; Pinnick, H. W. Tetrahedron 1981, 37, 2091. (c) Mann, J.; Thomas, A. Tetrahedron Lett. 
1986, 27, 3533. 
53
 (a) Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155. (b) Dess, D. B.; Martin, J. C. J. Am. 
Chem. Soc. 1991, 113, 7277. 
54
 Devos, A.; Remion, J.; Frisque-Hesbain, A. M.; Colens, A.; Ghosez, L. J. Chem. Soc., Chem. 
Commun. 1979, 1180. 
55
 Yu, W.; Su, M.; Jin, Z. Tetrahedron Lett. 1999, 40, 6725. 
56
 1,2-benzenedimethanol is commercially available from Aldrich ($40.2/g), or it is easily 
prepared from cheap phthalic anhydride ($51/500g) in one step in almost quantitative yield. 
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Scheme 2.17. Preparation of Acyl Chloride under Neutral Conditions 
 
2.3.3 Preparation of C9-C16 Fragment 
 Efficient construction of C9-C16 fragment largely relied on rapid preparation of 
chiral dienol 2.90 (Scheme 2.13). According to previous observations,
57
 bis-TBS 
protected dienol ether 2.120 could participate in the Ni-catalyzed diastereoselective 
hydroboration (Chapter 1, Table 1.2, entry 10), while a very similar diene but with a 
PMB-protected primary alcohol was surprisingly inactive. This difference in reactivity 
might attributed to intramolecular binding of the basic benzyl ether to the nickel center 
inhibiting the hydroboration process, similar to terminal alkene and Weireb amide 
containing substrates (Chapter 1, Table 2.1). Thus, it is necessary to construct 
enantiomerically-enriched dienol ether 2.120 with a bulky and non-chelating TBS-
protecting group. Considering the anti-relationship of the propionate in 2.120, an anti-
aldol reaction was attempted. The synthesis of the required dienal 2.117 for aldol reaction 
was accomplished with a high yielding three-step sequence involving an olefination 
between methacrolein and a stabilized Wittig reagent 2.114, an LiAlH4 reduction and a 
TPAP catalyzed oxidation to afford aldehyde 2.117 with good yield and >20:1 (E)-
selectivity (Scheme 2.18, equation 9). A number of anti-aldol reactions were then 
evaluated on aldehyde 2.117. Chiral auxiliary containing ethyl ketone 2.118
58
 condensed 
with aldehyde 2.117 furnishing desired anti-aldol adduct 2.119 with good yield and 
                                                     
57
 Ely, R. J. Ph.D. Thesis, Boston College, 2012. 
58
 Abiko, A. Org. Syn. 2002, 79, 109. 
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excellent selectivity under Abiko-Massamune aldol
59
 reaction conditions (Scheme 2.18, 
equation 10). However, Evans anti-aldol
60
 was superior in this case due to its easier 
reaction set-up and more readily available reagents compared to the Abiko-Massamune 
aldol reaction. Subjecting aldehyde 2.117 to standard Evans anti-aldol reaction conditions, 
2.122 was isolated with excellent yield and diastereoselectivity (Scheme 2.18, equation 
11). In both cases, the auxiliaries were removed under reductive conditions furnishing a 
1,3-diol, which was protected as bis-TBS ether 2.120.  
Scheme 2.18. Synthesis of Chiral Dienol Ether by anti-Aldol Reactions 
 
 Though both auxiliary based anti-aldol reactions in Scheme 2.18 provided dienol 
ether 2.120 efficiently in a reasonably short sequence, it would be of great value if 2.120 
can be constructed via a catalytic method from readily available materials. The first 
thought was asymmetric catalytic aldol reactions; unfortunately, very few catalytic anti-
                                                     
59
 (a) Abiko, A.; Liu, J.-F.; Masamune, S. J. Am. Chem. Soc. 1997, 119, 2586. (b) Inoue, T.; Liu, 
J.-F.;Buske, D. C.; Abiko, A. J. Org. Chem. 2002, 67, 5250. (c) ref. 58 
60
 Evans, D. A.; Tedrow, J. S., Shaw, J. T.; Downey, C. W. J. Am. Chem. Soc. 2002, 124, 392. 
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aldol
61
 or crotylation
62
 reactions are highly enantio- and diastereoselective with aliphatic 
or α,β-unsaturated aldehydes.63 A former group member, Dr. Robert J. Ely,57 employed 
an Ir-catalyzed transfer hydrogenation reaction, developed by Krische and co-workers.
64
 
The reaction between alcohol 2.116 and crotyl acetate established the anti-propionate 
moiety in 2.123 with good diastereo- and enantioselectivity (Scheme 2.19). Desired diene 
2.120 was obtained after a series of subsequent transformations including a Pt-catalyzed 
diboration/oxidation,
65
 oxidative cleavage of 1,2-diol, reduction and TBS-protection. 
While Ir-catalyzed transfer hydrogenation reaction constructed desired anti-aldol moiety 
efficiently, we didn’t pursue this method further because the transfer hydrogenation 
reaction only gave partial conversion after 48 h at 60 
o
C and too many transformations 
were required converting 2.123 to bis-TBS ether substrate 2.120. Thus, a shorter and 
more efficient method needed to be developed to construct the important precursor 2.120 
for the C9-C16 fragment. 
 
 
 
 
                                                     
61
 (a) Denmark, S. E.; Heemstra Jr., J. R.; Beutner, G. L. Angew. Chem., Int. Ed. 2005, 44, 4682. 
(b) Brodmann, T.; Lorenz, M.; Schäckel, R.; Simsek, S.; Kalesse, M. Synlett 2009, 174. 
62
 For a review on catalytic asymmetric carbonyl allylation, see: (a) Denmark, S. E.; Fu, J. Chem. 
Rev. 2003, 103, 2763. 
63
 The proline catalyzed cross-aldol reaction was unsuccessful with aldehyde 2.117, see; Northrup, 
A. B.; MacMillan, D. W. C. J. Am. Chem. Soc. 2002, 124, 6798.  
 
64
 For references, see Chapter 1, Section 1.1. 
65
 (a) Coombs, J. R.; Haeffner, F.; Kliman L. T.; Morken, J. P. J. Am.Chem.Soc. 2013, 135, 11222. 
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Scheme 2.19. Synthesis of Chiral Dienol Ether via Transfer Hydrogenation 
 
Besides anti-aldol and crotylation reactions, another class of methods to establish 
anti-propionate moieties is chelation controlled neucleophilic addition to a β-hydroxyl 
aldehyde, using an existing stereogenic center to influence the introduction of new 
stereocenter(s) (Scheme 2.20).
66
 Moreover, the outcome of the new stereocenter(s) could 
be controlled by a number of methods, such as Felkin-Ann selectivity,
67
 Cram-chelation 
model.
68
 Thus, in order to construct 1,2-anti-propionate moiety in 2.127, chelation 
controlled neucleophilic addition should be applied, which usually requires using a small 
protecting group, such as MOM, Bn, and Me ether protected alcohol (Scheme 2.20, 
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 (a) Corey, E. J.; Cheng, X.-M. The Logic of Chemical Synthesis; Wiley: New York, 1989. (b) 
Koskinen, A. Asymmetric Synthesis of Natural Products; Wiley: Chichester, NY, 1993. (c) 
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Wiley-VCH: Weinheim, Germany, 2009. 
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Felkin, H. Tetrahedron Lett. 1968, 9, 2205. (c) Anh, N. T.; Eisenstein, O. Tetrahedron Lett. 1976, 
17, 155. (d) Anh, N.; Eisenstein, O. Nouv. J. Chim. 1977, 1, 61. (e) Anh, N. T. Top. Curr. Chem. 
1980, 88, 145. 
68
 (a) Cram, D. J.; Elhafez, F. A. A. J. Am. Chem. Soc. 1952, 74, 5828. (b) Cram, D. J.; Kopecky, 
K. R. J. Am. Chem. Soc. 1959, 81, 2748. (c) Leitereg, T. J.; Cram, D. J. J. Am. Chem. Soc. 1968, 
90, 4019. 
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equation 12).
69
 However, as aforementioned, a bulky and non-chelating silyl protecting 
group of primary alcohol is crucial for the Ni-catalyzed hydroboration to proceed, and the 
corresponding starting material, β-siloxyl aldehyde 2.128, disfavors chelation and usually 
gave Felkin 1,2-syn-product 2.126. To avoid a protecting group swap, it would be 
extremely valuable if the β-siloxyl aldehyde 2.128 underwent chelation controlled 
neucleophilic addition itself and constructed Cram 1,2-anti-product 2.127 selectively. 
Unfortunately, there are only limited methods to promote chelation controlled additons to 
β-siloxyl aldehydes or ketones. For example, Evans and co-workers reported the ability 
of Me2AlCl and MeAlCl2 to chelate β-siloxyl aldehydes in Mukaiyama aldol reactions.
70
 
Recently, Walsh and co-workers also demonstrated that chelation controlled addition of 
organozinc reagents to β-siloxyl aldehydes could be accomplished in the presence of a 
remarkable zinc-derived Lewis acid, EtZnONf, EtZnOTf,
71
 or ZnBr2.
72
 Thus, it was 
proposed that desired 1,2-anti-product 2.130 could be accessed by a Lewis acid-mediated 
addition of vinylzinc 2.219 to β-siloxyl aldehyde 2.218 under chelation-controlled 
process (Scheme 2.20, equation 13).  
 
 
 
 
 
 
                                                     
69
 (a) Keck, G. E.; Castellino, S. J. Am. Chem. Soc. 1986, 108, 3847. (b) Reetz, M. T. Acc. Chem. 
Res. 1993, 26, 462. 
70
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 Jeon, S.-J.; Fisher, E. L.; Carroll, P. J.; Walsh, P. J. J. Am. Chem. Soc. 2006, 128, 9618. 
 121 
 
Scheme 2.20. 1,2-Asymmetric Induction for β-Hydroxyl Aldehyde 
 
Vinylzinc 2.134 could be generated in situ using Srebnik/Oppolzer procedure:
73
 
hydroboration of enyne 2.132 followed by transmetalation of vinyl group in 2.133 from B 
to Zn with Et2Zn (Scheme 2.21). However, the starting material, simple enyne 2.132, was 
a challenging compound to prepare due to its low molecular weight and low boiling point. 
Common terminal alkyne alkylation
74
 of commercial enyne 2.131, when carried out in 
THF or ether solution, did produce product enyne 2.132 as determined by crude 
1
H NMR. 
However, all attempts of its isolation and purification from solution phase failed due to 
unavoidable solvent contamination. After studying a number of reaction conditions and 
solvent screening, it was identified that a reaction sequence of deprotonation of enyne 
2.131 with sodium amide in liquid ammonia, methylation with dimethylsulfate, 
evaporating ammonia solvent and subsequent in situ distillation provided enyne 2.132 as 
a colorless liquid (bp~45 
o
C) in 55% reproducible yield on multiple grams scale. The 
successful preparation of enyne 2.132 paved the way to access key intermediate 
nucleophile 2.134 for the dienol ether’s (2.120) synthesis. 
                                                     
73
 (a) Srebnik, M. Tetrahedron Lett. 1991, 32, 2449. (b) Oppolzer, W.; Radinov, R. N. Helv. Chim. 
Acta 1992, 75, 170. (c) Oppolzer, W.; Radinov, R. N.; Brabander, J. D. Tetrahedron Lett. 1995, 
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Scheme 2.21. Preparation of Vinylzinc Nucleophile 
 
Following the procedure reported by Walsh and co-workers,
71
 a chelation 
controlled addition of in situ generated vinylzinc 2.134 (Scheme 2.22) to the TBS-
protected β-hydroxyl aldehyde 2.128 was accomplished in the presence of EtZnONf to 
afford diene 2.130 with good yield and diastereoselectivity (Scheme 2.22). EtZnONf was 
the most efficient Lewis acid compared to EtZnOTf, ZnBr2, and Me2AlCl.
75
  It is 
noteworthy that diene 2.130 is constructed in only two steps including an asymmetric 
hydroformylation of allyl ether 2.135 without using any chiral auxiliary or Roche ester 
(Chapter 3). Subsequent TBS-protection of the secondary alcohol in 2.130 gave desired 
diene 2.120 and set the stage for Ni-catalyzed hydroboration. However, no conversion 
was observed after subjecting diene 2.120 to standard reaction conditions (Scheme 2.22). 
It was suspected that an inseparable impurity in starting material 2.120 (<5% as 
determined by 
1
H NMR) inhibited the Ni-catalyzed hydroboration reaction. 
Unfortunately, no purification method was able to remove the unknown impurity in diene 
2.120. 
 
 
 
 
 
                                                     
75
 EtZnOTf, ZnBr2, and Me2AlCl did provide desired product 2.130, but with lower yield and 
diastereoselectivity.  
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Scheme 2.22. Synthesis of Dienol Ether 
 
At that point, the structure and properties of the impurity remained unknown, yet 
it was important and interesting to identify the impurity which might help prevent its 
formation or facilitate purification. After extensive characterization, the 
13
C NMR of 
contaminated diene 2.120 showed a characteristic peak of an allene central carbon at 203 
ppm. This was very exciting information and it certainly convinced us that an allene was 
the impurity inhibiting the Ni-catalyzed hydroboration reaction. Moreover, it is known 
that cyclization of an allene and an olefin happens simultaneously in the presence of 
nickel (0).
76
 This would consume the nickel catalyst and shut down the desired Ni-
catalyzed hydroboration. Accordingly, the origin of the allene impurity was studied. An 
NMR experiment indicated that hydroboration of enyne 2.132 with HBCy2 was not quite 
regioselective (6:1) and gave 2.133a as major isomer which undergoes transmetalations 
to furnish vinylzinc 2.134a (Scheme 2.23). It was considered that the minor regioisomer 
2.133b would afford vinylzinc 2.134b; subsequent allylation with aldehyde 2.128 would 
give allene 2.137. Not surprisingly, diene 2.130 and allene 2.137 have extremely similar 
physical properties and their separation would be challenging.  
                                                     
76
 Noucti, N. N.; Alexanian, E. J. Angew. Chem. Int. Ed. 2013, 52, 8424.  
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Scheme 2.23. Origin of Allene Impurity 
 
This problematic step was solved by treating the mixture of regioisomers (2.133a 
and 2.133b) with a surrogate benzylaldehyde prior to B to Zn transmetalation. Only 
undesired isomer 2.133b reacted with benzylaldehyde providing allene 2.138 and leaving 
desired regioisomer 2.133a untouched (Scheme 2.24). Subsequent transformations of 
2.133a provided 2.130 as sole compound; silica gel chromatography was efficient at 
separation due to the polarity difference of 2.130 and 2.138. As an aside, it was also very 
interesting to find that allene 2.138 was isolated as single diastereomer but its relative 
stereochemistry was not assigned. 
Scheme 2.24. Removal of Allene Impurity 
 
After removal of the allene byproduct, dienol ether 2.120 now participated in Ni-
catalyzed hydroboration reaction furnishing (Z)-trisubstituted allylboronic acid pinacol 
ester 2.136 with good yield and diastereoselectivity (Scheme 2.25). Conversion of 2.136 
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to 2.142 was accomplished using Hoppe type
77
 lithiated ethylcarbarmate 2.140 that 
served as a carbenoid equivalent to homologate a boronic ester (Chapter 1, section 1.1).
78
 
Unfortunately, the widely used and commercially available (−)-sparteine would give 
incorrect epimer at C16, and the desired enantiomeric auxiliary is not commercially 
available. This problem can be solved by using (+)-sparteine surrogate 2.143, developed 
by O’Brien and co-workers, which can be obtained in a few steps after isolation of (−)-
cytisine from commercially available Laburnum Anagyroides Cytisus seeds.
79
 With (+)-
sparteine surrogate 2.143, the homologation sequence was performed: to the 
enantiomerically enriched lithium species 2.140 that was prepared in situ from 
ethylcarbarmate 2.139 was added allylboronic ester 2.136 furnishing a boronate complex 
2.141, which, upon heating at reflux, underwent 1,2-migration displacing carbarmate and 
delivering the C9-C16 fragment 2.142. This fragment contained the anti/syn-stereotriad, 
adjacent (Z)-trisubstitued olefin, as well as an enantiomerically enriched secondary 
boronic ester that can serve as a functional handle to adjoin with the C17-C24 fragment 
(Scheme 2.28). Advanced segment 2.142 was synthesized in only 5 steps from 
commercially available achiral enyne 2.131. 
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Scheme 2.25. Synthesis of the C9-C16 Fragment 
 
Ni-catalyzed diastereoselective hydroboration of chiral 1,3-dienol (Chapter 1) 
rapidly delivered the C9-C16 fragment 2.142 from a simple hydrocarbon, while similar 
segments reported in literature were prepared from Roche ester and required more 
synthetic manipulations (Figure 2.2). Moreover, a methodology described herein enabled 
accesses to the C9-C16 fragments with different vinyl substituents at C14 position, such 
as phenyl and silyl substitutions (Chapter 1, table 2.2); thus, it is anticipated that 
discodermolide analogs with different C14 substitutions can be synthesized, whose 
biological activities remains underdeveloped.  
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Figure 2.2. Comparison of C1-C15/C16 Fragments Syntheses 
 
Schreiber (P1=P2=TBS):
18a, 18d
 7 steps from Roche 
ester, including Roush asymmetric allylation.
80
 
Myles (P1=Bn, P2=TIPS):
18e
 11 steps from Roche 
ester. 
Paterson (P1=PMB, P2=TBS):
18i
 10 steps from Roche 
ester, including a Paterson anti-aldol reaction.
81
 
Morken (P1=P2=TBS, after in situ oxidation of 2.136): 
4 steps from commercial enyne 2.131, no auxiliary 
involved. 
 
Muzler (P1=PMB, P2=TBS, R=CHO):
82
  17 steps 
from Roche ester, including an Oppolzer sultam
83
 
based alkylation to install C16 methyl. 
Morken (P1=P2=TBS, R=B(pin)): 5 steps from 
commercially available enyne 2.131 including a (+)-
sparteine surrogate mediated homologation. 
 
2.3.4 Preparation of the C17-C24 Fragment 
 It was envisioned that the (Z)-diene moiety can be synthesized via a selective 
elimination of the relatively less hindered alcohol of 1,6-diol 2.87 (Scheme 2.26). The 
diol 2.87 was prepared by asymmetric Pt-catalyzed 1,4-diboration of trans-pentadiene 
2.89 using oxaphos ligand 2.144
44b
 followed by bis-Matteson homologation
45
/oxidation; 
such single flask reaction produced 1,6-diol 2.87 on multigram scale with good yield and 
enantioselectivity. With diol 2.87 in hand, selective elimination of the relatively less 
hindered alcohol at C24 was investigated.  
 
                                                     
80
 Roush, W. R.; Palkowitz, A. D.; Ando, K. J. Am. Chem. Soc. 1990, 112, 6348. 
81
 a) Cowden, C. J.; Paterson, I. Asymmetric Aldol Reactions using Boron Enolates in Organic 
Reactions, Vol. 51 (Ed.: L. A. Paquette), Wiley, New York, 1997, p. 1; b) see ref. 37b 
82
 Prantz, K.; Mulzer, J. Chem.Eur. J. 2010, 16, 485. 
83
 Oppolzer, W. Pure Appl. Chem. 1990, 62, 1241. 
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Scheme 2.26. Synthesis of 1,6-Diol via Pt-Catalyzed Diboration 
 
 The most efficient strategy would involve installation of an activating group at 
C24 selectively followed by elimination to afford dienol 2.146 directly (Scheme 2.27a). 
The first attempt entailed treatment of diol 2.87 with 1.0 equivalent of tosylchloride at 0 
o
C; pleasingly, slight regioselectivity was observed preferring desired regioisomer 2.147a 
together with an equal amount of bis-tosylate compound 2.147c (Scheme 2.27b). This 
result suggested that the relatively less hindered alcohol at C24 did undergo sulfonylation 
faster. However, after screening various reaction conditions and bases, none of them 
enhanced regioselectivity and minimized the formation of bis-tosylate 2.147c. 
Considering the less sterically demanding tosylchloride might be responsible for the low 
regioselectivity, more steric hindered sulfonylchloride, 2,4,6-triisopropylbenzene 
sulfonylchloride, was tested. Under standard reaction conditions, desired regioisomer 
2.147a was formed with synthetically useful levels of selectivity comparing to tosylate 
(5:1 vs. 2:1), but minimization of bis-sulfonylated product 2.147c remained unimproved 
(Scheme 2.27b). Inspired by mono-silylation of a diol reported by McDougal and co-
workers,
84
 similar strategy was employed. Thus, after deprotonation of 1,6-diol 2.87 with 
1.0 equivalent NaH, the heterogeneous solution of alkoxide 2.148 was treated with 2,4,6-
                                                     
84
 McDougal, P. G.; Rico, J. G.; Oh, Y.-I.; Condon, B. J. Org. Chem. 1986, 51, 3388. 
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triisopropylbenzene sulfonylchloride to furnish mono-sulfonylated products (2.147a and 
2.147b) exclusively but with only 1:1 regioselectivity (Scheme 2.27c). It is well-
documented that continuous flow chemistry could improve batch reaction selectivity;
85
 
thus the sulfonylation reaction was carried out in a flow reactor to minimize bis-
sulfonylate 2.147c and enhance regioselectivity for 2.147a. Unfortunately, flow reaction 
system gave no improvement after several condition optimizations. (Scheme 2.27d). 
Scheme 2.27. Selective Sulfonylation of 1,6-Diol 
 
                                                     
85
 For recent general reviews on continuous flow chemistry, see: (a) Wirth, T. Microreactors in 
organic synthesis and catalysis; Wiley-VCH: Weinheim, 2008. (b) Hartman, R. L.; Jensen, K. F. 
Lab Chip 2009, 9, 2495. (c) Mason, B. P.; Price, K. E.; Steinbacher, J. L.; Bogdan, A. R.; 
McQuade, D. T. Chem. Rev. 2007, 107, 2300. (d) Geyer, K.; Gustafsson, T.; Seeberger, P. H. 
Synlett 2009, 2382. (e) Kirschning, A.; Solodenko, W.; Mennecke, K. Chem.;Eur. J. 2006, 12, 
5972. (f) Wiles, C.; Watts, P. Eur. J. Org. Chem. 2008, 10, 1655. (g) Ley, S. V.; Baxendale, I. R. 
Proc. Bosen Symp. Syst. Chem. 2008, 65. (h) Jahnisch, K.; Hessel, V.; Lowe, H.; Baerns, M. 
Angew. Chem. Int. Ed. 2004, 43, 406. 
 130 
 
 Since mono-activation of diol 2.87 was challenging, a three-step sequence was 
employed to synthesize dienol 2.150. After bis-tosylation of diol 2.87 with 2.0 
equivalents of TsCl, 2.149 underwent selective elimination with 1.0 equivalent of a 
sterically hindered base, such as KOt-Bu, furnishing (Z)-diene 2.150 (Scheme 2.28). 
Kornblum oxidation
86
 was examined to convert tosylate 2.150 to aldehyde 2.151 in one 
step, but diene isomerization always dominated due to harsh reaction conditions.
57 
Therefore, a two-step strategy was used to synthesize dienal 2.151: removal of tosyl 
group (2.150) with magnesium powder in dry methanol followed by Dess-Martin 
oxidation of product alcohol 2.146. Aldehyde 2.151 was subject to reductive aldol 
reaction with acryloymorpholine 2.152
87
 providing syn/anti-stereotriad 2.153 as a single 
diastereomer, and this is the only aldol-type reaction used in the synthesis of (+)-
discodermolide. Though the Evans aldol reaction with aldehyde 2.151 was also effective 
furnishing syn/anti-stereotriad (61% yield over two steps, single diastereomer), the 
advantage of Roush reductive aldol reaction is that the morpholine amide moiety in 
product 2.153 is equivalent to a Weinreb amide in ketone synthesis,
88
 which facilitates 
further transformations (Scheme 2.32). Subsequent LiAlH4 reduction of amide 2.153 to a 
1,3-diol, protection as acetal 2.154, followed by selectively acetal ring opening with 
DIBAL
89
 furnished primary alcohol 2.155 in good yield over three steps. Conversion of 
alcohol 2.155 to diisopropylcarbarmate 2.156 set the stage to test the key step, a 1,2-
migration strategy between lithiated 2.156 and secondary boronic ester 2.142 
constructing C16-C17 bond (Scheme 2.13). Overall, the synthesis of C17-C24 (Z)-diene 
                                                     
86
 Kornblum, N,; Jones, W. J.; Anderson, G. J. J. Am. Chem. Soc. 1959, 81, 4113. 
87
 Nuhant, P.; Allais, C.; Roush, W. R. Angew. Chem. Int. Ed. 2013, 52, 8703. 
88
 Martín, R.; Romea, P.; Tey, C.; Urpí, F.; Vilarrasa, J. Synlett. 1997, 12, 1414. 
89
 Horita, K.; Abe, R.; Yonemitsu, O. Tetrahedron Lett. 1988, 29, 4139. 
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fragment was accomplished in 10 steps from simple trans-pentadiene without using 
Roche ester. 
Scheme 2.28. Synthesis of C17-C24 Fragment 
 
2.3.5. C16-C17 Bond Formation via Homologation Strategy 
 Similar to the homologation strategy used in Scheme 2.25, stereoselective 
Aggarwal homologation was examined for joining carbarmate 2.156 and boronic ester 
2.142. Enantioselective deprotonation of 2.156 should give lithium species 2.157 which 
would coordinate to boronic ester 2.142 providing a boronate complex 2.159. It was 
anticipated that the boronate intermediate would undergo 1,2-migration upon heating, 
thereby furnishing 2.158 (Scheme 2.29). The proposed fragment union strategy requires 
that allylboronic ester 2.136 perform two homologations with 2.140 and 2.157 
sequentially in a single flask operation.
90
 This would transfer boron from 2.136 to 
                                                     
90
 For examples of similar strategies in total synthesis, see: (a) Rasappan, R.; Aggarwal.V. K. 
Nature Chem. 2014, 6, 810. (b) Pulis, A. P.; Aggarwal, V. K. J. Am. Chem. Soc. 2012, 134, 7570. 
(c) Dutheuil, G.; Webster, M. P.; Worthington, P. A.; Aggarwal, V. K. Angew. Chem. Int. Ed. 
2009, 48, 6317. (d) Stymiest, J. L.; Dutheuil, G.; Mahmood, A.; Aggarwal, V. K. Angew. Chem. 
Int. Ed. 2007, 46, 7491. 
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product 2.158. Unfortunately, no desired product 2.158 was observed after extensive 
reaction condition screening, such as addition of Lewis acid to promote 1,2-boronate 
migration,
91
 changing diamine to achiral TMEDA,
92
 switching to a better leaving group 
instead of carbarmate,
93
 and in situ generation of organolithium species preventing 
potential decomposition. 
Scheme 2.29. Construction of C16-C17 Bond 
 
 To analyze the problem, the enantioselective deprotonation was studied to find 
out whether the first step of the homologation sequence works. Carbarmate 2.156 was 
subject to standard deprotonation condition, and MeOD was then used to quench any 
generated carbon anion (Scheme 2.30). Instead of introducing deuterium at expected 
carbinol C17 position (2.161), surprisingly, deuterium was installed at allylic C20 
position (2.160). Thus, direct deprotonation of carbarmate resulted in substantial 
deprotonation at allylic position, which was also observed by Aggarwal and co-workers 
                                                     
91
 (a) Pulis, A. P.; Aggarwal, V. K. J. Am. Chem. Soc. 2012, 134, 7570. (b) Stymiest, J. L.; 
Dutheuil, G.; Mahmood, A.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2007, 46, 7491. (c) Tsai, D. 
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 Alexander P. Pulis, Philipp Fackler, Varinder K. Aggarwal. Angew. Chem. Int. Ed. 2014, 126, 
4471. 
93
 Larouche-Gauthier, R.; Fletcher, C. J.; Couto, I.; Aggarwal, V. K. Chem. Commun. 2011, 47, 
12592. 
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with compound 2.162 (Scheme 2.30).
94
 They solved this problem by introducing a chiral 
α-hydroxylstannane 2.164, which gave required organolithium species 2.165 by Li-Sn 
exchange; this avoids challenging deprotonation in the presence of allylic protons. 
Though a few attempts to use a similar strategy on diene 2.156 were made, we didn’t 
pursue it any further because it significantly increased the number of steps in the 
synthesis also incorporated toxic organotin compounds making the synthesis less 
appealing. Except for the Aggarwal homologation, several strategies were also evaluated 
to unite these two fragments (2.156 and 2.142). For example, transmetalation from 
enantiomerically enriched boronic ester 2.142 to magnesium
95
 or zinc
96
 with 
stereoretention would furnish an organometalic nucleophile, which could add to an 
aldehyde prepared by oxidation of 2.155 (Scheme 2.28). Unfortunately, no success was 
achieved for this transmetalation strategy. It looks quite challenging to connect the two 
fragments at C16-C17 bond. Thus, the synthesis was redesigned. 
Scheme 2.30. Unexpected Allylic Deprotonation 
 
                                                     
94
 Robinson, A.; Aggarwal, V. K. Org. Biomol. Chem. 2012, 10, 1795. 
95
 Reichle, M. A.; Breit, B. Angew. Chem. Int. Ed. 2012, 51, 5730. 
96
 Hupe, E.; Calaza, M. I.; Knochel, P. J. Organometallic Chem. 2003, 680, 136. 
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2.3.6. Revised Fragments Union and Completion of the Synthesis 
 Instead of breaking C16-C17 bond in (+)-discodermolide, an enolate alkylation 
was considered to establish C15-C16 linkage between an allyl electrophile 2.242 and 
enolate 2.243, both of which can be prepared without significantly changing existed 
fragments (Scheme 2.31). Similar bond construction via enolate alkylation in previous 
syntheses of discodermolide have employed (Z)-enolates that engaged in chelation with 
the β-oxygen at C19 (Scheme 2.2 and 2.3); these reactions proceeded in moderate 
selectivity (6:1 dr) and required an excess of precious electrophile 2.167 (2.0 equivalents). 
It would be of great value and importance to develop a methodology to improve this 
long-standing problem.  
Scheme 2.31. Revised Retrosynthetic Analysis 
 
 Inspired by the anti-aldol reactions where an α-chiral (E)-enolate controls the 
outcome of α'-position using A(1,3) strain, 97  we considered an α'-alkylation of non-
chelated α-chiral (E)-enolate. In line with established strategies for acyclic 
conformational analysis,
98
  it was considered that the (E)-enolate 2.170 derived from 
ethyl ketone 2.169, in the absence of any chelation effects between neighboring 
functional groups and the metal enolate, might favor conformer 2.170a such that 
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 (a) Paterson, I.; Goodman, J. M.; Isaka, M. Tetrahedron Lett. 1989, 30, 7121.  (b) Evans, D. A.; 
Ng, H. P.; Clark, J. S.; Rieger, D. L. Tetrahedron Lett. 1992, 48, 2127. (c) Paterson, I.; Wallace, 
D. J.; Velázquez, S. M. Tetrahedron Lett. 1994, 35, 9083.  (d) For a review, see: Cowden, C. J.; 
Paterson, I. Organic Reactions 1997, 51, 1-200. 
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 E. L. Eliel, S. H. Wilen, L. N. Mander, Stereochemistry of organic compounds, Ed. J. Wiley & 
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alkylation occurs preferentially from the less hindered Re face furnishing product 2.171 
(Table 2.2). A preliminary experiment was carried out to test this proposal, and 
pleasingly, alkylation product 2.175 was formed with high yield and diastereoselectivity 
by treating (E)-enolate (which was generated by ethyl ketone deprotonation with lithium 
tetramethyl-piperidide (LTMP) in the presence of LiBr
99
) with allyl iodide at low 
temperature (Table 2.2, entry 1). Of vital importance for eventual scale-up of complex 
fragment couplings, the reaction yield was excellent as well as diastereoselectivity even 
when a 1:1 stoichiometry of enolate:electrophile was employed. Furthermore, ketones 
with adjacent syn- and anti-propionate moiety (2.172 and 2.173) gave desired products 
(2.175 and 2.176) with good yield and selectivity (Table 2.2, entry 1 and 2). Even simple 
hydrocarbon derived ethyl ketone 2.174 can exhibit useful levels of selectivity and good 
yield (Table 2.2, entry 3). 
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Table 2.2. Diastereoselective (E)-Enolate Alkylationa 
 
entry substrate product d.r.
b 
yield (%) 
1 
  
6:1  85 
2 
  
7:1  92 
3 
  
3:1 74 
a
 LTMP and LiBr were generated in situ with 1.0 equivalent of TMP·HBr 
and 1.95 equiv. n-BuLi. 
b
 dr was determined by 
1
H NMR. 
 
 With diastereoselective enolate alkylation methodology in place, construction of 
(+)-discodermolide commenced. Desired allyl iodide 2.179 was readily available from 
iodinolysis of allyl alcohol 2.178 obtained by oxidation of allylboronic ester 2.136 after 
Ni-catalyzed hydroboration of chiral dienol 2.120 (Scheme 2.32a); ethyl ketone 2.181 
was prepared by direct alkylation
88
 of reductive aldol product morpholine amide 2.153 
furnishing a ketoalcohol that was protected as non-chelating trimethylsilylether (2.181) 
(Scheme 2.32b). Both fragments were rapidly synthesized from readily available achiral 
hydrocarbons by catalytic stereoselective borylation reactions. 
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Scheme 2.32. Revised Fragments Syntheses 
 
In line with enolate alkylation reactions described above (Table 2.2), the (E)-
enolate derived from 2.181 was treated with 1.0 equivalent of allyl iodide 2.179 
furnishing 2.182 with excellent yield and diastereoselectivity (Scheme 2.33). After 
selective removal of the TMS protecting group and installation of requisite carbarmate 
functionality, the primary TBS-protecting group was removed and the product alcohol 
was oxidized by Dess-Martin periodinane furnishing aldehyde 2.183. Similar to the 
Paterson third generation synthesis, a late stage Still-Gennari olefination
19
 was employed 
between the aldehyde 2.183 and phosphonate 2.110 to provide the full carbon skeleton 
(2.184) of (+)-discodermolide in good yield. The less hindered α,β-unsaturated ketone at 
C7 was selectively reduced with K-Selectride
®
 at −78 oC in high diastereoselectivity, and 
it was suggested by Paterson and co-workers that the high diastereoselectivity was 
controlled by the conformational preference of C1-C6 region in the presence of cyclic 
moiety (C3-C5 acetonide).
100
 Then, a chelation controlled reduction of the crude mono-
ketone at C17 with LiAl(Ot-Bu)3H gave an intermediate diol, which was treated with 
aqueous HCl for deprotective lactonization to complete the (+)-discodermolide synthesis.  
                                                     
100
 Paterson, I.; Lyothier, I. J. Org. Chem. 2005, 70, 5494. 
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Scheme 2.33. Fragments Union and Completion of the Synthesis 
 
Overall, (+)-discodermolide was synthesized in a total of 36 steps with the longest 
linear sequence of 17 steps (13% overall yield) from commercially available achiral 
hydrocarbons.   
2.4. Progress toward Synthesis of Oxidation-Resistant Analog 
The potential therapeutic applications and unique biological activities of (+)-
discodermolide have driven a number of research programs toward the design, synthesis, 
and evaluation of its analogs. After disclosure of discodermolide’s undesired pulmonary 
toxicity in early phase clinical trials by Novartis,
101
 it became more important to find an 
analog that was less toxic while maintaining cytotoxicity.
102
 Up to date, hundreds of 
                                                     
101
 Longley, R. E. Discodermolide: past, present, and future. Natural Products and Cancer Drug 
Discovery. Springer New York, 2013, p 39-58. 
102
 For a review see: Smith, A. B. III; Freeze, B. S. Tetrahedron, 2008, 64, 261. For selected 
recent discodermolide analogue synthesis, see: (a) Lemos, E. L; Agouridas, E.; Sorin, G.; 
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discodermolide analogs were prepared and studied, and such a huge analog library helps 
scientists understand the drug’s structure activity relationship (SAR). For example, it was 
proved that the C8-C9 (Z)-olefin as well as C13-C14 region are critical to maintain potent 
cell growth inhibition activity.
103
 Perturbation of the C11 and C17 hydroxyl groups is 
detrimental to discodermolide biological activity.
104
 On the other hand, some significant 
changes to discodermolide structure are well-tolerated. For instance, the carbarmate and 
the C23-C24 olefin can be completely removed or appended with various substitutions, 
while maintaining cell growth inhibitory activity.
18d 
The lactone C1-C7 region could be 
simplified without losing significant potency.
105
 
Further studies on metabolism of discodermolide revealed that nearly complete 
oxidation occurred in one hour after treatment with human liver microsomes; oxidation 
happened largely around electronically enriched C13-C14 trisubstituted olefin area, such 
as allylic oxidation and dihydroxylation.
106
 However, it is unknown whether the 
pulmonary toxicity alluded to above arises from discodermolide itself or from metabolic 
byproducts. Thus it is reasonable to conclude that synthesis of analogs targeting a C13-
C14 trisubstituted olefin might render more oxidation-resistant and even more potent 
drug candidates. However, limited analogs have been prepared and studied to probe the 
C13-C14 substitution for SAR (Figure 2.3). Both Schreiber and Smith/Kosan Bioscience 
                                                                                                                                                              
Guerreiro, A.; Commerçon, A.; Pancrazi, A.; Betzer, J.-F.; Lannou, M.-I.; Ardisson, J. Chem. Eur. 
J. 2011, 17, 10123. b) Paterson, I.; Naylor, G. J.; Gardner, N.M.; Guzman, E.; Wright, A. E. 
Chem. Asian J. 2011, 6, 459 c) Paterson, I.; Naylor, G. J.; Fujita, T.; Guzman, E.; Wright, A. E. 
Chem. Commun. 2010, 46, 261 d) Fan, Y.; Schreiber, E. M.; Day, B. W. J. Nat. Prod. 2009, 72, 
1748. 
103
 Gunasekera, S. P.; Longley, R. E.; Isbrucker, R. A. J. Nat. Prod. 2002, 65, 1830. 
104
 (a) Gunasekera, S. P.; Longley, R. E.; Isbrucker, R. A. J. Nat. Prod. 2001, 64, 171; (b) 
Isbrucker, R. A.; Gunasekera, S. P.; Longley, R. E. Cancer Chemother. Pharmacol. 2001, 48, 29. 
105
 Shaw, S. J.; Sundermann, K. F.; Burlingame, M. A.; Myles, D. C.; Freeze, B. S.; Xian, M.; 
Brouard, I.; Smith, A. B., III. J. Am. Chem. Soc. 2005, 127, 6532. 
106
 Kowalski, R. J.; Giannakakou, P.; Gunasekera, S. P.; Longley, R. E.; Day, B. W.; Hamel, E. 
Mol. Pharmacol. 1997, 52, 613. 
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synthesized 14-normethyl-discodermolide 2.185, which showed little impact on 
inhibitory potency. Novartis introduced an N-methyl amide (2.186) which was intended 
to mimic the C13-C15 trisubstituted olefin; this resulted in significant loss in the drug’s 
potency. These are the only two designed examples of trisubstituted (Z)-olefin variations 
in literature, and it was suspected that the lack of examples may be attributed to the 
difficulties in trisubstituted (Z)-olefin synthesis (Scheme 2.11).
6
 It was anticipated that 
our synthetic approach together with novel borylation strategies developed for (+)-
discodermolide synthesis will offer access to new discodermolide analogs (2.187) that 
may address biological limitations of the natural product itself. 
Figure 2.3. Synthetic Analogs of C13-C15 Variants 
 
 It was considered that a Ni-catalyzed hydroboration/oxidation sequence, applied 
to a silicon-substituted (Z)-allylic alcohol (Chapter 1, Table 1.2), would provide a vinyl 
silane that can be converted to various substitutions (Chapter 1). In line with the synthesis 
of chiral dienol ether 2.120 (Scheme 2.25), it is necessary to prepare silicon substituted 
1,3-enyne 2.189 for diene synthesis. The initial attempts employed Sonogashira 
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coupling
107
 of vinylbromide 2.188 and excess propyne. Unfortunately, byproduct 2.190 
was obtained as major compound, which was inseparable from desired 2.289 by silica gel 
chromatography (Scheme 2.34a). The byproduct 2.190 might arise from hydro-
propynation of 2.189
108
 or from carbopalladation of 2,4-hexadiyne (from propyne 
dimerization) with vinylpalladium derived from vinyl bromide 2.188.
109
 A new 
methodology was developed to address this problem: Kumada
110
 type sp-sp
2
 coupling 
was accomplished between premetalated propyne and vinylbromide 2.188 at room 
temperature, furnishing enyne 2.189 cleanly in excellent yield (Scheme 2.34b). With 
enyne 2.189 in hand, a reaction sequence of hydroboration, boron to zinc transmetalation, 
and chelation controlled addition to aldehyde 2.128 gave a dienol and the product alcohol 
was protected as TBS-ether to afford desired chiral dienol 2.191 with good 
diastereoselectivity (Scheme 2.34c). Pleasingly, diene 2.191 participated in Ni-catalyzed 
hydroboration reaction providing (Z)-allylic alcohol 2.192 with good diastereoselectivity 
and moderate/unoptimized yield. Utilizing conditions developed by Zakarian and 
Holton,
111
 the (Z)-vinyl silane 2.192 can be stereoselectively converted to (Z)-vinyl 
iodide 2.193, which can participate in various cross coupling reactions to install different 
functional groups at C14 vinyl position (2.194). Further transformations, including (E)-
enolate alkylation and Still-Gennari olefination,
19
 would provide discodermolide analogs 
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2.187 with different substitution at C14, which haven’t been systemically synthesized and 
studied previously. 
Scheme 2.34. Synthesis of C9-C15 Trisubstituted Vinyl Silane Fragment 
 
Another important but challenging analog candidate is 14-CF3-discodermolide 
2.195, which is sterically similar to discodermolide (Figure 2.4); however, the fluorine 
atoms can greatly affect natural products’ metabolic stability. 112  For example, the 
presence of fluorine substitutions has rendered 26-trifluoro-epothilone B (fludelone) 
2.196 with increased drug stability toward oxidation and enhanced activity in treating 
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 Smart, B. E. J. Fluorine Chem. 2001, 109, 3.  
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xenograft tumors in nude mice; this was synthesized and studied by Danishefsky and co-
workers.
113
 Thus, it is reasonable to consider a 14-trifluoromethyl discodermolide as an 
oxidation-resistant analog toward metabolic degradation, which might resolve the 
undesired pulmonary toxicity. Retrosynthetic analysis of 2.195 is quite similar to that 
used for (+)-discodermolide (Scheme 2.13 and Scheme 2.31), disconnecting the molecule 
to three equally complex fragments.  
Figure 2.4. Trifluoromethyl Substitued Discodermolide and Fludelone 
 
 It is important to synthesize the central fragment 2.198 bearing a (E)-CF3-
substituted olefin. The first thought was to directly apply Ni-catalyzed hydroboration 
onto a trifluoromethyl-substituted diene 2.197 (Scheme 2.35a). After a number of 
attempts, Negishi cross coupling
114
 of commercially available vinyl bromide 2.200 and 
vinyl zinc derived from vinyl iodide 2.199 was found to be the only effective method to 
synthesize the model substrate 2.201 (Scheme 2.35b). Diene 2.201 was subjected to the 
standard Ni-catalyzed hydroboration conditions, but no desired product 2.202 was 
isolated. Another possibility to prepare 2.202 is using cross coupling method
115
 to convert 
vinyl iodide (2.203) (available from corresponding vinylsilane, Scheme 2.34) to vinyl-
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114
 (a) Negishi, E.; King, A. O.; Okukado, N. J. Org. Chem. 1977, 42, 1821. (b) E. Negishi in 
Aspects of Mechanism and Organometallic Chemistry, Plenum, New York, 1978, pp. 285-317. 
115
 (a) Hafnera, A.; Brase, S. Adv. Synth. Catal. 2011, 353, 3044. (b) Urata, H. Fuchikamp, T.  
Tetrahedron Lett. 1991, 32, 91. 
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trifluoromethyl substituent (2.204) (Scheme 2.35c). However, both electrophilic and 
nucleophilic methods
116
 for this transformation gave an isomerized mixture of (Z)- and 
(E)-olefins (2.204 and 2.205) in low yield or no conversion at all. Developed by Iseki and 
co-workers, a Pd-catalyzed allylic rearrangement of vinyl trifluoromethyl-substituted 
allyl-acetate generating highly (E)-selective product was considered.
117
 This method was 
first tested on a model substrate 2.207, which was prepared by addition of a vinyllithium 
to aldehyde 2.128 followed by acetate protection of the product alcohol (Scheme 2.35d). 
The model substrate 2.207 was subjected to Pd-catalyzed allylic rearrangement 
conditions and, pleasingly, (E)-allyl-acetate 2.208 was isolated with excellent 
stereoselectivity. Thus we believe that the desired C9-C15 fragment 2.211 can be 
synthesized by employing similar strategy on readily accessible acetate 2.210 (Scheme 
2.35e). 
 
 
 
 
 
 
 
 
 
 
                                                     
116
 For a review, see: Liang, T.; Neumann, C. N.; Ritter, T. Angew. Chem. Int. Ed. 2013, 52, 8214. 
117
 (a) Iseki, K.; Kuroki, Y.; Nagai, T.; Kobayashi, Y. J. Fluorine Chem, 1994, 69, 5. (b) Iseki, K.; 
Kuroki, Y.; Nagai, T.; Kobayashi, Y. Chem. Pharm. Bull. 1996, 44, 477. 
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Scheme 2.35. Synthesis of Vinyl-Trifluoromethyl Substituted C9-C15 Fragment 
 
With previous experience in synthesizing C1-C9 fragment (Scheme 2.16), a more 
concise sequence is employed to construct the δ-lactone (Scheme 2.36a). Orthoester 
derived aldehyde 2.213 (available from asymmetric hydroformylation of olefin 2.212)
118
 
participated in Ni-catalyzed borylative diene-aldehyde coupling reaction furnishing 
intermediate 1,3-diol 2.214. Subsequent orthoester ring opening under acidic conditions 
followed by lactonization provided 2.216 with good yield and excellent diastereo-
selectivity. This single-flask transformation directly built-up the challenging fully 
                                                     
118
 For similar asymmetric hydroformylation, see: Risi, R. M.; Burke, S. D. Org. Lett. 2012, 14, 
2572. 
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substituted δ-lactone 2.216 bearing a terminal olefin for further functionalization. After 
TBS-protection of the alcohol, 2.217 underwent cross metathesis
119
 with vinyl boronic 
ester providing an intermediate vinyl boron 2.218 with 3:1 E:Z ratio. The next step was 
proposed as its in situ oxidation directly furnishing aldehyde 2.219. However, only a 
trace amount of desired aldehyde 2.219 was isolated, which might due to the concomitant 
lactone ring opening during vinyl boron oxidation. This can be addressed by a two-step 
sequence (Scheme 2.36b): Ir-catalyzed hydroboration/oxidation sequence of terminal 
olefin 2.217
51
 followed by Dess-Martin periodinane oxidation of alcohol 2.220 gave 
aldehyde 2.219. The aldehyde 2.219 is not stable on silica gel chromatography,
100
 and 
was used for next step without further purification. 
 
 
 
 
 
 
 
 
 
 
 
 
                                                     
119
 Overview of cross metathesis: (a) Hoveyda, A. H.; Zhugralin, A. R. Nature 2007, 450, 243. (b) 
Prunet, J.; Grimaud, L. In Metathesis in Natural Product Synthesis: Strategies, Substrates and 
Catalysts; Cossy, J., Arseniyadis, S., Meyer, C., Eds; VCH-Wiley: Weinheim, 2010; p 287. 
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Scheme 2.36. Synthesis of C1-C7 -Lactone Fragment 
 
Ethyl ketone segment 2.181 could be simplified as 2.225 since the C23-C24 
terminal olefin of the diene is not biologically important.
18d
 Thus a much shorter and 
more efficient route to ethyl ketone 2.225 was examed (Scheme 2.37). A syn-aldol 
condensation between 3-pentanone 2.221 and asymmetric hydroformylation product 
aldehyde 2.100 gave ethyl ketone 2.222 with excellent yield and good diastereo-
selectivity via chelation controlled process.
120
 It is worth pointing out that this one step 
reaction constructed not only the stereotriad moiety but also a masked aldehyde motif 
                                                     
120
 Masamune, S.; Ellingboe, J. W.; Choy, W. J. Am. Chem. Soc. 1982,104. 5526. 
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that could be further functionalized to requisite cis-olefin. After installation of a non-
chaleting trimethylsilyl protecting group for future (E)-enolate alkylation, the o-xylyl 
acetal (2.223) can be removed under neutral conditions.
48
 Unfortunately, all attempts to 
isolate the product ketoaldehyde 2.224 failed, which might attribute to its rapid 
decomposition after removing the acetal protection (trace 2.224 was detected in crude 
1
H 
NMR). Protection of the ketone moiety may render a more stable product aldehyde and 
subsequent Wittig olefination/deprotection would afford desired ethyl ketone 2.225 
setting the stage for the diastereoselective (E)-enolate alkylation. 
Scheme 2.37. Synthesis of C16-C24 Ethyl Ketone 
 
Cis-vinyl iodide 2.226 can be prepared via Stork-Wittig olefination
26
 with the 
aldehyde derived from 2.211. Then, addition of 2.226-derived vinylmetal reagent to 
aldehyde 2.219 would provide 2.227 furnishing the left-half of the molecule (Scheme 
2.38). If the addition reaction is not diastereoselective, an oxidation/CBS reduction
121
 
sequence would establish correct stereochemistry at C7.
122
 After converting 2.227 to allyl 
                                                     
121
 (a) Corey, E. J.; Bakshi, R. K.; Shibata, S. J. Am. Chem. Soc. 1987, 109, 5551; (b) Corey, E. J. 
Helal, C. J. Angew. Chem. Int. Ed. 1998, 37, 1986. 
122
 For similar strategy in synthesis of discodermolide, see: ref. 18q 
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iodide 2.228, a late-stage alkylation with ethyl ketone 2.225-derived (E)-enolate 2.229 
would construct C15-C16 bond (2.230). Finally, subsequent transformations would 
complete the synthesis of 14-CF3-discodermolide 2.231. 
Scheme 2.38. Proposed Endgame of 14-CF3-Discodermolide 
 
2.5 Conclusion 
Figure 2.5. Summary of Total Synthesis of (+)-Discodermolide 
 
 In conclusion, the total synthesis of (+)-discodermolide was completed with a 
longest linear sequence of 17 steps (total 36 steps) in 13% overall yield from 
commercially available achiral hydrocarbons. Three advanced fragments were rapidly 
constructed by catalytic stereoselective borylation reactions that were developed in our 
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laboratory, and the fragment union was accomplished by the Still-Gennari olefination and 
a novel diastereoselective (E)-enolate alkylation. Taking advantage of the asymmetric 
hydroformylation of terminal olefins (Chapter 3), our approach also features the first 
Roche ester-free discodermolide synthesis. Furthermore, Roush reductive syn-aldol 
reaction was the only aldol type reaction used in the synthesis of this complex polyketide 
natural product. Most importantly, the synthetic strategy enabled preparation of 
challenging discodermolide analogs targeting a C13-C14 trisubstituted (Z)-olefin. It is 
also anticipated that oxidation-resistant analog 2.231 with increased in vivo stability may 
address biological limitations of the natural product itself. With the successful 
preparation of advanced intermediates and model substrate study, we believe that our 
synthetic route could provide challenging 14-CF3-discodermolide 2.231 in the near future 
and, hopefully, it would exhibit good biological activity serving as a promising drug 
candidate. 
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2.6. Experimental Procedures 
 
General Information  
 
1
H NMR spectra were recorded on either a Varian Gemini-400 (400 MHz), or a 
Varian Inova-500 (500 MHz) spectrometer. Chemical shifts were reported in ppm with 
the solvent resonance as the internal standard (CDCl3: 7.26 ppm, C6D6: 7.16 ppm). Data 
were reported as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, 
t = triplet, q = quartet, br = broad, m = multiplet), coupling constants (Hz), and 
assignment. 
13
C NMR spectra were recorded on either a Varian Gemini-400 (100 MHz), 
or a Varian Inova-500 (125 MHz) spectrometer with complete proton decoupling. 
Chemical shifts were reported in ppm with the solvent resonance as the internal standard 
(CDCl3: 77.23 ppm). Infrwered (IR) spectra were recorded on a Bruker alpha 
spectrophotometer, νmax cm
-1
. Bands were characterized as broad (br), strong (s), medium 
(m), and weak (w). High resolution mass spectrometry was performed at the Mass 
Spectrometry Facility, Boston College. 
Liquid Chromatography was performed using forced flow (flash chromatography) 
on silica gel (SiO2, 40-63 µm) purchased from Silicycle. Thin Layer Chromatography 
was performed on 25 µm silica gel plates purchased from Silicycle. Visualization was 
performed using ultraviolet light (254 nm), phosphomolybdic acid (PMA) in ethanol, 
potassium permanganate (KMnO4) in water, or cerium (IV) sulfate and ammonium 
molybdate in sulfuric acid (CAM). Analytical chiral supercritical fluid chromatography 
(SFC) was performed on a Thar Supercritical Chromatograph equipped with an auto 
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sampler and a Waters photodiode array detector with isopropanol as the modifier. 
Analytical chiral high-performance liquid chromatography (HPLC) was performed on a 
Agilent 1120 liquid chromatograph equipped with a UV detector and Chiraclpak-AD-H 
column or Chiraclpak-AS-H column. Hydroformylation was performed in an Argonaut 
Technologies Endeavor
® 
Catalyst Screening System using 1:1 H2/CO supplied by Airgas, 
Inc.  
All reactions were conducted in oven- or flame-dried glassware under an inert 
atmosphere of nitrogen or argon. Tetrahydrofuran (THF), dichloromethane (CH2Cl2), and 
diethyl ether were purified using a Pure Solv MD-4 solvent purification system from 
Innovative Technology Inc. Bis(pinacolato)diboron was obtained from AllyChem Co., 
Ltd. and recrystallized from pentane prior to use. Pinacol borane was obtained from 
BASF. Bis(1,5-cyclooctadiene)nickel(0) (Ni(cod)2), dicarbonylacetylacetonato rhodium 
(I) (Rh(acac)(CO)2), palladium oxide, bis(1,5-cyclooctadiene)diiridium(I) dichloride 
[Ir(cod)Cl]2 and phosphine ligands were purchased from Strem Chemicals, Inc. and used 
without further purification. trans-1,3-Pentadiene was purchased from ChemSampCo. 
Dess-Martin periodinane was purchased from Oakwood Products Inc. 2-methylpent-1-en-
3-yne is obtained from Acros Organics, allyl iodide is from Lancaster Chemicals. All 
other reagents were purchased from either Fisher or Aldrich and used without further 
purification. 
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I. C1-C8 Fragment (Scheme 2.16) 
 
For the preparation of terminal olefin 2.104 and aldehyde 2.100 see Chapter 3. 
 
Procedure for Borylative Diene Aldehyde Coupling 
 
An oven-dried 20 mL scintillation vial, equipped with a magnetic stir-bar, was 
charged with Ni(cod)2 (24.0 mg, 0.087 mmol), PBn3 (39.6.mg, 0.131 mmol), and THF 
(6.0 mL) in a dry box under an argon atmosphere. After stirring for 5 min, the aldehyde 
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2.100 (from asymmetric hydroformylation and used directly without further purification.) 
(360 mg, 1.74 mmol), trans-1,3-pentadiene (132 mg, 1.92  mmol) and B2(pin)2 (531 mg, 
2.1 mmol) were added sequentially. The vial was sealed with a polypropylene cap and 
removed from the dry box. The reaction mixture was allowed to stir at ambient 
temperature for 14 h. After this time, the mixture was poured into 100 mL round bottom 
flask with NaBO3 (870 mg, 8.7 mmol) and water (6.0 mL). The mixture was allowed to 
stir at ambient temperature for 20 h. The resulting mixture was diluted with water and the 
two-phase mixture was extracted with ethyl acetate (3 × 30 mL).  The combined organic 
layers were dried over anhydrous Na2SO4. The drying agent was removed by filtration 
and the solvent was evaporated in vacuo. The residue was passed through a pad of Celite 
with ethylacetate and evaporated in vacuo.  The crude material was re-dissolved in 1,1-
dimethoxypropane (1.0 mL) and catalytic amount of PPTS was added. Such mixture was 
stirred at room temperature until TLC showed full consumption of 1,3-diol (occasionally 
removal of methanol was necessary in order to achieve full conversion). The reaction 
mixture was concentrated and purified by silica gel chromatography to afford the titled 
compound as colorless oil (375 mg, 65% over two steps, 6:1 d.r.) Rf = 0.55 (ethyl acetate: 
hexanes=1:4, stain in KMnO4). 
 
 3-((R)-1-((4S,5S,6S)-2,2,5-Trimethyl-6-vinyl-1,3-dioxan-
4-yl)ethyl)-1,5-dihydrobenzo[e][1,3]dioxepine (Scheme 
2.16, 2.103). 
1
H NMR (500 MHz, CDCl3): δ 7.23-7.17 (4H, 
m), 5.76 (1H, ddd, J =17.5, 10.5, 8.0 Hz), 5.27 (1H, d, J = 17.5 Hz), 5.22 (1H, dd, J = 
10.5, 1.5 Hz), 4.88 (4H, d, J = 5.5 Hz), 4.79 (1H, d, J =8.0 Hz), 3.97 (1H, dd, J =11.0, 
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2.0 Hz), 3.92 (1H, dd, J = 10.0, 7.5 Hz), 1.98 (1H, qdd, J = 6.0, 6.0, 2.0 Hz), 1.49 (3H, s), 
1.50-1.48 (1H, m, overlap), 1.41 (3H, s), 0.99 (3H, d, J = 6.0 Hz), 0.70 (3H, d, J = 
6.0Hz); 
13
C NMR (125 MHz, CDCl3): δ 139.7, 139.6, 137.6, 127.7, 127.6, 118.3, 110.2, 
98.2, 77.7, 72.7, 72.3, 38.0, 35.0, 30.3, 20.0, 11.6, 8.3; IR (neat): 2988 (w), 2938 (w), 
1455 (w), 1378 (m), 1254 (m), 1201 (m), 1121 (s), 1042 (s), 938 (m), 738 (m); HRMS-
(ESI+) for C20H28O4Na [M+Na]
+
: calculated: 355.1880, found: 355.2873. [α]D
21 
= 
+22.219 (c = 0.64, CHCl3, l = 50 mm). 
 
Procedure for Hydroboration of Terminal Olefin
51
 
 
A flame dried 50 mL round-bottom ﬂask was charged with [Ir(cod)Cl]2 (12 mg, 
0.008 mmol) and dppm (14 mg, 0.016 mmol) in glove box. CH2Cl2 (7.0 mL), 
pinacolborane (344 mg, 2.7 mmol), and alkene 2.103 (750 mg, 2.26 mmol) were added 
successively at room temperature. The flask was sealed and brought out of box. The 
mixture was then stirred at room temperature overnight. The reaction mixture was 
concentrated under reduced pressure. THF (5.0 mL), water (5.0 mL) and NaBO3 (1.13 g, 
11.3 mmol) were added to the residue and was stirred for 10 h at room temperature. The 
resulting mixture was diluted with water and the two-phase mixture was extracted with 
ethyl acetate (3 × 15 mL).  The combined organic layers were dried over anhydrous 
Na2SO4. The drying agent was removed by filtration and the solvent was evaporated in 
vacuo. The residue was purified by silica gel chromatography to afford the titled 
 156 
 
compound 2.104 as colorless oil (560 mg, 71%). Rf = 0.31 (ethyl acetate: hexanes=1:2, 
stain in KMnO4). 
 
 2-((4S,5S,6S)-6-((R)-1-(1,5-Dihydrobenzo-
[e][1,3]dioxepin-3-yl)ethyl)-2,2,5-trimethyl-1,3-dioxan-
4-yl)ethan-1-ol (Scheme 2.16, 2.104). 
1
H NMR (500 
MHz, CDCl3): δ 7.23-7.17 (4H, m), 4.88 (4H, d, J = 8.5 Hz), 4.77 (1H, d, J = 8.5 Hz), 
3.94 (1H, dd, J = 10.0, 2.0 Hz), 3.82-3.74 (3H, m), 2.83 (1H, br, s), 1.99-1.90 (2H, m), 
1.72-1.69 (1H, m), 1.57 (1H, ddq, J = 10.0, 10.0, 7.0 Hz), 1.47 (3H, s), 1.38 (3H, s), 0.99 
(3H, d , J = 7.0 Hz), 0.71 (3H, d, J = 7.0 Hz); 
13
C NMR (100 MHz, CDCl3): δ 139.7, 
127.8, 127.6, 110.2, 98.2, 76.2, 72.8, 72.7, 72.4, 61.6, 38.0, 35.2, 35.0, 30.3, 19.9, 11.6, 
8.3; IR (neat): 3444 (w), 3091 (m), 2939 (m), 1455 (w), 1397 (s), 1259 (m), 1202 (s), 
1122 (s), 1044 (s), 942 (m), 738 (m); HRMS-(ESI+) for C20H31O5 [M+H]
+
: calculated: 
351.2172, found: 351.2178. [α]D
21 
= +22.829 (c = 0.30, CHCl3, l = 50 mm). 
 
Procedure for Removal of 1,2-Benzenedimethanol Actal Protecting Group
48
 
 
Dry THF (6.8 mL) was added to a mixture of alcohol 2.104 (240 mg, 0.68 mmol) 
and PdO (4.2 mg, 0.034 mmol) in 20-dram vial under nitrogen. The vial was purged with 
a hydrogen balloon and the mixture was stirred under 1 atm of hydrogen until TLC 
showed full consumption of starting material. Resulting mixture was diluted with diethyl 
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ether and passed through a pad of Celite with diethyl ether. The aldehyde 2.105 was used 
directly after concentration for next step without further purification.  
 
Procedure for Converting Aldehyde to Methyl ester 
 
Crude aldehyde 2.105 (max = 0.68 mmol) was dissolved in t-BuOH (5.6 mL) and 
a few drops of 2-methyl-2-butene. A water (5.6 mL) solution of NaClO2 (122 mg, 1.36 
mmol) and NaH2PO4·2H2O (563 mg, 4.08 mmol) was added dropwise, and the reaction 
mixture was stirred for 1 h before being partitioned between brine (10 mL) and CH2Cl2 
(10 mL). The aqueous layer was extracted with CH2Cl2 (5 × 10 mL). The combined 
organic extracts were dried over Na2SO4 and concentrated under reduced pressure. The 
crude acid was used for next step without any further purification. 
Crude acid (max = 0.68 mmol) was dissolved in hexane (6.8 mL) and MeOH 
(0.68 mL). TMS-CHN2 (2 M in hexane) was added dropwise at room temperature until 
the yellow color persisted. The reaction mixture was then stirred for 30 min, quenched 
with 1 drop of AcOH, and concentrated under reduced pressure. Purification by flash 
chromatography to afford methyl ester as a colorless oil (140 mg, 80% over three steps). 
Rf = 0.23 (1:2 hexanes:ethyl acetate, stain in KMnO4) 
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Methyl-(R)-2-((4S,5S,6S)-6-(2-hydroxyethyl)-2,2,5-
trimethyl-1,3-dioxan-4-yl)propanoate (Scheme 2.16, 2.106). 
1
H NMR (500 MHz, CDCl3): δ 4.06 (1H, dd, J = 15.5, 2.5 Hz), 
3.76 (2H, td, J = 9.5, 2.0 Hz), 3.72-3.67 (1H, m, overlap), 3,67 (3H, s), 2.73 (1H, br, s), 
2.67 (1H, qd, J = 7.5, 2.5 Hz), 1.95-1.90 (1H, m), 1.69-1.62 (1H, m), 1.52 (1H, qdd, J = 
10.0, 10.0, 6.5 Hz), 1.41 (3H, s), 1.31 (3H, s), 1.12 (3H, d, J = 7.5 Hz), 0.77 (3H, d, J 
=6.5 Hz); 
13
C NMR (100 MHz, CDCl3): δ 175.0, 98.5, 75.4, 74.7, 61.3, 51.9, 41.0, 35.5, 
34.9, 30.1, 19.6, 11.8, 8.7; IR (neat): 3428 (w), 2990 (m), 2945 (m), 2882 (m), 1734 (s), 
1380 (m), 1255 (m), 1203 (s), 1169 (s), 1142 (s), 1049 (s), 952 (m); HRMS-(ESI+) for 
C13H24O5Na [M+Na]
+
: calculated: 283.1516, found: 283.1516. [α]D
21 
= −5.699 (c = 0.50, 
CHCl3, l = 50 mm). 
 
Procedure for Converting Alcohol to β-Ketophosphonate100 
 
Alcohol 2.106 (140 mg, 0.54 mmol) was dissolved in CH2Cl2 (5 mL). NaHCO3 
(544 mg, 6.5 mmol) was added, followed by Dess-Martin periodinane (275 mg, 0.65 
mmol). The reaction mixture was stirred for 30 min, and aqueous Na2S2O3 was then 
added. After stirring at room temperature for 15 min, the mixture was extracted with 
CH2Cl2 (3 × 10 mL).  The combined organic layers were dried over anhydrous Na2SO4. 
The drying agent was removed by filtration and the solvent was evaporated in vacuo. 
Hexane (3 mL) was then added to the residue, and the precipitate was filtered through a 
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pad of silica and concentrated in vacuo. The aldehyde was sufficiently clean and was 
used for next step without further purification. 
Crude aldehyde (max = 0.54 mmol) was dissolved in t-BuOH (4.5 mL) and a few 
drops of 2-methyl-2-butene. A water (4.5 mL) solution of NaClO2 (97 mg, 1.08 mmol) 
and NaH2PO4·2H2O (447 mg, 3.24 mmol) was added dropwise, and the reaction mixture 
was stirred for 1 h before being partitioned between brine (10 mL) and CH2Cl2 (10 mL). 
The aqueous layer was re-extracted with ethylacetate (5 × 10 mL). The combined organic 
extracts were dried over Na2SO4 and concentrated under reduced pressure. The crude 
acid was used for next step without any further purification. 
Carboxylic acid (max = 0.54 mmol) was dissolved in CH2Cl2 (6.4 mL). 1-Chloro-
N,N,2-trimethyl-1-propenylamine 2.107 (158 mg, 1.20  mmol) was added dropwise and 
stirred at room temperature for 1 h before being concentrated under reduced pressure. 
The crude acid chloride 2.108 was dried under high vacuum for 30 min to remove all 
volatiles (Crude NMR spectrum of corresponding acid chloride has been attached). In 
the meantime, methylphosphonic acid bis(2,2,2-trifluoroethyl) ester 2.109 (458 mg, 1.76 
mmol) was dissolved in THF (1.5 mL) and cooled to −98 °C (methanol/liquid nitrogen). 
LiHMDS (1.0 M in THF, 1.76 mL, 1.76 mmol) was added, and the reaction mixture was 
stirred at −98 °C for 10 min before the addition of the crude acid chloride 2.108 in 
solution of THF (3.9 mL). The mixture was stirred for 1 h at −98 °C, quenched with 
aqueous NH4Cl (5 mL), and allowed to warm to room temperature. After dilution with 
water, the mixture was extracted with CH2Cl2 (3 × 10 mL), and the combined organic 
extracts were dried over Na2SO4, concentrated under reduced pressure, and purified by 
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flash chromatography affording β-ketophosphonate 2.110 as a viscous colorless oil (142 
mg, 51% over four steps). Rf = 0.50 (1:1 hexanes:ethyl acetate, stain in KMnO4) 
Note: excess methylphosphonic acid bis(2,2,2-trifluoroethyl) ester has exact the same Rf 
value with product 2.110, thus making purification extremely hard. But later we found 
that methylphosphonic acid bis(2,2,2-trifluoroethyl) ester can be removed under vacuum 
with gentle heating, leaving clean β-ketophosphonate with similar yield. 
 
Methyl-(R)-2-((4S,5S,6S)-6-(3-(bis(2,2,2-
trifluoroethoxy)phosphoryl)-2-oxopropyl)-
2,2,5-trimethyl-1,3-dioxan-4-yl)propanoate 
(Scheme 2.16, 2.110).  
1
H NMR (500 MHz, CDCl3): δ 4.44 (4H, qd, J =  8.0 Hz), 4.07 
(1H, dd, J = 10.0, 3.0 Hz), 3.99 (1H, td, J = 9.0, 3.0 Hz), 3.68 (3H, s), 3.36 (2H, dd, J = 
21.0, 2.0 Hz), 2.74 (1H, dd, J = 15.0, 3.5 Hz), 2.69-2.64 (2H, m), 1.45 (1H, qd, J = 6.5, 
4.0 Hz), 1.38 (3H, s), 1.28 (3H, s), 1.12 (3H, d, J = 7.0 Hz), 0.77 (3H, d, J = 6.5 Hz); 
13
C 
NMR (125 MHz, CDCl3): δ 200.4, 174.8, 98.7, 74.5, 72.0, 62.6 (q), 51.9, 48.0, 43.4, 42.3, 
41.0, 35.6, 29.8, 19.4, 11.7, 8.7; IR (neat): 2975 (w), 1724 (m), 1382 (w), 1290 (m), 1258 
(m), 1164 (s), 1066 (s), 960 (s), 845 (m), 655 (w); HRMS-(ESI+) for C18H31F6NO8P 
[M+NH4]
+
: calculated: 534.1692, found: 534.1691. [α]D
21 
= −12.584 (c = 1.34, CHCl3, l 
= 50 mm). 
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II. C9-C15 Fragment (Scheme 2.18) 
i) Synthesis of Chiral Dienol Ether by Abiko-Massamune Aldol Reaction 
 
For the preparation of aldehyde 2.117 see Chapter 1.   
To a flame-dried 100 mL round-bottom flask equipped with a magnetic stir bar 
was added 2.118 then the flask was purged with N2. NEt3 (1.60 mL, 11.50 mmol) and 
CH2Cl2 (24 mL) were then added and the flask was cooled to −78 °C. Cy2BOTf
58
 (5.30 
mL of a 2.0 M solution in hexanes, 10.55 mmol) was added dropwise and the reaction 
was allowed to stir at −78 °C for 30 min. Aldehyde 2.117 (528 mg, 4.80 mmol) was 
added dropwise and the reaction was allowed to at −78 °C for 30 min then gradually 
warm to room temperature and stir for 2 h. MeOH (10 mL), pH=7 buffer (10 mL), and 30 
wt % hydrogen peroxide (5 mL) were then sequentially added and the reaction was 
allowed to stir for 12 h. The reaction mixture was diluted with ethyl acetate (30 mL) and 
water (30 mL) and the layers were separated. The aqueous layer was extracted with ethyl 
acetate (4 x 30 mL). The combined organic layers were dried over Na2SO4, filtered, and 
concentrated by rotary evaporation. The crude reaction mixture was purified on silica gel 
(15:1:1 hexanes:ethyl acetate: CH2Cl2) to afford the title compound as a clear, colorless 
oil (2.10 g, 77%). Rf = 0.20 (15:1:1 hexanes:ethyl acetate: CH2Cl2, stain in KMnO4). 
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 (2R,3S,E)-(1R,2S)-2-(N-Benzyl-2,4,6-
trimethylphenylsulfonamido)-1-phenylpropyl 3-
hydroxy-2,4,6-trimethylhepta-4,6-dienoate (Scheme 
2.18, 2.119): 
1
H NMR (500 MHz, CDCl3): δ 7.35 (2H, d, J = 8.5 Hz), 7.26-7.17 (6H, m), 
6.90 (2H, s), 6.85 (2H, dd, J = 8.5 Hz, 1.0 Hz), 5.86 (1H, s), 5.83 (1H, d, J = 4.0 Hz), 
5.03 (1H, dd, J = 1.5 Hz, 1.5 Hz), 4.84 (1H, s), 4.82 (1H, d, J = 17.0 Hz), 4.61 (1H, d, J = 
17.0 Hz), 4.11-4.06 (2H, m), 2.64 (1H, dq, J = 14.5 Hz, 7.0 Hz), 2.52 (6H, s), 2.45 (1H, d, 
J = 3.5 Hz), 2.29 (3H, s), 1.85 (3H, s), 1.74 (3H, d, J = 1.0 Hz), 1.16 (3H, d, J = 7.0 Hz), 
0.97 (3H, d, J = 7.0 Hz);  
13
C NMR (125 MHz, CDCl3): δ 174.8, 142.8, 141.3, 140.5, 
139.0, 138.5, 135.5, 133.7, 132.5, 131.4, 128.6, 128.5, 128.1, 127.8, 127.3, 126.0, 116.1, 
80.8, 78.5, 57.0, 48.5, 43.7, 23.7, 23.2, 21.1, 14.5, 13.6, 12.5; IR (neat): 3546 (w), 2980 
(w), 2939 (w), 1746 (s), 1603 (m), 1453 (m), 1323 (s), 1152 (s), 1018 (m), 698 (m); 
HRMS-(ESI
+
) for C35H43NO5SNa [M+Na]: calculated:612.2760, found:  612.2748. 
 
Synthesis of Chiral Dienol Ether by Evans anti-Aldol Reaction 
 
 The reaction was following literature procedure.
60
 Oxazolidinone 2.121 (1.94 g, 
8.3 mmol) was treated with MgBr2·Et2O (430 mg, 1.6 mmol, 0.2 equivalent), 
triethylamine (1.68 g, 16.6 mmol), chlorotrimethylsilane (1.35 g, 12.5 mmol), aldehyde 
2.117 (1.1 g, 10 mmol) in 16.6 mL ethylacetate at room temperature for 24 h. The light 
yellow slurry was pushed through a plug of silica gel with Et2O. The reaction mixture 
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was concentrated in vacuo, and methanol was added along with two drops to TFA. This 
was stirred at room temperature for 30 min and concentrated to a pale yellow oil and 
passed through a plug of silica gel to afford titled compound 2.122 with almost 
quantitative yield and can be used for next step without further purification. Rf = 0.27 
(2:1 hexanes:ethyl acetate). 
 
(S)-4-Benzyl-3-((2R,3S,E)-3-hydroxy-2,4,6-
trimethylhepta-4,6-dienoyl)oxazolidin-2-one (Scheme 
2.18, 2.122) 
1
H NMR (500 MHz, CDCl3): δ  7.34-7.32 (2H, 
m), 7.28-7.24 (3H, m), 5.94 (1H, s), 5.03 (1H, s), 4.86 (1H, s), 4.72-4.68 (1H, m), 4.21-
4.16 (3H, m, overlap), 3.32 (1H, dd, J = 14.0, 3.5 Hz), 2.78 (1H, dd, J = 13.5, 9.5 Hz), 
1.87 (6H, s, overlap), 1.11 (3H, d, J = 7.0 Hz);  
13
C NMR (125 MHz, CDCl3): δ 176.8, 
154.0, 141.4, 136.2, 135.5, 130.8, 129.7, 129.1, 127.5, 116.0, 81.8, 66.3, 55.8, 40.9, 38.0, 
23.7, 15.0, 12.9; IR (neat): 3496 (b), 2973 (w), 1775 (s), 1696 (s), 1454 (w), 1383 (s), 
1350 (s), 1250 (m), 1209 (s), 1107 (m), 1011 (s), 895 (m), 761 (m), 702 (s), 509 (m); 
HRMS-(ESI
+
) for C20H24O3 [M+H-H2O]: calculated:326.1756, found:  326.1769. [α]D
21 
= 
+71.577 (c = 0.84, CHCl3, l = 50 mm). 
 
 
A dry round bottom flask containing a magnetic stir bar was charged with crude 
2.122 (~10 mmol), MeOH (0.67 mL, 20 mmol), and THF (100 mL) then sealed with a 
septum and cooled to 0 °C. Lithium borohydride (8.3 mL of a 2.0 M solution in 
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tetrahydrofuan, 16.6 mmol) was added dropwise and the reaction was allowed to stir for 1 
h. The reaction was quenched with H2O (20 mL) followed by the addition of saturated 
potassium sodium tartrate solution (50 mL) and the reaction mixture was allowed to stir 
for 3 h. The reaction was diluted with EtOAc (30 mL) and the layers were separated. The 
aqueous layer was extracted with ethyl acetate (3 x 50 mL), and the combined organics 
were dried over Na2SO4, filtered, and concentrated by rotary evaporation. The crude 
material was purified by silica gel chromatography (1:1 hexanes:EtOAc) to afford the 
diol 2.120-OH as a clear oil (1.10 g, 78%). Rf = 0.34 (1:1 hexanes:ethyl acetate, stain 
with KMnO4). 
 
(2S,3S,E)-2,4,6-Trimethylhepta-4,6-diene-1,3-diol (Scheme 2.22, 
2.120-OH) 
1
H NMR (500 MHz, CDCl3): δ 5.86 (1H, s), 5.02 (1H, 
s), 4.85 (1H, s), 3.91 (1H, d, J = 8.5 Hz), 3.76-3.65 (1H, m), 1.87 (3H, s), 1.81 (3H, s), 
0.76 (3H, d, J = 7.0 Hz); 
13
C NMR (125 MHz, CDCl3): δ 141.5, 137.7, 130.1, 115.7, 85.1, 
68.5, 37.7, 23.8, 14.0, 12.9; HRMS-(ESI+) for C10H19O2 [M+H]
+
: calculated: 171.1385, 
found: 171.1385. 
 
 
A flame-dried round-bottom flask containing a magnetic stir bar, under an 
atmosphere of nitrogen, was charged wtih diol 2.120-OH (80 mg, 0.47 mmol) in CH2Cl2 
(4 mL) and 2,6-lutidine (0.16 mL, 1.41 mmol). The reaction flask was cooled to −78 °C, 
followed by dropwise addition of freshly distilled TBSOTf (0.26 mL, 1.14 mmol). The 
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reaction was allowed to stir for 1 h or until done by TLC, then quenched with water. The 
layers were separated, and the aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The 
combined organics were dried over Na2SO4, filtered, and concentrated by rotary 
evaporation. The crude reaction mixture was purified by silica gel chromatography 
(hexanes) to afford a clear, colorless oil (105.0 mg, 58%). 
 
 (5S,6S)-2,2,3,3,6,9,9,10,10-Nonamethyl-5-((E)-4-
methylpenta-2,4-dien-2-yl)-4,8-dioxa-3,9-disilaundecane. 
(Scheme 2.18, 2.120). 
1
H NMR (500 MHz, CDCl3): δ 5.72 (1H, s), 4.97 (1H, quin, J = 
1.0 Hz), 4.79 (1H, t, J = 1.0 Hz), 3.76 (1H, d, J = 8.5 Hz), 3.73 (1H, dd, J = 9,5, 7.0 Hz), 
3.53 (1H, dd, J = 9.5, 7.0 Hz), 1.84 (3H, s), 1.77-1.73 (1H, m), 1.71 (3H, s), 0.90 (9H, s), 
0.88 (9H, s), 0.76 (3H, d, J = 6.5 Hz), 0.04 (6H, s), 0.03 (3H, s), −0.03 (3H, s); 13C NMR 
(125 MHz, CDCl3): δ 141.9, 138.3, 129.2, 114.7, 80.9, 65.1, 40.1, 26.2, 26.1, 23.8, 18.6, 
18.4, 14.1, 12.8, −4.3, −5.0, −5.1, −5.2; IR (neat): 2956 (m), 2929 (m), 2857 (m), 1462 
(w), 1251 (m), 1061 (s), 834 (s), 774 (s), 668 (w); HRMS-(ESI+) for C22H47O2Si2 
[M+H]
+
: calculated: 399.3115, found: 399.3121. [α]D
21 
= +11.476 (c = 1.00, CHCl3, l = 
50 mm). 
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ii) Synthesis of Chiral Dienol Ether without Using Auxiliary 
 
Procedure for Preparation of 1,3-Enyne 2.132 
 
A flame dried 100 mL two-neck round bottom flask was charged with NaNH2 
(1.40 g, 32 mmol) and stir bar in glove box. One neck was assembled with cold finger 
condenser and the other neck was sealed with rubber septum. And such separate was 
brought out of box and connect to nitrogen line.  Acetone/dry ice was added to the cold 
finger. Ammonia gas was introduced and condensed into the round bottom flask placed 
on cooling bath (isopropanol/dry ice). Ammonia gas line was removed when 15 mL 
liquid ammonia was collected. 2-methylbut-1-en-3-yne 2.131 (3.0 mL, 32 mmol) was 
added dropwise via syringe over 5 min and stirred further for 40 min. Dimethyl sulfate 
was added via cannula slowly and stirred for 1 hour at that temperature. (NOTE: strongly 
exothermic reaction! Extra caution needed). Cooling bath was removed, and the flask was 
allowed to warm to room temperature. Let ammonia reflux for 8 hours (keep refilling dry 
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ice of the cold finger). Cold finger was removed and quickly switched to rubber septum 
with ventilation needle leading to aqueous hydrogen chloride in Erlenmeyer flask. The 
ammonia was evaporated slowly by putting round bottom flask on ice bath. After all 
ammonia was removed, the residue was distilled under nitrogen via shortpath providing 
desired compound 2.132 as a colorless liquid (1.4 g, 55%) sufficiently clean and used for 
next step without further purification. 
 
 2-Methylpent-1-en-3-yne. (Scheme 2.21, 2.132). All spectrum data 
are in accordance with literature.
123
 
1
H NMR (500 MHz, CDCl3): δ 5.19 
(1H, s), 5.13 (1H, t, J = 1.5 Hz), 1.94 (3H, s), 1.86 (3H, s); 
13
C NMR (125 MHz, CDCl3): 
δ 127.5, 120.6, 85.1, 81.2, 24.0, 4.3. 
 
Modified Procedure for Chelation-Controlled Additions to β-Silyloxy Aldehyde71 
 
Preparation of EtZnONf: To a flame-dried 25 mL Schlenk flask equipped with 
magnetic stir bar and septum was added Et2Zn (1.90 mL, 3.8 mmol, 2 M in CH2Cl2). The 
solution was cooled to –78 °C in a dry ice/acetone bath, and nonafluorobutane-1-sulfonic 
acid (0.56 mL, 3.8 mmol) was added dropwise. The reaction was allowed to stir at –78 
                                                     
123
 Baird, M. S.; Hussain, H. H.; Nethercott, W. J. Chem. Soc., Perkin Trans. 1 1986, 1845. 
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°C for 5 min and was allowed to warm to room temperature and stirred for 1 h resulting 
white slurry. 
HBCy2 (536 mg, 3.0 mmol) and CH2Cl2 (2.0 mL) was added to a flame dried 100 
mL two-neck round bottom flask in glove box. The flask was cooled to 0 °C, and 2-
methylpent-1-en-3-yne 2.132 (240 mg, 3.0 mmol) was added dropwise. The reaction 
mixture was allowed to stir at 0 °C for 5 min and then stirred at room temperature for 20 
min providing a clear solution. Benzaldehyde (96 mg, 0.9 mmol) was added dropwise at 
room temperature and stirred for another 30 min. The flask was capped and brought out 
of glove box and cooled to –78 °C. Et2Zn (1.5 mL, 2.0 M in toluene) was added dropwise 
and stirred at –78 °C for 30 min. EtZnONf slurry was cannula transferred to the flask at –
78 °C in one portion, and the flask was transferred to a cooling bath at –20 °C. A toluene 
solution (8.0 mL) of the β-silyloxy aldehyde 2.128 (408 mg, 2.0 mmol) was added 
dropwise. The reaction was allowed to stir at –20 °C overnight. The reaction was 
quenched with a saturated solution of NH4Cl (15 mL) and extracted with diethyl ether (3 
× 20 mL). The combined organic layers were washed with brine, dried over Na2SO4, and 
filtered. The crude products were concentrated in vacuo and purified by flash 
chromatography on silica gel (diethyl ether:hexanes 1:10) to afford 2.130 as a colorless 
oil (433 mg, 76%). Rf = 0.56 (1:5 diethyl ether:hexanes, stain in KMnO4).  
 
 (2S,3S,E)-1-((tert-Butyldimethylsilyl)oxy)-2,4,6-
trimethylhepta-4,6-dien-3-ol (Scheme 2.22, 2.130). 
1
H NMR 
(500 MHz, CDCl3): δ 5.87 (1H, s), 4.99 (1H, t, J = 1.0 Hz), 4.07 (1H, d, J =2.5 Hz), 3.87 
(1H, dd, J = 8.0, 1.0 Hz), 3.80 (1H, dd, J =10.0, 4.0 Hz), 3.59 (1H, dd, J =7.4, 9.5 Hz), 
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1.89 (1H, qdd, J = 7.0, 7.0, 4.0 Hz), 1.85 (3H, s), 1.79 (3H, s), 0.91 (9H, s), 0.76 (3H, d, 
J = 7.0 Hz), 0.09 (6H, s); 
13
C NMR (125 MHz, CDCl3): δ 141.9, 137.8, 129.4, 115.0, 
84.4, 68.8, 37.6, 26.0, 23.9, 18.3, 13.9, 13.2, −5.4, −5.5; IR (neat): 3432 (w), 2955 (m), 
2929 (m), 2857 (m), 1470 (w), 1252 (m), 1088 (s), 1005 (s), 834 (s), 775 (s); HRMS-
(ESI+) for C16H31OSi [M−H2O+H]
+
: calculated: 267.2144, found: 267.2138. [α]D
21 
= 
+32.246 (c = 0.40, CHCl3, l = 50 mm). 
 
Procedure for tert-Butyldimethylsilyl Protection 
 
A flame-dried round-bottom flask containing a magnetic stir bar, under an 
atmosphere of nitrogen, was charged with alcohol 2.130 (240.0 mg, 0.84 mmol) in 
CH2Cl2 (8.4 mL) and 2,6-lutidine (0.15 mL, 1.3 mmol). The reaction flask was cooled to 
−78 °C, and freshly distilled TBSOTf (0.22 mL, 0.92 mmol) was added dropwise. The 
reaction was allowed to stir for 1 h until TLC showed full conversion of starting material, 
and the reaction was quenched with aqueous NaHCO3. The layers were separated, and 
the aqueous layer was extracted with CH2Cl2 (3 × 10 mL). The combined organics were 
dried over Na2SO4, filtered, and concentrated by rotary evaporation. The crude reaction 
mixture was purified by silica gel chromatography (diethyl ether:hexanes=1:20) to afford 
2.120 as a clear, colorless oil (310.0 mg, 96%). Rf = 0.25 (diethyl ether:hexanes = 1:20, 
stain in KMnO4). 
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 (5S,6S)-2,2,3,3,6,9,9,10,10-Nonamethyl-5-((E)-4-
methylpenta-2,4-dien-2-yl)-4,8-dioxa-3,9-disilaundecane. 
(Scheme 2.22, 2.120). 
1
H NMR (500 MHz, CDCl3): δ 5.72 (1H, s), 4.97 (1H, quin, J = 
1.0 Hz), 4.79 (1H, t, J = 1.0 Hz), 3.76 (1H, d, J = 8.5 Hz), 3.73 (1H, dd, J = 9,5, 7.0 Hz), 
3.53 (1H, dd, J = 9.5, 7.0 Hz), 1.84 (3H, s), 1.77-1.73 (1H, m), 1.71 (3H, s), 0.90 (9H, s), 
0.88 (9H, s), 0.76 (3H, d, J = 6.5 Hz), 0.04 (6H, s), 0.03 (3H, s), −0.03 (3H, s); 13C NMR 
(125 MHz, CDCl3): δ 141.9, 138.3, 129.2, 114.7, 80.9, 65.1, 40.1, 26.2, 26.1, 23.8, 18.6, 
18.4, 14.1, 12.8, −4.3, −5.0, −5.1, −5.2; IR (neat): 2956 (m), 2929 (m), 2857 (m), 1462 
(w), 1251 (m), 1061 (s), 834 (s), 774 (s), 668 (w); HRMS-(ESI+) for C22H47O2Si2 
[M+H]
+
: calculated: 399.3115, found: 399.3121. [α]D
21 
= +11.476 (c = 1.00, CHCl3, l = 
50 mm). 
 
Procedure for Diastereoselective Hydroboration of 1,3-Dienol 
 
In dry-box, an oven-dried 6-dram vial containing a magnetic stir bar was charged 
successively with Ni(cod)2 (10.0 mg, 0.034 mmol), PCy3 (10.0 mg, 0.034 mmol), THF 
(6.75 mL, 0.25M), and diene 2.120 (510 mg, 1.35 mmol). The vial was placed in the 
freezer in glove box for 10 min, and pinacolborane (185 mg, 1.45 mmol) was added 
while the vial was cold. The vial was sealed with a polypropylene cap, removed from the 
dry-box, immediately cooled to 0°C (ice/water), and allowed to stir overnight. The 
reaction mixture was kept at 0 °C and charged with 3.0 mL pH=7 buffer and 1.0 mL 30% 
w/w H2O2. The reaction was gradually warmed to room temperature and allowed to stir 
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for 12 h, at which time the vial was cooled to 0 °C (ice/water) and saturated aqueous 
sodium thiosulfate was added dropwise. The reaction mixture was diluted with ethyl 
acetate and the layers were separated. The aqueous layer was extracted with ethyl acetate 
(3 × 15 mL) and the combined organic layers were dried over Na2SO4, filtered, and 
concentrated by rotary evaporation. The crude reaction mixture was purified by silica gel 
chromatography (diethyl ether:hexanes = 1: 10) to afford 2.178 as a clear, colorless oil 
(480 mg, 92%, 9:1 dr). Rf = 0.38 (5:1 hexanes:diethyl ether, stain in KMnO4). 
 
 (4S,5R,6S,Z)-5,7-Bis((tert-butyldimethylsilyl)oxy)-2,4,6-
trimethylhept-2-en-1-ol. (Scheme 2.25, boronic ester 2.136 
was characterized as its alcohol 2.178) 
1
H NMR (500 MHz, CDCl3): δ 5.15 (1H, d, J = 
10.0 Hz), 4.18 (1H, dd, J = 10.0, 5.5 Hz), 3.99 (1H, dd, J = 12.0, 7.0 Hz), 3.72 (1H, dd, J 
= 10.0, 5.5 Hz), 3.41 (1H, dd, J = 6.0, 4.5 Hz), 3.37 (1H, dd, J =10.0, 7.5 Hz), 2.69 (1H, 
dqd, J = 10.0, 6.5, 6.5 Hz), 1.90-1.85 (1H, m), 1.79 (3H, s), 0.94 (3H, d, J = 6.5 Hz), 
0.91 (3H, d, J = 5.5 Hz), 0.91 (9H, s), 0.90 (9H, s), 0.05 (12H, s); 
13
C NMR (125 MHz, 
CDCl3): δ 133.7, 133.1, 78.7, 65.7, 62.0, 40.5, 36.0, 26.4, 26.2, 21.9, 18.7, 18.6, 17.7, 
15.0, −3.6, −3.7, −5.1, −5.2; IR (neat): 3347 (w), 2955 (m), 2929 (m), 2856 (m), 1472 
(w), 1251 (m), 1083 (m), 1004 (m), 833 (s), 771 (s), 668 (w); HRMS-(ESI+) for 
C22H49O3Si2 [M+H]
+
: calculated: 417.3220, found: 417.3236. [α]D
21 
= −9.486 (c = 0.52, 
CHCl3, l = 50 mm). 
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III. C16-C24 fragment 
 
Procedure for Diboration/Homologation/Oxidation Sequence 
 
A 100 mL flame-dried Schlenk flask vial equipped with magnetic stir bar in the 
dry box was charged with Pt(dba)3 (7.9 mg, 8.8 μmol), followed by the addition of 
toluene (16.0 mL). (3S,5S)-5-(tert-butyl)-2,2-diisobutyl-3-phenyl-1,3-oxaphospholane 
2.144
44b
 was added as a solution in toluene (0.0913 M, 0.19 mL, 17.3 μmol), followed by 
B2(pin)2 (4.7 g, 18.5 mmol). The flask was then sealed, removed from the dry box and 
heated to 80 
o
C for 20 minutes, during which the reaction mixture changes from a dark 
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purple solution to a light yellow solution. After cooling to room temperature, the flask 
was returned to the dry box and (E)-penta-1,3-diene 2.89 (1.20 g, 17.6 mmol) was added. 
The vial was sealed, removed from the dry box, and heated to 60 
o
C for 20 hours. 
Majority of the solvent was then removed by rotary evaporation and the flask was purged 
with N2. The flask was then charged with THF (100 mL) and bromochloromethane (3.53 
mL, 52.8 mmol) and cooled to −78 °C. n-BuLi (2.50 M in hexanes 21.0 mL, 52.8 mmol) 
was then added dropwise via syringe. After being allowed to stir for 10 min at −78 °C the 
reaction was allowed to warm to room temperature slowly and stirred for 12 h. The 
reaction mixture was cooled to 0 °C (ice/water) and charged with 3 M sodium hydroxide 
(30 mL), and 30 w/w % hydrogen peroxide (15 mL). The reaction was allowed to warm 
to room temperature and stir for 4 h, at which time the flask was cooled to 0 °C 
(ice/water) and saturated aqueous sodium thiosulfate (15 mL) was added dropwise. The 
reaction mixture was diluted with ethyl acetate (30 mL) and water (30 mL) and the layers 
were separated. The aqueous layer was extracted with ethyl acetate (4 × 30 mL). The 
combined organic layers were dried over Na2SO4, filtered, and concentrated by rotary 
evaporation. The crude reaction mixture was purified on silica gel (1:2 hexanes:ethyl 
acetate to 100% ethylacetate) to afford  the titled compound 2.87 as a clear, colorless oil 
(2.10 g, 92%). Rf = 0.10 (1:2 hexanes:ethyl acetate, stain in KMnO4). 
 
 (Z)-2-Methylhex-3-ene-1,6-diol. (Scheme 2.26, 2.87). 
1
H NMR 
(500 MHz, CDCl3): δ 5.48 (1H, ddd, J = 10.0, 6.0, 6.0 Hz), 5.28 
(1H, dd, J = 10.0, 10.0 Hz), 3.64 (1H, ddd, J = 10.0, 5.0, 5.0 Hz), 3.52 (1H, dd, J = 9.5, 
4.0 Hz), 3.46 (1H, dd, J = 10.0, 5.0 Hz), 3.21 (1H, dd, 10.0, 10.0 Hz), 3.20 (2H, s, br), 
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2.70-2.64 (1H, m), 2.45-2.34 (1H, m), 2.16-2.10 (1H, m), 0.84 (3H, d, J = 7.0 Hz); 
13
C 
NMR (125 MHz, CDCl3): δ 136.1, 127.8, 67.7, 61.8, 34.7, 31.0, 17.2; IR (neat): 3324 (s), 
3004 (s), 2956 (s), 2872 (s), 1455 (w), 1035 (s), 744 (s); HRMS-(ESI+) for C7H15O2 
[M+H]: calculated: 131.1078, found: 131.1072. [α]D
21 
= –49.476 (c = 0.64, CHCl3, l = 50 
mm).  
Analysis of Stereochemistry: 
The titled compound 2.87 was converted to corresponding bis-benzoate as shown 
below. The resulting bis-benzoate was compared to racemic material
124
 prepared as 
shown below. 
 
Chiral SFC (Chiralpak, AD-H, 35 
o
C, 5 mL/min, 10% Isopropanol, 100 bar, 210-270 nm) 
– analysis of bis-benzoate. 
 
  
                                                     
124
 Ely, R. J.; Morken, J. P. Org. Lett. 2010, 12, 4348. 
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Procedure for Monosulfonylation of 1,6-Diol via Flow Chemistry 
 
 All tubing and connectors were purchased from Upchurch Science and assembled 
as described in literature (Scheme 2.26d).
85
 Then the tubing was flushed with dry 5 mL 
CH2Cl2. One syringe was charged with a dry 1.0 mL CH2Cl2 solution of diol 2.87 (50 mg, 
0.385 mmol) while the second syringe with a dry CH2Cl2 solution of TEA (83 µL, 0.587 
mmol), DMAP (9.4 mg, 0.077 mmol) and sulfonyl chloride (127 mg, 0.385 mmol). The 
two syringes were pushed together by a syringe pump at a rate of 0.25 mL/min, and the 
two solutions were mixed together in ice bath via a T-connector (calculated reaction time 
to be 4.24h at 0
o
C). The end of flow reactor was connected to a vial containing water to 
quench reaction. The two layer mixture was extracted with EtOAc (3 x 5 mL). The 
combined organic layers were dried over Na2SO4, filtered, and concentrated by rotary 
evaporation. The bis-sulfonylation to mono-sulfonylation ratio was 2:1 as determined by 
1
H NMR and the regioselectivity was 4:1. The crude material was purified on silica gel 
chromatography to afford titled compound as a mixture of regioisomers. 
 
(S,Z)-6-Hydroxy-5-methylhex-3-en-1-yl-2,4,6-
triisopropylbenzenesulfonate (Scheme 2.27, 
2.147a). 
1
H NMR (500 MHz, CDCl3): δ 7.18 (2H, s), 5.48-5.43 (1H, m), 5.33-5.29 (1H, 
m), 4.07-4.03 (2H, m), 3.48 (1H, dd, J = 10.5, 6.0 Hz), 3.33 (1H, dd, J = 10.5, 8.0 Hz), 
[minor regioisomer 3.87 (1H, dd, J = 6.5, 3.0 Hz), 3.62 (1H, dd, J = 7.0, 7.0 Hz)], 2.93 
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(1H, m), 2.65 (1H, m), 2.50 (2H, q, J = 7.0 Hz), 1.25 (18H, d, J = 7.0 Hz), 0.92 (3H, d, J 
= 6.5 Hz); 
13
C NMR (125 MHz, CDCl3): δ 153.9, 151.0, 136.3, 127.8, 125.4, 123.9, 68.9, 
67.7, 35.2, 34.4, 29.8, 27.8, 24.9, 23.7, 17.0; IR (neat): 3392 (w), 2957 (s), 2930 (m), 
2871 (w), 1600 (w), 1462 (w), 1374 (m), 1177 (s), 1040 (m), 962 (m), 905 (m), 806 (w), 
779 (m), 750 (m), 563 (m). [α]D
21 
= +4.696 (c = 0.7, CHCl3, l = 50 mm). 
 
Procedure for bis-Tosylation of 1,6-Diol 
 
 To a flame-dried 100 mL round-bottom flask equipped with a magnetic stir bar was 
added diol 2.87 (2.1 g, 16.9 mmol) in CH2Cl2 (30 mL) and NEt3 (8.0 mL, 55.8 mmol) as 
well as DMAP (103 mg, 0.85 mmol). The flask was cooled to 0 °C and a CH2Cl2 solution 
(26 mL) of p-toluenesulfonyl chloride (7.1 g, 37.2 mmol) was added. The reaction was 
allowed to warm to room temperature and stir for 12 h. The crude slurry was then filtered 
through a plug of silica gel, rinsing with CH2Cl2, and concentrated by rotary evaporation. 
The crude reaction mixture was purified on silica gel (4:1 hexanes:ethyl acetate) to afford 
2.149 as a clear, light yellow oil (7.0 g, 94%). Rf = 0.30 (4:1 hexanes:ethyl acetate, stain 
in KMnO4). 
 
 (Z)-2-Methylhex-3-ene-1,6-diyl-bis(4-
methylbenzenesulfonate) (Scheme 2.28, 2.149). 
1
H NMR (500 
MHz, CDCl3): δ 7.79-7.75 (4H, m), 7.34-7.33 (4H, m),  5.30 (1H, ddt, J = 11.0, 7.5, 1.0 
Hz), 5.17 (1H, ddd, J = 11.0, 11.0, 1.5 Hz), 4.03 (2H, m), 3.81-3.75 (2H, m), 2.72 (1H, 
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qdtd, J = 11.0, 7.0, 5.0, 1.0 Hz), 2.45 (6H, s), 2.35 (2H, dt, J = 7.5 Hz), 0.91 (3H, d, J = 
7.0 Hz); 
13
C NMR (125 MHz, CDCl3): δ 145.0, 133.8, 133.3, 130.1, 128.1, 125.6, 74.0, 
69.6, 32.1, 27.6, 21.9, 17.1; IR (neat): 2964 (w), 2927 (w), 1598 (w), 1357 (m), 1175 (s), 
964 (m), 815 (m), 665 (m), 554 (m); HRMS-(ESI+) for C21H27O6S2 [M+H]
+
: calculated: 
439.1236, found: 439.1249. [α]D
21
 = +27.642 (c = 0.68, CHCl3, l = 50 mm). 
 
Procedure for Selective Elimination and Tosylate Removal 
 
 To a flame-dried 50 mL round-bottom flask equipped with a magnetic stir bar was 
added bistosylate 2.149 (6.0 g, 13.7 mmol) in dry THF (130 mL) under nitrogen. The 
reaction was cooled to 0 °C and KOtBu (1.50 g, 13.7 mmol) was added dropwise as a 
solution in THF (7 mL). The reaction was allowed to warm to room temperature and 
stirred for 30 min then concentrated by rotary evaporation. The crude oil was filtered 
through a short plug of silica gel, washing with Et2O, and concentrated to afford 2.150 as 
a clear, colorless oil. The material was used for next step without further purification. 
 
 (Z)-2-Methylhexa-3,5-dien-1-yl-4-methylbenzenesulfonate 
(Scheme 2.28, 2.150). Occasionally the titled compound 2.150 was 
purified for characterization. 
1
H NMR (500 MHz, CDCl3): δ 7.77 (2H, m), 7.34 (2H, m), 
6.48 (1H, dddd, J = 17.0 Hz, 12.0 Hz, 12.0 Hz, 1.0 Hz), 5.99 (1H, ddd, J = 12.0 Hz, 12.0 
Hz, 0.5 Hz), 5.21 (1H, ddd, J = 17.0 Hz, 1.0 Hz, 0.5 Hz), 5.14 (1H, ddd, J = 12.0 Hz, 1.0 
Hz, 0.5 Hz), 5.10 (1H, dd, 11.5 Hz, 11.5 Hz), 3.89-3.81 (2H, m), 2.99 (1H, m), 2.45 (3H, 
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s), 1.00 (3H, 6.5 Hz); 
13
C NMR (125 MHz, CDCl3): δ 144.9, 133.9, 131.9, 131.2, 130.0, 
128.1,  128.1, 119.1, 74.1, 32.4, 21.8, 17.4; IR (neat): 3073 (w), 2957 (s), 2871 (m), 1731 
(s), 1359 (m), 1267 (m), 1086 (s), 990 (m); HRMS-(ESI+) for C14H22NO3S [M+NH4]
+
: 
calculated: 284.1320, found: 284.1326. [α]D
21 
= +71.840 (c = 0.64, CHCl3, l = 50 mm). 
  
 The procedure for tosylate removal was reported in literature.
125
 Mg powder (383 
mg, 16.0 mmol) was added to a flame dried 100 mL round bottom flask equipped with 
magnetic stir bar in glove box, which was capped and removed from box. The flask was 
cooled on an ice bath and then charged with freshly distill MeOH (10 mL). A MeOH (6 
mL) solution of tosylate 2.150 (850 mg, 3.2 mmol) was added dropwise. The reaction 
was allowed to warm to room temperature slowly and stirred overnight (though reaction 
usually completes in 3 hours). Reaction was quenched by slow addition of 1.0 M HCl 
aqueous solution on ice bath and then diluted with ethylacetate. The layers were 
separated. The aqueous layer was extracted with ethyl acetate (3 × 10 mL). The combined 
organic layers were dried over Na2SO4, filtered, and concentrated by rotary evaporation. 
The crude reaction mixture was purified by silica gel chromatography (diethyl 
ether:hexanes=1:2) to afford the titled compound as a clear, colorless oil (360 mg, >95% 
over two steps). Rf = 0.56 (1:2 hexanes:ethyl acetate, stain in KMnO4). 
 
 (S,Z)-2-Methylhexa-3,5-dien-1-ol. (Scheme 2.28, 2.146) All 
spectrum data are in accordance with literature.
126
 
 
                                                     
125
 Sridhar, M.; Kumar, B. A.; Narender, R. Tetrahedron Lett. 1998, 39, 2847.  
126
 Francavilla, C.; Chen, W. C.; Kinder, F. R. Org. Lett. 2003. 5, 1233. 
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Slightly Modified Procedure for the Reductive Aldol Reaction
87
 
 
 A flame dried 100 mL round bottom flask was charged with Dess-Martin 
periodinae (976 mg, 2.3 mmol) and NaHCO3 (2.0 g, 23 mmol), and the flask was purged 
with nitrogen. A CH2Cl2 solution of alcohol 2.146 (220 mg, 2.0 mmol) was added in one 
portion at room temperature and the reaction mixture was stirred for 2 hours to reach 
completion. Reaction was quenched with saturated Na2S2O3 solution and stirred for 10 
min at room temperature. Layers were separated and aqueous layer was extracted with 
Et2O (3 × 15 mL). The combined organic layers were dried over Na2SO4, filtered, and 
concentrated by rotary evaporation carefully. Light yellow residue was passed through a 
plug of silica gel with Et2O and concentrated by rotary evaporation carefully to give 
desired aldehyde 2.151 as clear slight yellow oil, which was used for next step without 
further purification. All spectrum data are in accordance with literature.
126
  
To a suspension of (
l
Ipc)2BH (weighed in the glove box, 640 mg, 2.4 mmol) in 
Et2O (10 mL) at 0 °C was added 4-acryloylmorpholine 2.152 (326 μL, 2.6 mmol). The 
solution was stirred for 2 h at 0 °C resulted a clear solution. The resulting mixture was 
cooled to –78 °C, aldehyde 2.151 (max = 2.0 mmol) in ether (1.0 mL) was added 
dropwise, and the solution was stirred overnight at −78 °C. Reaction flask was charged 
with 2-methylaminoethanol (0.3 mL) and MeCN (10 mL) and temperature was increased 
to 80 
o
C and stirred for 6 hours. After cooling back to room temperature, the mixture was 
concentrated under reduced pressure. The residue was purified by flash chromatography 
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(1:1 hexanes:ethyl acetate to ethyl acetate) provided the β–hydroxymorpholine amide 
2.153 as white solid (310 mg, 62% over two steps). Rf = 0.54 (ethyl acetate, stain in 
KMnO4). 
 
 (2R,3S,4S,Z)-3-Hydroxy-2,4-dimethyl-1-morpholinoocta-
5,7-dien-1-one (Scheme 2.28, 2.153). 
1
H NMR (500 MHz, 
CDCl3): δ 6.55 (1H, dt, J = 17.5, 10.0 Hz), 6.07 (1H, t, 10.5 Hz), 5.49 (1H, t, J = 10.5 
Hz), 5.22 (1H, dt, J = 16.5, 1.0 Hz), 5.11 (1H, d, J = 9.5 Hz), 3.78 (1H, t, J = 5.5 Hz), 
3.76-3.68 (3H, m), 3.63-3.57 (2H, m), 3.48-3.38 (3H, m), 2.85 (1H, dqd, J = 10.0, 6.0, 
6.0 Hz), 2.69 (1H, qd, J = 7.0, 7.0 Hz), 1.20 (3H, d, J = 7.0 Hz), 1.02 (3H, d, J = 7.5 
Hz); 
13
C NMR (125 MHz, CDCl3): δ 175.1, 134.3. 132.5, 130.0, 118.1, 76.4, 67.0, 66.8, 
46.2, 42.0, 38.3, 35.2, 18.2, 12.9; IR (neat): 3419 (m), 2965 (m), 2928 (m), 2867 (m), 
1618 (s), 1462 (m), 1437 (m), 1224 (m), 1115 (s), 1026 (m), 989 (m), 585 (w); HRMS-
(ESI+) for C14H24NO3 [M+H]
+
: calculated: 254.1756, found: 254.1759. [α]D
21
 = +45.654 
(c = 0.20, CHCl3, l = 50 mm). 
 
Procedure for Reduction of Morpholine Amide to Alcohol 
 
To a solution of aldol adduct 2.153 (300 mg, 1.2 mmol) in THF (12 mL) was 
slowly added at −78 °C under inert atmosphere a solution of lithium aluminum hydride (1 
M in Et2O, 12 mL, 1.2 mmol); the reaction mixture was stirred at this temperature for 12 
h. A saturated aqueous solution of NH4Cl (3 mL) was then added followed by CH2Cl2 (10 
 181 
 
mL) and the mixture was allowed to warm up to room temperature. The aqueous layer 
was extracted two times with CH2Cl2 (10 mL), the combined organic layers were dried 
over Na2SO4 and the solvent was removed under reduce pressure. The crude aldehyde 
was dissolved in THF (12 mL) and the solution was cooled to -78 °C. A solution of 
lithium aluminum hydride (1M in Et2O, 12 mL, 12 mmol) was added dropwise under 
inert atmosphere and the reaction mixture was allowed to stir for 15 minutes. At that time, 
a saturated aqueous solution of Rochelle’s salt (3 mL) was added followed by CH2Cl2 (10 
mL) and the mixture was stir at room temperature until complete separation of layers. 
The aqueous layer was extracted two times with CH2Cl2 (10 mL), the combined organic 
layers were dried over Na2SO4 and the solvent was removed under reduce pressure. 
Crude material was purified on silica gel chromatography to afford titled compound 
2.154-OH as colorless oil (115 mg, 80%). Rf = 0.33 (EtOAc : hexane = 1:1).  
 
(2S,3S,4S,Z)-2,4-Dimethylocta-5,7-diene-1,3-diol (Scheme 
2.28, 2.154-OH) 
1
H NMR (500 MHz, CDCl3): δ 6.63 (1H, dt, J = 
17.0, 11.0 Hz), 6.17 (1H, t, J = 11.0 Hz), 5.29 (1H, t, J = 10.5 Hz), 5.25 (1H, d, J = 17.0), 
5.16 (1H, d, J = 10.5 Hz), 3.74 (1H, ddd, J = 10.5, 4.0, 2.0 Hz), 3.68 (1H, ddd, J = 10.5, 
6.0, 1.5 Hz), 3.51 (1H, dd, J = 9.0, 2.0 Hz), 2.79 (1H, qdd, J = 7.5, 7.5, 7.5 Hz), 2.23 (2H, 
bs), 1.89-1.85 (1H, m), 1.00 (3H, dd, J = 7.0, 1.5 Hz), 0.95 (3H, dd, J = 7.0, 1.5 Hz); 
13
C 
NMR (125 MHz, CDCl3): δ 134.8, 132.2, 131.8, 119.0, 67.8, 36.5, 36.0, 17.0, 9.1; IR 
(neat): 3355 (b), 2965 (s), 2931 (s), 2876 (m), 1457 (m), 1434 (w), 1378 (w), 1026 (s), 
981 (s), 903 (s), 794 (w), 664 (m); HRMS-(ESI+) for C10H19O2 [M+H]
+
: calculated: 
171.1385, found: 171.1386. [α]D
21
 = −5.263 (c = 0.30, CHCl3, l = 50 mm). 
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Procedure for Acetal Protection and Selective Acetal Opening 
 
 Diol 2.154-OH (115 mg, 0.68 mmol) and dimethoxyl acetal (185 mg, 1.01 mmol) 
was dissolved in 2 mL dry CH2Cl2 and catalytic amount of PPTS was added at room 
temperature. Water was added to quench reaction when TLC indicated full conversion of 
starting material. The aqueous phase was extracted with CH2Cl2 (3 x 10 mL), and the 
combined organic layers were dried over Na2SO4 and the solvent was removed under 
reduce pressure. Crude material 2.154 was used for next step without further purification.  
 Crude 2.154 was dissolved in 20 mL dry CH2Cl2 under N2 and cool to 0 
o
C. 
DIBAL (0.36 mL, 2.04 mmol) was added dropwise and the mixture was allowed to stir at 
0 
o
C until TLC showed full conversion of starting material (usually in two hours). 
Reaction was carefully quenched with a saturated aqueous solution of Rochelle’s salt (15 
mL) was added followed by CH2Cl2 (3 mL) and the mixture was stir at room temperature 
until complete separation of layer. The aqueous layer was extracted with CH2Cl2 (3 x 20 
mL), the combined organic layers were dried over Na2SO4 and the solvent was removed 
under reduce pressure. Crude material was purified on silica gel chromatography to 
afford titled compound 2.155 as colorless oil (152 mg, 77% over two steps). Rf = 0.24 
(EtOAc : hexane = 1:4). 
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 (2S,3S,4S,Z)-3-((4-Methoxybenzyl)oxy)-2,4-dimethylocta-5,7-
dien-1-ol (Scheme 2.28, 2.155). All spectrum data are in accordance 
with literature.
37b
 
 
Procedure for the Synthesis of Carbarmate 
 
To a solution of N,N-diisopropylcarbamoyl chloride (81 mg, 0.42 mmol) and NEt3 
(90 µL, 0.51 mmol) in CH2Cl2 (1.0 mL) was added alcohol 2.155 (120 mg, 0.42 mmol). 
This mixture was then heated to reflux and stirred for 24h. The reaction was cooled to rt 
and H2O (5 mL) was added. The aqueous layer was extracted with CH2Cl2 (3 x 5 mL) 
and combined organic layers were dried over Na2SO4 and the solvent was removed under 
reduce pressure. Crude material was purified on silica gel chromatography to afford titled 
compound 2.156 as colorless oil (150 mg, 86% yield). Rf = 0.18 (EtOAc : hexane = 1:4). 
 
 (2S,3S,4S,Z)-3-((4-Methoxybenzyl)oxy)-2,4-dimethylocta-5,7-
dien-1-yl diisopropylcarbamate (Scheme 2.28, 2.156). 
1
H NMR 
(500 MHz, CDCl3): δ 7.27 (2H, d, J =  8.5 Hz), 6.87 (3H, d, J = 9.0 Hz), 6.67 (1H, dt, J = 
17.0, 11.0 Hz), 6.05 (1H, t, J = 11.0 Hz), 5.51 (1H, t, J = 10.0 Hz), 5.22 (1H, d, J = 17.0 
Hz), 5.12 (1H, d, J = 10.0 Hz), 4.57 (1H, d, J = 10.5 Hz), 4.45 (1H, d, J =10.5 Hz), 4.09 
(1H, dd, J = 11.0, 6.5 Hz), 4.04 (1H, dd, J = 10.5, 6.5 Hz), 3.81 (3H, s), 3.35 (1H, dd, J = 
6.0, 4.0 Hz), 3.00 (1H, dqd, J = 10.5, 6.5 Hz), 2.13-2.08 (1H, m), 1.25 (12H, d, J = 6.5 
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Hz), 1.04 (3H, d, J = 7.0 Hz), 1.03 (3H, d, J = 7.0Hz); 
13
C NMR (125 MHz, CDCl3): δ 
159.2, 155.9, 135.5, 132.8, 131.2, 129..9, 129.6, 129.5, 117.6, 114.0, 113.8, 83.3, 74.6, 
67.7, 55.4, 36.1, 35.7, 18.5, 12.2; IR (neat): 2963 (b), 2932 (w), 1687 (s), 1612 (w), 1514 
(m), 1435 (m), 1368 (m), 1291 (s), 1247 (s), 1157 (m), 1049 (s), 823 (m), 772 (m); 
HRMS-(ESI+) for C25H40NO4 [M+H]
+
: calculated: 418.2957, found: 418.2951. [α]D
21
 = 
+99.483 (c = 0.396, CHCl3, l = 50 mm). 
 
IV. Diastereoselective Alkylation of (E)-Enolates 
 
i) Procedure for Ethyl Ketone Preparation 
Following general anti-aldol procedure
127
 and general TBS protection procedure, 
ethyl ketone 2.172 was obtained as single diastereomer. 
 
 
anti-5-((tert-Butyldimethylsilyl)oxy)-4-methylheptan-3-one. 
(Table 2.2, 2.172). All spectrum data are in accordance with 
literature.
128
 
 
 
                                                     
127
 Brown, H. C.; Dhar, R. K. Bakshi, R. K. Pandiarajan, P. K.; Singaram, B. J. Am. Chem. Soc. 
1989, 111, 3441. 
128
 Arimoto, H.; Yokoyama, R; Nakamurat, K.; Okumura, Y.; Uemura, D. Tetrahedron 1996. 52, 
13901. 
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Following general syn-aldol procedure
129
 and general TBS protection procedure, 
ethyl ketone 2.173 was obtained as single diastereomer. 
 
 
 syn-1-((tert-Butyldimethylsilyl)oxy)-2-methyl-1-phenylpentan-
3-one (Table 2.2, 2.173). And all spectrum data are in accordance 
with literature.
130
 
 
Ethyl ketone 2.174 was prepared as shown below. 
 
 
Methylcyclohexyl acetate (600 mg, 3.8 mmol) was added to a 100 mL flame dried 
round bottom flask with THF (10 mL) and cooled to −78 °C. A solution of LiHMDS (1.0 
M in THF/ethylbenzene, 4.4 mL, 4.4 mmol) was added to the mixture slowly and stirred 
for 1 h. MeI (280 µL, 4.6 mmol) was added dropwise at −78 °C and the reaction flask 
was allowed to warm to room temperature slowly and stirred overnight. The reaction was 
                                                     
129
 Evans, D. A.; Vogel, E.; Nelson, J. V. J. Am. Chem. Soc. 1979, 101, 6120. 
130
 Tanino, K.; Aoyagi, K.; Kirihara, Y.; Ito, Y.; Miyashita, M. Tetrahedron Lett. 2005, 26, 1169. 
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quenched with NH4Cl aqueous solution and diluted with ethylacetate. The layers were 
separated and aqueous layer was extracted with ethyl acetate (3 × 5 mL). The combined 
organic layers were dried over Na2SO4, filtered, and concentrated by rotary evaporation. 
The crude reaction mixture was purified by silica gel chromatography to afford SI-1 as 
clear colorless oil (540 mg, 83%). Rf =0.55 (ethyl acetae:hexanes=1:10, stain in KMnO4) 
 
AlMe3 (1.0 M in CH2Cl2, 9.5 mL, 9.5 mmol) was added to a toluene (10.0 mL) 
suspension of HN(OMe)Me·HCl (910 mg, 9.53 mmol) at 0 
o
C dropwise and stirred for 
another 30 min. A toluene (3.0 mL) solution of methyl ester SI-1 (540 mg, 3.18 mmol) 
was added dropwise and stirred for 2 h at 0 
o
C. The reaction was heated to 70 
o
C and 
stirred overnight. After cooled back to room temperature, the reaction was quenched with 
NH4Cl aqueous solution and diluted with ethylacetate. The layers were separated and 
aqueous layer was extracted with ethyl acetate (3 × 5 mL). The combined organic layers 
were dried over Na2SO4, filtered, and concentrated by rotary evaporation. The crude 
reaction mixture was purified by silica gel chromatography to afford the Weinreb amide 
SI-2 as a clear colorless oil (310 mg, 50%). Rf =0.49 (ethyl acetae:hexanes=1:3, stain in 
KMnO4) 
 
The Weinreb amide SI-2 (310 mg, 0.8 mmol) was dissolved in dry THF (6.0 mL) 
in a round bottom flask equipped with magnetic stir bar. Ethyl magnesium bromide (3.0 
M in Et2O, 1.6 mL, 1.6 mmol) was added dropwise at 0 
o
C. The reaction was allowed to 
warm to room temperature slowly and stirred overnight. The reaction was quenched by 
slow addition of 1.0 M HCl aqueous solution on ice bath. The layers were separated and 
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the aqueous layer was extracted with ethyl acetate (3 × 10 mL). The combined organic 
layers were dried over Na2SO4, filtered, and concentrated by rotary evaporation. The 
crude reaction mixture was purified on silica gel to afford the titled compound 2.174 as a 
clear, colorless oil (160 mg, 61%). Rf = 0.65 (ethyl acetate: hexanes=1:10, stain in 
KMnO4) 
 
 2-Cyclohexylpentan-3-one. (Table 2.2, 2.174).   All spectrum data 
are in accordance with literature.
131
 
 
ii) General Procedure for (E)-Enolate Alkylation 
 
The (E)-enolates were prepared following literature procedure.
99
 To a rapidly 
stirred suspension of TMP∙HBr (1.0 equiv.) and a spatula-tip of 1,10-phenanthroline in 
THF at 0 
o
C under nitrogen was added a 2.50 M solution of n-BuLi in hexanes dropwise 
until deep red color persisted and disappearance of any solid. Then a second portion of 
the same volume of n-BuLi was added to the dark red solution. After being stirred for an 
additional 3 min at 0 
o
C, the resulted dark red solution was cooled to −78 oC and 
corresponding ethyl ketone (1.0 equiv.) was added as a 10% solution in THF dropwise. 
Such solution was stirred at −78 oC for 30 min followed by addition of allyl iodide (1.5 
equiv.) dropwise at −78 oC and stirred overnight until TLC showed full conversion of 
ethyl ketone. The reaction was quenched with aqueous NH4Cl and allowed to warm to 
                                                     
131
 Maruoka, K.; Concepcion, A. B.; Yamamoto, H. Synthesis 1994, 12, 1283. 
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room temperature. The reaction mixture was diluted with ethyl acetate and the layers 
were separated. The aqueous layer was extracted with ethyl acetate (3 × 5 mL) and the 
combined organic layers were dried over Na2SO4, filtered, and concentrated by rotary 
evaporation. Diastereoselectivity (d.r.) was determined by 
1
H NMR. The crude reaction 
mixture was purified by silica gel chromatography. 
 
 (4S,6R,7R)/(4R,6S,7S)-7-((tert-Butyldimethylsilyl)oxy)-4,6-
dimethylnon-1-en-5-one. (Table 4.2, 2.175). The titled 
compound 2.175 was prepared according to enolate alkylation general procedure with 
ethyl ketone 2.172 (40.0 mg, 0.15 mmol), TMP∙HBr (33.3 mg, 0.15 mmol), allyl iodide 
(23 µL, 0.23 mmol) and THF (3.8 mL) and isolated as a light yellow oil (38 mg, 85% 
yield, 6:1 d.r., two diastereomers are inseparable). 
1
H NMR (500 MHz, CDCl3): δ 5.72 
(1H, ddt, J = 15.5, 10.5, 6.5 Hz), 5.40 (1H, d, J = 15.5 Hz), 5.01 (1H, d, J = 10.5 Hz), 
3.92 (2H, dt, J = 8.0, 7.5 Hz), 2.90 (1H, qd, J = 7.0, 7.0 Hz), 2.61 (1H, m), 2.44 (1H, dt, 
J = 14.0, 5.0 Hz), 1.47 (2H, m), 1.08 (3H, d, J = 7.5 Hz), 0.96 (3H, d, J = 6.0 Hz), 0.88 
(3H, t, J = 7.0 Hz), 0.86 (9H, s), 0.04 (3H, s), −0.01 (3H, s); 13C NMR (100 MHz, 
CDCl3): δ 216.4, 136.5, 116.8, 74.2, 49.0, 46.5, 36.5, 26.1, 25.9, 18.2, 15.9, 12.8, 7.9, 
−4.4, −4.5; IR (neat): 2960 (m), 2931 (m), 2882 (w), 2857 (m), 1713 (m), 1460 (m), 1369 
(w), 1252 (m), 1022 (s), 996 (s), 865 (m), 833 (s), 774 (s); HRMS-(ESI+) for C17H35O2Si 
[M+H]
+
: calculated: 299.2406, found: 299.2412. 
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Proof of Stereochemistry 
 
The titled compound 2.175 was converted to the corresponding alcohols SI-3 and 
SI-4 which were separable by silica gel chromatography. The spectrum data of SI-3
132
 
and SI-4
133
 were compared with literature and completely matched.  
 
 (4R,5r,6S)/(4S,5s,6R)-4,6-Dimethylnonan-5-ol (SI-3). 
1
H 
NMR (500 MHz, CDCl3): δ 3.19 (1H, dd, J = 5.5, 5.5 Hz), 
1.65-1.60 (2H, m), 1.40-1.25 (6H, m), 1.17-1.11 (2H, m), 0.90 (6H, t, J = 7.0 Hz), 0.89 
(6H, d, J = 6.5 Hz); 
13
C NMR (100 MHz, CDCl3): δ 78.9, 36.2, 35.2, 20.3, 14.6, 14.4. Rf 
= 0.40 (ethylacetate:hexanes=1:10, stain in KMnO4). 
 
  (4R,5s,6S)/(4S,5r,6R)-4,6-Dimethylnonan-5-ol (SI-4). 
 1
H 
NMR (500 MHz, CDCl3): δ 3.10 (1H, dd, J = 6.0, 6.0 Hz), 
                                                     
132
 Brady, P. B.; Yamamoto, H. Angew. Chem. Int. Ed. 2012, 51, 1942. 
133
 Whitesell, J. K.; Hildebrandt, B. J. Org. Chem. 1985, 50, 4975. 
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1.65-1.60 (2H, m), 1.55-1.42 (4H, m), 1.26-1.19 (4H, m), 0.91 (6H, t, J = 7.0 Hz), 0.89 
(6H, d, J = 7.0 Hz); 
13
C NMR (100 MHz, CDCl3): δ 81.3, 35.4, 33.2, 20.5, 16.8, 14.7. Rf 
= 0.47 (ethylacetate:hexanes=1:10, stain in KMnO4). 
 
 (1R,2R,4S)/(1S,2S,4R)-1-((tert-Butyldimethylsilyl)oxy)-2,4-
dimethyl-1-phenylhept-6-en-3-one. (Table 2.2, 2.176).  The 
titled compound 2.176 was prepared according to enolate alkylation general procedure 
with ethyl ketone 2.173 (30.6 mg, 0.1 mmol), TMP∙HBr (22.2 mg, 0.1 mmol), allyl 
iodide (15 µL, 0.15 mmol) and THF (1.9 mL) and was isolated as a light yellow oil (32 
mg, 92% yield, 7:1 d.r., two diastereomers are inseparable). Stereochemistry was 
assigned by analogy. 
1
H NMR (500 MHz, CDCl3): δ 7.29-7.20 (5H, m), 5.26 (1H, dtd, J 
= 8.5, 8.5, 6.5 Hz), 4.83 (1H, d. J = 11.0 Hz), 4.79 (1H, d, J = 17.0 Hz), 4.67 (1H, d, J = 
9.0 Hz), 3.04 (1H, dq, J = 7.0, 7.0 Hz), 2.02 (1H, qt, J = 6.5, 2.0 Hz), 1.86 (1H, ddd, J = 
16.0, 6.5, 6.5 Hz), 1.63 (1H, ddd, J = 13.0, 8.0, 8.0 Hz), 1.25 (3H, d, J = 6.5 Hz), 0.90 
(3H, d, J = 7.5 Hz), 0.87 (9H, s), 0.05 (3H, s), −0.23 (3H, s); 13C NMR (100 MHz, 
CDCl3): δ 216.2, 143.9, 136.0, 128.3, 127.7, 127.1, 116.5, 77.0, 54.9, 46.8, 35.4, 26.0, 
18.4, 15.4, 15.3, −4.3, −4.8; IR (neat): 2958 (s), 2931 (s), 2887 (w), 2858 (m), 1710 (s), 
1455 (w), 1362 (w), 1256 (m), 10087 (s), 1067 (s), 999 (s), 914 (w), 872 (s), 837 (s), 777 
(s), 701 (s); HRMS-(ESI+) for C21H35O2Si [M+H]
+
: calculated: 347.2406, found: 
347.2415. 
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 (2R,4S)/(2S,4R)-2-Cyclohexyl-4-methylhept-6-en-3-one. (Table 
2.2, 2.177). The titled compound 2.177 was prepared according to 
enolate alkylation general procedure with ethyl ketone 2.174 (14.0 mg, 0.085 mmol), 
TMP∙HBr (19.0 mg, 0.085 mmol), allyl iodide (12 µL, 0.13 mmol) and THF (1.9 mL). 
Product was obtained as light yellow oil (13 mg, 74% yield, 3:1 d.r., two diastereomers 
are inseparable). 
1
H NMR (500 MHz, CDCl3): δ 5.72 (1H, ddt, J = 17.5, 11.5, 7.5 Hz), 
5.44 (1H, d, J = 17.5 Hz), 5.01 (1H, d, J = 11.5 Hz), 2.64 (1H, q, J = 7.0 Hz), 2.48 (1H, 
qd, J = 6.5, 6.5 Hz), 2.48-2.38 (1H, m), 2.02-1.97 (1H, m), 1.74-1.60 (6H, m), 1.59-1.53 
(2H, m), 1.26-1.17 (3H, m), 1.06 (3H, d, J = 7.0 Hz), 0.99 (3H, d, J = 7.0 Hz); 
13
C NMR 
(100 MHz, CDCl3): δ 217.8, 136.3, 116.9, 50.9, 40.0, 37.4, 36.7, 32.3, 29.6, 29.4, 26.6, 
16.5, 15.8, 13.7; IR (neat): 2967 (w), 2924 (s), 2852 (m), 1709 (s), 1449 (m), 1373 (w), 
997 (m), 917 (w); HRMS-(ESI+) for C14H25O [M+H]
+
: calculated: 209.1905, found: 
109.1895. 
 
Proof of Stereochemistry 
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The stereochemistry of 2.177 was proved by making authentic sample SI-6. Aldol 
adduct SI-5 was prepared following literature procedure as known compound.
134
 The 
spectrum data of SI-6 (major diastereomer) and SI-7 were matched.  
 
 (2,4-syn)-2-Cyclohexyl-4-methylheptan-3-one (SI-6/SI-7). 
1
H 
NMR (500 MHz, CDCl3): δ 2.60 (1H, tq, J = 7.0 Hz), 2.46 (1H, 
dq, J = 7.0Hz), 1.74-1.54 (7H, m), 1,32-1.20 (5H, m), 1.18-1.10 (3H, m), 1.04 (3H, d, J =  
6.5 Hz), 0.98 (3H, d, J = 7.0Hz), 0.89 (3H, t, J = 7.5Hz); 
13
C NMR (100 MHz, CDCl3): δ 
218.6, 50.9, 40.0, 34.7, 32.3, 29.5, 26.7, 26.6, 26.5, 20.7, 16.7, 14.4, 13.9. IR (neat): 2959 
(m), 2925 (s), 2852 (m), 1708 (s), 1449 (m), 1374 (w), 1035 (w), 995 (w); HRMS-(ESI+) 
for C14H27O [M+H]
+
: calculated: 211.2062, found: 211.2063. Rf = 0.73 (ethylacetate : 
hexanes=1:7, stain in KMnO4). 
 
V. C15-C16 Connection 
Procedure for Converting Allyl Alcohol to Allyl Iodide 
 
PPh3 (79.4 mg, 0.3 mmol) and imidazole (22.0 mg, 0.32 mmol) were added to a 
flame-dried 20-dram vial with stir bar. The vial was purged with nitrogen. Dry CH2Cl2 
(2.0 mL) was added under nitrogen forming clear solution. I2 (71.0 mg, 0.28 mmol) was 
added in one portion at 0 
o
C and stirred for 5 min until all I2 was dissolved resulting light 
yellow heterogeneous solution. CH2Cl2 (2.0 mL) solution of alcohol 2.178 (84.0 mg, 0.20 
                                                     
134
 Boxer, M. B.; Yamamoto, H. J. Am. Chem. Soc. 2006, 128, 48. 
 193 
 
mmol) was added dropwise at 0 
o
C under nitrogen. When reaction completed indicating 
by TLC (usually in 1 h), all volatiles were removed under reduced pressure and the 
residue was loaded on silica gel for chromatography to afford corresponding allyl iodide 
2.179 as clear colorless oil (105 mg, quantative yield). Rf = 0.76 (diethyl ether: 
hexanes=1:20, stain in KMnO4). 
 
(5R,6S)-5-((S,Z)-5-Iodo-4-methylpent-3-en-2-yl)-
2,2,3,3,6,9,9,10,10-nonamethyl-4,8-dioxa-3,9-disilaundecane. 
(Scheme 2.32, 2.179). 
1
H NMR (500 MHz, CDCl3): δ 5.29 (1H, dd, J = 10.0, 1.5 Hz), 
3.94 (1H, d, J = 9.0 Hz), 3.90 (1H, d, J = 9.0 Hz), 3.64 (1H, dd, J = 10.5, 6.0 Hz), 3.58 
(1H, dd, J = 5.5, 5.5 Hz), 3.40 (1H, dd, J = 9.5, 7.0 Hz), 2.60 (1H, dqd, J = 10.0. 6.5, 6.5 
Hz), 1.83 (3H, d, J = 1.0 Hz), 1.83-1.81 (1H, m), 0.95 (3H, d, J = 6.5 Hz), 0.94 (3H, d, J 
=7.0 Hz), 0.91 (9H, s), 0.90 (9H, s), 0.05 (3H, s), 0.04 (6H, s), 0.02 (3H, s); 
13
C NMR 
(125 MHz, CDCl3): δ 135.5, 130.6, 76.5, 65.4, 41.1, 36.2, 26.4, 26.2, 22.6, 18.6, 15.1, 
14.0, 7.1, −3.8, −3.9, −5.0, −5.1; IR (neat): 2955 (m), 2928 (m), 2856 (m), 1471 (w), 
1387 (w), 1251 (m), 1079 (s), 1023 (m), 834 (s), 772 (s), 670 (w); HRMS-(ESI+) for 
C22H48IO2Si2 [M+H]
+
: calculated: 527.2238, found: 527.2242. [α]D
21 
= +17.284 (c = 1.40, 
CHCl3, l = 50 mm). 
 
Procedure for the Alkylation of Morpholine Amide 
 
 β–hydroxymorpholine amide 2.153 (200 mg, 0.8 mmol) was dissolved in dry THF 
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(8.0 mL) in a round bottom flask equipped with magnetic stir bar under nitrogen. Ethyl 
magnesium bromide (3.0 M in Et2O, 1.1 mL, 3.3 mmol) was added dropwise at 0 
o
C. It 
was allowed to warm to room temperature slowly and stirred overnight. Reaction was 
quenched by slow addition of 1.0 M HCl aqueous solution on ice bath. The layers were 
separated and the aqueous layer was extracted with ethyl acetate (3 × 10 mL). The 
combined organic layers were dried over Na2SO4, filtered, and concentrated by rotary 
evaporation. The crude reaction mixture was purified on silica gel (1:5 hexanes:diethyl 
ether) to afford the titled compound 2.181-OH as a clear, colorless oil (120 mg, 77%). Rf 
= 0.37 (1:5 hexanes:ethyl acetate, stain in KMnO4). 
 
 (4R,5S,6S,Z)-5-Hydroxy-4,6-dimethyldeca-7,9-dien-3-one 
(Scheme 2.32, 2.181-OH). 
1
H NMR (500 MHz, CDCl3): δ 6.54 
(1H, dt, J = 16.5, 10.5 Hz), 6.11 (1H, t, J = 10.5 Hz), 5.39 (1H, t, J = 10.5 Hz), 5.22 (1H, 
dt, J = 16.5, 1.0 Hz), 5.12 (1H, d, J = 10.0 Hz), 3.74-3.72 (1H, m), 2.74 (1H, dqd, J = 
10.5, 6.5, 6.5 Hz), 2.67 (1H, dq, J = 9.0, 7,5 Hz), 2.54 (1H, dqd, J = 18.0, 7.5, 7.5 Hz), 
2.45 (1H, dqd, J = 18.0, 7.5, 7.5 Hz), 2.23 (1H, br, s), 1.16 (3H, d, J = 7.5 Hz), 1.03 (3H, 
t, J = 7.0 Hz), 0.99 (3H, d, J = 7.0 Hz); 
13
C NMR (100 MHz, CDCl3): δ 215.6, 134.1, 
132.2, 130.7, 118.4, 75.4, 48.4, 35.7, 35.0, 17.8, 10.9, 7.8; IR (neat): 3505 (m), 2970 (m), 
2932 (m), 2876 (w), 1705 (s), 1458 (m), 1376 (m), 1144 (w), 974 (s), 905 (m), 805 (m); 
HRMS-(ESI+) for C14H21O2 [M+H]
+
: calculated: 197.1542, found: 197.1542. [α]D
21
 = 
+34.145 (c = 0.48, CHCl3, l = 50 mm). 
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Procedure for Trimethylsilyl Protection 
 
A flame-dried round-bottom flask containing magnetic stir bar was charged with 
alcohol 2.181-OH (100.0 mg, 0.50 mmol) in CH2Cl2 (5 mL) and 2,6-lutidine (0.09 mL, 
0.77 mmol) under nitrogen. The reaction flask was cooled to −78 °C, followed by 
dropwise addition of freshly distilled TMSOTf (0.11 mL, 0.61 mmol). The reaction was 
allowed to stir for 1 h until TLC showed full conversion of starting material. Reaction 
was quenched with saturated aqueous NaHCO3. The layers were separated, and the 
aqueous layer was extracted with CH2Cl2 (3 × 10 mL). The combined organic layer was 
dried over Na2SO4, filtered, and concentrated by rotary evaporation. The crude reaction 
mixture was purified by triethylamine neutralized silica gel chromatography (100:1:1 
hexanes:diethyl ether:triethylamine) to afford 2.181 as a clear, colorless oil (130 mg, 
97%). Rf = 0.40 (diethyl ether:hexanes=1:20, stain in KMnO4) 
 
 (4R,5S,6S,Z)-4,6-Dimethyl-5-((trimethylsilyl)oxy)deca-7,9-
dien-3-one (Scheme 2.32, 2.181). 
1
H NMR (500 MHz, 
CDCl3): δ 6.42 (1H, dt, J = 16.5, 11.0 Hz), 6.03 (1H, t, J = 11.0 Hz), 5.49 (1H, t, J = 
10.5 Hz), 5.18 (1H, dt, J = 16.5, 1.0 Hz), 5.08 (1H, d, J = 10.0 Hz), 3.86 (1H, dd, J = 8.5, 
3.0 Hz), 2.67-2.61 (2H, m), 2.47 (1H, dqd, J = 18.5, 7.5, 7.5 Hz), 2.37 (1H, dqd, J = 18.5, 
7.5, 7.5 Hz), 1.08 (3H, d, J = 7.0 Hz), 0.99 (3H, t, J = 7.5 Hz), 0.98 (3H, t, J = 7.5 Hz), 
0.13 (9H, s); 
13
C NMR (125 MHz, CDCl3): δ 215.1, 134.0, 132.4, 129.7, 117.7, 78.0, 
50.9, 36.4, 36.1, 19.3, 15.0, 7.6, 1.0; IR (neat): 2962 (m), 2937 (w), 1710 (s), 1377 (m), 
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1250 (s), 1135 (m), 1075 (s), 1025 (s), 883 (s), 835 (s), 749 (s), 684 (m); HRMS-(ESI+) 
for C15H29O2Si [M+H]
+
: calculated: 269.1937, found: 269.1933. [α]D
21
 = +18.674 (c = 
0.34, CHCl3, l = 50 mm). 
 
Procedure for Enolate Alkylation Construct C15-C16 Bond 
 
Enolate alkylation general procedure was used. To a rapidly stirred suspension of 
TMP·HBr (50 mg, 0.224 mmol) and a spatula-tip of 1,10-phenanthroline in THF (3.0 mL) 
at 0 
o
C under nitrogen was added 2.5 M solution of n-BuLi in hexanes dropwise until 
deep red color persists as well as no solid left at bottom. Then a 0.95 equiv. of n-BuLi as 
previously added was transferred to the dark red solution dropwise. After being stirred for 
an additional 5 min at 0 
o
C, the resulting dark red solution was cooled to −78 oC and ethyl 
ketone 2.181 (60 mg, 0.224 mmol) was added as THF (0.8 mL) solution dropwise. Such 
solution was stirred at −78 oC for 30 min. A THF (1.0 mL) solution of allyl iodide 2.179 
(130 mg, 0.246 mmol) was added dropwise at −78 oC and stirred overnight until TLC 
showed full conversion of ethyl ketone. Reaction was quenched with aqueous NH4Cl and 
allowed to warm to room temperature. The reaction mixture was diluted with ethyl 
acetate and layers were separated. The aqueous layer was extracted with ethyl acetate (3 
× 15 mL) and the combined organic layers were dried over Na2SO4, filtered, and 
concentrated by rotary evaporation. Diastereoselectivity was determined by 
1
H NMR. 
The crude was purified through triethylamine neutralized silica gel chromatography 
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(Et2O:TEA:hexanes = 1:1:100) to afford titled compound 2.182 as light yellow oil (120 
mg, 81% yield, >10:1 d.r.). Rf = 0.58 (diethyl ether:hexanes=1:20, stain in KMnO4). 
 
 (4S,5R,7S,11S,12R,13S,Z)-12-((tert-
Butyldimethylsilyl)oxy)-4-((S,Z)-hexa-3,5-dien-
2-yl)-2,2,5,7,9,11,13,16,16,17,17-undecamethyl-
3,15-dioxa-2,16-disilaoctadec-9-en-6-one (Scheme 2.33, 2.182). 
1
H NMR (500 MHz, 
CDCl3): δ 6.44 (1H, dt, J = 17.0, 11.5 Hz), 6.03 (1H, t, J = 11.0 Hz), 5.59 (1H, t, J = 
10.5 Hz), 5.17 (1H, d, J = 16.5 Hz), 5.15 (1H, d, J = 9.5 Hz), 5.06 (1H, d, J = 10.0 Hz), 
3.88 (1H, dd, J = 8.0, 2.5 Hz), 3.63 (1H, dd, J = 10.0, 5.5 Hz), 3.41 (1H, dqd, J = 11.0, 
7.5, 7.5 Hz), 3.34 (1H, dd, J = 9.5, 7.5 Hz), 2.79 (1H, qd, J = 7.0 Hz), 2.68 (1H, dqd, J = 
11.0, 7.5, 7.5 Hz), 2.61-2.58 (1H, m), 2.51 (1H, dqd, J = 10.0, 5.5, 5.5 Hz), 2.20 (1H, dd, 
J = 13.0, 11.0 Hz), 2.00 (1H, dd, J = 13.0, 3.0 Hz), 1.82-1.77 (1H, m), 1.58 (3H, s), 1.11 
(3H, d, J = 7.5 Hz), 1.00 (3H, d, J = 6.5 Hz), 0.96 (3H, d, J = 6.5 Hz), 0.89 (3H, d, J = 
5.5 Hz), 0.88 (3H, d, J = 6.5 Hz), 0.91 (9H, s), 0.89 (9H, s), 0.14 (9H, s), 0.03 (9H, s), 
0.01 (3H, s); 
13
C NMR (100 MHz, CDCl3): δ 217.2, 133.6, 133.4, 132.6, 130.1, 130.0, 
118.0, 77.8, 77.6, 65.7, 50.1, 43.9, 41.3, 36.7, 35.3, 34.2, 26.4, 26.2, 23.3, 19.9, 18.6, 18.5, 
16.5, 15.4, 15.3, 14.0, 1.1, −3.7, −3.8, −5.0, −5.1 (δ  31.8, 22.9, 14.3 belong to hexanes); 
IR (neat): 2957 (m), 2929 (m), 2856 (m), 1707 (w), 1471 (w), 1251 (s), 1078 (s), 1023 (s), 
1001 (s), 834 (s), 772 (s), 670 (w); HRMS-(ESI+) for C37H74O4NaSi3 [M+Na]
+
: 
calculated: 689.4787, found: 689.4778. [α]D
21
 = +3.172 (c = 0.52, CHCl3, l = 50 mm).  
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VI. Preparation of Aldehyde for Still-Gennari Olefination 
 
 
Procedure for Removal of Trimethylsilyl Protecting Group 
 
Ketone 2.182 (30.0 mg, 0.045 mmol) was dissolved in 1.0 mL MeOH and cooled 
to 0 
o
C. Several crystalline of PPTS were added to the solution and stirred at 0 
o
C. The 
reaction was monitored by TLC carefully. Once reaction was completed, all volatiles 
were removed under reduced pressure. Residue was purified immediately by silica gel 
chromatography to afford SI-8 as a clear colorless oil (26.0mg, 96% yield). Rf = 0.68 
(ethylacetate:hexanes=1:3, stain in KMnO4) . 
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 (3Z,5S,6S,7R,9S,11Z,13S,14R,15S)-14,16-
Bis((tert-butyldimethylsilyl)oxy)-6-hydroxy-
5,7,9,11,13,15-hexamethylhexadeca-1,3,11-trien-
8-one. (SI-8). 
1
H NMR (500 MHz, CDCl3): δ 6.59 (1H, dt, J = 17.5, 9.5 Hz), 6.11 (1H, t, 
J = 11.0Hz), 5.43 (1H, t, J = 10.0 Hz), 5.23 (1H, d, J = 16.5 Hz), 5.18 (1H, d, J = 10.0 
Hz), 5.13 (1H, d, J = 9.5 Hz), 3.71 (1H, dd, J = 7.5, 3.5 Hz), 3.63 (1H, dd, J = 10.0, 5.0 
Hz), 3.42 (1H, dd, J = 5.5, 5.5 Hz), 3.35 (1H, dd, 9.5, 7.5 Hz), 2.86-2.81 (2H, m), 2.75 
(1H, dqd, J = 10.0, 7.0, 7.0 Hz), 2.52 (1H, dqd, J = 10.5, 6.0, 6.0 Hz), 2.24 (1H, dd, J = 
13.5, 9.5 Hz), 2.07 (1H, dd, J = 13.0, 4.5), 1.79 (1H, qd, J = 9.5, 9.5 Hz), 1.63 (3H, s), 
1.18 (3H, d, J = 7.5 Hz), 0.95 (3H, d, J = 6.5 Hz), 0.99 (3H, d, J = 6.0 Hz),, 0.91 (3H, d, 
overlap), 0.90 (9H, s), 0.90 (3H, d, overlap), 0.89 (9H, s), 0.04 (3H, s), 0.03 (6H, s), 0.02 
(3H, s); 
13
C NMR (100 MHz, CDCl3): δ 218.7, 134.5, 133.5, 132.3, 130.5, 130.0, 118.4, 
77.8, 74.9, 65.6, 47.1, 43.2, 41.2, 35.6, 35.4, 35.2, 26.4, 26.2, 25.9, 23.6, 18.6, 18.5, 17.8, 
16.6, 15.8, 14.1, 10.3, −3.6, −3.7, −5.1; IR (neat): 3496 (w), 2957 (s), 2929 (s), 2856 (s), 
1701 (m), 1460 (s), 1374 (m), 1251 (s), 1080 (s), 1022 (s), 833 (s), 772 (s), 667 (m); 
HRMS-(ESI+) for C38H67OSi2 [M+H]
+
: calculated: 689.4787, found: 689.4778. [α]D
21
 = 
+28.102 (c = 0.66, CHCl3, l = 50 mm).   
 
Procedure for Installation of Primary Carbamate 
 
To a CH2Cl2 (1.0 mL) solution of alcohol SI-8 (26 mg, 0.045 mmol) was added 
trichloroacetyl isocyanate (34 µL) under nitrogen at room temperature. After one hour of 
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stirring, neutral alumina (1.2 g) was added. After stirring vigorously for an additional 4 
hours, the reaction mixture was concentrated. Residue (adsorbed on the alumina) was 
placed on the top of silica gel column, and was purified by flash chromatography to give 
the titled compound SI-9 as a clear oil (28 mg, 97% yield). Rf = 0.48 (ethyl acetate: 
hexanes=1:3, stain in KMnO4). 
 
 (3Z,5S,6S,7R,9S,11Z,13S,14R,15S)-14,16-
Bis((tert-butyldimethylsilyl)oxy)-5,7,9,11,13,15-
hexamethyl-8-oxohexadeca-1,3,11-trien-6-yl 
carbamate (SI-9). 
1
H NMR (500 MHz, CDCl3): δ 6.48 (1H, dt, J = 16.5, 10.0 Hz), 6.05 
(1H, t, J = 11.0 Hz), 5.43 (1H, t, J = 11.0 Hz), 5.20 (1H, d, J = 16.0 Hz), 5.15 (1H, d, J = 
10.5 Hz), 5.10 (1H, d, J = 9.5 Hz), 5.09 (1H, d, J = 10.5 Hz), 4.62 (2H, br, s), 3.62 (1H, 
dd, J = 10.0, 5.5 Hz), 3.41 (1H, dd, J = 5.0, 5.0 Hz), 3.33 (1H, dd, J = 10.0, 8.0 Hz), 2.95 
(1H, qd, J = 7.5, 7.5 Hz), 2.90-2.86 (1H, m), 2.77 (1H, dqd, J = 7.0, 7.0, 3.5 Hz), 2.50 
(1H, dqd, J = 6.5, 6.5, 3.5 Hz), 2.42 (1H, dd, J = 13.5, 11.5 Hz), 1.99 (1H, dd, J = 13.5, 
2.5 Hz), 1.79 (1H, qd, J = 5.5 Hz), 1.60 (3H, s), 1.13 (3H, d, J = 6.5 Hz), 1.03 (3H, d, J 
= 6.0 Hz), 0.97 (3H, d, J = 7.0 Hz), 0.90 (9H, s), 0.89 (9H, s), 0.88 (3H, d, overlap), 0.87 
(3H, d, overlap), 0.03 (9H, s), 0.01 (3H, s); 
13
C NMR (100 MHz, CDCl3): δ 214.7, 156.5, 
133.4, 132.5, 131.9 ,130.5, 129.9, 118.4, 77.6, 76.8, 65.5., 47.0, 42.7, 41.1, 35.1, 34.7, 
33.9, 26.2, 26.0, 23.1, 18.4, 18.3, 18.0, 16.4, 15.4, 13.7, 12.5, −3.9, −4.0, −5.2, −5.3; IR 
(neat): 2957 (m), 2929 (m), 2856 (m), 1708 (s), 1600 9w), 1471 (m), 1387 (m), 1323 (m), 
1252 (m), 1079 (m), 1003 (s), 834 9s), 772 (s), 667 (w); HRMS-(ESI+) for C35H68NO5Si2 
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[M+H]
+
: calculated: 638.4630, found: 638.4665. [α]D
21
 = +27.497 (c = 0.40, CHCl3, l = 
50 mm). 
 
Procedure for Selective Removal of Primary TBS Protecting Group 
 
bis-TBS ether SI-9 (26 mg, 0.041 mmol) was dissolved in methanol (1.0 mL) and 
cooled to 0
 o
C. Several crystalline of p-TsOH were added to the solution and stirred at 0 
o
C. The reaction was monitored by TLC carefully. Once it showed full consumption of 
starting material, triethylamine (1.0 mL) was added to quench the reaction. All volatiles 
were removed under reduced pressure. Residue was purified immediately via silica gel 
chromatography to afford titled compound SI-10 as clear colorless oil (20 mg, 93%). Rf 
= 0.29, (ethylacetate:hexanes=1:3, stain in KMnO4). 
 
 (3Z,5S,6S,7R,9S,11Z,13S,14R,15S)-14-((tert-
Butyldimethylsilyl)oxy)-16-hydroxy-5,7,9,11,13,15-
hexamethyl-8-oxohexadeca-1,3,11-trien-6-yl 
carbamate (SI-10). 
1
H NMR (500 MHz, CDCl3): δ 6.49 (1H, dt, J = 17.5, 11.0 Hz), 6.05 
(1H, t, J = 10.5 Hz), 5.41 (1H, t, J = 10.0 Hz), 5.21 (1H, d, J = 17.5 Hz), 5.12-5.06 (2H, 
m), 4.64 (2H, br, s), 3.62 (1H, dd, J = 11.0, 5.0 Hz), 3.56 (1H, dd, J = 11.0, 5.5 Hz), 3.40 
(1H, dd, J = 6.0, 4.0 Hz), 2.95 (1H, qd, J = 7.5 Hz), 2.93-2.86 (1H, m), 2.82 (1H, dqd, J 
= 14.0, 7.0, 7.0 Hz), 2.60 (1H, dqd, J = 10.5, 6.5, 6.5 Hz), 2.23 (1H, dd, J = 13.5, 11.0 
 202 
 
Hz), 2.5 (1H, dd, J = 14.0, 3.0 Hz), 1.83-1.78 (1H, m), 1.62 (3H, s), 1.13 (3H, d, J = 7.0 
Hz), 1.03 (3H, d, J = 7.0 Hz), 0.98 (6H, d, J = 7.5 Hz overlap), 0.92 (3H, d, J = 7.0 Hz), 
0.92 (9H, s), 0.09 (3H, s), 0.06 (3H, s); 
13
C NMR (100 MHz, CDCl3): δ 214.9, 156.7, 
132.8, 132.3, 132.2, 131.4, 130.7, 118.6, 81.5, 65.6, 47.1, 42.7, 38.7, 36.9, 34.9, 34.2, 
26.4, 23.3, 18.6, 18.2, 17.4, 16.1, 15.9, 12.3, −3.4, −3.7; IR (neat): 3664 (m), 2963 (s), 
2856 (s), 1712 (s), 1601 (m), 1460 (m), 1361 (m), 1324 (s), 1254 (m), 1026 (s), 1003 (s), 
836 (s), 774 (s); HRMS-(ESI+) for C29H54NO5Si [M+H]
+
: calculated: 524.3771, found: 
524.3798. [α]D
21
 = +19.997 (c = 0.34, CHCl3, l = 50 mm). 
 
Procedure for Dess-Martin Oxidation of Alcohol 
 
A CH2Cl2 (1.0 mL) solution of alcohol SI-10 (20 mg, 0.038 mmol) was added to a 
20-dram vial with NaHCO3 (38 mg, 0.456 mmol) and Dess-Martin periodinane (19.0 mg, 
0.046 mmol) at room temperature under nitrogen and stirred for 4 hours to reach full 
conversion. Et2O (4.0 mL), saturated aqueous NaHCO3 (2.0 mL), and Na2S2O3 (2.0 mL) 
were added and allowed to stir vigorously for 15 minutes. The layers were separated and 
the aqueous layer was extracted with CH2Cl2 (3 × 5 mL). The organic layers were 
combined, dried over Na2SO4 and concentrated under reduced pressure. The crude 
product was purified by flash chromatography to afford titled aldehyde 2.183 as colorless 
oil (18 mg, 92% yield). Rf = 0.48 (ethylacetate:hexanes=1:3, stain in KMnO4). 
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 (3Z,5S,6S,7R,9S,11Z,13S,14R,15R)-14-((tert-
Butyldimethylsilyl)oxy)-5,7,9,11,13,15-
hexamethyl-8,16-dioxohexadeca-1,3,11-trien-6-yl 
carbamate. (Scheme 2.33, 2.183). 
1
H NMR (500 MHz, CDCl3): δ 9.62 (1H, d, J = 1.5 
Hz), 6.49 (1H, dt, J = 16.5, 10.5 Hz), 6.06 (1H, t, J = 11.5 Hz), 5.42 (1H, t, J = 10.5 Hz), 
5.21 (1H, dd, J = 17.0, 1.0 Hz), 5.11 (1H, dd, J = 16.0, 10.0 Hz), 4.92 (1H, d, J = 10.5 
Hz), 4.58 (2H, br, s), 3.75-3.73 (2H, m), 2.96 (1H, qd, J = 7.0, 7.0 Hz), 2.92-2.89 (1H, 
m), 2.79 (1H, dqd, J = 7.5, 7.5, 4.0 Hz), 2.59 (1H, dqd, J = 10.5, 7.0 Hz), 2.52-2.47 (1H, 
m), 2.26 (1H, dd, J = 13.5, 11.0 Hz), 1.97 (1H, dd, J = 11.0, 3.0 Hz), 1.59 (3H, s), 1.14 
(3H, d, J = 7.0 Hz), 1.08 (3H, d, J = 6.5 Hz), 1.04 (3H, d, J = 6.5 Hz), 0.96 (3H, d, J = 
6.5 Hz), 0.95 (3H, d, J = 6.5 Hz), 0.90 (9H, s), 0.08 (3H, s), 0.06 (3H, s); 
13
C NMR (100 
MHz, CDCl3): δ 214.7, 203.6, 156.7, 133.6, 132.7, 132.1, 131.6, 131.0, 130.7, 118.7, 
78.6, 77.6, 51.9, 47.1, 36.6, 34.8, 34.4, 26.1, 23.1, 18.4, 18.2, 17.0, 15.7, 12.6, 10.3, −3.9, 
−4.0; IR (neat): 2960 (m), 2929 (m), 2856 (m), 1711 (s), 1598 (w), 1459 (m), 1360 (m), 
1322 (m), 1253 (m), 1037 (s), 1002 (s), 08 (m), 836 (s), 774 (s), 732 (m), 670 (m); 
HRMS-(ESI+) for C29H51NO5NaSi [M+Na]
+
: calculated: 544.3434, found: 544.3438. 
[α]D
21
 = +15.598 (c = 0.20, CHCl3, l = 50 mm). 
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VII. Still-Gennari Olefination and End Game 
 
 
NaH (1.2 mg, 0.051 mmol) was suspended in dry THF (1.0 mL) in a flame dried 
10-dram vial with septa in glove box. The vial was brought out of box and cooled to −10 
oC. A THF (2.0 mL) solution of β-keto-phosphonate 2.110 (28.0 mg, 0.054 mmol) that 
was freshly purified via silica gel chromatography and azeotropically dried with benzene 
was cannula transferred to the vial dropwise at −10 oC. Such mixture was allowed to stir 
another 40 min at −10 oC resulted a light yellow and homogeneous solution. Then the 
vial was cooled to −20 oC. A THF (1.0 mL) solution of aldehyde 2.183 (14.0 mg, 0.027 
mmol) that was freshly purified via silica gel chromatography and azeotropically dried 
with benzene was added to the light yellow solution at −20 oC dropwise, and the reaction 
mixture was allowed to warm to room temperature slowly and stirred for another 24 h 
until TLC showed full consumption of aldehyde. The reaction was quenched with 
aqueous NH4Cl and layers were separated. The aqueous phase was extracted with 
ethylacetate (3 × 15 mL). The organic layers were combined and dried over Na2SO4, 
concentrated under reduced pressure. The Z:E ratio was determined by 
1
H NMR as being 
4.3:1. The residue was purified by flash chromatography to afford pure (Z)-olefin as a 
colorless oil (18.6 mg, 63%). Rf = 0.31 (ethylacetate:hexanes=1:3, stain in KMnO4). For 
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(E)-isomer, Rf = 0.23 (ethylacetate:hexanes=1:3, stain in KMnO4). These two isomers 
were easily separated through silica gel chromatography.  
 
Methyl-(R)-2-((4S,5S,6S)-6-
((3Z,5S,6S,7S,8Z,11S,13R,14S,15S,
16Z)-6-((tert-
butyldimethylsilyl)oxy)-14-(carbamoyloxy)-5,7,9,11,13,15-hexamethyl-2,12-
dioxononadeca-3,8,16,18-tetraen-1-yl)-2,2,5-trimethyl-1,3-dioxan-4-yl)propanoate 
(Scheme 2.33, 2.184). 
1
H NMR (500 MHz, CDCl3): δ 6.50 (1H, dt, J = 16.5, 11.0 Hz), 
6.23 (1H, dd, J = 11.5, 9.5 Hz), 6.12 (1H, d, J = 11.5 Hz), 6.05 (1H, t, J = 10.5 Hz), 5.41 
(1H, t, J = 11.0 Hz), 5.21 (1H, d, J = 17.0 Hz), 5.11 (1H, d, J = 10.0 Hz), 5.07 (1H, t, J = 
6.5 Hz), 4.96 (1H, d, J = 10. Hz), 4.61 (2H, br, s), 4.13-4.07 (2H, m), 3.68 (3H, s), 3.61 
(1H, t, J = 7.0 Hz), 3.39 (1H, dd, J = 7.0, 3.0 Hz), 2.95 (1H, qd, J = 6.0, 6.0 Hz), 2.88 
(1H, dqd, J = 10.5, 6.0, 6.0 Hz), 2.79-2.72 (1H, m), 2.70-2.65 (2H, m), 2.56 (1H, dd, J = 
16.0, 7.5 Hz), 2.37 (1H, dqd, J = 10.0, 7.0, 7.0 Hz), 2.25 (1H, t, J = 11.5 Hz), 1.85 (1H, 
d, J = 11.5 Hz), 1.60-1.57 (1H, m), 1.57 (3H, s), 1.45-1.41 (1H, m), 1.41 (3H, s), 1.30-
1.25 (2H, m), 1.27 (3H, s), 1.12 (3H, d, J = 6.5 Hz), 1.15 (3H, d, J = 7.0 Hz), 1.03 (3H, 
d, J = 7.0 Hz), 0.99 (3H, d, J = 7.0 Hz), 0.93 (3H, d, J = 7.5 Hz), 0.92 (9H, s), 0.88 (3H, 
d, J = 7.0 Hz), 0.76 (3H, d, J = 7.0 Hz), 0.08 (3H, s); 
13
C NMR (100 MHz, CDCl3): δ 
215.0, 199.0, 175.1, 156.5, 151.5, 132.9, 132.2, 132.1, 131.3, 130.7, 128.6, 125.8, 118.5, 
98.5, 80.6, 77.5, 74.8, 71.6, 51.9, 48.7, 46.8, 42.6, 41.0, 37.8, 37.7, 36.2, 34.9, 34.1, 30.0, 
26.4, 26.3, 23.1, 19.5, 18.7, 18.1, 15.8, 12.1, 12.0, 8.8, −3.4, −3.5; IR (neat): 2964 (m), 
2930 (m), 2856 (w), 1734 (s), 1459 (m), 1360 (m), 1321 (m), 1257 (m), 1207 (m), 1038 
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(m), 836 (w), 798 (w); HRMS-(ESI+) for C43H73NO9NaSi [M+Na]
+
: calculated: 
798.4952, found: 798.4952. [α]D
21
 = +53.858 (c = 0.22, CHCl3, l = 50 mm). 
 
Procedure for Sequential Reduction of bis-Ketone 
 
Following literature procedure
18d,100Error! Bookmark not defined. 
with slightly 
modification, bis-ketone 2.184 (7.0 mg, 10 µmol) was dissolved in toluene (1.0 mL) and 
cooled to −78oC under nitrogen. K-Selectride® (1M in THF, 20 µL, 20 µmol) was added 
dropwise, and the reaction mixture was stirred for 3 h at −78oC. The mixture was 
quenched with water (2 mL) and THF (2.0 mL). Sodium perborate (20 mg, 0.2 mmol) 
was added. The mixture was stirred vigorously at room temperature for 1h. The layers 
were separated and the aqueous phase was extracted with ethyl acetate (3 × 10 mL). 
Combined organic layers were dried over NaSO4 and concentrated. The residue was 
passed through a plug of silica gel with ethyl acetate and used for next step without 
further purification. Rf = 0.63 (ethyl acetate: hexane=1:1).  
Following literature procedure
18d
 with slightly modification, the alcohol SI-11 
was dissolved in dry THF (1.0 mL) and cooled to 0 
o
C in a 20-dram vial. Li(Ot-Bu)3AlH 
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(1M in THF, 50 µL, 50 µmol) was added dropwise at 0 
o
C and the mixture was allowed 
to warm to room temperature slowly and stirred for additional 2 h. Aqueous NH4Cl (0.3 
mL) was added to quench reaction and stirred for 2 h at room temperature. A spatula of 
MgSO4 was added to the vial to remove water. The residue was directly loaded on the top 
of a plug of silica gel and flashed with ethyl acetate, and concentrated under reduced 
pressure. The crude diol SI-12 was used for next step without further purification. Rf = 
0.41 (ethyl acetate:hexane=1:1). 
The diol SI-12 was dissolve in MeOH (1.0 mL) in 20 dram vial and cooled to 0 
o
C. 3 M aqueous HCl (0.5 mL) was added dropwise and the mixture was allowed to 
warm to room temperature and stir for 24 h until TLC showed full conversion of starting 
material. Aqueous NaHCO3 was added carefully until bubbling ceased. The layers were 
separated and the aqueous phase was extracted with ethyl acetate (5 × 5 mL), combined 
organic layers were dried over NaSO4 and concentrated. The residue was purified 
through silica gel (MeOH: CH2Cl2=1:20 to 1:10) to afford (+)-discodermolide 2.1 as 
white solid (4.5 mg, 76% over three steps). 
 
(+)-Discodermolide (2.1). All spectrum 
data are in accordance with literature 
reports. 
1
H NMR (500 MHz, CDCl3): δ 
6.62 (1H, dt, J = 16.5, 10.0 Hz), 6.04 (1H, 
t, J = 11.0 Hz), 5.53 (1H, dd, J = 11.5, 8.0 Hz), 5.43 (1H, dd, J = 10.5, 10.5 Hz), 5.36 (1H, 
dd, J = 11.0, 11.0 Hz), 5.22 (1H, d, J = 17.0 Hz), 5.18 (1H, d, 15.5 Hz), 5.12 (1H, d, J = 
10.0 Hz), 4.75 (1H, ddd, J = 7.5, 7.5, 2.5 Hz), 4.71 (1H, dd, J =7.5, 4.5 Hz), 4.62 (1H, 
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ddd, J = 10.5, 10.5 Hz), 4.61 (2H, br, s), 3.75 (1H, d, J = 3.5 Hz), 3.29 (1H, dd, J = 4.5, 
4.5 Hz), 3.20 (1H, dd, 7.0, 5.0 Hz), 3.00 (1H, ddq, J = 10.0, 7.0, 7.0 Hz), 2.80 (1H, ddq, J 
= 10.0, 7.0, 7.0 Hz), 2.68 (1H, dq, J = 1H, dq, J = 7.5, 4.5 Hz), 2.62-2.58 (1H, m), 2.02-
1.80 (10H, m), 1.74-1.67 (1H, m), 1.65 (3H, s), 1.32 (3H, d, J = 7.5 Hz), 1.08 (3H, d, J = 
7.0 Hz), 1.02 (3H, d, J = 6.0 Hz), 1.00 (3H, d, J = 6.0 Hz), 0.95 (3H, d, J = 6.5 Hz), 0.83 
(3H, d, J = 6.0 Hz); 
13
C NMR (100 MHz, CDCl3): δ 173.9, 157.3, 134.6, 133.9, 133.7, 
133.1, 132.4, 130.1, 129.9, 118.2, 79.2, 79.1, 77.4, 75.9, 73.4, 64.6, 43.3, 41.2, 37.6, 36.3, 
36.2, 36.0, 35.5, 35.0, 33.3, 23.5, 18.6, 17.7, 15.9, 15.8, 13.9, 12.8, 9.2; HRMS-(ESI+) 
for C33H55NO8Na [M+Na]
+
: calculated: 616.3825, found: 616.3527. [α]D
21
 = +6.794 (c = 
0.20, MeOH, l = 50 mm), literature
5
: [α]D
21
 = +7.2 (c = 0.72, MeOH). 
 
VIII. Synthesis of Oxidation Resistant Analog 
 
Preparation of Silicon Substituted Enyne 
 
 Pd(PPh3)4 (96 mg, 0.083 mmol) and vinyl bromide 2.188 (1.0 g, 4.15 mmol) was 
added to a flame dried round bottom flask with stir bar. Then a THF solution of propynyl 
magnesium bromide (0.5 M, 16.7 mL, 8.3 mmol) was added to the flask under N2 slowly 
at room temperature result a clear solution, which was allowed to stir overnight. The 
reaction was carefully quenched with NH4Cl (a.q.). The layers were separated and the 
aqueous layer was extracted with Et2O (3 × 15 mL). The organic layers were combined, 
dried over Na2SO4 and concentrated under reduced pressure. The crude product was 
purified by flash chromatography to afford 2.189 as colorless oil (750 mg, 90% yield). Rf 
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= 0.18 (hexanes, stain in KMnO4). 
 
Dimethyl(pent-1-en-3-yn-2-yl)(phenyl)silane (Scheme 2.34, 
2.189). 
1
H NMR (500 MHz, CDCl3): δ 7.57-7.56 (2H, m), 7.36 
(3H, m), 6.09 (1H, d, J = 3.0 Hz), 5.60 (1H, d, J = 2.5 Hz), 1.97 (3H, s), 0.43 (6H, s), 
0.33 (3H, s); 
13
C NMR (125 MHz, CDCl3): δ 134.8, 134.2, 133.2, 129.5, 128.0, 127.9, 
81.1, 4.7, 1.1, −3.2. 
 
Preparation of Silicon Substituted Chiral Dienol 
 
Preparation of EtZnONf: To a flame-dried 25 mL Schlenk flask equipped with 
magnetic stir bar and septum was added Et2Zn (0.9 mL, 1.8 mmol, 2 M in CH2Cl2). The 
solution was cooled to –78 °C in a dry ice/acetone bath, and nonafluorobutane-1-sulfonic 
acid (0.23 mL, 1.5 mmol) was added dropwise. The reaction was allowed to stir at –78 
°C for 5 min and was allowed to warm to room temperature and stirred for 1 h resulting 
white slurry. 
HBCy2 (213 mg, 1.2 mmol) and CH2Cl2 (1.2 mL) was added to a flame dried 100 
mL two-neck round bottom flask in glove box. The flask was cooled to 0 °C, and 2-
methylpent-1-en-3-yne 2.189 (241 mg, 1.2 mmol) was added dropwise. The reaction 
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mixture was allowed to stir at 0 °C for 5 min and then stirred at room temperature for 20 
min providing a clear solution. Benzaldehyde (10 mg, 0.12 mmol) was added dropwise at 
room temperature and stirred for another 30 min. The flask was capped and brought out 
of glove box and cooled to –78 °C. Et2Zn (0.6 mL, 2.0 M in toluene) was added dropwise 
and stirred at –78 °C for 30 min. EtZnONf slurry was cannula transferred to the flask at –
78 °C in one portion, and the flask was transferred to a cooling bath at –20 °C. A toluene 
solution (8.0 mL) of the β-silyloxy aldehyde 2.128 (204 mg, 2.0 mmol) was added 
dropwise. The reaction was allowed to stir at –20 °C overnight. The reaction was 
quenched with a saturated solution of NH4Cl (15 mL) and extracted with diethyl ether (3 
× 20 mL). The combined organic layers were washed with brine, dried over Na2SO4, and 
filtered. The crude products were concentrated in vacuo and purified by flash 
chromatography on silica gel (diethyl ether:hexanes 1:10) to afford 2.191-OH as a 
colorless oil (160 mg, 49%). Rf = 0.19 (diethyl ether:hexanes=1:20, stain in KMnO4). 
 
 (2S,3S,E)-1-((tert-Butyldimethylsilyl)oxy)-6-
(dimethyl(phenyl)silyl)-2,4-dimethylhepta-4,6-dien-3-ol 
(Scheme 2.34, 2.191-OH). 
1
H NMR (500 MHz, CDCl3): δ 7.52-7.50 (2H, m), 7.35-7.33 
(3H, m), 6.00 (1H, s), 5.67 (1H, dd, J = 3.5 Hz, 2.0 Hz), 5.56 (1H, t, J = 3.5 Hz), 4.00 
(1H, d, J =2.0 Hz), 3.84 (1H, dd, J = 8.5, 2.5 Hz), 3.76 (1H, dd, J = 9.5, 4.0 Hz), 3.56 (1H, 
dd, J = 10.0, 8.0 Hz), 1.89-1,84 (1H, m), 1.64 (3H, s), 0.90 (9H, s), 0.65 (3H, d, J =7.0 
Hz), 0.37 (3H, s), 0.36 (3H, s), 0.08 (3H, s), 0.07 (3H, s); 
13
C NMR (100 MHz, CDCl3): δ 
148.0, 138.0, 137.0, 134.2, 129.4, 129.2, 128.5, 127.9, 84.2, 77.1, 69.0, 37.6, 26.0, 18.3, 
13.8, 12.4, −3.0, −3.03, −5.3, −5.4; HRMS-(ESI+) for C23H39OSi2 [M+H−H2O]
+
: 
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calculated: 387.2539, found: 387.2557. 
 
Procedure for tert-Butyldimethylsilyl Protection 
 
A flame-dried round-bottom flask containing a magnetic stir bar, under an 
atmosphere of nitrogen, was charged with alcohol 2.191-OH (250.0 mg, 0.62 mmol) in 
CH2Cl2 (3 mL) and 2,6-lutidine (0.14 mL, 1.24 mmol). The reaction flask was cooled to 
−78 °C, and freshly distilled TBSOTf (0.17 mL, 0.74 mmol) was added dropwise. The 
reaction was allowed to stir for 1 h until TLC showed full conversion of starting material, 
and the reaction was quenched with aqueous NaHCO3. The layers were separated, and 
the aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The combined organics were 
dried over Na2SO4, filtered, and concentrated by rotary evaporation. The crude reaction 
mixture was purified by silica gel chromatography (diethyl ether:hexanes=1:20) to afford 
2.191 as a clear, colorless oil (263.0 mg, 82%). Rf = 0.77 (diethyl ether:hexanes = 1:20, 
stain in KMnO4). 
 
 (5S,6S)-5-((E)-4-(Dimethyl(phenyl)silyl)penta-2,4-
dien-2-yl)-2,2,3,3,6,9,9,10,10-nonamethyl-4,8-dioxa-
3,9-disilaundecane. (Scheme 2.34, 2.191). 
1
H NMR (500 MHz, CDCl3): δ 7.52-7.50 (2H, 
m), 7.35-7.33 (3H, m), 5.81 (1H, s), 5.63 (1H, dd, J = 4.0 Hz, 1.5 Hz), 5.54 (1H, dd, J = 
3.5 Hz, 1.0 Hz), 3.73 (1H, d, J = 9.5 Hz), 3.72 (1H, dd, J = 10.0 Hz, 7.0 Hz), 3.46 (1H, 
dd, J = 10.0, 7.0 Hz), 1.76-1.70 (1H, m), 0.89 (9H, s), 0.85 (9H, s), 0.70 (3H, d, J = 7.0 
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Hz), 0.37 (3H, s), 0.36 (3H, s), 0.03 (9H, s), −0.01 (3H, s), −0.08 (3H, s); 13C NMR (100 
MHz, CDCl3): δ148.0, 138.0, 137.6, 134.2, 129.2, 128.7, 128.4, 128.0, 80.6, 65.3, 40.1, 
26.2, 26.1, 18.6, 18.4, 14.1, 12.2, −2.9, −3.0, −4.2, −5.0, −5.1, −5.2. 
 
Procedure of Ni-Catalyzed Hydroboration 
In dry-box, an oven-dried 6-dram vial containing a magnetic stir bar was charged 
successively with Ni(cod)2 (1.9 mg, 6.8 µmol), PCy3 (1.9 mg, 6.8 µmol), THF (0.7 mL), 
and diene 2.191 (60 mg, 0.12 mmol). The vial was placed in the freezer in glove box for 
10 min, and pinacolborane (52 mg, 0.41 mmol, 3.0 equivalents) was added while the vial 
was cold. The vial was sealed with a polypropylene cap, removed from the dry-box, and 
allowed warming to 40
o
C and stir overnight. The reaction mixture cooled to 0 °C and 
charged with 1.0 mL pH=7 buffer and 0.5 mL 30% w/w H2O2. The reaction was 
gradually warmed to room temperature and allowed to stir for 12 h, at which time the vial 
was cooled to 0 °C (ice/water) and saturated aqueous sodium thiosulfate was added 
dropwise. The reaction mixture was diluted with ethyl acetate and the layers were 
separated. The aqueous layer was extracted with ethyl acetate (3 × 15 mL) and the 
combined organic layers were dried over Na2SO4, filtered, and concentrated by rotary 
evaporation. The crude reaction mixture was purified by silica gel chromatography 
(diethyl ether:hexanes = 1: 10) to afford 2.192 as a clear, colorless oil (32 mg, 50%, 
>10:1 dr). Rf = 0.41 (hexanes:diethyl ether = 10:1, stain in KMnO4). 
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 (4S,5R,6S,E)-5,7-Bis((tert-butyldimethylsilyl)oxy)-2-
(dimethyl(phenyl)silyl)-4,6-dimethylhept-2-en-1-ol 
(Scheme 2.34, 2.192). 
1
H NMR (500 MHz, CDCl3): δ 7.54-7.52 (2H, m), 7.35-7.33 (3H, 
m), 5.84 (1H, d, J = 9.5 Hz), 4.32 (1H, dd, J = 12.5 Hz, 5.0 Hz), 4.21 (1H, dd, J = 12.5 
Hz, 7.0 Hz), 3.69 (1H, dd, J = 10.5 Hz, 6.5 Hz), 3.53 (1H, dd, J = 5.0 Hz), 3.40 (1H, dd, J 
= 10.0 Hz, 7.0 Hz), 2.90-2.86 (1H, m), 1.88-1.83 (1H, m), 0.97 (3H, d, J = 7.0 Hz), 0.90 
(9H, s), 0.89 (9H, s), 0.41 (3H, s), 0.40 (3H, s), 0.06 (3H, s), 0.041 (3H, s), 0.040 (3H, s), 
0.03 (3H, s); 
13
C NMR (125 MHz, CDCl3): δ 148.7, 139.1, 137.8, 134.1, 129.1, 128.0, 
77.5, 65.6, 61.0, 41.3, 36.8, 26.3, 26.2, 18.6, 18.5, 17.3, 14.5, −2.2, −2.3, −3.6, −3.7, −5.0, 
−5.1; IR (neat): 2955 (m), 2929 (m), 2885 (m), 2857 (m), 1472 (w), 1360 (w), 1251 (m), 
1087 (m), 1025 (m), 965 (m), 834 (m), 813 (s), 773 (s), 700 (w); HRMS-(ESI+) for 
C29H57O3Si3 [M+H]
+
: calculated: 537.3616, found: 537.3620. [α]D
21 
= −18.608 (c = 0.96, 
CHCl3, l = 50 mm). 
 
Preparation of δ-Lactone 
 
Vinyl orthoester 2.212 was prepared following literature procedure.
118
 Details for 
asymmetric hydroformylation of 2.212 is included in Chapter 3. 
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An oven-dried 20 mL scintillation vial, equipped with a magnetic stir-bar, was 
charged with Ni(cod)2 (13.8 mg, 0.05 mmol), PBn3 (22.8.mg, 0.075 mmol), and THF (4.0 
mL) in a dry box under an argon atmosphere. After stirring for 5 min, the aldehyde 2.213 
(186 mg, 1.0 mmol), trans-1,3-pentadiene (75 mg, 1.1 mmol) and B2(pin)2 (303 mg, 1.2 
mmol) were added sequentially. The vial was sealed with a polypropylene cap and 
removed from the dry box. The reaction mixture was allowed to stir at ambient 
temperature for 14 h. After this time, the mixture was poured into 100 mL round bottom 
flask with NaBO3 (500 mg, 5 mmol) and water (4.0 mL). The mixture was allowed to stir 
at ambient temperature for 20 h. The resulting mixture was diluted with water and the 
two-phase mixture was extracted with ethyl acetate (3 × 30 mL).  The combined organic 
layers were dried over anhydrous Na2SO4. The drying agent was removed by filtration 
and the solvent was evaporated in vacuo. The residue was passed through a pad of Celite 
with ethylacetate and evaporated in vacuo.  The crude material was re-dissolved in THF 
and added several drops of AcOH, and the mixture was allowed to stir at room 
temperature overnight. The solution was basified with 1.0 M aqueous LiOH and allowed 
to stir at room temperature for 1h; then the solution was acidified with 3.0 M aqueous 
HCl until pH=1.0. The reaction mixture was diluted with ethyl acetate and the layers 
were separated. The aqueous layer was extracted with ethyl acetate (3 × 15 mL) and the 
combined organic layers were dried over Na2SO4, filtered, and concentrated by rotary 
evaporation. The crude reaction mixture was purified by silica gel chromatography (ethyl 
acetate:hexanes = 1: 1) to afford 2.216 contaminated by pinacol. Rf = 0.38 (hexanes:ethyl 
acetate = 1:1, stain in KMnO4). This mixture was used for next step without further 
separation. 
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Procedure for tert-Butyldimethylsilyl Protection 
 
A flame-dried round-bottom flask containing a magnetic stir bar, under an 
atmosphere of nitrogen, was charged with pinacol contaminated alcohol 2.216 (112 mg 
with pinacol) in CH2Cl2 (3 mL) and 2,6-lutidine (4.0 equivalent to lactone 2.216). The 
reaction flask was cooled to −78 °C, and freshly distilled TBSOTf (>2.0 equivalent, 
depending on the ratio of the lactone 2.216 to pinacol determined by 
1
H NMR) was added 
dropwise. The reaction was allowed to stir for 1 h until TLC showed full conversion of 
starting material, and the reaction was quenched with aqueous NaHCO3. The layers were 
separated, and the aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The combined 
organics were dried over Na2SO4, filtered, and concentrated by rotary evaporation. The 
crude reaction mixture was purified by silica gel chromatography (ethyl acetate:hexanes 
= 1:10) to afford 2.217 as white solid (124 mg, 44% over two steps). Rf = 0.39 
(ethylacetate:hexanes = 1:7, stain in KMnO4). 
 
 (3R,4S,5S,6S)-4-((tert-Butyldimethylsilyl)oxy)-3,5-dimethyl-6-
vinyltetrahydro-2H-pyran-2-one (Scheme 2.36, 2.217). 
1
H NMR 
(500 MHz, CDCl3): δ 5.81 (1H, ddd, J = 17.0 Hz, 10.5 Hz, 7.0 Hz), 
5.34 (1H, d, J = 17.0 Hz), 5.29 (1H, d, J =10.0 Hz), 4.71 (1H, dd, J = 7.5 Hz), 3.70 (1H, 
t, J = 2.5 Hz), 2.66 (1H, qd, J = 8.0 Hz, 3.5 Hz), 1.92 (1H, qdd, J = 7.0 Hz, 7.0 Hz, 2.0 
Hz,), 1.28 (3H, d, J = 8.0 Hz), 0.99 (3H, d, J = 8.0 Hz), 0.90 (9H, s), 0.08 (3H, s), 0.07 
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(3H, s); 
13
C NMR (100 MHz, CDCl3): δ 173.9, 135.5, 118.9, 82.2, 74.0, 44.0, 34.6, 25.9, 
18.2, 16.5, 13.5, −4.3, −4.6; IR (neat): 2978 (w), 2928 (w), 2855 (w), 1725 (s), 1383 (w), 
1224 (m), 1104 (m), 1033 (s), 1024 (s), 927 (w), 837 (s), 779 (m); HRMS-(ESI+) for 
C15H29O3Si [M+H]
+
: calculated: 285.1886, found: 285.1890. [α]D
21 
= −18.731 (c = 1.0, 
CHCl3, l = 50 mm). 
 
Procedure for Hydroboration of Terminal Olefin
51
 
 
A flame dried 20-dram vial was charged with [Ir(cod)Cl]2 (1.4 mg, 2.1 µmol) and 
dppm (1.6 mg, 4.2 µmol), CH2Cl2 (0.4 mL), pinacolborane (20 mg, 0.16 mmol), and 
alkene 2.217 (50 mg, 0.14 mmol) were added successively at room temperature in glove 
box.. The flask was sealed and brought out of box and was allowed to stir at room 
temperature overnight. The reaction mixture was concentrated under reduced pressure. 
THF (1.0 mL), water (1.0 mL) and NaBO3 (70 mg) were added to the residue and was 
stirred for 10 h at room temperature. The resulting mixture was diluted with water and the 
two-phase mixture was extracted with ethyl acetate (3 × 15 mL).  The combined organic 
layers were dried over anhydrous Na2SO4. The drying agent was removed by filtration 
and the solvent was evaporated in vacuo. The residue was purified by silica gel 
chromatography to afford the titled compound 2.220 as colorless oil (36 mg, 85%) Rf = 
0.44 (ethyl acetate:hexanes=1:1, stain in KMnO4). 
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 (3R,4S,5S,6S)-4-((tert-Butyldimethylsilyl)oxy)-6-(2-
hydroxyethyl)-3,5-dimethyltetrahydro-2H-pyran-2-one 
(Scheme 2.36, 2.220). All spectrum data are in accordance with 
literature.
100
 
 
Procedure for Aldol Condensation
120
 
 
 n-BuLi solution (2.5 M in hexane, 0.44 mL, 1.1 mmol) was added dropwise to a 
dry THF (2.0 mL) solution of HN(SiPhMe2)2 (314 mg, 1.1 mmol) at 0 
o
C under N2 and 
allowed to stir at that temperature for 30 min. The homogeneous solution was cooled to 
−78 oC followed by addition of 3-pentanone (104 µL, 1.0 mmol) slowly. The light yellow 
solution was allowed to stir at −78 oC for 1h, then a dry THF (2.0 mL) solution of 
aldehyde 2.100 (248 mg, 1.2 mmol) was added slowly via syringe along the flask inner 
wall. After stirring at −78 oC for 2h, the reaction was quenched with NH4Cl aqueous 
solution. The resulting mixture was diluted with water and the two-phase mixture was 
extracted with ethyl acetate (3 × 15 mL).  The combined organic layers were dried over 
anhydrous Na2SO4, filtered and the solvent was evaporated in vacuo. The residue was 
purified by silica gel chromatography to afford the titled compound 2.222 as colorless oil 
(300 mg, >95% yield). Rf = 0.34 (ethyl acetate:hexanes=1:4, stain in KMnO4). 
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 (4R,5S,6R)-6-(1,5-Dihydrobenzo[e][1,3]dioxepin-3-yl)-5-
hydroxy-4-methylheptan-3-one (Scheme 2.37, 2.222). 
1
H 
NMR (500 MHz, CDCl3): δ 7.25-7.18 (4H, m), 5.07 (1H, d, J 
= 3.5 Hz), 4.97 (1H, d, J = 14.0 Hz), 4.92 (1H, d, J = 14.0 Hz), 4.851 (1H, d, J =14.0 Hz), 
4.848 (1H, d, J = 14.0 Hz), 4.01 (1H, ddd, J = 9.0 Hz, 3.0 Hz, 3.0 Hz), 3.47 (1H, d, J = 
2.5 Hz), 2.65 (1H, qd, J = 7.0, 3.0 Hz), 2.54 (2H, q, J = 7.0 Hz), 1.98-1.94 (1H, m), 1.12 
(3H, d, J = 7.0 Hz), 1.05 (3H, t, J =7.5 Hz), 0.94 (3H, d, J = 7.5 Hz); 
13
C NMR (125 
MHz, CDCl3): δ 215.6, 139.6, 139.5, 128.0, 127.9, 111.7, 73.9, 73.6, 48.0, 40.9, 34.4, 
11.6, 9.3, 7.9; IR (neat): 3502 (b), 2976 (m), 2904 (m), 2850 (w), 1707 (s), 1456 (m), 
1375 (m), 1301 (w), 1261 (w), 1106 (s), 1029 (s), 975 (m), 921 (w), 773 (w), 739 (w); 
HRMS-(ESI+) for C17H25O4 [M+H]
+
: calculated: 293.1753, found: 293.1743. [α]D
21 
= 
−11.474 (c = 1.0, CHCl3, l = 50 mm). 
 
Procedure for TMS-Protection 
 
TMSCl (128 µL, 1.02 mmol) was added dropwise to a dry CH2Cl2 solution of 
alcohol 2.222 (270 mg, 0.92 mmol) and imidazole (125 mg, 1.84 mmol) at room 
temperature. Once TLC showed full conversion of starting material (usually < 20 min), 
the reaction was quenched with NaHCO3 aqueous solution. The resulting mixture was 
diluted with water and the two-phase mixture was extracted with ethyl acetate (3 × 15 
mL).  The combined organic layers were dried over anhydrous Na2SO4, filtered and the 
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solvent was evaporated in vacuo. The residue was purified by triethylamine neutralized 
silica gel chromatography to afford the titled compound 2.223 as colorless oil (289 mg, 
86% yield). Rf = 0.50 (ethyl acetate:hexanes=1:10, stain in KMnO4). 
 
 (4R,5S,6R)-6-(1,5-Dihydrobenzo[e][1,3]dioxepin-3-yl)-4-
methyl-5-((trimethylsilyl)oxy)heptan-3-one (Scheme 2.37, 
2.223). 
1
H NMR (500 MHz, CDCl3): δ 7.24-7.18 (4H, m), 
4.93 (1H, d, J = 4.5 Hz), 4.84-4.81 (4H, m), 4.12 (1H, dd, J = 6.5 Hz, 5.0 Hz), 2.97 (1H, 
qd, J = 7.0 Hz, 5.0 Hz), 2.51 (2H, dq, J = 13.5 Hz, 7.5 Hz), 1.93 (1H, qdd, J = 7.0 Hz, 7.0 
Hz, 5.0 Hz), 1.09 (3H, d, J = 7.0 Hz), 1.03 (3H, t, J = 7.0 Hz), 0.93 (3H, d, J = 7.5 Hz), 
0.14 (9H, s); 
13
C NMR (100 MHz, CDCl3): δ 214.1, 139.9, 139.7, 127.8, 127.7, 109.4, 
74.8, 73.3, 72.7, 49.2, 42.8, 34.9, 12.1, 11.7, 7.9, 0.93; IR (neat): 2955 (m), 2891 (w), 
2842 (w), 1712 (s), 1455 (w), 1374 (w), 1250 (s), 1121 (s), 1099 (s), 1043 (s), 973 (w), 
890 (m), 950 (m), 840 (s), 740 (m); HRMS-(ESI+) for C20H33O4Si [M+H]
+
: calculated: 
365.2148, found: 365.2154. [α]D
21 
= −39.099 (c = 0.52, CHCl3, l = 50 mm). 
 
2.7. Unpublished Spectrums 
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Chapter 3 
Asymmetric Hydroformylation of Terminal Olefins 
with Readily Available Ligand
1 
3.1 Introduction 
 Discovered by Roelen in 1938,
2
 rhodium catalyzed hydroformylation of alkenes 
has become one of the largest industrial processes producing billions of pounds of achiral 
aldehydes per year. It is preeminent in catalytic manufacturing is due to its perfect atom 
economy, fast reaction rates, high turn-over numbers, and mild conditions as well as the 
versatility of aldehyde products.
3
 Hydroformylation of a terminal alkene gives two 
distinct products, a linear achiral aldehyde 3.1 and a branched constitutional isomer 3.2 
(Scheme 3.1). Though many advances have been made to produce the linear aldehyde 3.1, 
selective construction of branched aldehyde 3.2 still remains underdeveloped, especially 
in a catalytic asymmetric fashion. The branched, optically pure aldehydes 3.2 are 
important building blocks for organic syntheses, and their one-step syntheses via the 
asymmetric hydroformylation (AHF) from inexpensive feedstocks (olefin, syngas) would 
be extremely attractive and valuable. Thus, it is of great importance to solve the 
challenges in controlling regio- and enantioselectivity of hydroformylation of simple 
alkenes.  
                                                     
1
 Yu, Z.; Eno, M. S.; Annis, H. A.; Morken, J. P. manuscript in preparation. 
2
 Roelen, O. Chem. Abstr. 1944, 38, 550. 
3
 Rhodium Catalyzed Hydroformylation; Claver, C., van Leeuwen, P. W. N. M., Eds.; Kluwer 
Academic Publishers: Dordrecht, The Netherlands, 2000. 
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Scheme 3.1. Hydroformylation of Terminal Olefins 
 
3.2 Background 
As mentioned above, it is important to control regioselectivity for asymmetric 
hydroformylation, because undesired linear isomer could be regarded as an “impurity” 
which has very similar chemical and physical properties making purification a 
challenging task. The widely accepted dissociative mechanism can explain the origin of 
regioselectivity (Figure 3.1).
4
 Coordination of the alkene to open site of complex b 
furnishes hydrido olefin complex c. The subsequent migratory insertion of Rh-H bond 
(III) can occur in two ways providing isomeric complexes d and d’. This is the 
regioselectivity determining step, having more stable complex d results higher ratio for 
branched aldehyde 3.2, and vice versa. Subsequent CO coordination (IV) and migratory 
insertion (V) give acyl complexed f and f’. Oxidative addition of molecular hydrogen (VI) 
followed by reductive elimination (VII) regenerates the active rhodium catalyst b after 
liberating aldehyde 3.2 and 3.1. Thus, the regioselectivity is determined, in part, by 
intrinsic substrate preference to avoid steric interactions and create a more stable 
intermediate d or d’. Alkenes with different substitution patterns will be discussed under 
different context. 
 
 
                                                     
4
 (a) Torrent, M.; Solà, M.; Frenking, G. Chem. Rev. 2000, 100, 439. (b) Nozaki, K.; Ojima, I. In 
Catalytic Asymmetric Synthesis; 2nd ed.; Ojima, I., Ed.; Wiley-VCH: New York, 2000, p 429. 
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Figure 3.1. Rhodium-Catalyzed Hydroformylation of Alkenes 
 
3.2.1. Hydroformylation of 1,1-Disubstituted and Trisubstituted Alkenes 
1,1-Disubstituted and trisubstituted alkenes generally only provide one 
regioisomeric product based on Keulemans’ rule:5 the formyl group is attached such to 
avoid the formation of a quaternary carbon (Scheme 3.2a and Scheme 3.2b). In other 
words, only complex d’ would be formed to avoid severe steric interacetion (Figure 3.1). 
However, a scaffold ligand, pioneered by Tan and co-workers, completely turned over 
such intrinsic preference, and successfully built all carbon-quaternary center via 
hydrofromylation of 1,1-disubstituted alkenes (Scheme 3.2c).
6
 Furthermore, 
nonsymmetrical 1,2-disubstituted alkenes are also challenging substrates, and their 
                                                     
5
 Keulemans, A. I. M.; Kwantes, A.; van Bavel, T. Recl. Trav. Chim. Pays-Bas 1948, 67, 298. 
6
 (a) Sun, X.; Frimpong, K.; Tan, K. L. J. Am. Chem. Soc. 2010, 132, 11841. (b) Tan, K. L.; Sun, 
X.; Worthy, A. D. Synlett, 2012, 23, 321. 
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regioselective hydroformylation remains unsolved (Scheme 3.2d). While the use of 
directing groups to control hydroformylation regioselectivity is a proven strategy,
7
 these 
examples will not be covered here. 
Scheme 3.2. Hydroformylation of 1,1-Disubstituted and Trisubstituted Alkenes 
 
3.2.2. Hydroformylation of Styrene Derivatives and Vinyl Ethers 
Styrene derivatives preferentially form the branched regioisomer 3.4 due to the 
formation of stable π-benzyl intermediate 3.38 representing compex d (Figure 3.1) after 
alkene hydrometalation (III). 
Scheme 3.3. Hydroformylation of Styrene Derivatives 
 
                                                     
7
 Rousseau, G.; Breit, B. Angew. Chem. Int. Ed. 2011, 50, 2450. 
8
 (a) Tanaka, M.; Watanabe, Y.; Mitsudo, T.; Takegami, Y. Bull. Chem. Soc. Jpn 1974, 74, 1698. 
(b) O’Connor, C. J. Inorg. Nucl. Chem. 1970, 32, 2299. 
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Thus, styrene derivatives are the most studied substrates for asymmetric 
hydroformylation due to their inherent preference for branched isomer. The initial 
success of rhodium catalyzed asymmetric hydroformylation of styrene was from Union 
Carbide using a bis-phosphite ligand, (2R, 4R)-chiraphite 3.5.
9
 Good enantioselectivity 
(90% e.e.) was obtained with this ligand but only when the reaction was carried out near 
room temperature with a 2.5:1 ligand/metal ratio. Further studies from van Leeuwen and 
co-workers demonstrated that different length of the diolate bridge and substitution on the 
bridge (Scheme 3.4, ligand 3.6, 3.7 and 3.8) caused significant decrease in 
enantioselectivity.
10
  
Scheme 3.4. Asymmetric Hydroformylation of Styrene with Chiraphite Ligands 
 
The major break-through for rhodium-catalyzed asymmetric hydroformylation 
was made using a phosphine-phosphite ligand, binaphos 3.9, synthesized by Tanaka and 
                                                     
9
 (a) Babin, J. E.; Whiteker, G. T. Asymmetric Synthesis, World Patent, WO 9303839, 1993. (b) 
Whiteker, G. T.; Briggs, J. R.; Babin, J. E.; Barne, B. A. Asymmetric Catalysis Using 
Bisphosphite Ligands. In Chemical Industries; Marcel Dekker, Inc.: New York, 2003; Vol. 89, pp 
359. 
10
 (a) Buisman, G. J. H.; Vos, E. J.; Kamer, P. C. J.; van Leeuwen, P. W. N. M. J. Chem. Soc. 
Dalton Trans.1995, 409. (b) Buisman, G. J. H.; van der Veen, L. A.; Klootwijk, A.; de Lange, W. 
G. J.; Kamer, P. C. J.; van Leeuwen, P. W. N. M.; Vogt, D. Organometallics. 1997, 16, 2929. 
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Nozaki.
11
 Hydroformylation using binaphos 3.9 gave excellent enantioselectivity for both 
styrene derivatives and vinylacetate (Scheme 3.5); however, regioselectivities were 
typically lower compared to the chiraphite promoted reactions. The NMR studies showed 
that rhodium complex existed as a defined single species (3.10) where phosphine 
occupies an equatorial position and the phosphite an apical position that is trans to the 
hydride. The formation of this single reactive rhodium species 3.10 was the key to induce 
highly enantioselective hydroformylation. 
Scheme 3.5. Asymmetric Hydroformylation of Alkenes with Binaphos 
 
Since the discovery of chiraphite 3.5 and binaphos 3.9, a number of effective 
chiral ligands have been developed for asymmetric hydrofromylation of styrene 
derivatives and vinylacetates (Figure 3.2). They have been thoroughly discussed in 
                                                     
11
 (a) Nozaki, K.; Sakai, N.; Nanno, T.; Higashijima, T.; Mano, S.; Horiuchi, T.; Takaya, H. J. Am. 
Chem. Soc. 1997, 119, 4413. (b) Diéguez, M.; Pàmies, O.; Claver, C. Tetrahedron: Asymmetry 
2004, 15, 2113. 
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several reviews and book chapters.
12
 However, asymmetric hydroformylation of 
monoalkyl-substituted alkenes still remains a challenging task, not only because of the 
difficulties in controlling regioselectivity in the absence of stabilized intermediate 
complex d (Figure 3.1) but also in controlling enantioselectivity due to the similar sizes 
of vinyl substitutions (Scheme 3.6, alkyl to H vs. Ph to H). Binaphos 3.9 might be the 
very first ligand used for asymmetric hydroformylation of monoalkyl-substituted alkenes 
(1-hexene, Scheme 3.5), and gave the corresponding branched aldehyde, 2-
methylhexanal, with good enantiomeric excess as the minor regioisomer (only 1:3 
branch:linear). Thus, it is of great importance to find a more effective ligand for this 
valuable transformation. 
Figure 3.2. Selected Chiral Ligands for Asymmetric Hydroformylation of Styrenes 
 
                                                     
12
 For book chapters, see: (a) Nozaki, K.; Ojima, I. In Catalytic Asymmetric Synthesis; 2
nd
 ed.; 
Ojima, I., Ed.; Wiley-VCH: New York, 2000, p 429. (b) Eilbracht, P. In Houben-Weyl; 4th ed., 
Vol. E21c. Helmchen, G.; Hoffmann, R. W.; Mulzer, J.; Schaumann, E., Eds; Thieme: Stuttgart, 
1995; p 2488. For journal reviews, see: (c) Agbossou, F.; Carpentier, J. F.; Mortreux, A. Chem. 
Rev. 1995, 95, 2485. (d) Gladiali, S.; Bayon, J. C.; Claver, C. Tetrahedron: Asymmetry 1995, 6, 
1453. (e) Breit, B.; Seiche, W. Synthesis, 2001, 1. and reference therein. 
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3.2.3. Asymmetric Hydroformylation of Alkyl-substituted 1-Alkenes 
In the planning stage of total synthesis of (+)-discodermolide (Chapter 2), it was 
realized that a readily accessible asymmetric hydroformylation of allylic ethers and 
related compounds would effectively streamline the synthesis of key building blocks. 
While a number of advances of asymmetric hydroformylation have been disclosed, the 
substrates have been only limited to highly activated and electronically biased substrates, 
such as styrene, vinylacetate and vinylamide as described above. For alkyl-substituted 1-
alkenes, standard rhodium catalyzed hydroformylation is slightly linear selective due to 
steric interactions and lack of preference for intermediate d (Scheme 3.6). Though the 
regioselectivity can be controlled to some extent by reaction conditions, it is mainly 
controlled by the nature of chelating ligand.
13
 Thus, it is of great importance to find an 
easily accessible and effective ligand for the valuable asymmetric hydroformylation of 
allyl ethers and related compounds. Only recently have novel chiral ligands been 
designed to target this set of alkene substrates in asymmetric hydroformylation. 
Scheme 3.6. Hydroformylation of Monoalkyl-substituted Alkenes 
 
In 2010, Zhang and co-workers reported a rhodium-yanphos complex catalyzed 
asymmetric hydroformylation of N-allylamides and N-allylsulfonamides (Scheme 3.7).
14
 
Yanphos 3.13 is structurally similar to binaphos 3.11, where an oxygen atom was 
replaced by a NEt fragment. Enantiomerically pure β2-amino aldehydes were obtained 
                                                     
13
 Klosin, J.; Landis, C. R. Acc. Chem. Res, 2007, 40, 1251. 
14
 Zhang, X. W., Cao, B. N., Yu, S. C.; Zhang, X. M. Angew. Chem. Int. Ed. 2010, 49, 4047. 
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from allylamines (3.14 and 3.15) with moderate regioselectivity. This reaction system 
also worked for allyl ether 3.16 as well as allylbenzene 3.17 furnishing the corresponding 
branched aldehydes with good regioselection and enantiomerically excess. Unfortunately, 
yanphos 3.13 is only available through a seven-step synthesis from expensive (+)-
NOBIN.
15
  
Scheme 3.7. Asymmetric Hydroformylation of Alkenes with Yanphos 
 
 Later, a novel unsymmetrical chiral ligand, bobphos 3.18, was designed by Clark 
and Cobley for asymmetric hydroformylation of various alkyl substituted 1-alkenes 
(Scheme 3.8).
16
 Allylbenzene 3.17 and homoallylbenzene 3.19 participated in this 
reaction providing branched aldehydes with good regioselectivity but only moderate 
enantioselectivity. Importantly, non-electronically biased 1-hexene 3.20 also served as 
good substrate producing (+)-1-methyl hexanal with good branch to linear ratio and 
enantiomeric excess. The basic amide function group in 3.21 was also well-tolerated in 
the catalytic hydroformylation. Bobphos 3.18 is one of the first ligands generating 
                                                     
15
 Yan, Y.; Zhang, X. J. Am. Chem. Soc. 2006, 128, 7198. 
16
 Noonan, G. M., Fuentes, J. A., Cobley, C. J.; Clarke, M. L. Angew. Chem. Int. Ed. 2012, 51, 
2477. 
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branched aldehyde with good selectivity in hydroformylation of alkyl substituted 1-
alkenes. The low reaction temperature (16
o
C) is necessary for good regio- and 
enantioselectivity, but caused incomplete conversion as well as prolonged reaction time 
(21-66 h). The low turnover numbers and slow reaction rate is not suitable for an 
industrial processes. Moreover, bobphos 3.18 is not readily accessible, and requires 
multistep synthesis.  
Scheme 3.8. Asymmetric Hydroformylation of Alkenes with Bobphos 
 
  Another highly reactive and selective asymmetric hydroformylation example is 
the reaction using bisdiazaphos 3.22 that was developed by Landis and co-workers. 
Bisdiazaphos (3.22) mediated asymmetric hydroformylation gave excellent enantio- and 
regioselectivity for styrene derivatives;
17
 most importantly, the reaction system was also 
effective for less activated terminal olefins.
18
 Allyl ethers (3.16 and 3.23) with various 
protecting groups participated in this hydroformylation reaction providing β-
                                                     
17
 Clark, T. P.; Landis, C. R.; Freed, S. L.; Klosin, J.; Abboud, K. A. J. Am. Chem. Soc. 2005, 127, 
5040. 
18
 McDonald, R. I.; Wong, G. W.; Neupane, R. P.; Stahl, S. S.; Landis, C. R. J. Am. Chem. Soc. 
2010, 132, 14027. 
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hydroxylaldehydes with moderate branch selectivity and good enantiomeric excess 
(Scheme 3.9). Similar to Zhang’s example (Scheme 3.7), optically active β2-amino 
aldehydes were produced via asymmetric hydroformylation of allylamine 3.24. 
Interestingly, TMS-protected cis-crotylalcohol 3.25 underwent asymmetric 
hydroformylation smoothly to produce corresponding chiral aldehyde with moderate 
regioselectivity and good enantioselectivity. Synthetically useful malondialdehyde 
equivalent was generated by asymmetric hydroformylation of acetal protected acrolein 
3.26 with higher regioselectivity and good enantiomeric excess. Each reaction reached 
full conversion of starting material rapidly with turnover numbers calculated as high as 
2000 h
-1
. It is proposed that the observed high reactivity results from electron-deficient 
nature of bisdiazaphos, as indicated by the IR carbonyl stretching frequency of its Rh-
complex.
19
 Though bisdiazaphos 3.22 served as a great ligand for asymmetric 
hydroformylation of various terminal olefins, similar to the aforementioned ligands, it is 
not readily available
20
 and requires multistep synthesis. 
 
 
 
 
 
 
 
 
                                                     
19
 Landis, C. R.; Nelson, R. C.; Jin, W.; Bowman, A. C. Organometallics. 2006, 25, 1377. 
20
 Once upon a time, bisdiazaphos 3.22 and its diastereomer were commercial from Sigma-
Aldrich (product number 685232 and 685259) but they were discontinued later. 
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Scheme 3.9. Asymmetric Hydroformylation of Alkenes with Bisdiazaphos 
 
 Asymmetric hydroformylation is a rapid and efficient method to construct 
synthetically useful building blocks from inexpensive olefins; however, it is rarely used 
in complex molecule synthesis.
21
 It is suspected that the limited availability of efficient 
chiral ligands limits the broad application of asymmetric hydroformylation. The 
aforementioned beautifully designed chiral ligands require multistep syntheses, though 
they are effective ligands for asymmetric hydroformylation of 1-alkenes. For example, 
optically active bisdiazaphos 3.22 can be prepared in a three-step sequence starting from 
condensation of phthalaldehydic acid 3.27 furnishing azine 3.28 (Scheme 3.10). 
Subsequent cyclization of azine 3.28 with diphosphinobenzene 3.29 and di-acidchloride 
3.30 provides racemic tetra-acid 3.31 as single diastereomer with only 33% yield. 
Derivatization of tetra-acid 3.31 with enantiomerically enriched amine 3.32 furnishes a 
pair of diastereomers; however, only one diastereomer is active representing 
                                                     
21
 (a) Ho, S.; Bucher, C.; Leighton, J. L. Angew. Chem. Int. Ed. 2013, 52, 6757. (b) Risi, R. M.; 
Burke, S. D. Org. Lett. 2012, 14, 2572. 
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match/mismatch case. Thus it is necessary to separate the two diastereomers, which 
requires the use of LC with a Zorbax Rx-Sil column providing more active diastereomer 
3.22 with only 21% yield. Though the ligand synthesis sequence is short and straight 
forward from commercially available materials, the use of pyrophoric 
diphosphinobenzene 3.29 as well as LC separation in low yield might prevent its wide 
applications.  
Scheme 3.10. Synthesis of Bisdiazaphos 
 
 Thus, it is of great importance to find a readily accessible ligand for asymmetric 
hydroformylation to enable rapid construction of synthetically useful building blocks 
from inexpensive olefins. Moreover, such asymmetric hydroformylation would be greatly 
beneficial for the total synthesis of (+)-discodermolide (Chapter 2). 
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3.3 Development of Asymmetric Hydroformylation of Terminal Olefins 
with Readily Available Ligand 
 Considering the success of bisdiazaphos 3.22 in asymmetric hydrofromylation, 
we considered that a structurally and electronically similar bidentate phosphine ligand 
would be as effective. Thus, the bis(phospholano)benzene (DuPhos) and 
bis(phospholano)ethane (BPE) families of ligands appear to be logical candidates (Figure 
3.3). Moreover, both enantiomers of each ligand are commercially available from various 
venders.
22
 
Figure 3.3. Bisdiazaphos, DuPhos and BPE ligands 
 
  The DuPhos and BPE ligands have proved to be excellent ligands for asymmetric 
hydrogenation of various substrates,
23
 but their use in asymmetric hydroformylation 
reactions has been reported only once where 1,2-bis-(2,5-diphenylphospholano)ethane 
(Ph-BPE) was identified as an excellent ligand for asymmetric hydroformylation of 
                                                     
22
 For example, 22 DuPhos and BPE ligands are available from Sigma-Aldrich, 20 from Strem 
Chemicals Inc., 6 from Alfa Aesar, and 5 from Acros (data as of 10/6/2014). The price may vary 
from different vendors. 
23
 Tang, W.; Zhang, X. Chem. Rev. 2003, 103, 3029. 
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styrene, allylcyanide and vinyl acetate.
24
 But more interesting and challenging 
monoalkyl-substituted alkenes, such as allyl ethers and 1-dodecene, haven’t been studied. 
Herein, we tested several DuPhos and BPE ligands for asymmetric hydroformylation 
using non-electronically biased 1-dodecene as model substrate.  
Table 3.1. Ligand Screening for Asymmetric Hydroformylation 
 
entry ligand b:l
 a 
e.e. % 
b 
1 3.32 1.1:1 85 
2 3.33 0.5:1 18 
3 3.34 0.9:1 10 
4 3.35 1.2:1 90 
a
 branch/linear ratio were determined by 
1
H NMR. 
b
 determined after 
conversion to its benzoate derivative. 
Under conditions of 150 psi syngas (CO:H2=1:1) and 80 
o
C with 0.5 mol % of 
Rh(acac)(CO)2 and 0.55 mol % phosphine ligand, both Me-DuPhos and Me-BPE 
promoted hydroformylation converting 1-dodecene 3.36 to desired aldehyde 3.37 with 
serviceable regioselectivity, but with poor enantioselectivity (Table 3.1, entry 2 and 3). 
This might be attributed to the small 2,5-dimethyl substitutions on the ligand which don’t 
provide sufficient chiral environment. As expected, changing phospholane 2,5-
substituents to larger isopropyl (3.32) and phenyl (3.35) groups provided much higher 
enantioselectivity, 85% and 90% enantiomeric excess respectively (Table 3.1, entry 1 and 
4). Ph-BPE 3.35 was identified as the most effective ligand and gave the highest 
                                                     
24
 Axtell, A. T.; Cobley, C. J.; Klosin, J.; Whiteker, G. T.; Zanotti-Gerosa, A.; Abboud, K. A. 
Angew. Chem. Int. Ed. 2005, 44, 5834. 
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enantioselectivity and slightly better branch to linear ratio compared to other tested 
ligands. The high reaction temperature might cause the low but serviceable 
regioselectivity; however, this temperature is crucial for fast hydroformylation reaction 
rate. After balancing reaction regioselectivity and reaction rate, we decided to take 150 
psi syngas and 80 
o
C in toluene as optimum reaction conditions and Ph-BPE 3.35 as the 
best ligand.  
We moved forward to examine the substrate scope of this rhodium catalyzed 
asymmetric hydroformylation reaction. Optically pure β-siloxyl aldehydes (3.40 and 3.42) 
were obtained with higher regioselectivity by subjecting slightly electronically biased 
TBS- and TES-protected allyl alcohol (3.39 and 3.41) to standard reaction conditions 
(Table 3.2, entry 1 and 2). The branched to linear aldehyde ratio for TBS-ether 3.39 is 
almost doubled comparied to the bisdiazaphos mediated asymmetric hydroformylation 
(Table 3.2, entry 1).
19
 Para-methoxylbenzyl allyl ether 3.43 was found to produce 
aldehyde 3.44 with even higher regioselectivity while maintaining a high level of 
enantioselectivity (Table 3.2, entry 3). The good regioselection with allyl ether (3.39, 
3.41 and 3.43) is likely due to the stabilization of the partial negative charge at internal 
carbon by oxygen functionality,
25
 enhancing the preference of intermediate d after 
hydrometalation (III) (Figure 3.1). Some protecting groups for allyl alcohols are not 
suitable for this asymmetric hydroformylation, such as acetate, mesylate and tosylate, 
which might be attributed to the formation of corresponding rhodium π-allyl intermediate 
in the presence of a good allylic leaving group.
26
 Acrolein-derived acetals (3.47 and 3.49) 
                                                     
25
 Ojima, I. Chem. Rev. 1988, 88, 1011. 
26
 (a) Tsuji, J.; Minami, I.; Shimidzu, I. Tetrahedron Lett. 1984, 25, 5157. (b) Evans, P. A.; 
Nelson, J. D. J. Am. Chem. Soc. 1998, 120, 5581. (c) Evans, P. A.; Robinson, J. E. J. Am. Chem. 
Soc. 2001, 123, 4609. 
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gave optically active aldehydes (3.48 and 3.50) that are equivalent to synthetically useful 
malondialdehydes in good branch to linear ratio (>10:1) (Table 3.2, entry 4 and 5). Vinyl 
orthoester 3.49
21b
 was smoothly converted to desired aldehyde 3.50 with excellent 
regioselectivity (Table 3.2, entry 6), which served as a key starting material for the 
synthesis of oxidation-resistant discodermolide analog (Chapter 2). 
Table 3.2. Asymmetric Hydroformylation of Allyl Ethers, Allylacetals and Vinyl 
Orthoestera 
 
entry substrate product conv. (%) b:lb e.e. (%) 
1 
 
 
99 
3.9:1 
2.0:1c 
97 
96c 
2 
 
 
99 3.5:1 90 
3 
 
 
99 5.5:1 93 
4 
  
99 12:1 93 
5 
  
99 10:1 93 
6 
  
99 
15:1 
12:1c 
89 
93c 
a reactions preformed with 0.5 mol % Rh cat. and 0.55 mol % ligand, [substrate] 
=1.0 M. b b:l ratios are determined by 1H NMR anaylsis. c Data reported in 
literature using bisdiazaphos.18,21b  
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It is important to test such asymmetric hydroformylation on large scale to 
facilitate organic syntheses. Pleasingly, no erosion in stereoselection was observed when 
7.5 grams of allyl ether 3.39 was subject to standard hydroformylation conditions with 
lower catalyst loading (0.02 mol %) and little organic solvent (1.0 equivalent) (Scheme 
3.11). Moreover, the reaction reached full conversion in 4 hours (indicated by syngas 
uptake graph) and the turnover frequency was calculated as 1250 h
-1
. Starting from 
commodity allyl alcohols and commercially available chiral ligand, this method provides 
an attractive two-step route to large quantities of synthetically important β-hydroxyl 
aldehyde 3.40, which was historically prepared in a three-step sequence from fairly 
expensive Roche ester (~$20/g from Sigma-Aldrich).
27
 Thus, the advantage of 
asymmetric hydroformylation was fully demonstrated in the Roche ester-free synthesis of 
(+)-discodermolide (Chapter 2). 
Scheme 3.11. Multigram Scale Asymmetric Hydroformylation 
 
                                                     
27
 For selected examples, see: (a) Smith, A. B., III; Beauchamp, T. J.; LaMarche, M. J.; Kaufman, 
M. D.; Qiu, Y.; Arimoto, H.; Jones, D. R.; Kobayashi, K. J. Am. Chem. Soc. 2000, 122, 8654. (b) 
Smith, A. B., III; Adams, C. M.; Barbosa, S. A. L.; Degnan, A. P. Proc. Natl. Acad. Sci. U.S.A. 
2004, 101, 12042. (c) Mickel, S. J.; Sedelmeier, G. H.; Niederer, D.; Schuerch, F.; Koch, G.; 
Kuesters, E.; Daeffler, R.; Osmani, A.; Seeger-Weibel, M.; Schmid, E.; Hirni, A.; Schaer, K.; 
Gamboni, R.; Bach, A.; Chen, S.; Chen, W.; Geng, P.; Jagoe, C. T.; Kinder, F. R., Jr.; Lee, G. T.; 
McKenna, J.; Ramsey, T. M.; Repic, O.; Rogers, L.; Shieh, W.-C.; Wang, R.-M.; Waykole, L. 
Org. Process Res. Dev. 2004, 8, 107. (d) Lawhorn, B. G.; Boga, S. B.; Wolkenberg, S. E.; Colby, 
D. A.; Gauss, C.-M.; Swingle, M. R.; Amable, L.; Honkanen, R. E.; Boger, D. L. J. Am. Chem. 
Soc. 2006, 128, 16720. 
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Encouraged by the reactions of allyl alcohol and acrolein derived terminal olefins, 
we investigated much less electronically biased and more challenging substrates (Table 
3.3). Optically active γ-hydroxyl aldehydes were obtained with moderate regioselectivity 
and high levels of enantiomeric excess from homoallyl alcohol derivatives (Table 3.3, 
entry 1). Homoallylic alcohols with more electron withdrawing protecting groups were 
found to give higher branch to linear ratios (TFA (3.61)>Bz (3.57)>TBS (3.51)). 
Substrates 3.63 and 3.65 with ketone and ester oxidation state at homoallylic position 
further enhanced regioselectivity and maintained excellent enantioselectivity due to the 
stronger electron withdrawing nature of the substitutions (Table 3.3, entry 2 and 3). Bis-
homoallylic alcohol-derived TBS-ether 3.67 provided the same regioselectivity as 1-
dodecene 3.36, which indicated that the terminal olefin is barely disturbed by hydroxyl 
functionality at remote bis-homoallylic position in this hydroformylation reaction (Table 
3.3, entry 4).  
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Table 3.3. Asymmetric Hydroformylation of Less Electronically Biased 1-Alkenesa 
 
entry substrate product conv.(%) b:lb e.e. (%) 
1  
 
   
 P=TBS 3.51 3.52 99 2.2:1 95 
 P=PMB 3.53 3.54 99 2.3:1 86 
 P=Ac 3.55 3.56 99 2.2:1 90
 
 P=Bz 3.57 3.58 99 2.6:1 92 
 P=THP 3.59 3.60 99 2:1 78 
 P=TFA 3.61 3.62 99 3:1 ND
c 
2 
 
 
99 5.5:1 90 
3 
  
99 3.9:1 NDc 
4 
 
 
99 1.2:1 90 
a reactions preformed with 0.5 mol % Rh cat. and 0.55 mol % ligand, 
[substrate]=1.0M. b branch to linear ratios were determined by 1H NMR anaylsis. 
c ND=not determined, because of instability of related aldehyde products. 
 
 As mentioned above, the observed good reactivity and regioselectivity of 
hydroformylation were not only due to intrinsic substrate preference but also a result of 
the nature of Ph-BPE ligand 3.35. The high reactivity of Ph-BPE ligand might be 
attributed to the presence of electron-withdrawing phenyl rings that reduces overall 
basicity of the phosphine center; it is known that electron-poor phosphine ligands lead to 
more active catalysts in Rh-catalyzed hydroformylation.
3
 According to the natural bite 
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angle concept introduced by Casey and Whitaker,
28
 bidentate phosphine ligands with 
larger natural bite angle (e.g. BISBI 3.69, Xantphos 3.70) gives a higher linear to 
branched ratio in hydroformylation (Table 3.4). This is because ligand with large bite 
angle (≥120°) will bind equatorial/equatorial at rhodium center, while ligand with small 
bite angle will bind equatorial/axial at rhodium center. Though the natural bite angle was 
calculated based on molecular mechanics methods, it is quite close to the bite angle 
measured from X-ray crystallography of corresponding metal complex. For example, the 
natural bite angle of dppe is 84.5° in rhodium complex while the measured bite angle is 
85.8°. Thus, it is safe to say that the natural bite angle of Ph-BPE is close to the measured 
bite angle, 85.5°,
29
 and this small bite angle would disfavor formation of linear product 
rendering higher branched to linear ratio. Combination of large 2,5-phenyl groups on 
phopholano ring, a less basic phosphine center and a small bite angle makes Ph-BPE an 
effective ligand for asymmetric hydroformylation reactions. Moreover, both enantiomers 
of the ligand are commercially available from various venders, which could make 
asymmetric hydroformylation a powerful tool in complex molecule syntheses. 
 
 
 
 
 
                                                     
28
 (a) Casey, C. P.; Whiteker, G. T.; Melville, M. G.; Petrovich, L. M.; Gavey, J. A.; Powell, D. R. 
J. Am. Chem. Soc. 1992, 114, 5535. (b) Casey, C. P.; Whiteker, G. T. Isr. J. Chem. 1990, 30, 299. 
(c) Dierkes, P.; van Leeuwen, P. W. N. M. J. Chem. Soc., Dalton Trans. 1999, 1519. 
29
 Measured from X-ray structure reported in ref. 24. 
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Table 3.4. Bite Angle and Regioselectivity of Phosphine Ligands30 
ligand b:l natural bite angle measured bite angle 
BISBI 3.69 1:66.5 112.6 122.2 
Xanphos 3.70 1:53 111.7 107.1 
T-BDCP 3.71 1:12.1 106.6 - 
 DIOP 3.72 1:8.5 102.2 97.6 
 dppe 3.73 1:2.4 84.5 85.8 
 Ph-PBE 3.35 1.2:1 - 85.5
29
 
 
 
 The Ph-BPE mediated asymmetric hydroformylation is not limited to terminal 
olefins, cis-allyl alcohol-derived PMB ether 3.74 also participated in this reaction to 
furnish optically pure aldehyde 3.75 with good regioselectivity (α:β = 7.8:1) (Scheme 
3.12). This is one of the rare examples of regioselective asymmetric hydroformylation for 
internal olefins. Unfortunately, trans-crotyl alcohol-derived TBS-ether 3.76 gave roughly 
equal amount of two regioisomeric aldehydes with incomplete conversion and 
significantly diminished enantioselectivity (determined by the Mosher ester
31
 prepared 
from aldehyde 3.63). 
 
 
 
                                                     
30
 van Leeuwen, P.W.N.M. Homogeneous Catalysis: Understanding the Art, Springer; 2004. 
31
 (a) Dull, D. L.; Mosher, H. S. J. Am. Chem. Soc. 1967, 89, 4230. (b) Dale, J. A.; Dull, D. L.; 
Mosher, H. S. J. Org. Chem. 1969, 34, 2543. (c) Dale, J. A.; Mosher, H. S. J. Am. Chem. Soc. 
1973, 95, 512. 
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Scheme 3.12. Asymmetric Hydroformylation of Internal Olefins 
 
 Good enantioselectivity of Rh/Ph-BPE catalyzed asymmetric hydroformylation 
has been observed for a broad range of substrates. In contrast, regioselectivity is highly 
substrate dependent and ranged from 15:1 to 1:1. As mentioned previously, the presence 
of an electron-withdrawing group would polarize the olefin and stabilize negative charge 
at internal carbon enhancing the preference for the intermediate d after hydrometalation 
(III) (Figure 3.1); this increases the hydroformylation branch selectivity. Thus, it is 
anticipated that the regioselectivity correlates to substituent’s electronic property. 13C 
NMR spectroscopy is a useful tool to study substitution effect on the electronic 
environment of a carbon,32 and it appears reasonable to study the relationship between 
regioselectivity and relative 13C (Δδ 13C) chemical shifts of each terminal alkene (Table 
3.2 and Table 3.3). It was found that Δδ 13C is affected by substituents’ electronic 
properties: the more electron withdrawing substituents that are closer to the olefin result 
smaller Δδ 13C. Then, the plots of regioselectivity and Δδ 13C for different substrates 
(Table 3.2 and Table 3.3) are shown in Figure 3.4.  Good correlations have been found in 
                                                     
32
 (a) Kalinowski, H. O.; Berger, S.; Braun, S. Carbon-13 NMR spectroscopy; Wiley: Chichester, 
1988; Chapter 3, p 92. (b) Sohar, P. Nuclear Magnetic Resonance Spectroscopy; CRC Press: Boca 
Raton, 1983; Vol. 2, Chapter 4, p 145. (c) Mei, T. S.; Werner, E. W.; Burckle, A. J.; Sigman, M. S. 
J. Am. Chem. Soc. 2013, 135, 6830. 
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both cases revealing that a substrate’s electronic property governs the regioselectivity, 
though other scenarios can’t be ruled out. A steeper slope of allyl alcohol derivatives 
(Figure 3.4A) indicates that substitution at the allylic position has a larger effect on 
polarizing olefin compared to the substitution at the homoallylic position (Figure 3.4B) 
due to closer proximity to the double bond.  
Figure 3.4. Plots of Δδ 13C Chemical Shifts v.s. Regioselectivity (A: Table 3.2, B: Table 
3.3) 
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3.4 Conclusion 
 A rhodium complex with a commercially available Ph-BPE ligand has proved to 
be an efficient catalyst for asymmetric hydroformylation of lowly activated and non-
electronically biased terminal olefins. A number of terminal alkenes, even including an 
internal olefin, participate in this reaction to furnish synthetically useful and optically 
active aldehydes with moderate to high regioselectivities. This reaction works equally 
well on multigram scale with low catalyst loading while maintaining fast reaction rate 
and regioselection. Furthermore, good correlations are found between substitutions’ 
electronic properties and branched to linear selectivities. This asymmetric 
hydroformylation reaction could greatly benefit organic syntheses by rapidly constructing 
synthetically important chiral aldehyde building blocks from inexpensive alkenes. It is 
also anticipated that the development of this asymmetric hydroformylation with readily 
accessible catalyst would encourage its use in fine chemical and complex molecule 
syntheses as well as the preparation of biologically active compounds. 
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3.5. Experimental Procedure 
 
General Information 
 
 
1
H NMR spectra were recorded on a Varian Gemini-500 (500 MHz) 
spectrometer. Chemical shifts are reported in ppm with the solvent resonance as the 
internal standard (CDCl3: 7.26 ppm). Data are reported as the following: chemical shift, 
integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, 
app = apparent), and coupling constants (Hz). Coupling constants are reported to the 
nearest 0.5 Hz. 
13
C NMR spectra were recorded on a Varian Gemini-500 (125 MHz) 
spectrometer with complete proton decoupling. Chemical shifts are reported in ppm with 
the solvent resonance as the internal standard (CDCl3: 77.23 ppm). Infrared (IR) spectra 
were recorded on a Burker alpha spectrophotometer, νmax cm
-1
. Bands are characterized 
as broad (br), strong (s), medium (m), and weak (w). High-resolution mass spectrometry 
(ESI) was performed at the Mass Spectrometry Facility, Boston College.  
 Liquid Chromatography was performed using forced flow (flash 
chromatography) on silica gel (SiO2, 230×450 Mesh) purchased from Silicycle. Thin 
Layer Chromatography was performed on 25 μm silica gel plates purchased from 
Silicycle. Visualization was performed using ultraviolet light (254 nm), potassium 
permanganate (KMnO4) in water, 2,4-dinitrophenylhydrazine (2,4-DNP) in water/ethanol 
or phosphomolybdic acid (PMA) in ethanol. Optical rotations were measured on a 
Rudolph Analytical Research Autopol IV Polarimeter. Analytical chiral supercritical 
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fluid chromatography (SFC) was performed on a TharSFC Method Station II equipped 
with Waters 2998 Photodiode Array Detector.  
 All reactions were conducted in oven- or flame-dried glassware under an inert 
atmosphere of nitrogen or argon. Tetrahydrofuran (THF), toluene, diethyl ether (Et2O) 
and dichloromethane (CH2Cl2) were purified using a Pure Solv MD-4 solvent purification 
system from Innovative Technology Inc. by passing through two activated alumina 
columns after being purged with argon. Hydroformylation reactions were performed in an 
Argonaut Technologies Endeavor® Catalyst Screening System or 100-600 mL pressure 
vessel by Parr Instrument Company with a gage block using 1:1 H2/CO supplied by 
Airgas, Inc. (Acetylacetonato)dicarbonylrhodium (I) [Rh(acac)(CO)2] and (−)-1,2-
Bis((2R,5R)-2,5-diphenylphospholano)ethane [(S,S)-Ph-BPE] were purchased from Strem 
Chemicals, Inc. and used without further purification. All other reagents were purchased 
from Aldrich, Alfa Aesar, or Fisher and used without further purification.  
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I. Preparation of Terminal Olefins 
Preparation of (Allyloxy)(tert-butyl)dimethylsilane 
 
(Allyloxy)(tert-butyl)dimethylsilane 3.39 (Table 3.2, entry 1) was prepared using 
known procedure and all spectrum data are in accordance with literature report.
33
 Similar 
procedure was used to prepare (allyloxy)triethylsilane 3.41 (Table 3.2, entry 2). 
 
Preparation of 1-((allyloxy)methyl)-4-methoxybenzene 
 
1-((Allyloxy)methyl)-4-methoxybenzene 3.43 (Table 3.2, entry 3) was prepared 
using known procedure and all spectrum data are in accordance with literature report.
34
 
 
Preparation of 5,5-dimethyl-2-vinyl-1,3-dioxane 
 
 Acetal 3.45 (Table 3.2, entry 4) was prepared using known procedure and all 
spectrum data are in accordance with literature report.
35
 
 
                                                     
33
 Su, C. C.; Williard, P. G. Org. Lett. 2010, 12, 5378. 
34
 Chênevert, R.; Dasser, M. J. Org. Chem. 2000, 65, 4529. 
35
 Doumèche, B.; Archelas, A.; Furstoss, R. Adv. Synth. Catal. 2006, 348, 1948. 
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Preparation of 3-vinyl-1,5-dihydrobenzo[e][1,3]dioxepine 
 
1,2-Benzenedimethanol SI-1 was prepared according to literature procedure.
36
 
Diol (3.3 g, 23.9 mmol) and catalytic p-TsOH were dissolved in dry CH2Cl2 (12 
mL) in a 50 mL round bottom flask suspended with MgSO4 under nitrogen. Acrolein 
(1.59 mL, 23.9 mmol) was added dropwise to the mixture at room temperature and stirred 
overnight. The resulting mixture was filtered and concentrated. The residue was purified 
by silica gel chromatography to afford the titled compound 3.47 (Table 3.2, entry 5) as 
colorless oil (3.3 g, 79%). All spectrum data are in accordance with literature report.
37
 
 
Preparation of 4-methyl-1-vinyl-2,6,7-trioxabicyclo[2.2.2]octane 
 
 Vinyl-OBO 3.49 (Table 3.2, entry 6) was prepared using known sequence from 
commercial oxetane and all spectrum data are in accordance with literature report.
21b
  
 
 
                                                     
36
 Steffen, J.; Lei, X. G.; Li, W.; Liu, Z. -Q.; Turro, N. J.; Ottaviani, M. F.; Abrams, L. J. Org. 
Chem. 2002 , 67, 2606. 
37
 Arab, K. E.; Hanan, A. Q,; Patrick, M. H. J. Organomet. Chem. 2002, 656, 168. 
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Preparation of (but-3-en-1-yloxy)(tert-butyl)dimethylsilane 
 
Homoallyl ether 3.51 (Table 3.3, entry 1) was prepared using known procedure 
and all spectrum data are in accordance with literature report.
38
 
 
Preparation of 1-((but-3-en-1-yloxy)methyl)-4-methoxybenzene 
 
  Homoallyl ether 3.53 (Table 3.3, entry 1) was prepared using known procedure 
and all spectrum data are in accordance with literature report.
39
  
 
Preparation of 3-buten-1-yl acetate 
 
Homoallyl acetate 3.55 (Table 3.3, entry 1) was prepared by known procedure 
and all spectrum data are in accordance with literature report.
40
 
 
Preparation of but-3-en-1-yl benzoate 
 
                                                     
38
 Ghosh, A. K.; Li, J. -F. Org. Lett. 2009, 11, 4164. 
39
 Raghavan, S.; Krishnaiah, V. J. Org. Chem. 2010, 75, 748.  
40
 Fürstner, A.; Müller, T. Synlett. 1997, 1010. 
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Homoallyl benzoate 3.57 (Table 3.3, entry 1) was prepared by known procedure 
and all spectrum data are in accordance with literature report.
41
 
 
Preparation of 2-(but-3-en-1-yloxy)tetrahydro-2H-pyran 
 
Tetrahydropyran 3.59 (Table 3.3, entry 1) was prepared using known procedure 
and all spectrum data are in accordance with literature report.
42
  
 
Preparation of but-3-en-1-yl 2,2,2-trifluoroacetate 
 
 Trifluoroacetate 3.61 (Table 3.3, entry 1) was prepared using known procedure 
and all spectrum data are in accordance with literature report.
43
 
 
Preparation of but-3-enoic acid tert-butyl ester 
 
t-Butyl ester 3.63 (Table 3.3, entry 2) was prepared using known procedure and 
all spectrum data are in accordance with literature report.
44
 
                                                     
41
 Zhang, M.; Vedanthanm, P.; Flynn, D. L.; Hanson, P. R. J. Org. Chem. 2004, 69, 8340. 
42
 Hernandez, D.; Nielsen, L.; Lindsay, K. B.; Lopez-Garcia, A.; Bjerglund, K.; Skrydstrup, T.; 
Org. Lett. 2010, 12, 3528. 
43
 Abd El Samii, Z. K. M.; Al Ashmawy, M. I.; Mellor, J. M. J. Chem. Soc., Perkin Trans. 1, 
1988, 2509. 
44
 Ramachandran, P.V.; Nicponski, D.; Kim, B. Org. Lett. 2013, 15, 1398. 
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Preparation of 1-phenyl-but-3-en-1-on 
 
To an oven dried 50 mL round bottom flask with stir bar was added aluminum 
chloride (730.0 mg, 5.5 mmol), capped with septa and purged with N2.  To this was 
added CH2Cl2 (20 mL) followed by dropwise addition of benzoyl chloride (0.58 mL, 5.0 
mmol).  The reaction was allowed to stir for 20 minutes followed by dropwise addition of 
allyltrimethylsilane (0.96 mL in 2.0 mL CH2Cl2, 6.0 mmol).  The reaction was allowed to 
stir for 4 hours at room temperature. Upon completion, the reaction mixture was 
quenched with ice-cold deionized water and extracted three times with CH2Cl2.  Organic 
layers were combined, dried over magnesium sulfate, concentrated in vacuo and purified 
on silica gel (30:1 pentane: diethyl ether) to afford a clear, colorless oil (866.4 mg, 
quantitative yield) (Table 3.3, entry 3). Rf = 0.31 (30:1 pentane: diethyl ether, stain in 
KMnO4).  All spectral data are in accordance with the literature.
45 
 
Preparation of (1,1-dimethylethyl)(dimethyl)(4-pentenyloxy)silane 
 
Bis-homoallyl ether 3.67 (Table 3.3, entry 4) was prepared using literature 
procedure and all spectrum data are in accordance with literature report.
46
 
                                                     
45
 Moriyama, K.; Takemura, M.; Togo, H. J. Org. Chem. 2014, 79, 6094. 
46
 (a) Kovtonyuk, V.N.; Kobrina, L.S.; Gatilov, Y.V.; Bagryanskaya, I.Y.; Fröhlich, R.; Haufe, G. 
J. Chem. Soc., Perkin Trans. 1 2000, 1929. (b) Kwan, E. E.; Scheerer, J. R.; Evans, D. A. J. Org. 
Chem. 2013, 78, 175. 
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Preparation of Internal Cis-Allyl Ether 
 
 A flamed dried 100 mL round bottom flask with stir bar was charged with NaH 
(360 mg, 15 mmol) and 20 mL THF under N2. After cooling to 0
o
C, cis-2-penten-1-ol 
(1.1 mL, 11 mmol) was added dropwise via syringe, which was allowed to stir at 0
o
C for 
45 min. Then Bu4NI (50 mg, catalytic amount) and PMBCl (1.4 mL, 10 mmol) were 
added sequentially at 0 
o
C, and the solution was allowed to warm to room temperature 
and stir overnight. The reaction was quenched with NH4Cl aqueous solution and the 
layers were separated. The aqueous layer was extracted with EtOAc (3 × 20 mL), and the 
combined organics were dried over Na2SO4, filtered, and concentrated by rotary 
evaporation. The crude reaction mixture was purified by silica gel chromatography 
(diethyl ether:hexanes = 1:10) to afford 3.74 as a clear, colorless oil. Rf = 0.53 (6:1 
hexanes: diethyl ether, stain in KMnO4). 
 
 (Z)-1-Methoxy-4-((pent-2-en-1-yloxy)methyl)benzene (Scheme 
3.11, 3.74). 
1
H NMR (500 MHz, CDCl3): δ 7.27 (2H, d, J = 9.5 Hz), 
6.88 (2H, d, J = 9.0 Hz), 5.60-5.54 (2H, m), 4.44 (2H, s), 4.04 (2H, d, J = 6.0 Hz), 3.81 
(3H, s), 2.06 (2H, qd, J = 7.5, 7.5 Hz), 0.97 (3H, t, J = 7.5 Hz); 
13
C
 
NMR (125 MHz, 
CDCl3): δ 159.4, 135.6, 130.8, 129.6, 125.7, 114.0, 71.9, 65.5, 55.5, 21.1, 14.4; IR (neat): 
3011 (w), 2836 (w), 1613 (m), 1513 (s), 1463 (w), 1302 (m), 1247 (s), 1172 (m), 1082 (s), 
1036 (s), 820 (s) cm
-1
. 
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II. Asymmetric Hydroformylation Reactions 
Representative Procedure A: (Endeavor, 0.5% catalyst loading): Reactions were 
conducted in an Argonaut Endeavor
®
 reactor system which has eight reactor wells. Each 
well to be used was charged with approximately 0.5 mL of toluene and an oven dried 
glass vial placed in each well. The Endeavor was sealed and purged with nitrogen (4 x 
100 psi). Meanwhile an oven-dried two dram vial in dry box under an argon atmosphere 
was charged with alkene (1.0 mmol) and 0.5 mL of toluene followed by 0.5 mL of a 
rhodium/ligand stock solution (0.010 M Rh(acac)(CO)2/0.011 M (S,S)-Ph-BPE in 
toluene). The reaction mixture was then taken up in a syringe, removed from dry box and 
injected into the Endeavor. After injection the Endeavor was purged with nitrogen (1 x 
100 psi), stirring at 250 rpm, and heated and held at 80 °C for 10 min. Stirring was 
stopped and the Endeavor charged with 150 psi of syn-gas (1:1 CO/H2), stirring was 
brought to 700 rpm and heated to 80 °C. When the reaction was complete the Endeavor 
was vented, cooled and the vials were removed.  
 
Representative Procedure B: (Endeavor, lower catalyst loading and less solvent): similar 
to representative procedure A but with different amount of olefin and solvent with lower 
catalyst loading. 
 
 (S)-2-Methyldodecanal (Table 3.1, entry 4): The 
titled compound 3.37 was prepared with Representative 
Procedure A, on a 1.0 mmol scale with 1-dodecene 3.36. The crude reaction mixture was 
purified on silica gel (100% pentane to 40:1 pentane: diethyl ether) to afford a clear 
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colorless oil (mixture of branched and linear isomers). Rf  = 0.07 (40:1 pentane: diethyl 
ethere, stain in 2,4-DNP). [α]22D = +38.667 (c = 0.421, CHCl3, l = 50 mm). Spectral data 
are in accordance with literature.
47
 
 
Analysis of Stereochemistry:  
 The titled compound 3.37 was subjected to NaBH4 reduction followed by 
benzoate protection, as depicted below. The analogous racemic material was prepared via 
the same route, using triphenylphoshine as achiral ligand in the hydroformylation 
reaction. Optical purity was determined by SFC analysis of the derived benzoate. 
Absolute stereochemistry was determined by analogy to the optical rotation of (S)-2-
methyldecanal reported in the literature.
48
 
 
 
 
 
 
                                                     
47
 Wakabayashi, T.; Mori, K.; Kobayashi, S. J. Am. Chem. Soc. 2001, 123, 1372. 
48
 Oppolzer, W.; Darcel, C.; Rochet, P.; Rosset, S.; Brabander, J. D. Helv. Chim Acta 1997, 80, 
1319. 
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Chiral SFC (Chiralpak, AD-H, 35 
o
C, 3 mL/min, 2% mixed solvent (Isopropanol:hexane = 
1:1) 100 bar, 210-270 nm) – analysis of benzoate. 
      
                   Enatnioenriched Sample                                                 Racemic Sample  
    
 
 (S)-3-((tert-Butyldimethylsilyl)oxy)-2-methylpropanal. (Table 3.2, 
3.40).  Representative Procedure B was applied with olefin 3.39 (7.7 g, 
45 mmol), Rh(acac)(CO)2 (4.6 mg, 0.018 mmol), (S,S)-Ph-BPE (17.4 mg, 0.022 mmol) 
and toluene (5.1 mL). Reaction reached full conversion after 8 h. (b:l = 3.8:1, 97% e.e.). 
The crude reaction mixture was purified on silica gel (hexane:diethyl ether = 20:1) to 
afford a clear colorless oil. [α]D
21 
= +31.942 (c = 0.72, CHCl3, l = 50 mm). All spectrum 
data are in accordance with literature.
49
 
 
 
 
                                                     
49
 Altendorfer, M.; Raja, A.; Sasse, F.; Irschikc, H.; Menche, D. Org. Biomol. Chem. 2013, 11, 
2116. 
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Analysis of Stereochemistry 
The titled compound 3.40 was converted to the corresponding p-methoxybenzyl 
ether as shown below. The resulting benzyl ether was compared to racemic material 
prepared from 2-methyl-propan-1,3-diol. Absolute stereochemistry was assigned by 
comparing optical rotation to literature [α]D
22 
= +19.5 (c = 1.00, CHCl3, l = 50 mm).
49
 
Literature (the other enantiomer) [α]D
23 
= −34.6 (c = 1.0, CHCl3)).
18
 
 
Chiral HPLC (Chiralpak, AD-H, 25 
o
C, 3 mL/min, 5% Isopropanol in hexane, 220 nm) – 
analysis of benzyl ether. 
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 (S)-3-((4-Methoxybenzyl)oxy)-2-methylpropanal. (Table 3.2, 3.44). 
Representative Procedure B was used with olefin 3.43 (8.0 g, 45 mmol), 
Rh(acac)(CO)2 (4.6 mg, 0.018 mmol), (S,S)-Ph-BPE (17.4 mg, 0.022 mmol) and toluene 
(5.1 mL). Reaction was stopped after 12 h with 95% conversion (b:l = 5.6:1, 93% e.e.) 
[α]D
21 
= +28.886 (c = 0.72, CHCl3, l = 50 mm). All spectrum data are in accordance with 
literature report.
49
 
 
Analysis of Stereochemistry: 
The titled compound 3.44 was reduced to the corresponding p-methoxybenzyl 
ether as shown below. The resulting benzyl ether was compared to racemic material 
prepared from 2-methyl-1,3-propanediol as shown below. Absolute stereochemistry was 
assigned by comparing optical rotation to literature [α]D
22
 = +30.5 (c = 1.00, CHCl3).
49 
 
 
Chiral HPLC (Chiralpak, AD-H, 25 
o
C, 3 mL/min, 5% Isopropanol in hexane, 220 nm) – 
analysis of benzyl ether. 
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 (R)-2-(5,5-Dimethyl-1,3-dioxan-2-yl)propanal (Table 3.2, 3.46). 
Representative Procedure B was applied with olefin 3.45 (2.0 g, 7.4 
mmol), Rh(acac)(CO)2 (1.5 mg, 0.014 mmol), (S,S)-Ph-BPE (5.4 mg, 
0.017 mmol) and toluene (1.6 mL). Reaction was stopped after 12 h with full conversion 
(b:l = 12:1, 93% e.e.). [α]D
21 
= +53.630 (c = 0.88, CHCl3, l = 50 mm). All spectrum data 
are in accordance with literature report.
50
 
 
Analysis of Stereochemistry: 
The titled compound 3.46 was compared to racemic material. Absolute 
stereochemistry was assigned by analogy. 
 
Chiral GC (β-dex, supelco, 100 oC, 20 psi)-analysis of 3.46. 
 
                                                     
50
 Tanaka, K.; Fujimori, Y.; Saikawa, Y; Nakata, M. J. Org. Chem. 2008, 73, 6292. 
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 (R)-2-(1,5-Dihydrobenzo[e][1,3]dioxepin-3-yl)propanal. (Table 3.2, 
3.48). Representative Procedure B was applied with olefin 3.47 (3.3 g, 
18.8 mmol), Rh(acac)(CO)2 (1.94 mg, 7.52 µmol), (S,S)-Ph-BPE (7.26 
mg, 9.02 µmol) and toluene (4.3 mL). The reaction was stopped after 12 h with full 
conversion. (93% e.e., b:l = 13:1). The aldehyde was obtained as light yellow solid after 
concentration. 
1
H NMR (500 MHz, CDCl3): δ 9.80 (1H, d, J = 2,0 Hz), 7.28-7.21 (4H, 
m), 5.09 (1H, d, J = 6.0 Hz), 4.97 (1H, d, J = 14.5 Hz), 4.96 (1H, d, J = 14.5 Hz), 4.92 
(1H, d, 1H, d, J = 14.0 Hz), 4.90 (1H, d, J = 14.5 Hz), 2.79 (1H, qdd, J = 7.0, 7.0, 2.0 
Hz),, 1.18 (3H, d, J = 7.0 Hz); 
13
C NMR (125 MHz, CDCl3): δ 202.7, 139.21, 139.20, 
128.1, 127.9, 109.1, 73.5, 73.0, 51.3, 9.7; IR (neat): 2960 (w), 2848 (w), 1724 (s), 1454 
(m), 1373 (m), 1101 (s), 1043 (s), 1030 (s), 773 (m), 738 (s); HRMS-(ESI+) for 
C12H18NO3 [M+NH4]
+
: calculated: 224.1287, found: 224.1278. [α]D
21 
= +46.492 (c = 
0.90, CHCl3, l = 50 mm). 
 
Analysis of Stereochemistry: 
The titled compound 3.48 was converted to the corresponding alcohol as shown 
below. The resulting alcohol was compared to racemic material prepared from racemic 
aldehyde as shown below. Absolute stereochemistry was assigned by analogy. 
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Chiral SFC (Chiralpak, AS-H, 35 
o
C, 5 mL/min, 5% Isopropanol, 100 bar, 210-270 nm) 
– analysis of alcohol. 
  
   
 
 (R)-2-(4-Methyl-2,6,7-trioxabicyclo[2.2.2]octan-1-yl)propanal 
(Table 3.2, 3.50). Representative Procedure B was applied with olefin 
3.49 (1.6 g, 10.3 mmol), Rh(acac)(CO)2 (2.0 mg, 0.082 mmol), (S,S)-
Ph-BPE (8.0 mg, 0.098 mmol) and toluene (1.0 mL). Reaction reached full conversion 
after 5 h (b:l > 15:1, 89% e.e.). [α]D
21 
= +65.933 (c = 0.72, CHCl3, l = 50 mm). All 
spectrum data are in accordance with literature report.
21b
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Analysis of Stereochemistry: 
The titled compound 3.50 was converted to corresponding p-methoxybenzyl ether 
as shown below. The resulting benzyl ether was compared to racemic material prepared 
from 2-methyl-1,3-propanediol as shown below. 
 
 
Chiral HPLC (Chiralpak, AD-H, 25 
o
C, 1 mL/min, 5% Isopropanol in hexane, 220 nm) – 
analysis of benzyl ether. 
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 (S)-4-((tert-Butyldimethylsilyl)oxy)-2-methylbutanal (Table 3.3, 
3.52). The titled compound was prepared with Representative 
Procedure A on a 1.0 mmol scale with olefin 3.51. Reaction reached full conversion after 
5 h (b:l = 2:1, 95% e.e.). The crude reaction mixture was purified on silica gel (20:1 
hexane:diethyl ether) to afford a clear, colorless oil. [α]22D = +18.347 (c = 1.0, CHCl3. l = 
50 mm). All spectrum data are in accordance with literature.
51
 
 
Analysis of Stereochemistry:  
 The titled compound 3.52 was subjected to NaBH4 reduction followed by 
benzoate protection and TBS removal, as depicted below. The analogous racemic 
material was prepared by employing PPh3 as ligand in hydroformylation of olefin 3.51. 
Optical purity was determined by chiral HPLC analysis of the derived alcohol. Absolute 
stereochemistry was determined by analogy the optical rotation reported in the 
literature.
51
  
 
 
                                                     
51
 (a) Fürst, R.; Rinner, U. J. Org. Chem. 2013, 78, 8748. (b) Enders, D.; Vicario, J. L.; Job, A.; 
Wolberg, M.; M ller, M. Chem. Eur. J. 2002, 8, 4272. 
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Chiral HPLC (Chiralpak, AD-H, 25 
o
C, 1 mL/min, 3 % Isopropanol in hexane, 220 nm) – 
analysis of alcohol. 
  
 
 
 (S)-4-((4-Methoxybenzyl)oxy)-2-methylbutanal (Table 3.3, 3.54): 
The titled compound was prepared with Representative Procedure A 
on a 1.0 mmol scale with olefin 3.53. The crude reaction mixture was purified on silica 
gel (10:1 pentane: diethyl ether) to afford a clear, colorless oil. Rf =0.17 (5:1 pentane: 
diethyl ether, stain KMnO4). [α]
22
D = +15.453 (c = +0.522, CHCl3, l = 50 mm). All 
spectral data are in accordance with the literature.
52
 
 
Analysis of Stereochemistry:  
 The title compound 3.54 was subjected to NaBH4 reduction followed by benzoate 
protection, as depicted below. The analogous racemic material was prepared via the same 
route, using triphenylphoshine as achiral ligand in the hydroformylation reaction. Optical 
purity was determined by SFC analysis of the derived compound as compared to racemic 
                                                     
52
 Takagi, R.; Tsuyumine, S.; Nishitani, H.; Miyanaga, W.; Ohkata, K. Aust. J. Chem. 2004, 57, 
439. 
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product. Absolute stereochemistry was determined by comparing to the optical rotation 
reported in the literature.
53
  
 
Chiral SFC (OD-H, Chiralpak, 215nm, 3.0 mL/min, 10% i-PrOH, 100 bar, 35°C)-
analysis of benzoate protected compound.  
  
Enatnioenriched Sample   Racemic Sample                         Co-injection 
 
 
 (S)-4-Acetoxy-2-methyl butanal (Table 3.3, 3.56): The title compound 
3.56 was prepared with Representative Procedure A on a 1.0 mmol scale 
with olefin 3.55. The crude reaction mixture was purified on silica gel (7:1 pentane: 
diethyl ether) to afford a clear, colorless oil. Rf  = 0.26 (7:1 pentane: diethyl ether, stain in 
KMnO4). 
1
H NMR (500 MHz, CDCl3): δ 9.63 (1H, d, J = 1.5 Hz), 4.14-4.11 (2H, m), 
                                                     
53
 Chen, J. L.-Y.; Brimble, M. A. J. Org. Chem. 2011, 76, 9417. 
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2.48 (1H, ddd, J = 14.0 Hz, 7.0 Hz, 7.0 Hz), 2.11-2.04 (1H, m), 2.02 (3H, m), 1.73-1.66 
(1H, m) 1.14 (3H, dd, J = 7.5 Hz, 2.0 Hz); 
13
C
 
NMR (125 MHz, CDCl3): δ 203.7, 170.9, 
61.8, 43.5, 29.3, 20.8, 13.2; IR (neat): 2968 (w), 2932 (w), 1737 (s), 1459 (w), 1388 (w), 
1367 (w), 1237 (s), 1052 (w) cm
-1
; HRMS-(ESI+) for C7H12O3 [M+NH4]
+
: calculated: 
162.1130, found 162.1134. [α]22D = +2.245 (c = 0.481, CHCl3, l = 50 mm).  
 
Analysis of Stereochemistry:  
  The title compound 3.56 was subjected to NaBH4 reduction followed by benzoate 
protection, as depicted below. The analogous racemic material was prepared via the same 
route, using triphenylphoshine as achiral ligand in the hydroformylation reaction.  Optical 
purity was determined by SFC analysis of the derived compound as compared to racemic 
product. Absolute stereochemistry was determined by analogy.  
 
Chiral SFC (OD-H, Chiralpak, 215nm, 3.0 mL/min, 1% i-PrOH, 100 bar, 35°C)-analysis 
of benzoate.  
  
     Enantioenriched Sample                             Racemic Sample                               Co-injection 
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 (S)-3-Methyl-4-oxobutyl benzoate (Table 3.3, 3.58): The title 
compound 3.58 was prepared with Representative Procedure A on a 1.0 
mmol scale with olefin 3.57. The crude reaction mixture was purified on silica gel (3:1 
pentane: diethyl ether) to afford a clear, colorless oil. Rf = 0.19 (3:1 pentane: diethyl 
ether, stain in 2,4-DNP). 
1
H NMR (500 MHz, CDCl3): δ 9.71 (1H, d, J = 1.5 Hz), 8.10-
8.00 (2H, m), 7.56 (1H, dddd (app tt), J = 7.5 Hz, 7.5 Hz, 1.5 Hz, 1.5 Hz), 7.44 (2H, dd 
(app t), J = 8.0 Hz, 8.0 Hz), 4.44-4.37 (2H, m), 2.59 (1H, dddd (app tt), J = 7.0 Hz, 7.0 
Hz, 7.0 Hz, 1.5 Hz), 2.25 (1H, dddd (app dq), J = 14.5 Hz, 6.5 Hz, 6.5 Hz, 6.5 Hz), 1.85 
(1H, dddd (app dq), J = 14.5 Hz, 6.5 Hz, 6.5 Hz, 6.5 Hz), 1.21 (3H, d, J = 7.5 Hz); 
13
C
 
NMR (125 MHz, CDCl3): δ 203.8, 166.4, 133.0, 129.6, 128.4, 62.4, 29.5, 13.3; IR (neat): 
2968 (m), 2931 (m), 1717 (s), 1452 (m), 1272 (s), 1070 (m), 936 (w), 711 (m) cm
-1
; 
HRMS-(ESI+) for C12H15O3 [M+H]: calculated: 207.1021, found 207.1015. [α]
22
D = 
+38.947 (c = 0.723, CHCl3).  
 
Analysis of Stereochemistry:  
The title compound 3.58 was subjected to NaBH4 reduction followed by benzoate 
protection, as depicted below. The analogous racemic material was prepared via the same 
route, using triphenylphoshine as achiral ligand in the hydroformylation reaction.  Optical 
purity was determined by SFC analysis of the derived compound as compared to racemic 
product. Absolute stereochemistry was determined by analogy.  
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Chiral SFC (OJ-H, Chiralpak, 215nm, 3.0 mL/min, 2% i-PrOH, 100 bar, 35°C)-analysis 
of bis-benzoate.  
  
           Enatnioenriched Sample                   Racemic Sample                               Co-injection 
 
 
 (2S)-2-Methyl-4-((tetrahydro-2H-pyran-2-yl)oxy)butanal (Table 
3.3, 3.60): The title compound 3.60 was prepared with Representative 
Procedure A on a 1.0 mmol scale with 2-(but-3-en-1-yloxy)tetrahydro-2H-pyran 3.59 and 
obtained as 1:1 mixure of inseparable diasteromers. The crude reaction mixture was 
purified on silica gel (20:1 pentane: diethyl ether) to afford a clear, colorless oil. Rf = 0.17 
(10:1 pentane: diethyl ether, stain in 2,4-DNP). 
1
H NMR (500 MHz, CDCl3): δ 9.65 (1H, 
d, J = 1.5 Hz), 9.64 (1H, d, J = 2.0 Hz), 4.56-4.55 (2H, m), 3.52-3.48 (2H, m), 3.43 (2H, 
dddd, J = 22.0 Hz, 12.5 Hz, 7.0 Hz, 6.0 Hz), 2.56-2.47 (2H, m), 2.03 (2H, ddt, J = 14.0 
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Hz, 7.5 Hz, 5.5 Hz), 1.80-1.66 (6H, m), 1.58-1.49 (8H, m), 1.13 (3H, d, J = 1.5 Hz), 1.12 
(3H, d, J = 2.0 Hz); 
13
C
 
NMR (125 MHz, CDCl3): δ 204.7, 98.9, 98.8, 64.8, 64.5, 62.2, 
44.0, 43.8, 31.0, 30.8, 30.5, 25.4, 19.4, 13.3, 13.1; IR (neat): 2939 (m), 2872 (m), 2714 
(w), 1723 (s), 1120 (m), 1022 (m), 973 (s), 732 (m), cm
-1
; HRMS-(ESI+) for C10H19O3 
[M+H]: calculated: 187.1334, found 187.1344. [α]D
22
 = +26.258 (c = 0.646, CHCl3, l = 
50 mm).  
 
Analysis of Stereochemistry:  
 The title compound 3.60 was subjected to NaBH4 reduction, followed by removal 
of the tetrahydropyranyl ether group and bis-benzoyl protection, as depicted below. The 
analogous racemic material was prepared via the same route, using tricylcohexylphoshine 
as achiral ligand in the hydroformylation reaction. Optical purity was determined by SFC 
analysis of the derived compound. Absolute stereochemistry was determined by analogy. 
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Chiral SFC (OJ-H, Chiralpak, 215nm, 3.0 mL/min, 2% i-PrOH, 100 bar, 35°C)-analysis 
of benzoate protected compound.  
 
Enantioenriched Sample                                    Racemic Sample                               Co-injection 
 
 
 tert-Butyl-(S)-3-methyl-4-oxobutyl (Table 3.3, 3.64): The titled 
compound 3.64 was prepared with Representative Procedure A on a 
1.0 mmol scale with but-3-enoic acid tert-butyl ester 3.63. The crude reaction mixture 
was purified on silica gel (10:1 pentane: diethyl ether) to afford a clear, colorless oil. Rf = 
0.12 (10:1 pentane: diethyl ether, stain in KMnO4). 
1
H NMR (500 MHz, CDCl3): δ 9.69 
(1H, d, J = 1.0 Hz), 2.78 (1H, ddd (app dq), J = 14.0 Hz, 14.0 Hz, 7.0 Hz), 2.64 (1H, dd, 
J = 16.0 Hz, 7.0 Hz), 2.34 (1H, dd, J = 16.5 Hz, 6.5 Hz), 1.44 (9H, s); 
13
C
 
NMR (125 
MHz, CDCl3): δ 202.9, 170.9, 81.0, 42.8, 36.4, 28.0, 13.2; IR (neat): 2978 (w), 2933 (w), 
2717 (w), 1727 (s), 1367 (w), 1156 (w) cm
-1
; HRMS-(ESI+) for C9H16O3 [M+H]: 
calculated: 173.1178, found 173.1184. [α]22D = −98.065 (c = 0.153, CHCl3, l = 50 mm).  
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Analysis of Stereochemistry:  
The title compound 3.64 was subjected to NaBH4 reduction followed by benzoate 
protection, as depicted below. The analogous racemic material was prepared via the same 
route, using triphenylphoshine as achiral ligand in the hydroformylation reaction. Optical 
purity was determined by SFC analysis of the derived compound as compared to racemic 
product. Absolute stereochemistry was determined by analogy. 
 
Chiral SFC (OD-H, Chiralpak, 215nm, 3.0 mL/min, 1% i-PrOH, 100 bar, 35°C)-analysis 
of benzoate protected compound.  
 
      Enantioenriched Sample                                 Racemic Sample                         Co-injection 
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(S)-2-Methyl-4-oxo-4-phenylbutanal (Table 3.3, 3.66). The titled 
compound was prepared with Representative Procedure A on a 1.0 
mmol scale with olefin 3.65. All spectral data are in accordance with the literature.
54
  
 
 (S)-5-((tert-Butyldimethylsilyl)oxy)-2-methylpentanal (Table, 
3.3, 3.68): The titled compound was prepared with Representative 
Procedure A (but using (R,R)-Ph-BPE ligand) on a 1.0 mmol scale with (1,1-
dimethylethyl)(dimethyl)(4-pentenyloxy)silane 3.67. The crude reaction mixture was 
purified on silica gel (10:1 pentane: diethyl ether) to afford a clear, colorless oil. Rf = 
0.26 (10:1 pentane: diethyl ether, stain in KMnO4).  [α]
22
D = −46.830 (c = 0.556, l = 50 
mm, CHCl3). All spectral data were in accordance with the literature.
55
 
 
Analysis of Stereochemistry:  
The titled compound 3.68 was subjected to NaBH4 reduction followed by 
benzoate protection, as depicted below. The analogous racemic material was prepared via 
the same route, using triphenylphoshine as achiral ligand in the hydroformylation 
reaction. Optical purity was determined by SFC analysis of the derived compound as 
compared to racemic product. Absolute stereochemistry was determined by comparison 
with literature.
55
 
                                                     
54
 Zhang, J.; Xing, C.; Tiwari, B.; Chi, Y. J. Am. Chem. Soc. 2013, 135, 8113. 
55
 Rentsch, A.; Kalesse, M. Angew. Chem. Int. Ed. 2012, 51, 11381. 
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Chiral SFC (OD-H, Chiralpak, 215nm, 3.0 mL/min, 3% i-PrOH, 100 bar, 35°C)-analysis 
of benzoate.  
 
Enantioenriched Sample               Racemic Sample 
 
 
 (S)-2-(((4-Methoxybenzyl)oxy)methyl)pentanal (Scheme 3.11, 
3.75).
 
Representative Procedure B was applied with olefin 3.74 (207 
mg, 1.0 mmol), Rh(acac)(CO)2 (2.6 mg, 0.01 mmol), (S,S)-Ph-BPE (8.0 mg, 0.012 mmol) 
and toluene (1.0 mL). Reaction reached full conversion after 5 h (b:l = 7.8:1, 81% e.e.). 
The crude reaction mixture was purified on silica gel (12:1 hexane: diethyl ether) to 
afford a clear, colorless oil. Rf = 0.35 (6:1 hexane:diethyl ether, stain in KMnO4). 
1
H 
NMR (500 MHz, CDCl3): δ 9.68 (1H, d, J = 2.5 Hz), 7.23 (2H, d, J = 9.0 Hz), 6.88 (2H, 
d, J = 8.5 Hz), 4.43 (2H, m), 3.80 (3H, s), 3.66 (1H, dd, J = 9.0 Hz, 7.0 Hz), 3.61 (1H, dd, 
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J = 9.5 Hz, 5.0 Hz), 2.55 (1H, m), 1.65 (1H, ddt, J = 14.5 Hz, 7.5 Hz, 7.5 Hz), 1.45 (1H, 
ddt, J = 14.5 Hz, 7.0 Hz, 7.0 Hz), 1.33 (2H, 2H, qt, J = 7.0 Hz, 7.0 Hz), 0.91 (3H, t, J = 
7.0 Hz); 
13
C
 
NMR (125 MHz, CDCl3): δ 204.4, 159.5, 130.2, 129.4, 114.0, 73.1, 68.5, 
55.5, 52.2, 28.2, 20.4, 14.3; IR (neat): 2958 (w), 2933 (w), 2864 (w), 1725 (s), 1612 (m), 
1513 (s), 1465 (w), 1247 (s), 1086 (s), 1034 (s), 819 (s) cm
-1
; HRMS-(ESI+) for 
C14H19O3 [M+H]: calculated: 235.1334, found: 235.1343. [α]D
22
 = −17.033 (c = 0.95, 
CHCl3). 
 
Analysis of Stereochemistry:  
The titled compound 3.75 was converted to the corresponding alcohol as shown 
below. The resulting alcohol was compared to racemic material prepared from 2-propyl-
propan-1,3-diol. Absolute stereochemistry was assigned by comparing optical rotation of 
the alcohol to literature [lit. [α]D
22
 = −14.0 (c = 1.1, CHCl3)].
56
 
 
 
 
 
                                                     
56
 Yadav, J. S.; Nanda, S. Tetrahedron: Asymmetry, 2001, 12, 3223. 
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Chiral SFC (AS-H, Chiralpak, 215nm, 3.0 mL/min, 15% i-PrOH, 100 bar, 35°C)-
analysis of alcohol.  
  
 
 
 
3.6. Spectrum 
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Chapter 4 
Development of Nickel-Catalyzed Borylative Ketone 
Diene Coupling Reactions
1 
4.1 Introduction 
 Metal-catalyzed multi-component coupling reactions can rapidly construct 
complex molecules from simple substrates, and are regarded as one of the most attractive 
and valuable strategies in organic syntheses. In particular, multi-component coupling 
reactions involving a di-π-components can construct complex molecules not only in a 
stereo- and regioselective fashion, but also provide stereodefined versatile olefins. 
Pioneered by Mori
2
 and Tamaru,
3
 catalytic reductive coupling reactions involving 
organometallic reagents (M-R) or metal hydrides (M-H) have expanded on earlier work 
by Sato
4
 and Montgomery
5
 (Scheme 4.1, equation 1). More recently, it was revealed that 
incorporating a dimetalic reagent (e.g. R2B-BR2, R2B-SiR3, R3Si-SnR3) to this reaction 
generated an additional valuable allylmetal moiety that can be used to further build 
molecule complexity (Scheme 4.1, equation 2).
6
 
 
                                                     
1
 Part of this project has been published: Cho, H. Y.; Yu, Z.; Morken, J. P. Organic Letters 2011, 
13, 5267. 
2
 Sato, Y.; Takimoto, M.; Hayashi, K.; Katsuhara, T.; Takagi, K.; Mori, M. J. Am. Chem. Soc. 
1994, 116, 9771. 
3
 Kimura, M.; Ezoe, A.; Shibata, K.; Tamaru, Y. J. Am. Chem. Soc. 1998, 120, 4033. 
4
 Ikeda, S.; Sato, Y. J. Am. Chem. Soc. 1994, 116, 5975. 
5
 Montgomery, J.; Savchenko, A. V. J. Am. Chem. Soc. 1996, 118, 2099. 
6
 For a recent review, see: Cho, H. -Y.; Morken, J. P. Chem. Soc. Rev. 2014, 43, 4368. 
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Scheme 4.1. Reductive and Bismetallative Multicomponent Coupling Reactions 
 
 
4.2 Background 
 Diene-carbonyl coupling reactions have been extensively studied and these 
transformations were carried out under reductive conditions with either silane reagents 
and organozinc reductants,
7
 or organoboronate reagents.
8
 Thus, these transformations 
won’t be covered here. Instead, metal catalyzed multicomponent cross coupling reactions 
involving carbonyls, di-π-systems and dimetal reagents are discussed below.  
4.2.1. Intramolecular Bismetallative Carbonyl Di-π-Component Reactions 
 In 2002, Kang and co-workers disclosed a Pd-catalyzed carbonyl-allene 
cyclization using a Sn-Si reagent (Scheme 4.2).
9
 When the allenyl aldehyde 4.1 was 
treated with Me3Si-SnBu3 in the presence of catalytic [(π-allyl)PdCl]2 at ambient 
temperature, it underwent silastannylative coupling efficiently to produce cis-
cyclopentanol 4.2 with good yield and stereoselection. An even more challenging 
substrate (4.3) containing a sterically hindered and less reactive ketone electrophile also 
participated in this coupling reaction, furnishing the tertiary-alcohol product 4.4. The 
                                                     
7
 (a) For a recent review on reductive multicomponent reactions, see: de Graaff, C.; Ruijter, E.; 
Orru, R. V. A. Chem. Soc. Rev. 2012, 41, 3969. (b) Montgomery, J. Angew. Chem. Int. Ed. 2004, 
43, 3890. 
8
 (a) Saito, N.; Yamazaki, T.; Sato, Y. Chem. Lett. 2009, 38, 594. (b) Saito, N.; Yamazaki, T.; 
Sato, Y. Tetrahedron Lett. 2008, 49, 5073. 
9
 Kang, S.-K.; Ha, Y.-H.; Ko, B.-S.; Lim, Y. Jung, J. Angew. Chem. Int. Ed. 2002, 41, 343. 
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mechanism is proposed in Scheme 4.2 and begins with palladium (0) oxidatively 
inserting in the Sn-Si bond, producing Me3Si-Pd(II)-SnBu3 (4.5) intermediate. 
Subsequent addition across allene 4.3 gave an allylpalladium intermediate 4.7, a more 
stable form than 4.6, avoiding the interaction between the methyl and TMS groups, 
resulting in a cisoid intermediate. Finally, allylpalladium 4.7 undergoes intramolecular 
allylation to furnish alkoxyl-palladium 4.8 that gives cis-cyclopentanol 4.4 after reductive 
elimination and workup.  
Scheme 4.2. Kang’s Intramolecular Carbonyl-Allene Coupling and Proposed Mechanism 
 
 An intramolecular coupling of a diene and an aldehyde was reported by Mori and 
co-workers (Scheme 4.3a).
10
 In the presence of a catalytic amount of nickel (0) and 1.0 
equivalent Me3Sn-SnBu3 reagent, dienal 4.9 cyclized to generate a cis-cyclopentanol 4.10 
                                                     
10
 Sato, Y.; Saito, N.; Mori, M. Chem. Lett. 2002, 18. 
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with moderate yield. As mentioned above, one of the advantages of using a dimetallic 
reagent in diene-aldehyde coupling reaction is that a versatile allylmetal moiety is 
embedded in the product, which can be further functionalized (Scheme 4.1). Yu and co-
workers have taken advantage of this by trapping the allylmetal intermediate in situ with 
benzaldehyde, thereby furnishing adduct 4.13 with good yield and diastereoselectivity 
(Scheme 4.3b).
11
 The reaction mechanism is proposed in Scheme 4.3. Beginning with 
nickel (0) oxidative addition to the dimetal reagent, a diene insertion provides a π-allyl 
intermediate 4.17. Subsequent intramolecular allylation with the aldehyde gives cyclized 
compound 4.18. In the absence of additional aldehyde (e.g. benzyladehyde), cis-
cyclopentanol 4.10 was generated after reductive elimination of 4.18; otherwise, the 
reaction proceeded further after reductive elimination of 4.18. The intermediate 
allylboronic ester 4.19 underwent a second allylation with the additional aldehyde to 
furnish 4.13. It is worth pointing out that the corresponding cyclized product 4.14 can be 
prepared with moderated enantiomeric excess (50% e.e.) when the chiral monodentate 
ligand 4.15 was used (Scheme 4.3c).
12
 
 
 
 
 
 
 
                                                     
11
 Yu, C.-M.; Youn, J.; Yoon, S.-K.; Hong, Y.-T. Org. Lett. 2005, 7, 4507. 
12
 Saito, N.; Mori, M.; Sato, Y. J. Organomet. Chem. 2007, 692, 460. 
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Scheme 4.3. Mori and Yu’s Intramolecular Carbonyl-Diene Coupling and Proposed 
Mechanism 
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4.2.2. Intermolecular Bismetallative Carbonyl Di-π-Component Reactions 
 Ito and co-workers have developed a Pt-catalyzed silaborative intermolecular 
aldehyde-diene coupling reaction.
13
 In the presence of catalytic Pt(ethylene)(PPh3)2, a 
1,3-diene (symmetrical butadiene or unsymmetrical diene 4.23), an aldehyde (aromatic 
4.20 or aliphatic 4.22) and PhMe2Si-B(pin) were successfully assembled together 
regioselectively, furnishing a highly diastereoselective homoallylic alcohol (4.21 or 4.24). 
The proposed mechanism is shown in Scheme 4.4. Platinum (0) oxidatively adds to the 
Si-B bond to form PhMe2Si-Pt(II)-B(pin) (4.25), which coordinates to the s-cis 
conformer of 1,3-diene (4.26). Subsequent diene migratory insertion into the Pt-B bond 
forms a C-B bond at the terminal carbon of less hindered olefin to provide the cis-
allylplatinum 4.27. This platinum complex then reacts with an aldehyde followed by 
reductive elimination to afford desired product 4.29 and regenerate the platinum (0) 
catalyst. 
 
 
 
 
 
 
 
 
 
 
                                                     
13
 Suginome, M.; Nakamura, H.; Matsuda, T.; Ito, Y. J. Am. Chem. Soc. 1998, 120, 4248. 
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Scheme 4.4. Ito’s Intermolecular Carbonyl-Diene Coupling and Proposed Mechanism 
 
 Morken and co-workers developed a borylative diene-aldehyde three-component 
coupling reaction in 2008 (Scheme 4.5).
14
 Various aromatic aldehydes (4.30) participated 
in this reaction as well as different substituted 1,3-dienes (4.31 and 4.33), which gave 
highly diastereoselective 1,5-diols (4.32 and 4.34) after oxidation (Scheme 4.5).
14a
 The 
homoallylic alcohol products with adjacent anti-propionate moieties are valuable 
                                                     
14
 (a) Cho, H. Y. Morken, J. P. J. Am. Chem. Soc. 2008, 130, 16140. (b) Cho, H. Y.; Morken, J. P. 
J. Am. Chem. Soc. 2010, 132, 7576. 
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building blocks for organic syntheses (Chapter 1). The mechanism is proposed as shown 
in Scheme 4.5, which is different compared to the above examples. Initial oxidative 
cyclization between the diene and aldehyde delivers nickelacycle 4.36 from a nickel 
complex 4.35, which then undergoes σ-bond metathesis with a diboron reagent to provide 
a nickel π-allyl intermediate 4.37. Subsequent π-σ-π rearrangement and reductive 
elimination gives allylboronic ester 4.38 when PCy3 is used as phosphine ligand.  
Scheme 4.5. Morken Borylative Diene Aldehyde Coupling and Proposed Mechanism 
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This proposed mechanism was supported by X-ray crystallography of a 
structurally similar complex 4.41, which was prepared by treating benzaldehyde and 
diene 4.40 with stoichiometric Ni(cod)2 (Scheme 4.6).
15
 After addition of an alkylmetal 
reagent, Me2Zn, the complex 4.41 was reduced to Ni-π-allyl intermediate 4.42 followed 
by reductive elimination to afford homoallyl alcohol 4.43. This study has secured the 
proposed mechanism for borylative diene-aldehyde coupling reaction shown in Scheme 
4.5. 
Scheme 4.6. Support for Morken Proposed Mechanism 
 
Interestingly, changing the phosphine ligand from PCy3 to P(TMS)3 resulted in a 
different regioisomeric product (4.45) from the diboron promoted cross coupling reaction 
(Scheme 4.7).
14b
 A number of aromatic aldehydes participated in this reaction and 
constructed highly diastereoselective 1,3-diols (4.45). The coupling reactions with 
aliphatic aldehydes were also effective but with slightly lower yield under the same 
reaction conditions (results not shown). Moreover, α-chiral aldehyde 4.46 participated in 
this reaction giving 4.47 with Felkin selectivity
16
 and rapidly delivering a syn/anti/anti-
stereotetrad moiety that maps onto various polyketide natural products. The power of this 
                                                     
15
 Ogoshi, S.; Tonomori, K.; Oka, M.; Kurosawa, H. J. Am. Chem. Soc. 2006, 128, 7077. 
16
 Chérest, M.; Felkin, H.; Prudent, N. Tetrahedron Lett. 1968, 9, 2199. 
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transformation has already been demonstrated in the total synthesis of (+)-discodermolide 
(Chapter 2). The formation of the different regioisomers is due to the unique properties of 
P(TMS)3: it has a large cone angle and electron accepting ability,
17
 which facilitate 
reductive elimination to furnish1,3-diol 4.39 before allyl isomerization of 4.37 that will 
lead to 1,5-diol 4.38 (Scheme 4.5). 
Scheme 4.7. Ligand Effect on Regioselectivity 
 
A Ni-catalyzed enantioselective silaborylative diene-aldehyde coupling reaction 
was disclosed by Saito and Sato (Scheme 4.8).
 18 
A silylboron reagent, PhMe2Si-B(pin), 
was employed in this process along with 1,3-dienes (4.49 and 4.53) and aldehydes in the 
presence of nickel catalyst and chiral phosphoramidite ligand 4.55 (Scheme 4.8). High 
levels of enantioselectivity were observed for electron rich aromatic aldehyde 4.48-OMe 
and aliphatic aldehyde 4.51; however, electron deficient aldehyde 4.48-CF3 gave poor 
yield while maintaining good enantiomeric excess. It is worth noting that the coupling 
product has an embedded α-chiral allylsilane functionality, making it a useful reagent for 
                                                     
17
 (a) Bartik, T.; Himmler, T.; Schulte, H.-G.; Seevogel, K. J. Organomet. Chem. 1984, 272, 29. 
(b) McCampbell, T. A.; Kinkel, B. A.; Miller, S. M. Helm, M. L. J. Chem. Crystallogr. 2006, 36, 
271. 
18
 Saito, N.; Kobayashi, A.; Sato, Y. Angew. Chem. Int. Ed. 2012, 51, 1228. 
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polyketide synthesis (Chapter 1). Internal diene 4.53 also participated in this reaction to 
furnish the anti/anti-stereotriad 4.54 with high diastereo- and enantioselectivity, albeit in 
low yield. This coupling reaction represents the first example of intermolecular 
asymmetric coupling of an aldehyde and di-π-reagent with a bimetallic reagent. 
Scheme 4.8. Saito and Sato Asymmetric Diene-Aldehyde Coupling 
 
 Most of the aforementioned examples employed aldehydes as electrophiles; 
ketones, on the other hand, are underdeveloped and rarely used in multicomponent 
coupling reaction, especially in an intermolecular fashion.
19
 Since borylative diene-
aldehyde coupling reactions worked exceptionally well (Scheme 4.5 and 4.7), it would be 
                                                     
19
 For diene-carbonyl couplings that employ ketones, see: (a) Sato, Y.; Takimoto, M.; Hayashi, K.; 
Katsuhara, T.; Takagi, K.; Mori, M. J. Am. Chem. Soc. 1994, 116, 9771. (b) Sato, Y.; Takimoto, 
M.; Mori, M. Tetrahedron Lett. 1996, 37, 887. (c) Kimura, M.; Fujimatsu, H.; Ezoe, A.; Shibata, 
K.; Shimizu, M.; Matsumoto, S.; Tamaru, Y. Angew. Chem., Int. Ed. 1999, 38, 397. (d) Kimura, 
M.; Matsuo, S.; Shibata, K.; Tamaru, Y. Angew. Chem., Int. Ed. 1999, 38, 3386. (e) Sato, Y.; 
Takimoto, M.; Mori, M. J. Am. Chem. Soc. 2000, 122, 1624. (f) Ezoe, A.; Kimura, M.; Inoue, T.; 
Mori, M.; Tamaru, Y. Angew. Chem., Int. Ed. 2002, 41, 2784. (g) Kimura, M.; Kojima, K.; 
Tamaru, Y. Synthesis 2004, 3089. (h) Kimura, M.; Ezoe, A.; Mori, M.; Tamaru, Y. J. Am. Chem. 
Soc. 2005, 127, 201. (i) Kimura, M.; Ezoe, A.; Mori, M.; Iwata, K.; Tamaru, Y. J. Am. Chem. Soc. 
2006, 128, 8559.  
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interesting to apply such strategy to ketone (4.56) electrophiles and to determine whether 
the high stereoselection would be maintained (Scheme 4.9). Moreover, this 
transformation would provide a synthetically useful product containing the biologically 
important tertiary alcohol functionality, which is hard to prepare in a diastereoselective 
fashion.
20
 
Scheme 4.9. Proposed Borylative Diene Ketone Coupling 
 
4.3 Development of Ni-Catalyzed Borylative Diene-Ketone Coupling 
Reactions 
 Acetophenone 4.58 and trans-pentadiene 4.31 were chosen as model substrates to 
initiate the proposed ketone-diene coupling reaction. We first evaluated a number of 
monodentate phosphine ligands which were known to play an important role in metal 
catalyzed reactions (Table 4.1, entry 1-6). Under similar reaction conditions shown in 
Scheme 4.5 and 4.7 (10 mol % Ni(cod)2, 15 mol % ligand, 2.0 equiv B2(pin)2 in THF), 
tri-tert-butylphosphine was the only ligand that afforded the desired tertiary alcohol 
product 4.60 with good yield and excellent diastereoselectivity after oxidative work-up 
(Table 4.1, entry 6). In addition to achiral phosphines, several chiral monodentate ligands 
were tested and proved to be non-effective (data not shown). The multicomponent 
coupling reaction was also temperature dependent (Table 4.1, entry 6-8). Lower reaction 
temperature (0 
o
C) caused diminished conversion (Table 4.1, entry 7), while elevated 
                                                     
20
 (a) Garcia, C.; Martin, V. S. Curr. Org. Chem. 2006, 10, 1849. (b) Riant, O.; Hannedouche, J 
Org. Biomol. Chem. 2007, 5, 873. (c) For selected review, see: Shibasaki, M.; Kanai, M. Chem.l 
Rev. 2008, 108, 2853. 
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temperature proved to be detrimental to diastereoselectivity (Table 4.1, entry 8). It was 
also crucial to use excess diboron reagent to obtain good yield in a reasonable reaction 
time period. Thus, the most effective reaction condition was identified as using P(t-Bu)3 
ligand at room temperature for nickel-catalyzed borylative diene-ketone three-component 
coupling reaction. 
Table 4.1. Reaction Condition Screening 
 
entry ligand temperature yield (%)
a 
dr
b 
1 PCy3 rt 0 n/a 
2 P(OEt)3 rt 0 n/a 
3 PPh3 rt 0 n/a 
4 P(TMS)3 rt 0 n/a 
5 PMe3 rt 0 n/a 
6 P(t-Bu)3 rt 76 >20:1 
7 P(t-Bu)3 0 
o
C <20 n/a 
8 P(t-Bu)3 60 
o
C 47 5:1 
a
 yields refer to isolated yield of purified material. 
b
 stereoselectivity determined by 
1
H 
NMR analysis. 
 With optimized reaction conditions in hand, a number of substrates were 
examined for this ketone-diene coupling reaction. Various acetophenone derivatives were 
tested, and, pleasingly, they participated in the multicomponent coupling reaction to 
afford tertiary alcohol containing products with good yield and excellent diastereo-
selectivity (Table 4.2). Para-methyl substitution (4.61) was tolerated (Table 4.2, entry 1) 
as well as fluorine substitution on any position of the phenyl ring (ortho-4.67, meta-4.63, 
para-4.65) (Table 4.2, entry 2-4). Aryl chloride moiety (4.69) also survived in this nickel 
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catalysis to deliver the corresponding 1,3-diol 4.70 (Table 4.2, entry 5). Furthermore, 
aromatic rings with either highly electron-withdrawing (4.71) or electron-donating groups 
(4.73 and 4.75) were also competent reaction partners for this transformation (Table 4.2, 
entry 6-8). Besides substituted benzene rings, 2-naphthyl (4.77) and 2-furyl (4.79) 
substituted methyl ketones were successfully coupled with trans-pentadiene and B2(pin)2 
to afford the corresponding tertiary alcohols (Table 4.2, entry 9 and 10). In all cases 
surveyed, >20:1 syn:anti diastereoselectivity was observed in the coupling reaction 
products. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 328 
 
Table 4.2. Borylative Coupling Reactions with Aryl Methyl ketones 
 
entry substrate product yield (%)
a 
dr
b 
1 
  
79 >20:1 
2 
  
73 >20:1 
3 
  
71 >20:1 
4 
  
70 >20:1 
5 
  
63 >20:1 
6 
  
63 >20:1 
7 
  
69 >20:1 
8 
  
52 >20:1 
9 
  
72 >20:1 
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10 
  
51 >20:1 
11 
  
24 >20:1 
a
 yields refer to isolated yield of purified material; value is an average of two or more 
experiments. 
b
 stereoselectivity was determined by 
1
H NMR analysis. 
 
 Whereas functionalized aryl methyl ketones formed highly diastereoselective 1,3-
diols with good yield and stereoselection, dialkylketones delivered regioisomeric 1,5-
diols (Table 4.3). For example, 4-phenyl-2-butanone (4.83) (Table 4.3, entry 1) 
underwent cross coupling with trans-pentadiene and B2(pin)2 to furnish the 1,5-diol 4.84 
in a connection similar to that observed for reactions of benzaldehyde (Scheme 4.5). This 
outcome is in contrast to the regioselectivity of aryl methyl ketones (Table 4.2). It was 
suspected that the reversal in C-C bond connection forming the 1,5-diol occurred because 
of lowered steric encumberance of the carbonyl. To test this hypothesis, the more 
sterically hindered ketone, 3-methyl-2-butanone 4.81, was subject to the reaction 
conditions; as expected, 1,3-diol 4.82 was formed which is the same regioisomeric 
product produced from hindered aryl methyl ketones (Table 4.2, entry 10). Constrained 
cyclic ketones also gave 1,5-diol products with good yield (Table 4.3, entry 2 and 3). It is 
worth pointing out that the product of 4-substituted cyclohexanone 4.89 appears to arise 
by preferred equatorial attachment of the diene to the carbonyl carbon of the substrate 
leading to high diastereoselectivity. 
 
 
 330 
 
Table 4.3. Borylative Coupling Reactions with Diakylketones 
 
entry substrate product yield (%)
a 
dr
b 
1 
  
69 7:1 
2 
 
 
56 - 
3 
 
 
52 - 
4 
  
53 >20:1 
a
 yields refer to isolated yield of purified material; value is an average of two or more 
experiments. 
b
 stereoselectivity determined by 
1
H NMR analysis. 
 
 In the same context, when isoprene 4.91 was employed in the multicomponent 
coupling reaction instead of trans-pentadiene, 1,5-diol 4.92 was produced, albeit in lower 
yield (Scheme 4.10). 
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Scheme 4.10. Borylative Coupling Reaction with Acetophenone and Isoprene 
 
 As mentioned above, the borylative diene-ketone coupling reactions constructed 
not only the challenging tertiary alcohol moiety but also a synthetically useful 
allylboronic ester. So far, the only utility demonstrated for the versatile allylboron 
substituent has been the oxidation to allylic alcohols (Table 4.2 and 4.3); however, 
allylboronic esters can participate in various transformations, such as allylation with a 
carbonyl (Chapter 1). Thus, it was considered that in the presence of a second carbonyl 
group, a cascade intramolecular allylation would take place.
21
 To initiate the borylative 
bisketone-diene coupling reactions, 1,3-cyclohexanedione 4.93 was treated with trans-
pentadiene 4.31 and B2(pin)2 in the presence of catalytic Ni(cod)2 and P(t-Bu)3 (Scheme 
4.11). We were pleased to see that both the three-component coupling reaction and a 
cascade intramolecular allylation worked smoothly to provide a bicyclic molecule (4.94) 
with moderate yield and excellent diastereoselectivity. This tandem reaction directly 
constructed a structurally, functionally, and stereochemically enriched product whose 
synthesis would otherwise require multiple steps. 
 
 
 
 
                                                     
21
 For similar strategy, see: Ferris, G. E.; Hong, K. Roundtree, I. A. Morken, J. P. J. Am. Chem. 
Soc. 2013, 135, 2501. 
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Scheme 4.11. Tandem Bisketone-Diene Coupling/Allylation Reaction 
 
 Due to the similarities of this reaction and the borylative diene-aldehyde coupling 
reactions (Scheme 4.5 and Scheme 4.7), they should share similar mechanism which can 
be used to understand the different regiochemical outcome of the coupling processes with 
hindered and non-hindered carbonyl substrates (Scheme 4.12). The reaction of less 
hindered carbonyl 4.95 with trans-pentadiene 4.31 occurs to give a nickelacycle 4.96. 
Subsequent σ-bond metathesis with B2(pin)2 delivers an intermediate 4.97, which 
undergoes fast π-σ-π isomerization prior to reductive elimination, providing Ni-complex 
4.98. This complex then gives 1,5-bisboronate 4.99 after reductive elimination. 
 For more hindered carbonyls 4.96, it is tenable that steric effects retard C-C bond 
formation with the substituted terminus of the diene 4.31 and, instead, the less hindered 
end of the diene 4.31 adds to carbonyl. The formation of this new C-C bond leads to a 
nickelacycle 4.101, and subsequent σ-bond metathesis gave a nickel-complex 
intermediate 4.102, a compound that undergoes reductive elimination furnishing 1,3-
bisboronic ester 4.103. It is conceivable that, with a substituted allyl metal as in 4.102, 
the π-σ-π isomerization is retarded relative to reductive elimination and the geometry of 
the initial bond metathesis product 4.102 dictates the regiochemical outcome of the 
reaction. 
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Scheme 4.12. Proposed Reaction Mechanism for Diene-Ketone Coupling Reactions 
 
4.4 Conclusion 
 We have extended the borylative carbonyl-diene coupling reaction to less reactive 
ketone substrates and that it occurs in a regio- and stereoselective fashion. Moreover, the 
regioselection for different ketone substrates has been explained by the known 
mechanism, which can serve as a guide to predict the reaction outcome. This 
multicomponent coupling reaction delivers corresponding product with synthetically 
valuable tertiary alcohol as well as allyl alcohol/allyl boronic ester. In the presence of a 
second carbonyl, the embedded allyl boronic ester in the ketone-diene coupling product 
could participate in a cascade reaction to construct a highly diastereoselective bicyclic 
compound.  
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The future work would focus on synthesizing an efficient chiral phosphine ligand 
for asymmetric borylative carbonyl-diene coupling reaction, providing a new route for 
polyketide natural product syntheses (Chapter 1).  
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4.5. Experimental Procedure 
 
General Information  
 
1
H NMR spectra were recorded on either a Varian Gemini-400 (400 MHz), or a 
Varian Inova-500 (500 MHz) spectrometer. Chemical shifts are reported in ppm with the 
solvent resonance as the internal standard (CDCl3: 7.26 ppm, C6D6: 7.16 ppm). Data are 
reported as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, qn = quintet, br = broad, and m = multiplet), coupling constants (Hz), 
and assignment. 
13
C NMR spectra were recorded on either a Varian Gemini-400 (100 
MHz), or a Varian Inova-500 (125 MHz) spectrometer with complete proton decoupling. 
Chemical shifts are reported in ppm with the solvent resonance as the internal standard 
(CDCl3: 77.23 ppm). Infrared (IR) spectra were recorded on a Bruker alpha 
spectrophotometer, νmax cm
-1
. Bands are characterized as broad (br), strong (s), medium 
(m), and weak (w). High resolution mass spectrometry was performed at the Mass 
Spectrometry Facility, Boston College, MA.  
Liquid Chromatography was performed using forced flow (flash chromatography) 
on silica gel (SiO2, 40-63 m) purchased from Silicycle. Thin Layer Chromatography 
was performed on 25 m silica gel plates purchased from Silicycle. Visualization was 
performed using ultraviolet light (254 nm), phosphomolybdic acid (PMA) in ethanol, 
potassium permanganate (KMnO4) in water, or cerium (IV) sulfate and ammonium 
molybdate in sulfuric acid. 
All reactions were conducted in oven- or flame-dried glassware under an inert 
atmosphere of nitrogen or argon. Tetrahydrofuran (THF), dichloromethane, and diethyl 
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ether were purified using a Pure Solv MD-4 solvent purification system from Innovative 
Technology Inc. Bis(pinacolato)diboron [B2(pin)2] was obtained from AllyChem Co., Ltd. 
and recrystallized from pentane prior to use. Ketones were purchased from Aldrich and 
distilled/recrystallized prior to use. Bis(1,5-cyclooctadiene)nickel(0) [Ni(cod)2] and 
phosphine ligands were purchased from Strem Chemicals, Inc. and used without further 
purification. 1,3-trans-pentadiene was purchased from ChemSampCo and distilled prior 
to use. All other reagents were purchased from either Fisher or Aldrich and used without 
further purification. 
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I. General Procedure for Borylative Ketone‒Diene Coupling 
 
An oven-dried 20 mL scintillation vial, equipped with a magnetic stir-bar, was 
charged with Ni(cod)2 (0.05 mmol, 0.10 equiv), P(t-Bu)3 (0.075 mmol, 0.15 equiv), and 
THF (2.5 mL, 0.2 M) in a dry box under an argon atmosphere. After stirring for 5 min, 
the ketone (0.5 mmol. 1.0 equiv), trans-1,3-pentadiene (1.0 mmol, 2.0 equiv), and 
B2(pin)2 (1.0 mmol, 2.0 equiv) were added sequentially. The vial was sealed with a 
polypropylene cap and removed from the dry box. The reaction mixture was then allowed 
to stir at ambient temperature for 48 h. After this time, the mixture was cooled to 0 
o
C 
(ice-water bath), and 2 mL of 3 M NaOH and 1.5 mL of 30% H2O2 were added dropwise 
with caution. The mixture was then allowed to stir at ambient temperature for 10 h. The 
resulting solution was cooled to 0 
o
C and quenched by the addition of 2 mL of saturated 
aqueous Na2S2O3. The two-phase mixture was extracted with ethyl acetate (3 × 20 mL), 
and the combined organic layers were dried over anhydrous Na2SO4. The drying agent 
was removed by filtration and the solvent was evaporated in vacuo. The crude material 
was purified by silica gel chromatography (hexanes/EtOAc) to afford the title compounds. 
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II. Full Characterization Data of Products 
 
(2S*,4R*,E)-2-Phenylhept-5-ene-2,4-diol (Table 4.1, entry 6). 
The reaction was performed according to the general procedure 
with 13.8 mg (0.05 mmol) of Ni(cod)2, 15.2 mg (0.075 mmol) of P(t-Bu)3, 60.1 mg (0.5 
mmol) of acetophenone, 68.1 mg (1.0 mmol) of trans-1,3-pentadiene, and 253.9 mg (1.0 
mmol) of B2(pin)2 in THF (2.5 mL) for 48 h, followed by oxidation, to afford the title 
compound 4.60 as a colorless oil (78.2 mg, 76% yield). Rf = 0.32 (1:1 hexanes:Et2O); 
1
H 
NMR (500 MHz, CDCl3):  7.46 (2H, d, J = 7.5 Hz), 7.34 (2H, t, J = 7.0 Hz), 7.23 (1H, t, 
J = 7.0 Hz), 5.68 (1H, dq, J = 15.5 Hz, 6.5 Hz), 5.47 (1H, dd, J = 15.5 Hz, 7.0 Hz), 4.52 
(1H, br t, J = 7.5 Hz), 3.66 (1H, br s), 2.89 (1H, br s), 1.97 (1H, dd, J = 15.0 Hz, 10.0 Hz), 
1.85 (1H, dd, J = 15.0 Hz, 3.0 Hz), 1.67 (3H, s), 1.66 (3H, d, J = 6.0 Hz); 
13
C NMR (125 
MHz, CDCl3): 149.2, 133.9, 128.4, 127.1, 126.8, 124.5, 74.8, 71.0, 49.5, 28.3, 17.7; IR 
(neat): 3328 (br), 2973 (w), 2915 (w), 1446 (m), 1375 (m), 1211 (m), 1099 (m), 1065 (s), 
964 (s), 842 (m), 761 (s), 698 (s), 565 (m) cm
-1
; HRMS (ESI+) calculated for C13H15 [M–
2H2O+H]
+
: 171.1174, found:  171.1182. 
 
Proof of Stereochemistry. The relative configuration was assigned as syn (C2-C4) by 
analysis of the spectral data, after conversion of the title compound 4.60 into SI-1 as 
shown below.   
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(2S*,4S*,6R*)-2,4-Dimethyl-4-phenyl-6-((E)-prop-1-en-1-yl)-1,3-dioxane (SI-1). A 
flame-dried 10 mL round-bottom flask, equipped with a magnetic stir-bar, was charged 
with diol 4.60 (59.8 mg, 0.29 mmol, 1 equiv), acetaldehyde (25.5 mg, 0.58 mmol, 2 
equiv), p-toluenesulfonic acid (2.9 mg, 0.015 mmol, 0.05 equiv), and dichloromethane 
(1.5 mL, 0.2 M). After stirring at ambient temperature for 6 h, a saturated aqueous 
NaHCO3 solution was added. The reaction mixture was extracted with diethyl ether (3 × 
10 mL) and the organic layer was washed with brine. The combined organic layers were 
dried over anhydrous Na2SO4. The drying agent was removed by filtration and the 
solvent was evaporated in vacuo. The crude product was purified by silica gel 
chromatography to afford SI-1 as a colorless oil. Rf = 0.23 (9:1 hexanes:Et2O); 
1
H NMR 
(500 MHz, CDCl3):  7.46 (2H, d, J = 8.5 Hz), 7.34 (2H, t, J = 8.5 Hz), 7.24 (1H, t, J = 
8.5 Hz), 5.79 (1H, dq, J = 15.5 Hz, 6.5 Hz), 5.49 (1H, dd, J = 15.5 Hz, 7.0 Hz), 5.25 (1H, 
q, J = 5.0 Hz), 4.37-4.33 (1H, m), 1.83 (1H, dd, J = 13.5 Hz, 3.0 Hz), 1.77 (1H, dd, J = 
14.0 Hz, J = 11.5 Hz), 1.71 (3H, d, J = 6.0 Hz), 1.63 (3H, s), 1.44 (3H, d, J = 5.0 Hz); 
13
C 
NMR (125 MHz, CDCl3): 148.9, 131.2, 128.5, 128.3, 126.8, 124.1, 92.3, 74.6, 73.6, 
42.0, 23.2, 21.8, 17.9; IR (neat): 2980 (w), 2934 (w), 2852 (w), 1495 (w), 1447 (m), 1405 
(w), 1378 (w), 1173 (m), 1121 (s), 1042 (w), 969 (s), 937 (w), 763 (m), 676 (s), 544 (w) 
cm
-1
; HRMS (ESI+) calculated for C15H24NO2 [M+NH4]
+
: 250.1807, found:  250.1806. 
 
 (2S*,4R*,E)-2-(p-Tolyl)hept-5-ene-2,4-diol (Table 4.2, 
entry 1). The reaction was performed according to the 
general procedure with 13.8 mg (0.05 mmol) of Ni(cod)2, 15.2 mg (0.075 mmol) of P(t-
Bu)3, 67.1 mg (0.5 mmol) of 4′-methylacetophenone, 68.1 mg (1.0 mmol) of trans-1,3-
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pentadiene, and 253.9 mg (1.0 mmol) of B2(pin)2 in THF (2.5 mL) for 48 h, followed by 
oxidation, to afford the title compound 4.62 as a colorless oil (86.9 mg, 79% yield). Rf = 
0.26 (1:1 hexanes:Et2O); 
1
H NMR (500 MHz, CDCl3):  7.35 (2H, d, J = 8.5 Hz), 7.15 
(2H, d, J = 8.5 Hz), 5.69 (1H, dq, J = 15.5 Hz, 6.5 Hz), 5.48 (1H, dd, J = 15.0 Hz, 7.0 
Hz), 4.52 (1H, br t, J = 7.5 Hz), 3.32 (1H, br s), 2.71 (1H, br s), 2.33 (3H, s), 1.96 (1H, dd, 
J = 15.0 Hz, 10.5 Hz), 1.85 (1H, dd, J = 15.0 Hz, 3.0 Hz), 1.67 (3H, d, J = 6.0 Hz), 1.66 
(3H, s); 
13
C NMR (125 MHz, CDCl3): 146.3, 136.4, 134.0, 129.1, 127.0, 124.4, 74.8, 
71.0, 49.6, 28.4, 21.1, 17.7; IR (neat): 3331 (br), 2973 (m), 2917 (m), 2883 (w), 1514 (w), 
1450 (m), 1420 (m), 1375 (m), 1218 (m), 1207 (m), 1135 (m), 1094 (s), 1074 (s), 1043 
(m), 1020 (w), 965 (s), 846 (s), 817 (s), 723 (w), 565 (s), 504 (w) cm
-1
; HRMS (ESI+) 
calculated for C14H17 [M–2H2O+H]
+
: 185.1330, found:  185.1336. 
 
Proof of Stereochemistry. The relative configuration was assigned as syn (C2-C4) by 
analysis of the spectral data, after conversion of the title compound 4.62 into SI-2 as 
shown below.   
 
(2S*,4S*,6R*)-2,4-Dimethyl-6-((E)-prop-1-en-1-yl)-4-(p-tolyl)-1,3-dioxane (SI-2). 
The acetonide (SI-2) was prepared in the same method as described for acetonide SI-1. Rf 
= 0.22 (9:1 hexanes:Et2O); 
1
H NMR (500 MHz, CDCl3):  7.34 (2H, d, J = 8.5 Hz), 7.15 
(2H, d, J = 8.5 Hz), 5.78 (1H, dq, J = 15.0 Hz, 6.0 Hz), 5.48 (1H, dd, J = 15.5 Hz, 7.0 
Hz), 5.23 (1H, q, J = 5.0 Hz), 4.36-4.32 (1H, m), 2.33 (3H, s), 1.80 (1H, dd, J = 13.5 Hz, 
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3.0 Hz), 1.75 (1H, dd, overlapped), 1.70 (3H, d, J = 6.5 Hz), 1.61 (3H, s), 1.43 (3H, d, J = 
5.5 Hz); 
13
C NMR (125 MHz, CDCl3): 146.1, 136.3, 131.3, 129.0, 128.5, 124.0, 92.3, 
74.5, 73.6, 42.1, 23.2, 21.8, 21.1, 18.0; IR (neat): 3024 (w), 2990 (m), 2937 (m), 2919 
(m), 2869 (w), 1515 (w), 1450 (w), 1406 (m), 1377 (w), 1172 (s), 1115 (s), 969 (s), 875 
(w), 837 (w), 817 (m), 721 (w), 560 (w), 460 (w) cm
-1
; HRMS (ESI+) calculated for 
C16H26NO2 [M+NH4]
+
: 264.1963, found:  264.1953. 
 
 (2S*,4R*,E)-2-(3-Fluorophenyl)hept-5-ene-2,4-diol 
(Table 4.2, entry 2). The reaction was performed according 
to the general procedure with 13.8 mg (0.05 mmol) of Ni(cod)2, 15.2 mg (0.075 mmol) of 
P(t-Bu)3, 69.1 mg (0.5 mmol) of 3′-fluoroacetophenone, 68.1 mg (1.0 mmol) of trans-
1,3-pentadiene, and 253.9 mg (1.0 mmol) of B2(pin)2 in THF (2.5 mL) for 48 h, followed 
by oxidation, to afford the title compound 4.64 as a colorless oil (81.8 mg, 73% yield). Rf 
= 0.27 (1:1 hexanes:Et2O); 
1
H NMR (500 MHz, CDCl3):  7.31-7.26 (1H, m), 7.22-7.19 
(2H, m), 6.94-6.89 (1H, m), 5.69 (1H, dq, J = 15.5 Hz, 6.5 Hz), 5.46 (1H, dd, J = 15.0 Hz, 
7.0 Hz), 4.53 (1H, br t, J = 8.0 Hz), 3.93 (1H, br s), 2.58 (1H, br s), 1.93 (1H, dd, J = 14.0 
Hz, 9.5 Hz), 1.83 (1H, dd, J = 14.5 Hz, 3.0 Hz), 1.67 (3H, d, J = 6.5 Hz), 1.65 (3H, s); 
13
C NMR (125 MHz, CDCl3): 163.0 (d, 
1
JCF = 244.4 Hz), 152.1, 133.7, 129.7, 127.4, 
120.2, 113.5 (d, 
2
JCF = 20.7 Hz), 111.9 (d, 
2
JCF = 22.5 Hz), 74.4, 71.2, 49.2, 28.3, 17.7; 
IR (neat): 3239 (br), 2940 (m), 2879 (m), 1614 (m), 1589 (s), 1485 (m), 1439 (s), 1377 
(m), 1272 (m), 1252 (m), 1178 (m), 966 (s), 786 (m), 699 (s) cm
-1
; HRMS (ESI+) 
calculated for C13H21FNO2 [M+NH4]
+
: 242.1556, found:  242.1565. 
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Proof of Stereochemistry. The relative configuration was assigned as syn (C2-C4) by 
analysis of the spectral data, after conversion of the title compound 4.64 into SI-3 as 
shown below.   
 
(2S*,4S*,6R*)-4-(3-Fluorophenyl)-2,4-dimethyl-6-((E)-prop-1-en-1-yl)-1,3-dioxane 
(SI-3). The acetonide (SI-3) was prepared in the same method as described for acetonide 
SI-1. Rf = 0.23 (9:1 hexanes:Et2O); 
1
H NMR (500 MHz, CDCl3):  7.31-7.27 (1H, m), 
7.22-7.17 (2H, m), 6.94-6.90 (1H, m), 5.79 (1H, dq, J = 15.5 Hz, 6.0 Hz), 5.36 (1H, dd, J 
= 15.5 Hz, 8.5 Hz), 5.33 (1H, q, J = 5.0 Hz), 4.36-4.32 (1H, m), 1.81 (1H, dd, J = 13.0 
Hz, 2.5 Hz), 1.74 (1H, dd, overlapped), 1.71 (3H, d, J = 6.5 Hz), 1.61 (3H, s), 1.44 (3H, d, 
J = 5.0 Hz); 
13
C NMR (125 MHz, CDCl3): 163.0 (d, 
1
JCF = 244.4 Hz), 151.7, 131.0, 
129.7, 128.7, 119.6, 113.6 (d, 
2
JCF = 21.1 Hz), 111.5 (d, 
2
JCF = 23.1 Hz), 92.4, 74.4, 73.5, 
41.9, 23.2, 21.7, 17.9; IR (neat): 2989 (w), 2939 (w), 2873 (w), 1618 (w), 1589 (m), 1484 
(w), 1437 (w), 1271 (m), 1156 (s), 1109 (s), 1040 (w), 968 (s), 899 (m), 864 (m), 784 (s), 
744 (s), 482 (w) cm
-1
; HRMS (ESI+) calculated for C15H23FNO2 [M+NH4]
+
: 268.1713, 
found:  268.1708. 
 
 (2S*,4R*,E)-2-(4-Fluorophenyl)hept-5-ene-2,4-diol 
(Table 4.2, entry 3). The reaction was performed according 
to the general procedure with 13.8 mg (0.05 mmol) of Ni(cod)2, 15.2 mg (0.075 mmol) of 
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P(t-Bu)3, 69.1 mg (0.5 mmol) of 4′-fluoroacetophenone, 68.1 mg (1.0 mmol) of trans-
1,3-pentadiene, and 253.9 mg (1.0 mmol) of B2(pin)2 in THF (2.5 mL) for 48 h, followed 
by oxidation, to afford the title compound 4.66 as a colorless oil (79.3 mg, 71% yield). Rf 
= 0.23 (1:1 hexanes:Et2O); 
1
H NMR (500 MHz, CDCl3):  7.43-7.41 (2H, m), 7.02-6.98 
(2H, m), 5.68 (1H, dq, J = 15.0 Hz, 6.5 Hz), 5.46 (1H, dd, J = 15.5 Hz, 7.0 Hz), 4.52 (1H, 
br t, J = 7.5 Hz), 3.88 (1H, br s), 2.71 (1H, br s), 1.92 (1H, dd, J = 15.0 Hz, 10.5 Hz), 
1.81 (1H, dd, J = 14.5 Hz, 2.5 Hz), 1.66 (3H, d, J = 6.0 Hz), 1.65 (3H, s); 
13
C NMR (125 
MHz, CDCl3): 161.7 (d, 
1
JCF = 244.4 Hz), 145.0, 133.8, 127.3, 126.3, 114.9 (d, 
2
JCF = 
21.2 Hz), 74.4, 71.2, 49.5, 28.3, 17.7; IR (neat): 3324 (br), 2941 (m), 2876 (m), 1602 (w), 
1510 (s), 1420 (w), 1375 (w), 1223 (s), 1160 (m), 1090 (m), 1074 (w), 967 (m), 849 (m), 
836 (s), 814 (w), 563 (w) cm
-1
; HRMS (ESI+) calculated for C13H14F [M–2H2O+H]
+
: 
189.1080, found:  180.1083. 
 
Stereochemistry. The relative configuration was assigned as syn (C2-C4) by analogy. 
 
 (2S*,4R*,E)-2-(2-Fluorophenyl)hept-5-ene-2,4-diol (Table 
4.2, entry 4). The reaction was performed according to the 
general procedure with 13.8 mg (0.05 mmol) of Ni(cod)2, 15.2 mg (0.075 mmol) of P(t-
Bu)3, 69.1 mg (0.5 mmol) of 2′-fluoroacetophenone, 68.1 mg (1.0 mmol) of trans-1,3-
pentadiene, and 253.9 mg (1.0 mmol) of B2(pin)2 in THF (2.5 mL) for 48 h, followed by 
oxidation, to afford the title compound 4.68 as a colorless oil (70.9 mg, 63% yield). Rf = 
0.31 (1:1 hexanes:Et2O); 
1
H NMR (500 MHz, CDCl3):  7.67 (1H, t, J = 8.0 Hz), 7.24-
7.20 (1H, m), 7.14 (1H, t, J = 8.0 Hz), 7.00 (1H, dd, J = 12.0 Hz, 8.0 Hz), 5.68 (1H, dq, J 
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= 15.5 Hz, 7.0 Hz), 5.45 (1H, dd, J = 15.0 Hz, 7.0 Hz), 4.55 (1H, br t, J = 7.5 Hz), 3.99 
(1H, br s), 2.47 (1H, br s), 2.17 (1H, dd, J = 14.5 Hz, 3.0 Hz), 1.99 (1H, dd, J = 15.0 Hz, 
10.0 Hz), 1.70 (3H, s), 1.65 (3H, d, J = 6.5 Hz); 
13
C NMR (125 MHz, CDCl3): 159.5 (d, 
1
JCF = 243.7 Hz), 135.6, 135.5, 133.7, 128.6, 127.1 (d, 
2
JCF = 21.6 Hz), 124.2, 116.0 (d, 
2
JCF = 24.0 Hz), 73.6, 71.1, 46.5, 27.5, 17.7; IR (neat): 3340 (br), 2972 (w), 2917 (w), 
1614 (w), 1485 (m), 1448 (s), 1376 (w), 1214 (s), 1066 (m), 1037 (w), 965 (m), 818 (m), 
757 (s), 447 (w) cm
-1
; HRMS (ESI+) calculated for C13H14F [M–2H2O+H]
+
: 189.1079, 
found:  189.1074. 
 
Proof of Stereochemistry. The relative configuration was assigned as syn (C2-C4) by 
analysis of the spectral data, after conversion of the title compound 4.68 into SI-4 as 
shown below.   
 
(2S*,4S*,6R*)-4-(2-Fluorophenyl)-2,4-dimethyl-6-((E)-prop-1-en-1-yl)-1,3-dioxane 
(SI-4). The acetonide (SI-4) was prepared in the same method as described for acetonide 
SI-1. Rf = 0.33 (9:1 hexanes:Et2O); 
1
H NMR (500 MHz, CDCl3):  7.69 (1H, t, J = 8.0 
Hz), 7.23-7.19 (1H, m), 7.13 (1H, t, J = 7.5 Hz), 6.98 (1H, dd, J = 12.0 Hz, 8.0 Hz), 5.78 
(1H, dq, J = 15.0 Hz, 6.5 Hz), 5.46 (1H, dd, J = 15.5 Hz, 7.0 Hz), 5.26 (1H, q, J = 5.0 
Hz), 4.37-4.33 (1H, m), 2.21 (1H, dd, J = 13.5 Hz, 2.5 Hz), 1.71 (1H, dd, overlapped), 
1.69 (3H, d, J = 6.5 Hz), 1.69 (3H, s), 1.45 (3H, d, J = 5.0 Hz); 
13
C NMR (125 MHz, 
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CDCl3): 159.4 (d, 
1
JCF = 245.5 Hz), 135.5, 135.4, 131.1, 128.4 (d, 
2
JCF = 22.2 Hz), 
126.4, 124.1, 115.9 (d, 
2
JCF = 23.2 Hz), 91.9, 73.5, 73.2, 40.0, 21.8, 21.7, 17.9; IR (neat): 
3089 (w), 2991 (w), 2876 (w), 1678 (w), 1616 (w), 1581 (m), 1488 (s), 1449 (w), 1125 
(s), 1110 (s), 1069 (w), 1037 (m), 971 (s), 879 (w), 804 (m), 758 (s), 498 (w) cm
-1
; 
HRMS (ESI+) calculated for C15H23FNO2 [M+NH4]
+
: 268.1713, found:  268.1722. 
 
 (2S*,4R*,E)-2-(3-Chlorophenyl)hept-5-ene-2,4-diol 
(Table 4.2, entry 5). The reaction was performed according 
to the general procedure with 13.8 mg (0.05 mmol) of Ni(cod)2, 15.2 mg (0.075 mmol) of 
P(t-Bu)3, 77.3 mg (0.5 mmol) of 3′-chloroacetophenone, 68.1 mg (1.0 mmol) of trans-
1,3-pentadiene, and 253.9 mg (1.0 mmol) of B2(pin)2 in THF (2.5 mL) for 48 h, followed 
by oxidation, to afford the title compound 4.70 as a colorless oil (75.5 mg, 63% yield). Rf 
= 0.33 (1:1 hexanes:Et2O); 
1
H NMR (500 MHz, CDCl3):  7.47 (1H, t, J = 2.0 Hz), 7.33 
(1H, dt, J = 8.0 Hz, 2.0 Hz), 7.26 (1H, t, J = 8.0 Hz), 7.20 (1H, d, J = 8.0 Hz), 5.69 (1H, 
dq, J = 15.5 Hz, 6.5 Hz), 5.46 (1H, dd, J = 15.5 Hz, 7.0 Hz), 4.53 (1H, br t, J = 8.5 Hz), 
3.94 (1H, br s), 2.50 (1H, br s), 1.93 (1H, dd, J = 15.0 Hz, 10.0 Hz), 1.83 (1H, dd, J = 
15.0 Hz, 3.0 Hz), 1.67 (3H, d, J = 6.5 Hz), 1.64 (3H, s); 
13
C NMR (125 MHz, CDCl3): 
151.4, 134.3, 133.7, 129.6, 127.4, 126.8, 125.1, 122.8, 74.4, 71.1, 49.1, 28.2, 17.7; IR 
(neat): 3320 (br), 2977 (m), 2897 (m), 1596 (w), 1571 (w), 1421 (s), 1376 (w), 1212 (m), 
1142 (w), 1112 (w), 1080 (m), 965 (s), 894 (w), 850 (w), 785 (s), 699 (s), 495 (w), 406 
(w) cm
-1
; HRMS (ESI+) calculated for C13H14Cl [M–2H2O+H]
+
: 205.0784, found:  
205.0784. 
 
 346 
 
Proof of Stereochemistry. The relative configuration was assigned as syn (C2-C4) by 
analysis of the spectral data, after conversion of the title compound 4.70 into SI-5 as 
shown below.   
 
(2S*,4S*,6R*)-4-(3-Chlorophenyl)-2,4-dimethyl-6-((E)-prop-1-en-1-yl)-1,3-dioxane 
(SI-5). The acetonide (SI-5) was prepared in the same method as described for acetonide 
SI-1. Rf = 0.28 (9:1 hexanes:Et2O); 
1
H NMR (500 MHz, CDCl3):  7.46 (1H, t, J = 1.5 
Hz), 7.31 (1H, d, J = 7.5 Hz), 7.26 (1H, t, J = 8.0 Hz), 7.21 (1H, d, J = 7.5 Hz), 5.79 (1H, 
dq, J = 15.5 Hz, 7.0 Hz), 5.48 (1H, dd, J = 15.5 Hz, 7.0 Hz), 5.22 (1H, q, J = 5.0 Hz), 
4.35-4.31 (1H, m), 1.80 (1H, dd, J = 13.5 Hz, 2.5 Hz), 1.71 (1H, dd, overlapped), 1.70 
(3H, d, J = 6.5 Hz), 1.61 (3H, s), 1.44 (3H, d, J = 5.0 Hz); 
13
C NMR (125 MHz, CDCl3): 
151.0, 134.3, 131.0, 129.6, 128.7, 127.0, 124.6, 122.3, 92.4, 74.4, 73.5, 41.9, 23.3, 21.7, 
17.9; IR (neat): 2990 (w), 2938 (w), 2918 (w), 2876 (w), 1597 (w), 1572 (w), 1474 (w), 
1419 (m), 1407 (m), 1223 (w), 1173 (s), 1124 (s), 1081 (w), 971 (s), 879 (w), 847 (w), 
785 (m), 697 (s), 610 (w) cm
-1
; HRMS (ESI+) calculated for C15H23ClNO2 [M+NH4]
+
: 
284.1417, found:  284.1410. 
 
 (2S*,4R*,E)-2-(3-(Trifluoromethyl)phenyl)hept-5-ene-
2,4-diol (Table 4.2, entry 6). The reaction was performed 
according to the general procedure with 13.8 mg (0.05 mmol) of Ni(cod)2, 15.2 mg 
 347 
 
(0.075 mmol) of P(t-Bu)3, 94.1 mg (0.5 mmol) of 3′-(trifluoromethyl)- acetophenone, 
68.1 mg (1.0 mmol) of trans-1,3-pentadiene, and 253.9 mg (1.0 mmol) of B2(pin)2 in 
THF (2.5 mL) for 48 h, followed by oxidation, to afford the title compound 4.72 as a 
colorless oil (96.3 mg, 70% yield). Rf = 0.27 (1:1 hexanes:Et2O); 
1
H NMR (500 MHz, 
CDCl3):  7.75 (1H, s), 7.64 (1H, d, J = 8.0 Hz), 7.49 (1H, d, J = 7.5 Hz), 7.44 (1H, t, J = 
7.5 Hz), 5.69 (1H, dq, J = 15.5 Hz, 6.5 Hz), 5.46 (1H, dd, J = 15.5 Hz, 7.0 Hz), 4.56 (1H, 
br t, J = 8.0 Hz), 4.19 (1H, br s), 2.50 (1H, br s), 1.94 (1H, dd, J = 14.5 Hz, 10.0 Hz), 
1.85 (1H, dd, J = 15.0 Hz, 3.0 Hz), 1.68 (3H, s), 1.66 (3H, d, J = 6.5 Hz); 
13
C NMR (125 
MHz, CDCl3): 150.3, 133.6, 130.6 (q, 
2
JCF = 31.8 Hz), 128.7, 128.1, 127.7, 124.0 (q, 
1
JCF = 272.1 Hz), 123.6 (q, 
3
JCF = 3.6 Hz), 121.6 (q, 
3
JCF = 3.6 Hz), 74.4, 71.3, 49.2, 28.2, 
17.7; IR (neat): 3333 (br), 2976 (m), 2919 (m), 1438 (w), 1377 (w), 1328 (s), 1207 (w), 
1164 (s), 1122 (s), 1072 (m), 966 (w), 899 (w), 852 (w), 804 (w), 730 (w), 704 (m), 657 
(w) cm
-1
; HRMS (ESI+) calculated for C13H21FNO2 [M+NH4]
+
: 292.1524, found:  
292.1525. 
 
Proof of Stereochemistry. The relative configuration was assigned as syn (C2-C4) by 
analysis of the spectral data, after conversion of the title compound 4.72 into SI-6 as 
shown below.   
 
(2S*,4S*,6R*)-2,4-Dimethyl-6-((E)-prop-1-en-1-yl)-4-(3-(trifluoromethyl)phenyl)-
1,3-dioxane (SI-6). The acetonide (SI-6) was prepared in the same method as described 
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for acetonide SI-1. Rf = 0.23 (9:1 hexanes:Et2O); 
1
H NMR (500 MHz, CDCl3):  7.72 
(1H, s), 7.64 (1H, d, J = 7.5 Hz), 7.50 (1H, d, J = 7.5 Hz), 7.45 (1H, t, J = 7.5 Hz), 5.80 
(1H, dq, J = 15.0 Hz, 6.5 Hz), 5.48 (1H, dd, J = 15.5 Hz, 7.0 Hz), 5.25 (1H, q, J = 5.0 
Hz), 4.38-4.35 (1H, m), 1.85 (1H, dd, J = 13.5 Hz, 2.5 Hz), 1.72 (1H, dd, overlapped), 
1.71 (3H, d, J = 6.5 Hz), 1.64 (3H, s), 1.45 (3H, d, J = 5.0 Hz); 
13
C NMR (125 MHz, 
CDCl3): 149.9, 130.9, 130.6 (q, 
2
JCF = 31.8 Hz), 128.8 (2 C′s), 127.6, 124.4 (q, 
1
JCF = 
272.5 Hz), 123.7 (q, 
3
JCF = 3.6 Hz), 121.1 (q, 
3
JCF = 3.6 Hz), 92.4, 74.4, 73.4, 41.8, 23.3, 
21.7, 18.0; IR (neat): 2990 (w), 2940 (w), 2921 (w), 2878 (w), 1440 (w), 1333 (s), 1287 
(w), 1220 (w), 1165 (s), 1125 (s), 1072 (m), 971 (m), 804 (w), 703 (m), 656 (w), 611 (w), 
546 (w) cm
-1
; HRMS (ESI+) calculated for C16H23F3NO2 [M+NH4]
+
: 318.1681, found:  
318.1694. 
 
 (2S*,4R*,E)-2-(2,3-Dihydrobenzo[b][1,4]dioxin-6-
yl)hept-5-ene-2,4-diol (Table 4.2, entry 7). The reaction 
was performed according to the general procedure with 13.8 mg (0.05 mmol) of Ni(cod)2, 
15.2 mg (0.075 mmol) of P(t-Bu)3, 89.1 mg (0.5 mmol) of 1,4-benzodioxan-6-yl methyl 
ketone, 68.1 mg (1.0 mmol) of trans-1,3-pentadiene, and 253.9 mg (1.0 mmol) of 
B2(pin)2 in THF (2.5 mL) for 48 h, followed by oxidation, to afford the title compound 
4.74 as a colorless oil (90.9 mg, 69% yield). Rf = 0.28 (1:2 hexanes:Et2O); 
1
H NMR (500 
MHz, CDCl3):  6.98 (1H, s), 6.91 (1H, d, J = 9.0 Hz), 6.82 (1H, d, J = 8.5 Hz), 5.67 (1H, 
dq, J = 15.5 Hz, 6.5 Hz), 5.46 (1H, dd, J = 15.0 Hz, 7.0 Hz), 4.49 (1H, br t, J = 8.5 Hz), 
4.25 (4H, s), 3.38 (1H, br s), 2.80 (1H, br s), 1.93 (1H, dd, J = 15.0 Hz, 10.0 Hz), 1.80 
(1H, dd, J = 15.0 Hz, 2.5 Hz), 1.67 (3H, d, J = 6.0 Hz), 1.63 (3H, s); 
13
C NMR (125 MHz, 
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CDCl3): 143.2, 142.8, 142.3, 133.9, 127.0, 117.6, 117.0, 113.8, 74.5, 71.0, 64.5 (2 C′s), 
49.5, 28.3, 17.8; IR (neat): 3412 (br), 2996 (m), 2930 (w), 2854 (w), 1590 (w), 1505 (s), 
1460 (w), 1424 (m), 1377 (m), 1309 (m), 1285 (s), 1258 (m), 1175 (w), 1126 (m), 1100 
(w), 1068 (s), 949 (w), 887 (w), 642 (w), 496 (w)  cm
-1
; HRMS (ESI+) calculated for 
C15H17O2 [M–2H2O+H]
+
: 229.1228, found:  229.1228. 
 
Stereochemistry. The relative configuration was assigned as syn (C2-C4) by analogy. 
 
 (2S*,4R*,E)-2-(4-Methoxyphenyl)hept-5-ene-2,4-diol 
(Table 4.2, entry 8). The reaction was performed 
according to the general procedure with 13.8 mg (0.05 
mmol) of Ni(cod)2, 15.2 mg (0.075 mmol) of P(t-Bu)3, 75.1 mg (0.5 mmol) of 4′-
methoxylacetophenone, 68.1 mg (1.0 mmol) of trans-1,3-pentadiene, and 253.9 mg (1.0 
mmol) of B2(pin)2 in THF (2.5 mL) for 48 h, followed by oxidation, to afford the title 
compound 4.76 as a colorless oil (61.3 mg, 52% yield). Rf = 0.31 (1:2 hexanes:Et2O); 
1
H 
NMR (500 MHz, CDCl3):  7.38 (2H, d, J = 9.0 Hz), 6.87 (2H, d, J = 9.0 Hz), 5.69 (1H, 
dq, J = 15.0 Hz, 6.5 Hz), 5.48 (1H, dd, J = 15.5 Hz, 7.0 Hz), 4.51 (1H, br t, J = 7.5 Hz), 
3.80 (3H, s), 3.35 (1H, br s), 2.72 (1H, br s), 1.96 (1H, dd, J = 14.5 Hz, 10.0 Hz), 1.83 
(1H, dd, J = 15.0 Hz, 3.0 Hz), 1.68 (3H, d, J = 6.5 Hz), 1.66 (3H, s); 
13
C NMR (125 MHz, 
CDCl3): 158.5, 141.5, 134.0, 127.0, 125.7, 113.7, 74.6, 71.1, 55.4, 49.7, 28.4, 17.8; IR 
(neat): 3372 (br), 2938 (w), 2916 (w), 2854 (w), 1611 (w), 1512 (s), 1459 (w), 1442 (w), 
1416 (w), 1302 (m), 1249 (s), 1215 (w), 1179 (s), 1094 (m), 1074 (w), 1035 (m), 966 (m), 
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847 (m), 832 (m), 802 (w), 491 (w)  cm
-1
; HRMS (ESI+) calculated for C14H19O2 [M–
H2O+H]
+
: 219.1385, found:  219.1386. 
 
Stereochemistry. The relative configuration was assigned as syn (C2-C4) by analogy. 
 
 (2S*,4R*,E)-2-(Naphthalen-2-yl)hept-5-ene-2,4-diol 
(Table 4.2, entry 9). The reaction was performed 
according to the general procedure with 13.8 mg (0.05 mmol) of Ni(cod)2, 15.2 mg 
(0.075 mmol) of P(t-Bu)3, 85.1 mg (0.5 mmol) of 2′-acetonaphthone, 68.1 mg (1.0 mmol) 
of trans-1,3-pentadiene, and 253.9 mg (1.0 mmol) of B2(pin)2 in THF (2.5 mL) for 48 h, 
followed by oxidation, to afford 4.78 (92.4 mg, 72% yield). Rf = 0.24 (1:1 hexanes:Et2O); 
1
H NMR (500 MHz, CDCl3):  7.95 (1H, s), 7.85-7.81 (3H, m), 7.56 (1H, dd, J = 8.5 Hz, 
2.0 Hz), 7.49-7.44 (2H, m), 5.70 (1H, dq, J = 15.5 Hz, 6.5 Hz), 5.50 (1H, dd, J = 15.5 Hz, 
7.0 Hz), 4.58 (1H, br t, J = 9.0 Hz), 3.71 (1H, br s), 2.64 (1H, br s), 2.06 (1H, dd, J = 14.5 
Hz, 10.0 Hz), 1.97 (1H, dd, J = 15.0 Hz, 3.5 Hz), 1.76 (3H, s), 1.67 (3H, d, J = 6.5 Hz); 
13
C NMR (125 MHz, CDCl3): 146.5, 133.9, 133.4, 132.4, 128.4, 128.1, 127.6, 127.3, 
126.2, 125.8, 123.5, 122.8, 74.9, 71.2, 49.3, 28.5, 17.7; IR (neat): 3325 (br), 3022 (w), 
2938 (w), 2853 (w), 1600 (w), 1506 (w), 1450 (m), 1435 (m), 1420 (m), 1376 (m), 1186 
(m), 1128 (s), 965 (m), 922 (w), 902 (w), 860 (s), 820 (s), 747 (s), 479 (m) cm
-1
; HRMS 
(ESI+) calculated for C17H17O [M–2H2O+H]
+
: 237.1279, found:  237.1283. 
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Proof of Stereochemistry. The relative configuration was assigned as syn (C2-C4) by 
analysis of the spectral data, after conversion of the title compound (4.78) into SI-7 as 
shown below.   
 
(2S*,4S*,6R*)-2,4-Dimethyl-4-(naphthalen-2-yl)-6-((E)-prop-1-en-1-yl)-1,3-dioxane 
(SI-7). The acetonide (SI-7) was prepared in the same method as described for acetonide 
SI-1. Rf = 0.22 (9:1 hexanes:Et2O); 
1
H NMR (500 MHz, CDCl3):  7.93 (1H, s), 7.86-
7.82 (3H, m), 7.59 (1H, dd, J = 8.5 Hz, 2.0 Hz), 7.49-7.44 (2H, m), 5.83 (1H, dq, J = 15.0 
Hz, 6.5 Hz), 5.52 (1H, dd, J = 15.5 Hz, 7.0 Hz), 5.32 (1H, q, J = 5.0 Hz), 4.44-4.40 (1H, 
m), 1.94 (1H, dd, J = 13.5 Hz, 2.5 Hz), 1.86 (1H, dd, J = 13.0 Hz, J = 11.5 Hz), 1.73 (3H, 
d, overlapped), 1.72 (3H, s), 1.51 (3H, d, J = 5.0 Hz); 
13
C NMR (125 MHz, CDCl3): 
146.2, 133.3, 132.5, 131.2, 128.6, 128.4, 128.0, 127.6, 126.0, 125.8, 123.0, 122.4, 92.4, 
74.8, 73.6, 42.0, 23.2, 21.8, 18.0; IR (neat): 2987 (w), 2936 (w), 2917 (w), 2869 (w), 
1405 (m), 1378 (m), 1163 (m), 1128 (s), 1108 (s), 1040 (w), 966 (s), 935 (m), 856 (m), 
817 (m), 746 (s), 663 (w), 652 (w), 478 (s) cm
-1
; HRMS (ESI+) calculated for C19H26NO2 
[M+NH4]
+
: 300.1963, found:  300.1953. 
 
 (3S,5R,E)-2,3-Dimethyloct-6-ene-3,5-diol (Table 2.4, entry 
11) The reaction was performed according to the general 
procedure with 13.8 mg (0.05 mmol) of Ni(cod)2, 15.3 mg (0.075 mmol) of P(t-Bu)3, 
49.0 mg (0.5 mmol) of 3-methylbutan-2-one, 68.0 mg (1.0 mmol) of trans-1,3-pentadiene, 
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and 253.0 mg (1.0 mmol) of B2(pin)2 in THF (2.5 mL) for 48 h, followed by oxidation, to 
afford the title compound 4.82 as a colorless liquid (47 mg, 51% yield). Rf = 0.49 (1:2 
hexanes:EtOAc); 
1
H NMR (500 MHz, CDCl3): δ 5.57 (1H, qn, J = 7.5 Hz), 5.56 (1H, dd, 
J = 15.5 Hz, 6.5 Hz), 4.25 (1H, qn, J = 6.5 Hz), 2.17 (1H, dd, J = 7.5 Hz, 7.0 Hz), 2.10 
(1H, dd, J=7.5 Hz, 7.0 Hz), 1.62 (1H, m), 1.53 (1H, br s), 1.21 (3H, d, J = 6.5 Hz), 1.01 
(3H, s), 0.86 (3H, d, J = 6.5 Hz), 0.84 (3H, d, J = 7.0 Hz); 
13
C NMR (100 MHz, CDCl3): 
δ 138.4, 125.8, 77.6, 68.9, 42.4, 37.0, 23.3, 23.0, 17.7, 17.0; IR (neat): 3371 (br), 2969 (s), 
2931 (s), 2877 (m), 1454 (w), 1385 (m), 1370 (m), 1218 (w), 1154 (w), 1063 (m), 974 
(m), 927 (w), 862 (w), 612 (w) cm
-1
; HRMS (ESI+) calculated for C10H20O2 [M+H
+
]
+
: 
173.1541, found:  173.1540. 
 
Proof of Stereochemistry. The relative configuration was assigned as syn (C2-C4) by 
analogy. 
 
 (4S*,5R*,E)-4,5-Dimethyl-7-phenylhept-2-ene-1,5-diol 
(Table 4.3, entry 1). The reaction was performed 
according to the general procedure with 13.8 mg (0.05 mmol) of Ni(cod)2, 15.2 mg 
(0.075 mmol) of P(t-Bu)3, 74.1 mg (0.5 mmol) of benzylacetone, 68.1 mg (1.0 mmol) of 
trans-1,3-pentadiene, and 253.9 mg (1.0 mmol) of B2(pin)2 in THF (2.5 mL) for 48 h, 
followed by oxidation, to afford the title compound 4.84 as a colorless oil (80.5 mg, 69% 
yield). Rf = 0.59 (1:2 hexanes:EtOAc); 
1
H NMR (500 MHz, C6D6):  7.19-7.12 (4H, m), 
7.08-7.04 (1H, m), 5.67 (1H, dd, J = 15.5 Hz, 8.0 Hz), 5.58 (1H, dt, J = 15.0 Hz, 5.0 H), 
3.95 (1H, dd, J = 9.0 Hz, 5.0 Hz), 3.92 (1H, dd, J = 9.0 Hz, 5.0 Hz), 2.78 (1H, br), 2.70 
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(2H, t, J = 7.5 Hz), 2.35 (1H, br), 2.20 (1H, qn, J = 7.0 Hz), 1.71 (2H, m), 1.02 (3H, s), 
0.88 (3H, d, J = 7.0 Hz); 
13
C NMR (100 MHz, CDCl3): 142.8, 133.9, 131.2, 128.6, 
128.5, 125.9, 74.1, 63.6, 46.1, 42.3, 29.9, 23.6, 15.5; IR (neat): 3356 (br), 2970 (m), 2934 
(m), 1454 (m), 1378 (m), 1090 (w), 1068 (w), 999 (s), 974 (w), 754 (w), 735 (m), 698 (s) 
cm
-1
; HRMS (ESI+) calculated for C15H26NO2 [M+NH4]
+
: 252.1964, found:  252.1963. 
 
Proof of Stereochemistry. The relative configuration was determined by analysis of the 
spectral data, after conversion of the title compound 4.84 into SI-8 by ozonolysis, 
reduction, and acetonide synthesis as illustrated below.   
 
(2S*,4R*,5S*)-2,4,5-Trimethyl-4-phenethyl-1,3-dioxane (SI-8). Rf = 0.78 (5:1 
hexanes:EtOAc); 
1
H NMR (500 MHz, CDCl3):  7.30-7.27 (2H, t, J = 7.5 Hz), 7.24-7.22 
(2H, d, J = 7.0 Hz), 7.19-7.16 (1H, t, J = 7.5 Hz), 4.94 (1H, q, J = 4.5 Hz), 3.74 (1H, dd, 
J = 11.5 Hz, 5.0 Hz), 3.55 (1H, t, J = 11.5 Hz), 2.80 (1H, td, 13.5 Hz, 5.0 Hz), 2.72 (1H, 
td, J = 13.5 Hz, 5.5 Hz), 2.09-2.02 (1H, m), 1.88-1.75 (2H, m), 1.30 (3H, d, J = 5.0 Hz), 
1.20 (3H, s), 0.72 (3H, d, J = 6.0 Hz); 
13
C NMR (100 MHz, CDCl3): 143.2, 128.6, 
128.4, 125.7, 92.5, 76.5, 68.5, 43.4, 36.2, 28.8, 21.6, 16.4, 11.9; IR (neat): 2959 (m), 
2938 (m), 2857 (w), 1454 (w), 1402 (s), 1386 (w), 1374 (w), 1149 (s), 1119 (s), 1095 (m), 
1038 (w), 973 (w), 947 (w), 848 (w), 754 (w), 698 (m) cm
-1
; HRMS (ESI+) calculated for 
C15H23O2 [M+H]
+
: 235.1698, found:  235.1687. 
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 (E)-1-(5-Hydroxypent-3-en-2-yl)cyclopentanol (Table 4.3, 
entry 2). The reaction was performed according to the general 
procedure with 13.8 mg (0.05 mmol) of Ni(cod)2, 15.2 mg (0.075 mmol) of P(t-Bu)3, 
42.0 mg (0.5 mmol) of cyclopentanone, 68.1 mg (1.0 mmol) of trans-1,3-pentadiene, and 
253.9 mg (1.0 mmol) of B2(pin)2 in THF (2.5 mL) for 48 h, followed by oxidation, to 
afford the title compound 4.86 as a colorless oil (47.3 mg, 56% yield). Rf = 0.35 (1:2 
hexanes:EtOAc); 
1
H NMR (500 MHz, CDCl3):  5.75 (1H, dd, J = 15.5 Hz, 7.5 Hz), 5.68 
(1H, dt, J = 15.5 Hz, 5.5 Hz), 4.10 (2H, d, J = 5.0 Hz), 2.25 (1H, qn, J = 7.0 Hz), 1.90 
(1H, br) 1.83-1.74 (2H, m), 1.62-1.53 (6H, m), 1.05 (3H, d, J = 7.5 Hz); 
13
C NMR (100 
MHz, CDCl3): 134.7, 130.1, 84.4, 63.5, 45.7, 38.6, 37.7, 24.0, 23.9, 15.3; IR (neat): 
3341 (br), 2960 (w), 2871 (w), 1453 (w), 1372 (w), 1326 (w), 1194 (w), 1124 (w), 1088 
(m), 1051 (w), 971 (s), 809 (w), 700 (w), 638 (m), 500 (w) cm
-1
; HRMS (ESI+) 
calculated for C10H22NO2 [M+NH4]
+
: 188.1650, found:  188.1657. 
 
 (E)-1-(5-Hydroxypent-3-en-2-yl)cyclohexanol (Table 4.3, 
entry 3). The reaction was performed according to the general 
procedure with 13.8 mg (0.05 mmol) of Ni(cod)2, 15.2 mg (0.075 mmol) of P(t-Bu)3, 
49.0 mg (0.5 mmol) of cyclohexanone, 68.1 mg (1.0 mmol) of trans-1,3-pentadiene, and 
253.9 mg (1.0 mmol) of B2(pin)2 in THF (2.5 mL) for 48 h, followed by oxidation, to 
afford the title compound 4.88 as a colorless oil (47.8 mg, 52% yield). Rf = 0.49 (1:2 
hexanes:EtOAc); 
1
H NMR (500 MHz, C6D6):  5.59 (1H, dd, J = 15.5 Hz), 5.47 (1H, dt, 
J = 15.0 Hz, 5.5 Hz), 3.84 (2H, d, J = 6.0 Hz), 1.96 (1H, m), 1.66-1.53 (3H, m), 1.45-1.35 
(4H, m), 1.23-1.16 (2H, m), 1.15-1.01 (1H, m), 0.95 (3H, d, J = 7.0 Hz); 
13
C NMR (100 
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MHz, CDCl3): 134.2, 130.2, 72.5, 63.6, 35.2, 34.4, 25.7, 21.7, 14.3; IR (neat): 3354 (br), 
2931 (s), 2858 (m), 1448 (w), 1373 (w), 1256 (w), 1164 (w), 1139 (w), 1080 (w), 1002 
(m), 972 (s), 664 (w) cm
-1
; HRMS (ESI+) calculated for C11H24NO2 [M+NH4]
+
: 
202.1807, found:  202.1800. 
 
 (E)-4-(tert-Butyl)-1-(5-hydroxypent-3-en-2-
yl)cyclohexanol (Table 4.3, entry 4). The reaction was 
performed according to the general procedure with 13.8 mg (0.05 mmol) of Ni(cod)2, 
15.2 mg (0.075 mmol) of P(t-Bu)3, 77.0 mg (0.5 mmol) of 4-tert-butylcyclohexanone, 
68.1 mg (1.0 mmol) of trans-1,3-pentadiene, and 253.9 mg (1.0 mmol) of B2(pin)2 in 
THF (2.5 mL) for 48 h, followed by oxidation, to afford the title compound 4.90 as a 
colorless oil (64.0 mg, 53% yield). Rf = 0.56 (1:2 hexanes:EtOAc); 
1
H NMR (500 MHz, 
C6D6):  5.65 (1H, ddt, J = 15.0 Hz, 8.5 Hz, 1.2 Hz), 5.54 (1H, dt, J = 15.0 Hz, 5.5 Hz), 
3.92 (2H, dd, J = 5.5 Hz, 1.2 Hz), 1.97 (1H, m), 1.62-1.40 (7H, m), 1.17 (2H, tt, J = 13.0 
Hz, 4.0 Hz), 0.99 (3H, d, J = 6.8 Hz), 0.91 (9H, s); 
13
C NMR (100 MHz, CDCl3): 134.5, 
130.5, 72.3, 63.8, 48.0, 47.9, 35.2, 34.7, 32.5, 27.7, 22.6, 22.5, 14.7; IR (neat): 3346 (br), 
2939 (s), 2866 (m), 1666 (w), 1461 (w), 1442 (w), 1392 (w), 1364 (m), 1316 (w), 1235 
(w), 1190 (w), 1140 (w), 1118 (w), 1091 (w), 1050 (w), 1003 (m), 973 (s), 915 (w), 890 
(w), 828 (w) cm
-1
; HRMS (ESI+) calculated for C15H32NO2 [M+NH4]
+
: 258.2433, found:  
258.2437. 
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Stereochemistry. The relative configuration was assigned as syn (C1-C4) by analysis of 
the 
13
C NMR spectrum based on the NMR studies of related compounds.
22
  
 
 (E)-3-Methyl-5-phenylhex-2-ene-1,5-diol (Scheme 4.9). The 
reaction was performed according to the general procedure with 
13.8 mg (0.05 mmol) of Ni(cod)2, 15.2 mg (0.075 mmol) of P(t-Bu)3, 60.1 mg (0.5 mmol) 
of acetophenone, 68.1 mg (1.0 mmol) of isoprene, and 253.9 mg (1.0 mmol) of B2(pin)2 
in THF (2.5 mL) for 48 h, followed by oxidation, to afford the title compound 4.92 as a 
colorless oil (40.1 mg, 39% yield). Rf = 0.28 (1:2 hexanes:EtOAc); 
1
H NMR (500 MHz, 
CDCl3):  7.45 (2H, d, J = 7.0 Hz), 7.34 (2H, d, J = 7.0 Hz), 7.24 (1H, t, J = 7.0 Hz), 5.34 
(1H, t, J = 7.5 Hz), 3.97 (2H, s), 2.60 (2H, d, J = 8.0 Hz), 1.95 (1H, br s), 1.64 (3H, s), 
1.57 (3H, s); 
13
C NMR (100 MHz, CDCl3): 147.9, 139.1, 128.3, 126.8, 124.9, 120.4, 
74.7, 68.8, 42.1, 30.0, 14.1; IR (neat): 3357 (br), 2965 (m), 2846 (m), 2792 (w), 1494 (w), 
1446 (s), 1373 (m), 1286 (w), 1218 (w), 1068 (m), 1028 (m), 1013 (m), 950 (w), 880 (w), 
764 (s), 700 (s), 623 (w), 555 (w) cm
-1
; HRMS (ESI+) calculated for C13H22NO2 
[M+NH4]
+
: 224.1650, found:  224.1645. 
 
Stereochemistry: The alkene configuration was assigned as E by NOESY analysis. 
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